,Date,Title,Url
0,2017-01-01,경영능력시험대오른윤재승대웅제약회장반전드라마는무리,http://www.mdtoday.co.kr/mdtoday/index.html?no=271401
1,2017-01-02,대웅16건종근당14건동아ST8건順광동0건,http://www.dailymedi.com/detail.php?number=814342&thread=22r05
2,2017-01-02,대웅제약올해매출1조원달성목표,http://www.dailypharm.com/News/220597
3,2017-01-02,대웅글로벌RD강화로경쟁력강화,http://www.kpanews.co.kr/article/show.asp?idx=180035&table=article&category=D
4,2017-01-02,대웅제약글로벌RD강화를통한경쟁력강화다짐,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=202446
5,2017-01-02,대웅제약2017년매출1조원달성목표,http://medipana.com/news/news_viewer.asp?NewsNum=193504&MainKind=A&NewsKind=5&vCount=12&vKind=1
6,2017-01-02,대웅대웅제약100개국수출네트워크구축글로벌화가속,http://www.hankyung.com/news/app/newsview.php?aid=201701021817i
7,2017-01-02,이종욱대웅제약부회장올해매출1조원달성목표”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1435985
8,2017-01-02,신년사이종욱대웅제약부회장글로벌RD강화통한경쟁력강화,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017010214413775838
9,2017-01-02,대웅제약글로벌경쟁력강화로올해매출1조원달성,http://view.asiae.co.kr/news/view.htm?idxno=2017010215150509040
10,2017-01-02,대웅제약RD강화를통한글로벌헬스케어그룹도약”,http://news.heraldcorp.com/view.php?ud=20170102000738
11,2017-01-02,대웅제약2017년제약1조클럽목표,http://www.ebn.co.kr/news/view/869958
12,2017-01-02,직원성장과글로벌화강조한녹십자와대웅제약시무식,http://www.kukinews.com/news/article.html?no=421178
13,2017-01-02,2017신년사이종욱대웅제약부회장글로벌경쟁력강화해매출1조원달성할것”,http://biz.chosun.com/site/data/html_dir/2017/01/02/2017010201872.html
14,2017-01-02,이종욱대웅제약부회장올해매출1조클럽달성,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201701020281
15,2017-01-02,대웅제약삶의질높이는글로벌헬스케어그룹도약,http://www.enewstoday.co.kr/news/articleView.html?idxno=670967
16,2017-01-02,신년사이종욱대웅제약부회장올해매출1조원달성,http://www.newspim.com/news/view/20170102000390
17,2017-01-02,신년사이종욱대웅제약부회장RD매진글로벌헬스케어그룹으로거듭날것,http://biz.newdaily.co.kr/news/article.html?no=10122604
18,2017-01-02,2017신년사이종욱대웅제약대표매출1조원달성하겠다”,http://www.ajunews.com/view/20170102191632560
19,2017-01-02,대웅대웅제약시무식서글로벌RD강화통한경쟁력강화다짐,http://www.anewsa.com/detail.php?number=1112076&thread=10r03
20,2017-01-02,대웅동아유한보령일동등주요제약사2일일제히시무식,http://www.viva100.com/main/view.php?key=20170102020018774
21,2017-01-03,대웅제약2017년매출1조원달성목표글로벌헬스케어그룹도약”,http://www.mdtoday.co.kr/mdtoday/index.html?no=277313
22,2017-01-03,인사대웅제약,http://news1.kr/articles/?2875538
23,2017-01-03,대웅제약RD역량강화‥한용해연구본부장영입,http://medipana.com/news/news_viewer.asp?NewsNum=193571&MainKind=A&NewsKind=5&vCount=12&vKind=1
24,2017-01-03,대웅제약연구본부장으로한용해박사영입조직개편도,http://www.g-enews.com/ko-kr/news/article/news_all/201701031222252921933_1/article.html
25,2017-01-03,대웅제약대대적인조직개편3개부서신설하고전문가영입,http://www.docdocdoc.co.kr/?p=238327
26,2017-01-03,인사대웅제약,http://www.newsis.com/ar_detail/view.html?ar_id=NISX20170103_0014617159&cID=10902&pID=16000
27,2017-01-03,대웅제약한용해박사연구본부장영입,http://www.kpanews.co.kr/article/show.asp?idx=180082&table=article&category=D
28,2017-01-03,대웅제약RD역량강화BMS출신한용해박사영입,http://www.dailypharm.com/News/220658
29,2017-01-03,대웅제약한용해박사연구본부장으로영입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1436461
30,2017-01-03,대웅제약연구본부장에다국적제약사출신한용해씨영입,http://www.newsis.com/ar_detail/view.html?ar_id=NISX20170103_0014617171&cID=10402&pID=13000
31,2017-01-03,대웅제약조직개편및인사단행글로벌경쟁력강화,http://view.asiae.co.kr/news/view.htm?idxno=2017010313364985362
32,2017-01-03,인사대웅제약,http://www.newspim.com/news/view/20170103000183
33,2017-01-03,대웅제약글로벌경쟁력강화조직개편,http://www.newspim.com/news/view/20170103000187
34,2017-01-03,대웅제약,http://www.medical-tribune.co.kr/news/articleView.html?idxno=70725
35,2017-01-03,대웅제약글로벌신약개발전문가영입해외공략강화,http://www.hankyung.com/news/app/newsview.php?aid=201701034611i
36,2017-01-03,대웅제약조직개편및인사발령한용해박사영입,http://www.metroseoul.co.kr/news/newsview?newscd=2017010300098
37,2017-01-03,대웅제약글로벌경쟁력강화하는조직개편및인사발령,http://www.viva100.com/main/view.php?key=20170103010000982
38,2017-01-03,대웅제약조직개편글로벌연구개발전문가영입,http://www.mediapen.com/news/view/221265
39,2017-01-03,인사대웅제약,http://news.heraldcorp.com/view.php?ud=20170103000668
40,2017-01-03,대웅제약인사,http://www.rapportian.com/news/articleView.html?idxno=101310
41,2017-01-03,대웅제약글로벌생산관리센터신설등조직개편,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170103117100017&did=1195m
42,2017-01-03,대웅제약글로벌RD역량강화위해조직개편,http://www.kormedi.com/news/news/drug_dist/1221371_2906.html
43,2017-01-03,대웅제약글로벌경쟁력강화채비,http://www.enewstoday.co.kr/news/articleView.html?idxno=671580
44,2017-01-03,대웅제약글로벌경쟁력강화위해조직개편한용해박사영입,http://www.fnnews.com/news/201701031525179944
45,2017-01-03,대웅제약연구본부장에한용해박사영입,http://www.newsway.co.kr/view.php?tp=1&ud=2017010315431793799
46,2017-01-03,대웅제약한용해연구본부장선임,http://www.newstomato.com/ReadNews.aspx?no=721299
47,2017-01-03,대웅제약글로벌경쟁력강화위해조직개편한용해박사영입,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017010315500932932
48,2017-01-03,대웅제약글로벌경쟁력강화위한조직개편인사발령,http://news.mk.co.kr/newsRead.php?no=6027&year=2017
49,2017-01-03,대웅제약글로벌생산관리센터신설한용해박사연구본부장으로영입,http://biz.chosun.com/site/data/html_dir/2017/01/03/2017010301848.html
50,2017-01-03,대웅제약글로벌경쟁력강화위한조직개편단행,http://www.ekn.kr/news/article.html?no=259560
51,2017-01-03,인사대웅제약,http://biz.newdaily.co.kr/news/article.html?no=10122719
52,2017-01-03,대웅제약조직개편및인사발령글로벌경쟁력강화,http://www.readersnews.com/news/articleView.html?idxno=68801
53,2017-01-03,대웅제약글로벌경쟁력강화조직개편및인사발령,http://www.dt.co.kr/contents.html?article_no=2017010302109976029007
54,2017-01-04,서울제약대웅JW출신박종전씨영입,http://www.dailypharm.com/News/220636
55,2017-01-04,대웅제약한용해박사영입RD박차,http://www.monews.co.kr/news/articleView.html?idxno=96261
56,2017-01-04,대웅제약경쟁력강화위해조직개편단행,http://www.nextdaily.co.kr/news/article.html?id=20170104800005
57,2017-01-04,대웅제약글로벌연구개발전문가한용해박사연구본부장영입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=202521
58,2017-01-04,대웅제약연구본부장에한용해박사영입,http://www.ajunews.com/view/20170103142301275
59,2017-01-04,대웅제약조직개편인사발령글로벌경쟁력강화,http://www.bosa.co.kr/news/articleView.html?idxno=2052004
60,2017-01-04,대웅제약글로벌경쟁력강화위한조직개편및인사발령,http://www.newscj.com/news/articleView.html?idxno=397967
61,2017-01-05,fnRASSI대웅제약069620전일대비585상승,http://www.fnnews.com/news/201701050939213459
62,2017-01-05,대웅제약인도네시아직접진출후최초바이오시밀러에포디온출시,http://www.asiatoday.co.kr/view.php?key=20170105010003201
63,2017-01-05,대웅제약인도네시아성과본격화현지생산바이오시밀러출시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017010510335333093
64,2017-01-05,대웅제약에포디온인도네시아품목허가획득,http://medipana.com/news/news_viewer.asp?NewsNum=193681&MainKind=A&NewsKind=5&vCount=12&vKind=1
65,2017-01-05,대웅제약인도네시아에서오픈콜라보레이션통한바이오시밀러에포디온출시,http://www.g-enews.com/ko-kr/news/article/news_all/201701051059249425025_1/article.html
66,2017-01-05,대웅제약인도네시아서오픈콜라보레이션통한제품개발생산본격화,http://www.m-i.kr/news/articleView.html?idxno=281363
67,2017-01-05,대웅제약인도네시아서빈혈치료제에포디온출시,http://news1.kr/articles/?2877517
68,2017-01-05,대웅제약빈혈약에포디온인도네시아허가획득1월발매,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=202574
69,2017-01-05,대웅제약에포디온출시인도네시아진출본격화,http://www.etoday.co.kr/news/section/newsview.php?idxno=1437636
70,2017-01-05,대웅제약인도네시아서바이오시밀러에포디온출시,http://www.metroseoul.co.kr/news/newsview?newscd=2017010500094
71,2017-01-05,대웅제약바이오시밀러에포디온인도네시아현지생산발매,http://biz.chosun.com/site/data/html_dir/2017/01/05/2017010501289.html
72,2017-01-05,대웅제약인도네시아에서오픈콜라보레이션통한제품개발생산본격화,http://www.kukinews.com/news/article.html?no=422012
73,2017-01-05,대웅제약빈혈치료제인도네시아서허가시판,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170105094400017&did=1195m
74,2017-01-05,대웅제약에포디온인니품목허가획득,http://www.bosa.co.kr/news/articleView.html?idxno=2052139
75,2017-01-05,대웅제약인도네시아서빈혈치료제판매돌입,http://view.asiae.co.kr/news/view.htm?idxno=2017010513085578612
76,2017-01-05,대웅제약바이오시밀러에포디온인도네시아서발매,http://www.ebn.co.kr/news/view/870564
77,2017-01-05,대웅제약에포디온인도네시아허가획득,http://www.monews.co.kr/news/articleView.html?idxno=96372
78,2017-01-05,특징주대웅제약빈혈치료제인도네시아품목허가↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03135686615794768
79,2017-01-05,대웅인도네시아서바이오시밀러에포디온출시,http://www.dailypharm.com/News/220753
80,2017-01-05,대웅제약빈혈치료제에포디온인도네시아발매,http://www.mdtoday.co.kr/mdtoday/index.html?no=277455
81,2017-01-05,대웅제약바이오시밀러에포디온印尼서허가이달출시,http://www.newsis.com/view/?id=NISX20170105_0014622019&cID=10434&pID=13000
82,2017-01-05,대웅제약인도네시아서바이오시밀러에포디온출시,http://news.kmib.co.kr/article/view.asp?arcid=0011178967&code=61171911&cp=nv
83,2017-01-05,fnRASSI대웅제약069620599상승,http://www.fnnews.com/news/201701051424075027
84,2017-01-05,대웅인피온적혈구생성인자제제에포디온인도네시아에서1월부터발매,http://www.fnnews.com/news/201701051419597897
85,2017-01-05,대웅제약인도네시아서바이오시밀러출시,http://www.newspim.com/news/view/20170105000274
86,2017-01-05,대웅에포디온인도네시아품목허가획득,http://www.kpanews.co.kr/article/show.asp?idx=180150&table=article&category=D
87,2017-01-05,대웅제약인도네시아서빈혈치료제허가발매,http://www.hankyung.com/news/app/newsview.php?aid=201701050917i
88,2017-01-05,대웅제약암환자빈혈약에포디온인도네시아생산출시,http://www.ajunews.com/view/20170105161233858
89,2017-01-05,대웅제약인도네시아서바이오시밀러에포디온출시,http://www.newsway.co.kr/view.php?tp=1&ud=2017010516231692096
90,2017-01-05,대웅제약바이오시밀러에포디온인도네시아출시,http://www.dt.co.kr/contents.html?article_no=2017010502109976029004
91,2017-01-05,대웅제약인도네시아바이오의약품연구이끈다,http://sports.khan.co.kr/news/sk_index.html?art_id=201701051702063&sec_id=560101&pt=nv
92,2017-01-05,대웅제약인도네시아에국내최초바이오시밀러출시,http://www.kormedi.com/news/news/drug_dist/1221423_2906.html
93,2017-01-05,대웅제약적혈구생성빈혈치료제에포디온인도네시아서허가,http://www.viva100.com/main/view.php?key=20170105020018810
94,2017-01-05,대웅제약빈혈치료제인도네시아현지서생산및발매,http://www.ekn.kr/news/article.html?no=260071
95,2017-01-05,대웅제약인도네시아서제품생산본격화빈혈치료제발매,http://www.enewstoday.co.kr/news/articleView.html?idxno=673392
96,2017-01-05,대웅제약인도네시아서빈혈치료제에포디온판매,http://www.fnnews.com/news/201701051933391582
97,2017-01-06,서현진이앓던유루증에도전하는대웅나보타,http://www.dailypharm.com/News/220768
98,2017-01-06,대웅제약빈혈치료제에포디온인도네시아서판매,http://www.docdocdoc.co.kr/?p=238732
99,2017-01-06,부천시심곡2동KTI대웅태권도장나눔과배려실천,http://www.ajunews.com/view/20170106103806400
100,2017-01-06,매출1조원도전장낸대웅제약선봉은나보타제미글로,http://www.newspim.com/news/view/20170106000190
101,2017-01-06,정난영대웅전대표유바이오시스회장취임,http://www.fnnews.com/news/201701061544540551
102,2017-01-06,대웅제약인도네시아서오픈콜라보레이션통한제품개발생산본격화,http://ilyo.co.kr/?ac=article_view&entry_id=224660
103,2017-01-06,유바이오시스회장에정난영前대웅대표취임,http://www.dailypharm.com/News/220809
104,2017-01-06,정난영㈜대웅전대표유바이오시스회장취임,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017010615323929609
105,2017-01-06,정난영前대웅사장유바이오시스회장취임,http://www.edaily.co.kr/news/newspath.asp?newsid=03181606615795096
106,2017-01-06,정난영前대웅사장유바이오시스회장취임,http://stock.hankyung.com/news/app/newsview.php?aid=2017010640106
107,2017-01-06,정난영전대웅사장유바이오시스회장취임,http://www.shinailbo.co.kr/news/articleView.html?idxno=550006
108,2017-01-06,정난영前대웅사장유바이오시스회장취임,http://www.bosa.co.kr/news/articleView.html?idxno=2052255
109,2017-01-06,정난영대웅前대표유바이오시스회장취임,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=202611
110,2017-01-06,정난영前대웅대표유바이오시스회장취임,http://www.kukinews.com/news/article.html?no=422423
111,2017-01-06,정난영대웅前대표유바이오시스회장취임,http://www.newspim.com/news/view/20170106000394
112,2017-01-06,정난영㈜대웅前대표유바이오시스회장취임,http://www.anewsa.com/detail.php?number=1113925&thread=10r03
113,2017-01-07,정난영前대웅대표유바이오시스회장취임,http://www.newscj.com/news/articleView.html?idxno=398531
114,2017-01-07,정난영前대웅대표유바이오시스회장취임,http://www.viva100.com/main/view.php?key=20170106020018821
115,2017-01-07,메디톡스이적대웅제약임원스톡옵션받아,http://www.kpanews.co.kr/article/show.asp?idx=180191&table=article&category=D
116,2017-01-07,정난영㈜대웅前대표유바이오시스회장취임,http://www.readersnews.com/news/articleView.html?idxno=68918
117,2017-01-09,대웅제약알비스D에버그리닝특허에발목,http://www.medicaltimes.com/News/1109351
118,2017-01-09,정난영前대웅사장유바이오시스회장취임,http://www.dailymedi.com/detail.php?number=814620&thread=22r05
119,2017-01-09,정난영㈜대웅前대표유바이오시스회장취임,http://www.kpanews.co.kr/article/show.asp?idx=180216&table=article&category=D
120,2017-01-09,정난영대웅전대표유바이오시스회장취임,http://www.monews.co.kr/news/articleView.html?idxno=96465
121,2017-01-10,해외서힘못쓰는대웅제약글로벌경쟁력강화묘책은,http://www.ceoscoredaily.com/news/article.html?no=26145
122,2017-01-10,인사대웅건설,http://www.cnews.co.kr/uhtml/read.jsp?idxno=201701101528314140438
123,2017-01-10,제약톱10원외처방실적상승곡선대웅나홀로하락,http://www.seoulfn.com/news/articleView.html?idxno=270493
124,2017-01-11,더벨대웅제약퇴사임원들서울제약간이유,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201701100100018030001075
125,2017-01-11,인사대웅건설,http://www.constimes.co.kr/news/articleView.html?idxno=108078
126,2017-01-11,BioS대웅종근당새먹거리발굴분주작년임상최다,http://www.etoday.co.kr/news/section/newsview.php?idxno=1440072
127,2017-01-11,인도네시아거점으로동아시아진출하는대웅제약,http://www.dailypharm.com/News/220946
128,2017-01-12,판권회수에울었던대웅판권교체OTC로반등,http://www.medicaltimes.com/News/1109421
129,2017-01-12,대웅제약글리아티린판권잃어도잘나가네,http://www.dt.co.kr/contents.html?article_no=2017011302101076029001
130,2017-01-12,판권잃은대웅제약미래먹거리마련분주,http://www.sisaweek.com/news/articleView.html?idxno=85449
131,2017-01-13,조계사대웅전서기도하는불자들,http://www.newscj.com/news/articleView.html?idxno=399904
132,2017-01-13,대웅제약우루사효능재평가안갯속,http://www.sisaweek.com/news/articleView.html?idxno=85499
133,2017-01-14,한미약품이어대웅보령일동제약도가세,http://www.dailymedi.com/detail.php?number=814815&thread=22r05
134,2017-01-16,유통업계흑역사⑱대웅제약도입품목위주매출한계드러내,http://www.ajunews.com/view/20170115113110498
135,2017-01-17,큰손외면받은제약주옥석가려야종근당대웅제약추천,http://biz.chosun.com/site/data/html_dir/2017/01/17/2017011700361.html
136,2017-01-18,유바이오시스정난영전㈜대웅사장영입,http://www.hankyung.com/news/app/newsview.php?aid=201701182661h
137,2017-01-18,한올대웅바이오글루코파지XR특허회피성공,http://www.dailypharm.com/News/221217
138,2017-01-18,투자플러스2017년을기다린헬스케어株대웅제약제넥신등,http://stock.hankyung.com/news/app/newsview.php?aid=2017011834236
139,2017-01-18,대웅바이오작년영업익234억전년比42↑,http://www.newspim.com/news/view/20170118000354
140,2017-01-19,종근당원외처방1위휴텍스대웅바이오천억,http://www.dailypharm.com/News/221233
141,2017-01-19,한올바이오파마대웅바이오머크클루코파지XR제제특허회피,http://www.mdtoday.co.kr/mdtoday/index.html?no=277968
142,2017-01-19,더벨대웅제약슈글렛2년판매실적낙제점,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201701180100035110002088
143,2017-01-19,BioS종근당대웅제약처절했던글리아티린전쟁승자는,http://www.etoday.co.kr/news/section/newsview.php?idxno=1444092
144,2017-01-19,대웅바이오휴텍스원외처방액1천억돌파약진,http://medipana.com/news/news_viewer.asp?NewsNum=194270&MainKind=A&NewsKind=5&vCount=12&vKind=1
145,2017-01-19,포토조계사대웅전서축사하는문재인,http://www.ilyosisa.co.kr/news/articleView.html?idxno=120333
146,2017-01-20,대웅제약이종욱이봉용한용해트로이카구축RD속도낸다,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=202946
147,2017-01-20,조계사대웅전서절하는반기문,http://www.newsis.com/view/?id=NISI20170120_0012606394
148,2017-01-22,셀트리온대웅제약간장약격돌,http://www.newstomato.com/ReadNews.aspx?no=725941
149,2017-01-22,제약업계23세체제구축순항윤재승회장집권3년차대웅제약인재유출시름,http://www.asiatoday.co.kr/view.php?key=20170122010014162
150,2017-01-23,저력의대웅제약올해1조매출시대연다,http://www.bosa.co.kr/news/articleView.html?idxno=2053325
151,2017-01-23,대웅제약이종욱부회장2020년3조글로벌50위권제약도약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=202999
152,2017-01-23,CEOLetter이종욱대웅제약부회장메로페넴나보타美진출예정,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201701230143
153,2017-01-24,헬스케어대웅제약우루사UDCA주성분간기능개선도와,http://www.hankyung.com/news/app/newsview.php?aid=2017012470321
154,2017-01-24,대웅제약RD로미래먹거리확보총력,http://www.dt.co.kr/contents.html?article_no=2017012502101076029001
155,2017-01-25,대웅제약2020년글로벌랭킹50위간다,http://www.doctorsnews.co.kr/news/articleView.html?idxno=115126
156,2017-01-25,포토대웅제약리틀베어서펼치는명절체험활동,http://www.enewstoday.co.kr/news/articleView.html?idxno=685588
157,2017-01-25,대웅제약사내어린이집원아들설명절체험,http://medipana.com/news/news_viewer.asp?NewsNum=194535&MainKind=A&NewsKind=5&vCount=12&vKind=1
158,2017-01-25,대웅제약사내어린이집설명절체험행사진행,http://news.mk.co.kr/newsRead.php?no=59944&year=2017
159,2017-01-25,대웅제약사내어린이집서설명절체험행사열어,http://www.kukinews.com/news/article.html?no=427152
160,2017-01-25,대웅제약사내어린이집리틀베어서설맞이행사개최,http://www.readersnews.com/news/articleView.html?idxno=69488
161,2017-01-25,제약업계뉴리더⑧경영권분쟁으로부침겪은대웅제약윤재승오너2세리더십에쏠린눈,http://biz.chosun.com/site/data/html_dir/2017/01/25/2017012502090.html
162,2017-01-25,기업특집대웅제약바이오벤처대학과손잡고글로벌연구네트워크구축,http://www.viva100.com/main/view.php?key=20170125010008532
163,2017-01-25,대웅제약사내어린이집리틀베어서설날행사,http://www.ebn.co.kr/news/view/873675
164,2017-01-25,대웅제약사내어린이집리틀베어에서설맞이행사,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=203111
165,2017-01-25,대웅제약어린이집리틀베어설맞이행사,http://www.dailypharm.com/News/221530
166,2017-01-25,대웅제약사내어린이집전통민속놀이체험행사,http://www.rapportian.com/news/articleView.html?idxno=101669
167,2017-01-26,뜨는종근당지는대웅제약원외처방시장재편,http://www.mdtoday.co.kr/mdtoday/index.html?no=278299
168,2017-01-26,대웅제약사내어린이집리틀베어설맞이행사,http://www.bosa.co.kr/news/articleView.html?idxno=2053675
169,2017-01-28,조계사대웅전서봉행하는설합동다례재,http://www.newscj.com/news/articleView.html?idxno=402805
170,2017-01-31,대웅제약임상시험만16건에연구본부장영입2000억원어치간판약판권뺏기고도신약개발질주,http://biz.chosun.com/site/data/html_dir/2017/01/31/2017013101732.html
171,2017-02-01,대웅제약VS메디톡스기술분쟁점입가경으로치닫나,http://www.ebn.co.kr/news/view/874235
172,2017-02-01,대웅제약CP위반자13명감봉등징계조치,http://medipana.com/news/news_viewer.asp?NewsNum=194677&MainKind=A&NewsKind=5&vCount=12&vKind=1
173,2017-02-01,메디톡스는대중에호소하고대웅제약은법으로따지고,http://www.bosa.co.kr/news/articleView.html?idxno=2053892
174,2017-02-01,대웅제약나보타로큰폭의성장가능할것신영,http://www.mt.co.kr/view/mtview.php?type=1&no=2017020107480021590&outlink=1
175,2017-02-01,로봇뉴스대웅제약4분기처방의약품매수신규신영증권,http://www.etnews.com/20170201000013
176,2017-02-01,특징주대웅제약나보타기대감에강세,http://stock.hankyung.com/news/app/newsview.php?aid=2017020133126
177,2017-02-01,대웅제약나보타성장기대감에주가방긋,http://www.newsprime.co.kr/news/article.html?no=362972
178,2017-02-01,fnRASSI대웅제약069620전일대비513상승,http://www.fnnews.com/news/201702011000096409
179,2017-02-01,대웅제약2016년CP위반자13명징계,http://www.dailypharm.com/News/221653
180,2017-02-01,특징주대웅제약턴어라운드성장전망에강세,http://view.asiae.co.kr/news/view.htm?idxno=2017020110280289511
181,2017-02-01,대웅제약CP위반자13명감봉등징계조치,http://www.rapportian.com/news/articleView.html?idxno=101726
182,2017-02-01,대웅제약오픈컬래버레이션시행2020년글로벌50위제약사도약”,http://www.munhwa.com/news/view.html?no=2017020101032121086001
183,2017-02-01,CEOLetter이종욱대웅제약부회장메로페넴나보다美진출예정,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201701230144
184,2017-02-01,대웅제약4분기처방의약품매출회복가시화,http://daily.hankooki.com/lpage/economy/201702/dh20170201111337138110.htm
185,2017-02-01,이용일전대웅제약홍보이사휴온스글로벌합류,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=203196
186,2017-02-01,fnRASSI대웅제약069620733상승,http://www.fnnews.com/news/201702011524184849
187,2017-02-01,대웅제약자율정화메스위반자13명징계조치,http://www.sisaweek.com/news/articleView.html?idxno=86389
188,2017-02-01,대웅제약미국보톡스시장에가장빨리진출할듯,http://www.businesspost.co.kr/news/articleView.html?idxno=41802
189,2017-02-02,윤리경영강화하는제약업계대웅일동등위반자징계,http://www.shinailbo.co.kr/news/articleView.html?idxno=555464
190,2017-02-02,대웅제약임팩타민매출200억원돌파,http://www.dailypharm.com/News/221700
191,2017-02-02,보톡스전쟁대웅제약메디톡스소송전피하나,http://view.asiae.co.kr/news/view.htm?idxno=2017020210541202183
192,2017-02-02,개장전특징주대웅제약069620,http://www.newstomato.com/ReadNews.aspx?no=728605
193,2017-02-02,대웅제약임팩타민매출200억돌파‥올300억간다,http://medipana.com/news/news_viewer.asp?NewsNum=194765&MainKind=A&NewsKind=5&vCount=12&vKind=1
194,2017-02-02,대웅제약고활성비타민B임팩타민매출200억원돌파올해300억원달성목표,http://www.g-enews.com/ko-kr/news/article/news_all/201702021100561305924_1/article.html
195,2017-02-02,대웅제약고활성비타민B임팩타민200억돌파,http://www.edaily.co.kr/news/newspath.asp?newsid=02574806615826584
196,2017-02-02,대웅제약고활성비타민B임팩타민매출200억돌파,http://www.rapportian.com/news/articleView.html?idxno=101750
197,2017-02-02,대웅제약비타민임팩타민매출200억원돌파,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170202081200017&did=1195m
198,2017-02-02,대웅제약고활성비타민B임팩타민매출200억원돌파,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=203234
199,2017-02-02,대웅임팩타민호조TV광고없이200억돌파,http://www.dailymedi.com/detail.php?number=815369&thread=22r05
200,2017-02-02,대웅제약임팩타민TV광고없이도,http://www.bosa.co.kr/news/articleView.html?idxno=2054038
201,2017-02-02,대웅제약올해임팩타민매출300억원넘본다,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1038468
202,2017-02-02,대웅제약비타민제임팩타민매출200억돌파,http://www.hankyung.com/news/app/newsview.php?aid=201702027307i
203,2017-02-02,대웅제약임팩타민연매출200억원돌파,http://www.newspim.com/news/view/20170202000198
204,2017-02-02,대웅제약고활성비타민B임팩타민매출200억돌파,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017020211150481838
205,2017-02-02,대웅제약임팩타민TV광고없이200억,http://www.monews.co.kr/news/articleView.html?idxno=97356
206,2017-02-02,대웅제약비타민B임팩타민매출200억원돌파,http://www.dt.co.kr/contents.html?article_no=2017020202109976029004
207,2017-02-02,대웅제약임팩타민매출200억원돌파,http://www.asiatoday.co.kr/view.php?key=20170202010001648
208,2017-02-02,대웅제약비타민B임팩타민작년매출200억원돌파,http://www.ekn.kr/news/article.html?no=265260
209,2017-02-02,대웅제약고함량비타민제임팩타민매출200억원돌파,http://biz.chosun.com/site/data/html_dir/2017/02/02/2017020202756.html
210,2017-02-02,대웅제약SK바이오팜트럼프정책덕에신약출시수월해져,http://www.businesspost.co.kr/news/articleView.html?idxno=41912
211,2017-02-03,대웅제약CP위반자13명감봉․견책등징계,http://www.sisafocus.co.kr/news/articleView.html?idxno=156855
212,2017-02-03,일동대웅종합비타민지난해최대실적기록효자노릇톡톡,http://biz.newdaily.co.kr/news/article.html?no=10124938
213,2017-02-03,fnRASSI대웅363오르며거래량증가,http://www.fnnews.com/news/201702031118339829
214,2017-02-03,SK바이오팜대웅제약트럼프정책수혜신약출시수월,http://www.m-i.kr/news/articleView.html?idxno=287373
215,2017-02-03,대웅제약본격CP운영13명징계조치,http://www.m-i.kr/news/articleView.html?idxno=287383
216,2017-02-03,대웅제약임팩타민매출200억돌파,http://www.kormedi.com/news/news/drug_dist/1221819_2906.html
217,2017-02-03,대웅제약고활성비타민B임팩타민200억원돌파,http://www.newscj.com/news/articleView.html?idxno=403990
218,2017-02-03,식약처보톡스문제없다판정에대웅안도vs메디톡스계속이슈화,http://www.viva100.com/main/view.php?key=20170203020019028
219,2017-02-04,신약개발열기대한민국LG유한대웅주도,http://www.dailymedi.com/detail.php?number=815430&thread=22r05
220,2017-02-04,경동제약등중소제약사7곳대웅알비스D특허소송서勝,http://www.mdtoday.co.kr/mdtoday/index.html?no=278650
221,2017-02-06,LG화학〉일동〉대웅〉JW중외〉유한양행順,http://www.dailymedi.com/detail.php?number=815466&thread=22r05
222,2017-02-06,양병국전질병관리본부장대웅바이오대표이사로,http://www.edaily.co.kr/news/newspath.asp?newsid=02502646615827896
223,2017-02-06,대웅바이오대표이사에양병국前질병관리본부장,http://medipana.com/news/news_viewer.asp?NewsNum=194881&MainKind=A&NewsKind=5&vCount=12&vKind=1
224,2017-02-06,대웅자회사대웅바이오대표에양병국前질병관리본부장선임,http://www.g-enews.com/ko-kr/news/article/news_all/201702061106241101741_1/article.html
225,2017-02-06,대웅바이오대표이사에양병국전질병관리본부장,http://www.newsis.com/view/?id=NISX20170206_0014686261&cID=10434&pID=13000
226,2017-02-06,대웅바이오대표이사에양병국前질병관리본부장선임,http://www.breaknews.com/sub_read.html?uid=490364§ion=sc3
227,2017-02-06,양병국前질병관리본부장대웅바이오대표선임,http://www.dailymedi.com/detail.php?number=815480&thread=22r05
228,2017-02-06,대웅바이오대표이사에양병국前질병관리본부장선임,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=203295
229,2017-02-06,양병국전질병관리본부장대웅바이오대표선임,http://www.kpanews.co.kr/article/show.asp?idx=180919&table=article&category=D
230,2017-02-06,대웅바이오새대표에양병국전질병관리본부장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170206078100017&did=1195m
231,2017-02-06,대웅바이오대표이사에양병국전질병관리본부장선임,http://www.mediapen.com/news/view/232389
232,2017-02-06,대웅바이오대표에양병국전질병관리본부장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20170206144600017&did=1196m
233,2017-02-06,양병국전질병관리본부장대웅바이오대표이사로선임,http://www.rapportian.com/news/articleView.html?idxno=101800
234,2017-02-06,양병국前질병관리본부장대웅바이오대표이사선임,http://news1.kr/articles/?2904118
235,2017-02-06,양병국전질병관리본부장대웅바이오대표에,http://news.kmib.co.kr/article/view.asp?arcid=0011246586&code=61171911&cp=nv
236,2017-02-06,대웅바이오대표에양병국전질병관리본부장,http://www.dailypharm.com/News/221804
237,2017-02-06,대웅자회사대웅바이오대표이사에양병국씨선임,http://www.bosa.co.kr/news/articleView.html?idxno=2054248
238,2017-02-06,양병국전질병관리본부장대웅바이오에둥지틀어,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1038590
239,2017-02-06,양병국전질병관리본부장대웅바이오대표이사선임,http://www.asiatoday.co.kr/view.php?key=20170206010003269
240,2017-02-06,로봇뉴스대웅제약_외국인과개인은순매도기관은순매수한달누적,http://www.etnews.com/20170206000190
241,2017-02-06,대웅바이오대표에양병국前질병관리본부장,http://www.newspim.com/news/view/20170206000144
242,2017-02-06,대웅바이오대표에양병국전질본본부장,http://www.sedaily.com/NewsView/1OBZNMXING
243,2017-02-06,양병국前질병관리본부장대웅바이오대표이사선임,http://www.etoday.co.kr/news/section/newsview.php?idxno=1451173
244,2017-02-06,대웅바이오대표이사에양병국씨선임,http://www.monews.co.kr/news/articleView.html?idxno=97468
245,2017-02-06,대웅바이오대표이사에양병국前질병관리본부장,http://www.medical-tribune.co.kr/news/articleView.html?idxno=71159
246,2017-02-06,대웅대웅바이오대표이사에양병국前질병관리본부장선임,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017020614225136977
247,2017-02-06,대웅바이오신임대표에양병국전질병관리본부장선임,http://www.newstomato.com/ReadNews.aspx?no=729447
248,2017-02-06,대웅바이오새대표에양병국전질병관리본부장선임,http://www.ekn.kr/news/article.html?no=265953
249,2017-02-06,대웅바이오대표이사에양병국전질병관리본부장선임,http://ilyo.co.kr/?ac=article_view&entry_id=230099
250,2017-02-06,대웅바이오신임대표에양병국전질병관리본부장선임,http://www.polinews.co.kr/news/article.html?no=303035
251,2017-02-06,대웅바이오새대표에양병국전질병관리본부장,http://www.viva100.com/main/view.php?key=20170206010001870
252,2017-02-06,대웅바이오대표이사에양병국前질병관리본부장선임,http://www.mdtoday.co.kr/mdtoday/index.html?no=278719
253,2017-02-06,대웅바이오대표에양병국씨,http://news.mk.co.kr/newsRead.php?&year=2017&no=84841
254,2017-02-06,양병국대웅바이오대표선임,http://www.dt.co.kr/contents.html?article_no=2017020702101176029002
255,2017-02-06,대웅바이오대표양병국,http://www.hankyung.com/news/app/newsview.php?aid=2017020663511
256,2017-02-06,양병국전질병관리본부장대웅바이오대표,http://www.doctorsnews.co.kr/news/articleView.html?idxno=115267
257,2017-02-06,대웅바이오대표에양병국전질병관리본부장선임,http://biz.chosun.com/site/data/html_dir/2017/02/06/2017020602681.html
258,2017-02-06,대웅제약연내인도네시아서할랄인증글로벌공략,http://www.newspim.com/news/view/20170206000134
259,2017-02-07,지난해임상승인최다제약사는대웅제약,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170206153200017&did=1195m
260,2017-02-07,대웅바이오새대표에양병국,http://www.ajunews.com/view/20170206151718804
261,2017-02-07,LG화학제미글로매출급증이면에깔린대웅제약영업력,http://www.ajunews.com/view/20170206104614396
262,2017-02-07,지난해국내임상승인건수1위는대웅제약,http://www.ebn.co.kr/news/view/875328
263,2017-02-07,대웅제약계열사대표에관료선임메르스사태책임자를뒷말무성,http://view.asiae.co.kr/news/view.htm?idxno=2017020708035628910
264,2017-02-07,임상승인최다제약사는대웅제약,http://www.hankookilbo.com/v/0bdc3ee764024273af38d2d3fbee8d90
265,2017-02-07,fnRASSI대웅제약전일대비513상승,http://www.fnnews.com/news/201702071018528898
266,2017-02-07,대웅제약국내제약사중가장많은임상시험승인,http://www.viva100.com/main/view.php?key=20170207010002073
267,2017-02-07,대웅바이오대표이사에양병국전질본장선임,http://www.medicaltimes.com/News/1109866
268,2017-02-07,데이터뉴스작년임상승인최다제약사는대웅제약종근당2위,http://www.etoday.co.kr/news/section/newsview.php?idxno=1451642
269,2017-02-07,홍보인무덤불명예이어가는대웅제약,http://www.sedaily.com/NewsView/1OC045BWCG
270,2017-02-07,제약협회대웅바이오인사놓고잡음,http://www.kormedi.com/news/news/drug_dist/1221861_2906.html
271,2017-02-07,대웅제약지난해임상시험승인최다,http://www.shinailbo.co.kr/news/articleView.html?idxno=556485
272,2017-02-07,머니몬스터차트가좋다삼호개발대웅제약,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017020715131143661
273,2017-02-07,대웅제약나보타등제품다각화미국시장진출추진으로재도약노려,http://www.ekn.kr/news/article.html?no=266349
274,2017-02-08,대웅제약지난해국내임상승인최다,https://cnbc.sbs.co.kr/article_hub/10000846027?division=NAVER
275,2017-02-08,더벨계열분리윤재훈회장㈜대웅지분향방은,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201702070100012760000760
276,2017-02-08,양병국대웅바이오대표이사취임두고이견팽팽,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201702081104002&code=900303
277,2017-02-08,대웅국민건강사명감실천희귀의약품지속공급,http://www.medicaltimes.com/News/1109895
278,2017-02-08,대웅제약국민건강위해의약품지속공급,http://www.dailypharm.com/News/221903
279,2017-02-08,대웅제약국민건강최우선으로의약품공급,http://www.enewstoday.co.kr/news/articleView.html?idxno=1001382
280,2017-02-08,대웅제약희귀약프리미돈오메크린공급,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1038713
281,2017-02-08,대웅제약수익성보다국민건강과삶의질우선,http://medipana.com/news/news_viewer.asp?NewsNum=195003&MainKind=A&NewsKind=5&vCount=12&vKind=1
282,2017-02-08,대웅제약수익보다국민건강삶의질우선,http://www.dailymedi.com/detail.php?number=815578&thread=22r05
283,2017-02-08,대웅제약국민건강위해수요적은약지속공급,http://www.dt.co.kr/contents.html?article_no=2017020802109976029005
284,2017-02-08,대웅제약수요적은필요의약품공급지속,http://www.asiatoday.co.kr/view.php?key=20170208010005331
285,2017-02-08,대웅제약연간매출2억도안되지만,http://www.bosa.co.kr/news/articleView.html?idxno=2054471
286,2017-02-08,대웅제약사명감으로수요적은의약품도지속공급”,http://www.mdtoday.co.kr/mdtoday/index.html?no=278908
287,2017-02-08,대웅제약뇌전증옴치료제는수익성상관없이공급한다,http://www.ekn.kr/news/article.html?no=266512
288,2017-02-08,취재수첩한미보령대웅국내대표제약사답게자료정확도신뢰성높여야,http://biz.newdaily.co.kr/news/article.html?no=10125253
289,2017-02-08,연매출2억도안되는뇌전증옴치료제대웅제약사명감갖고공급,http://www.rapportian.com/news/articleView.html?idxno=101859
290,2017-02-08,대웅제약보톡스해결사보은인사논란,http://www.asiatoday.co.kr/view.php?key=20170208001758483
291,2017-02-08,대웅제약희귀질환약대웅프리미돈오메크린크림공급지속,http://www.viva100.com/main/view.php?key=20170208020019063
292,2017-02-09,더벨대웅제약자회사피인수1년만에흑자보답,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201702080100015550000939
293,2017-02-09,대웅바이오대표선임둘러싼따가운눈총,http://www.enewstoday.co.kr/news/articleView.html?idxno=1002039
294,2017-02-09,대웅제약수요적은희귀의약품계속공급,http://www.kormedi.com/news/news/drug_dist/1221890_2906.html
295,2017-02-09,대웅제약지난해영업이익353억원전년比3574↓,http://www.mt.co.kr/view/mtview.php?type=1&no=2017020916035331809&outlink=1
296,2017-02-09,대웅제약작년영업이익353억전년比357감소,http://news1.kr/articles/?2908003
297,2017-02-09,대웅제약작년4Q영업익70증가,http://view.asiae.co.kr/news/view.htm?idxno=2017020916202312774
298,2017-02-09,대웅제약지난해4Q영업익147억원전년대비70↑,http://www.newstomato.com/ReadNews.aspx?no=730690
299,2017-02-09,대웅제약지난해4Q영업익147억전년비7015증가,http://www.edaily.co.kr/news/newspath.asp?newsid=04444406615828880
300,2017-02-09,대웅제약지난해영업익354억전년比38↓,http://www.seoulfn.com/news/articleView.html?idxno=272533
301,2017-02-09,대웅제약작년영업익282억원전년比396감소,http://view.asiae.co.kr/news/view.htm?idxno=2017020917102062187
302,2017-02-09,대웅제약작년영업익354억35↓,http://www.dt.co.kr/contents.html?article_no=2017020902109976029008
303,2017-02-09,대웅제약작년매출7940억영업익35감소,http://www.dailypharm.com/News/221966
304,2017-02-09,대웅제약지난해영업익263억전년比396감소,http://www.edaily.co.kr/news/newspath.asp?newsid=04703526615828880
305,2017-02-09,대웅지난해영업익614억전년比230감소,http://www.edaily.co.kr/news/newspath.asp?newsid=04706806615828880
306,2017-02-09,대웅제약지난해영업익36감소한354억원신규도입품목마케팅비용RD비용증가”,http://biz.chosun.com/site/data/html_dir/2017/02/09/2017020902723.html
307,2017-02-09,대웅작년영업익109억원117증가,http://view.asiae.co.kr/news/view.htm?idxno=2017020917534372159
308,2017-02-09,대웅제약영업익순익곤두박질간판품목뺏긴탓상보,http://news1.kr/articles/?2908118
309,2017-02-09,대웅제약지난해연결영업익263억전년比40↓,http://www.newsis.com/view/?id=NISX20170209_0014694744&cID=10401&pID=10400
310,2017-02-09,대웅제약이시국에관피아논란진땀,http://www.sisaweek.com/news/articleView.html?idxno=86800
311,2017-02-09,대웅제약작년연결영업익263억전년비396↓,http://www.ajunews.com/view/20170209182728687
312,2017-02-09,실적발표대웅제약와이디온라인네오위즈게임즈,http://www.businesspost.co.kr/news/articleView.html?idxno=42426
313,2017-02-09,1천억대날아간대웅제약7940억매출로선전,http://medipana.com/news/news_viewer.asp?NewsNum=195080&MainKind=A&NewsKind=5&vCount=12&vKind=1
314,2017-02-10,대웅제약올해영업익호실적전망목표가↑”신한금융투자,http://www.dailian.co.kr/news/view/611775/?sc=naver
315,2017-02-10,동부증권대웅제약영업이익률회복기대향후수출부문성장도긍정적,http://www.g-enews.com/ko-kr/news/article/news_all/201702100835430369739_1/article.html
316,2017-02-10,ET투자뉴스대웅제약大熊재주를넘었매수유지동부증권,http://www.etnews.com/20170210000068
317,2017-02-10,대웅제약지난해영업이익263억396감소,http://www.kukinews.com/news/article.html?no=430860
318,2017-02-10,대신證대웅제약4분기깜짝실적올해나보타모멘텀기대,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201702100039
319,2017-02-10,종근당한미약품대웅제약피말리는매출1조전쟁,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201702100138
320,2017-02-10,대웅제약매출8843억동아에스티5603억,http://www.monews.co.kr/news/articleView.html?idxno=97666
321,2017-02-10,대웅제약작년매출7940억기록,http://www.rapportian.com/news/articleView.html?idxno=101884
322,2017-02-10,대웅그룹지주회사가치눈여겨봐야골든브릿지,http://www.choicenews.co.kr/news/articleView.html?idxno=31478
323,2017-02-10,대웅제약지난해매출5성장수익성은악화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=203444
324,2017-02-10,1조매출앞당기겠다던대웅제약작년8천억도못넘겨,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1038819
325,2017-02-10,ET투자뉴스대웅제약예상보다좋았던4TRADINGBUY유지신한금융투자,http://www.etnews.com/20170210000259
326,2017-02-10,ET투자뉴스대웅제약두드러진수출성장매수유지유진투자증권,http://www.etnews.com/20170210000361
327,2017-02-10,ET투자뉴스대웅제약154Q이후첫매수KTB투자증권,http://www.etnews.com/20170210000456
328,2017-02-10,요동친상위제약사판세1조수성녹십자깜짝급성장종근당선방한대웅추락한한미,http://biz.chosun.com/site/data/html_dir/2017/02/10/2017021002202.html
329,2017-02-11,대웅건설주태안군에장학금1000만원기탁,http://www.anewsa.com/detail.php?number=1127133&thread=09r02
330,2017-02-12,대웅건설주태안군에장학금1000만원기탁,http://www.daejonilbo.com/news/newsitem.asp?pk_no=1251397
331,2017-02-12,태안군대웅건설주태안군에장학금1천만원기탁,http://www.joongdo.co.kr/jsp/article/article_view.jsp?pq=201702120916
332,2017-02-12,대웅건설정원웅대표장학금1천만원기탁,http://www.ggilbo.com/news/articleView.html?idxno=347227
333,2017-02-12,대웅건설주태안군에장학금1천만원기탁,http://www.chungnamilbo.com/news/articleView.html?idxno=391612
334,2017-02-12,대웅건설태안군사랑장학금전달,http://www.ccdn.co.kr/news/articleView.html?idxno=452574
335,2017-02-12,대웅건설㈜태안군사랑장학회에1000만원기탁,http://www.cctoday.co.kr/news/articleView.html?idxno=1038673
336,2017-02-12,대웅건설㈜태안사랑장학금1000만원기탁,http://www.ccdailynews.com/news/articleView.html?idxno=910086
337,2017-02-13,BioS대웅제약어떻게매출1400억이탈단숨에만회했나,http://www.etoday.co.kr/news/section/newsview.php?idxno=1454171
338,2017-02-13,대웅제약간판도입상품상실타격실적하락그래프,http://www.mdtoday.co.kr/mdtoday/index.html?no=279089
339,2017-02-13,정원웅대웅건설대표태안군에장학금1000만원기탁,http://www.cnews.co.kr/uhtml/read.jsp?idxno=201702131504020420786
340,2017-02-14,연구개발비1천억원제약사4곳한미녹십자대웅종근당,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170213162100017&did=1195m
341,2017-02-14,제약업계지난해성적희비종근당웃고한미대웅울고,http://www.seoulfn.com/news/articleView.html?idxno=272726
342,2017-02-14,건약양병국전질병관리본부장대웅바이오취업에문제제기,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1038932
343,2017-02-14,한미녹십자대웅종근당RD에1천억투자,http://www.shinailbo.co.kr/news/articleView.html?idxno=557938
344,2017-02-14,신약연구개발비빅4한미녹십자대웅종근당,http://www.ebn.co.kr/news/view/876686
345,2017-02-14,신약개발1000억이상투자제약사4곳한미녹십자대웅종근당,http://www.dt.co.kr/contents.html?article_no=2017021402109976029001
346,2017-02-14,메트포르민머크대웅한올의아리송한경쟁,http://www.dailypharm.com/News/222114
347,2017-02-14,RD1천억↑대웅제약종근당신규진입,http://www.econovill.com/news/articleView.html?idxno=309096
348,2017-02-14,대웅제약힐리언스선마을이시형박사암극복특별강연,http://www.bosa.co.kr/news/articleView.html?idxno=2054852
349,2017-02-14,대웅제약힐리언스선마을이시형박사암극복특별강연개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=279273
350,2017-02-14,대웅제약이시형박사암극복특강개최,http://www.dailypharm.com/News/222127
351,2017-02-14,한미녹십자대웅종근당1천억대RD투자,http://www.m-i.kr/news/articleView.html?idxno=289679
352,2017-02-14,제약업체도RD투자1천억시대작년한미녹십자대웅종근당4곳서1천억대투자,http://www.ekn.kr/news/article.html?no=267706
353,2017-02-15,양병국전질병관리본부장대웅바이오신임대표선임논란,http://www.mdtoday.co.kr/mdtoday/index.html?no=279327
354,2017-02-15,지난해국내임상승인최다제약사는대웅,http://www.mdtoday.co.kr/mdtoday/index.html?no=279321
355,2017-02-15,연구개발비1천억원대대웅제약종근당합류,http://www.kormedi.com/news/news/drug_dist/1221977_2906.html
356,2017-02-16,서울제약등기이사6명중4명대웅출신‥전면배치,http://medipana.com/news/news_viewer.asp?NewsNum=195336&MainKind=A&NewsKind=5&vCount=12&vKind=1
357,2017-02-16,대웅제약2017년매출1조전문의약품비중줄고매출견인품목없어무리수전망,http://biz.newdaily.co.kr/news/article.html?no=10125903
358,2017-02-16,대웅제약수평적아이디어소통능률배가,http://www.dailypharm.com/News/222226
359,2017-02-16,대웅제약회사직원소통하는주니어보드운영,http://www.enewstoday.co.kr/news/articleView.html?idxno=1006895
360,2017-02-16,제약소식대웅제약주니어보드로소통잘되는회사만들어가요外,http://www.kukinews.com/news/article.html?no=432559
361,2017-02-16,대웅제약주니어보드로소통잘되는회사만들어가요,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=203619
362,2017-02-16,대웅제약직원이회사주요제도직접운영하는주니어보드2기운영,http://biz.newdaily.co.kr/news/article.html?no=10125983
363,2017-02-16,행정심판서이긴대웅글리아티린대조약지위회복,http://www.dailypharm.com/News/222239
364,2017-02-16,대웅글리아티린대조약간판찾아왔다,http://www.kpanews.co.kr/article/show.asp?idx=181253&table=article&category=D
365,2017-02-16,대웅제약주니어보드운영‥소통바탕동반성장,http://medipana.com/news/news_viewer.asp?NewsNum=195371&MainKind=A&NewsKind=5&vCount=12&vKind=1
366,2017-02-16,대웅제약주니어가의사결정참여주니어보드2기출범,http://www.bosa.co.kr/news/articleView.html?idxno=2055071
367,2017-02-16,대웅제약주니어보드운영소통하는회사로변화,http://www.mdtoday.co.kr/mdtoday/index.html?no=279444
368,2017-02-16,대웅제약주니어보드로소통하는회사만들어요,http://www.dt.co.kr/contents.html?article_no=2017021602109976029005
369,2017-02-16,대웅제약주니어급직원이기업문화만든다,http://www.ajunews.com/view/20170216164102863
370,2017-02-16,대웅제약주니어보드로소통문화활성인재육성동시에,http://www.viva100.com/main/view.php?key=20170216020019127
371,2017-02-16,대웅제약동반성장위한소통프로그램눈길주니어도의사결정참여,http://www.ekn.kr/news/article.html?no=268270
372,2017-02-17,대웅제약주니어보드프로그램운영,http://ilyo.co.kr/?ac=article_view&entry_id=232234
373,2017-02-17,빅데이터MSI시장심리톱5오리온락앤락동원FB현대글로비스대웅제약,http://www.newsis.com/view/?id=NISX20170217_0014711418&cID=10401&pID=10400
374,2017-02-17,대웅제약주니어보드로소통잘되는회사만들어가요,http://www.newscj.com/news/articleView.html?idxno=406772
375,2017-02-17,빅데이터MSI시장심리톱5오리온대웅제약상승마감,http://www.newsis.com/view/?id=NISX20170217_0014712373&cID=10427&pID=10400
376,2017-02-19,신약강국현장을가다대웅제약오픈콜라보레이션으로승부글로벌50위도약선언,http://news.kmib.co.kr/article/view.asp?arcid=0923696248&code=14130000&cp=nv
377,2017-02-20,신약강국현장을가다대웅제약오픈콜라보레이션활성화,http://www.kukinews.com/news/article.html?no=433239
378,2017-02-20,왜정부와소송했나싶더니판권뺏긴대웅의전략,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1039143
379,2017-02-21,내수부진대웅제약1조달성은무리수,http://www.ajunews.com/view/20170220105546110
380,2017-02-21,종근당승vs대웅제약패효자품목판권이희비갈라,http://www.ceoscoredaily.com/news/article.html?no=27329
381,2017-02-22,대웅주식분할결정2천500원→500원,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170222128500008&did=1195m
382,2017-02-22,대웅1주당2500→500원액면분할,http://www.edaily.co.kr/news/newspath.asp?newsid=03542406615833144
383,2017-02-22,대웅주당2500원→500원주식분할주당500원현금배당,http://www.mt.co.kr/view/mtview.php?type=1&no=2017022214490914426&outlink=1
384,2017-02-22,대웅주당500원현금배당결정총43억1800만원규모,http://www.nspna.com/news/?mode=view&newsid=209232
385,2017-02-22,대웅주당500원현금배당결정,http://www.getnews.co.kr/view.php?ud=2017022214555320126beeb3268c_16
386,2017-02-22,대웅2500원→500원주식분할결정,http://www.sedaily.com/NewsView/1OC6ZXZFEV
387,2017-02-22,대웅주식분할결정2500원→500원,http://biz.chosun.com/site/data/html_dir/2017/02/22/2017022201991.html
388,2017-02-22,대웅제약보통주1주당600원현금배당,http://www.edaily.co.kr/news/newspath.asp?newsid=03611286615833144
389,2017-02-22,대웅주당500원현금배당,http://view.asiae.co.kr/news/view.htm?idxno=2017022215033344728
390,2017-02-22,대웅주당500원현금배당결정,http://news.heraldcorp.com/view.php?ud=20170222000742
391,2017-02-22,대웅2500원→500원주식분할결정,http://news.heraldcorp.com/view.php?ud=20170222000741
392,2017-02-22,대웅주당가액2500원→500원액면분할,http://view.asiae.co.kr/news/view.htm?idxno=2017022215041148669
393,2017-02-22,대웅제약주당600원현금배당,http://www.mt.co.kr/view/mtview.php?type=1&no=2017022215043473379&outlink=1
394,2017-02-22,대웅제약주당600원현금배당,http://biz.chosun.com/site/data/html_dir/2017/02/22/2017022202066.html
395,2017-02-22,대웅제약주당600원현금배당,http://view.asiae.co.kr/news/view.htm?idxno=2017022215123598257
396,2017-02-22,대웅제약주당600원현금배당결정,http://news.heraldcorp.com/view.php?ud=20170222000753
397,2017-02-22,대웅제약주당600원현금배당결정총61억9200만원규모,http://www.nspna.com/news/?mode=view&newsid=209241
398,2017-02-22,대웅주당500원현금배당결정,http://www.asiatoday.co.kr/view.php?key=20170222010014711
399,2017-02-22,대웅2500원→500원주식분할결정,http://www.newstomato.com/ReadNews.aspx?no=733922
400,2017-02-22,대웅제약주당600원현금배당결정,http://www.asiatoday.co.kr/view.php?key=20170222010014717
401,2017-02-22,대웅주식분할결정,http://stock.hankyung.com/news/app/newsview.php?aid=2017022287236
402,2017-02-22,대웅1주당2500원→500원주식액면분할추진,http://medipana.com/news/news_viewer.asp?NewsNum=195609&MainKind=A&NewsKind=5&vCount=12&vKind=1
403,2017-02-22,대웅제약주당600원결산배당결정,http://stock.hankyung.com/news/app/newsview.php?aid=2017022287736
404,2017-02-22,대웅보통주액면가2500원→500원분할결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1459030
405,2017-02-22,대웅윤재승대표재선임결의,http://www.dailypharm.com/News/222484
406,2017-02-22,대웅2500원→500원주식분할,http://www.newspim.com/news/view/20170222000248
407,2017-02-22,대웅제약주당600원현금배당결정,http://www.newsis.com/view/?id=NISX20170222_0014721485&cID=10401&pID=10400
408,2017-02-22,대웅주당2500원→500원주식분할결정,http://www.newsis.com/view/?id=NISX20170222_0014721428&cID=10424&pID=10400
409,2017-02-22,대웅주당500원현금배당결정,http://www.newsis.com/view/?id=NISX20170222_0014721434&cID=10424&pID=10400
410,2017-02-22,공시대웅주식분할결정주당가액2500원→500원,http://www.g-enews.com/ko-kr/news/article/news_all/201702221552272218152_1/article.html
411,2017-02-22,대웅주식분할결정2500원→500원,http://www.cstimes.com/news/articleView.html?idxno=239276
412,2017-02-22,대웅주식분할결정주당2500원→500원,http://www.ebn.co.kr/news/view/878285
413,2017-02-22,동남아최대시장인도네시아기반구축대웅제약,http://www.dailymedi.com/detail.php?number=816073&thread=22r05
414,2017-02-22,대웅제약주당600원결산배당,http://www.ekn.kr/news/article.html?no=269475
415,2017-02-23,대웅제약보통주1주당600원씩총61억9252만현금배당,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=203801
416,2017-02-23,대웅보통주1주당500원씩총43억1846만원현금배당,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=203802
417,2017-02-23,대웅제약고객전문가파트너와개방형혁신,http://view.asiae.co.kr/news/view.htm?idxno=2017022310595236823
418,2017-02-23,코오롱머티리얼대웅다시부는액면분할바람,http://stock.hankyung.com/news/app/newsview.php?aid=2017022329521
419,2017-02-26,대웅보령제약등챔픽스특허회피성공,http://www.finomy.com/news/articleView.html?idxno=43170
420,2017-02-27,올해최선호제약바이오株종근당대웅제약하이,http://stock.hankyung.com/news/app/newsview.php?aid=2017022792936
421,2017-02-27,더벨대웅제약판권회수여파매출유지했어도수익뚝,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201702230100051060003117
422,2017-02-27,대웅제약연초부터마이너스성장으로불안한출발,http://sports.khan.co.kr/news/sk_index.html?art_id=201702271554003&sec_id=561801&pt=nv
423,2017-02-28,인베스트조선대웅제약판권회수우루사재평가이중고신용도악화우려,http://www.investchosun.com/2017/02/28/3209697
424,2017-02-28,더벨원가낮춘대웅제약계정분류변경착시효과,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201702240100053300003266
425,2017-02-28,대웅이지엔6진통제시장3위로껑충,http://www.dailypharm.com/News/222690
426,2017-02-28,대웅제약이지엔6고속성장진통제시장지형도확바꿨다,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=203958
427,2017-02-28,대웅제약액상진통제이지엔6판매1위,http://www.dt.co.kr/contents.html?article_no=2017022802109976029001
428,2017-02-28,대웅제약이지엔6펜잘누르고3위기록,http://medipana.com/news/news_viewer.asp?NewsNum=195857&MainKind=A&NewsKind=5&vCount=12&vKind=1
429,2017-02-28,대웅제약이지엔6입소문만으로40억매출,http://www.bosa.co.kr/news/articleView.html?idxno=2055925
430,2017-02-28,대웅제약액상진통제이지엔6판매1위동일계열제품중최다,http://www.ekn.kr/news/article.html?no=270717
431,2017-02-28,대웅제약이지엔6진통제시장지형도바꾸다펜잘누르고3위,http://www.etoday.co.kr/news/section/newsview.php?idxno=1461759
432,2017-02-28,대웅제약액상형진통제이지엔6연매출40억진통제시장3위,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017022814010776929
433,2017-02-28,대웅제약액상형진통제이지엔6작년44억매출달성,http://www.rapportian.com/news/articleView.html?idxno=102210
434,2017-02-28,대웅제약이지엔6지난해매출40억기록,http://www.mdtoday.co.kr/mdtoday/index.html?no=280249
435,2017-03-01,대웅제약이지엔6진통제시장지형도바꿨다,http://www.newscj.com/news/articleView.html?idxno=409230
436,2017-03-01,해외시장공들이는대웅제약올매출1조노린다,http://www.hankyung.com/news/app/newsview.php?aid=2017030170121
437,2017-03-02,대웅제약최다해외법인설립미국인니중국집중공략,http://biz.chosun.com/site/data/html_dir/2017/03/02/2017030200401.html
438,2017-03-03,대웅바이오논란의인사,http://www.ilyosisa.co.kr/news/articleView.html?idxno=123288
439,2017-03-04,판권회수에판권도입으로매출공백피한대웅제약장사실속은,http://www.mdtoday.co.kr/mdtoday/index.html?no=280474
440,2017-03-05,대웅제약글로벌시장본격공략,http://www.m-i.kr/news/articleView.html?idxno=293804
441,2017-03-05,대웅제약인니는바이오전진기지글로벌도약부푼꿈,http://news.kmib.co.kr/article/view.asp?arcid=0923704434&code=14130000&cp=nv
442,2017-03-06,BioS천기자의W진통제시장지형바꿨다는대웅의특이한계산법,http://www.etoday.co.kr/news/section/newsview.php?idxno=1463658
443,2017-03-06,유한녹십자이어올1조기업‥대웅한미등기대,http://medipana.com/news/news_viewer.asp?NewsNum=196016&MainKind=A&NewsKind=5&vCount=12&vKind=1
444,2017-03-07,대웅제약새홍보팀장영입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=204127
445,2017-03-07,대웅제약홍보팀장영입,http://www.rapportian.com/news/articleView.html?idxno=102352
446,2017-03-08,대웅제약조규철홍보팀장영입,http://www.dailypharm.com/Users/News/TodayFocus.html?mode=View&nKind=2&ID=14958
447,2017-03-08,대웅제약한미약품국내외서신약개발활발,http://www.finomy.com/news/articleView.html?idxno=43353
448,2017-03-09,종근당청구실적2위약진대웅제약BMS는흐림,http://www.dailypharm.com/News/222994
449,2017-03-09,대웅제약인도연구소글로벌허브로육성,http://www.dailypharm.com/News/223021
450,2017-03-09,대웅제약인도연구소글로벌인허가허브로육성,http://medipana.com/news/news_viewer.asp?NewsNum=196299&MainKind=A&NewsKind=5&vCount=12&vKind=1
451,2017-03-09,대웅제약인도연구소글로벌인허가허브로비전다져,http://www.viva100.com/main/view.php?key=20170309010003168
452,2017-03-09,대웅제약인도연구소전세계인허가허브로육성,http://www.hankyung.com/news/app/newsview.php?aid=201703096731i
453,2017-03-09,대웅제약인도연구소글로벌인허가허브기대,http://www.bosa.co.kr/news/articleView.html?idxno=2056533
454,2017-03-09,대웅제약인도연구소글로벌인허가허브육성논의,http://www.asiatoday.co.kr/view.php?key=20170309010005774
455,2017-03-09,대웅제약인도연구소글로벌인허가허브로키운다,http://www.edaily.co.kr/news/newspath.asp?newsid=03447286615861680
456,2017-03-09,대웅제약인도연구소를글로벌인허가허브로,http://www.metroseoul.co.kr/news/newsview?newscd=2017030900069
457,2017-03-09,조계사대웅전서삼배하는안희정충남지사,http://www.newsis.com/view/?id=NISI20170309_0012771620
458,2017-03-09,조계사대웅전서삼배하는안희정충남지사,http://www.newsis.com/view/?id=NISI20170309_0012771623
459,2017-03-09,조계사대웅전서삼배하는안희정충남지사,http://www.newsis.com/view/?id=NISI20170309_0012771619
460,2017-03-09,조계사대웅전서삼배하는안희정충남지사,http://www.newsis.com/view/?id=NISI20170309_0012771621
461,2017-03-09,조계사대웅전서삼배하는안희정충남지사,http://www.newsis.com/view/?id=NISI20170309_0012771629
462,2017-03-09,조계사대웅전서삼배하는안희정충남지사,http://www.newsis.com/view/?id=NISI20170309_0012771616
463,2017-03-09,조계사대웅전서삼배하는안희정충남지사,http://www.newsis.com/view/?id=NISI20170309_0012771628
464,2017-03-09,대웅제약인도연구소글로벌인허가허브비전다져,http://www.dt.co.kr/contents.html?article_no=2017030902109976029006
465,2017-03-09,이종욱대웅제약부회장인도연구소연구원격려,http://www.newspim.com/news/view/20170309000260
466,2017-03-09,대웅제약인도연구소글로벌인허가허브육성,http://www.monews.co.kr/news/articleView.html?idxno=98729
467,2017-03-09,대웅제약인도연구소글로벌인허가허브로키운다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017030915313428182
468,2017-03-09,대웅제약인도연구소글로벌인허가허브로육성,http://news1.kr/articles/?2931999
469,2017-03-09,이종욱대웅제약부회장인도연구소방문글로벌의약품인허가허브로키울것”,http://biz.chosun.com/site/data/html_dir/2017/03/09/2017030902431.html
470,2017-03-09,대웅제약인도연구소글로벌인허가허브로키운다,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=204230
471,2017-03-09,이종욱대웅제약부회장인도연구소글로벌허브로육성할계획,http://www.ekn.kr/news/article.html?no=272938
472,2017-03-09,비즈톡톡식약처행정처분에희비엇갈린메디톡스와대웅제약,http://biz.chosun.com/site/data/html_dir/2017/03/09/2017030902633.html
473,2017-03-09,대웅제약인도연구소글로벌인허가허브로키운다,http://www.mdtoday.co.kr/mdtoday/index.html?no=280887
474,2017-03-10,녹십자대웅제약글로벌시장에서빅파마와맞장,http://medipana.com/news/news_viewer.asp?NewsNum=196295&MainKind=A&NewsKind=5&vCount=12&vKind=1
475,2017-03-10,더벨대웅의앓는이IDSTRUST자본잠식겨우면해,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201703090100017030001083
476,2017-03-10,종근당대웅제약과치열한경쟁에서승리,http://www.sisafocus.co.kr/news/articleView.html?idxno=158349
477,2017-03-10,대웅제약인도연구소글로벌인허가허브로비전다져,http://www.newscj.com/news/articleView.html?idxno=411157
478,2017-03-13,바이오강화대웅제약옛명성되찾을까,http://www.ajunews.com/view/20170312081324125
479,2017-03-13,최다임상승인대웅제약주목할신약은,http://www.kormedi.com/news/news/drug_dist/1222351_2906.html
480,2017-03-14,ET투자뉴스대웅제약_주요매물대는68200원근방에존재,http://www.etnews.com/20170314000108
481,2017-03-14,대웅제약미국식품의약국수장교체로보톡스판매빨라질듯,http://www.businesspost.co.kr/news/articleView.html?idxno=44791
482,2017-03-15,대웅제약나보타이달말美시장두드린다,http://www.mt.co.kr/view/mtview.php?type=1&no=2017031311110922759&outlink=1
483,2017-03-15,대웅제약턱밑지방치료제개발에나서,http://www.dailypharm.com/News/223220
484,2017-03-15,50이종욱대웅제약사장제46회2008년,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=204392
485,2017-03-16,대웅제약희소성높은턱밑지방치료제시장에도전,http://www.mdtoday.co.kr/mdtoday/index.html?no=281278
486,2017-03-16,대웅제약인도네시아세계진출교두보삼는다,http://www.asiatoday.co.kr/view.php?key=20170316010010495
487,2017-03-17,대웅손습진약알리톡생동승인특허허들숙제,http://www.dailypharm.com/News/223288
488,2017-03-17,대웅제약나보타미국진출가시화투자의견매수토러스,http://www.edaily.co.kr/news/newspath.asp?newsid=01525206615864304
489,2017-03-17,대웅제약내년미국에보툴리눔톡신수출전망토러스,http://www.mt.co.kr/view/mtview.php?type=1&no=2017031707532335636&outlink=1
490,2017-03-17,뉴스줌인윤재승대웅제약회장역발상인재영입,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201703170021
491,2017-03-17,대웅인니합작사대웅인피온인니식약청장상수상,http://www.edaily.co.kr/news/newspath.asp?newsid=01974566615864304
492,2017-03-17,대웅인피온인도네시아에서최우수바이오제약사상수상,http://www.viva100.com/main/view.php?key=20170317010006099
493,2017-03-17,대웅제약리버스이노베이션실현,http://medipana.com/news/news_viewer.asp?NewsNum=196653&MainKind=A&NewsKind=5&vCount=12&vKind=1
494,2017-03-17,대웅인피온인도네시아식약청최우수바이오제약사상수상,http://www.fnnews.com/news/201703170952055473
495,2017-03-17,대웅인피온인도네시아서최우수바이오제약사상수상,http://www.ebn.co.kr/news/view/882206
496,2017-03-17,대웅제약대외협력실최기남실장모친상,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1040170
497,2017-03-17,대웅제약인니서최우수바이오제약사인정,http://www.m-i.kr/news/articleView.html?idxno=297066
498,2017-03-17,대웅인피온인도네시아에서최우수바이오제약사선정,http://www.bosa.co.kr/news/articleView.html?idxno=2057082
499,2017-03-17,ET투자뉴스대웅제약나보타보툴리눔톡신매수신규토러스투자증권,http://www.etnews.com/20170317000085
500,2017-03-17,대웅인피온인니최우수바이오제약사상수상,http://www.monews.co.kr/news/articleView.html?idxno=99037
501,2017-03-17,대웅제약인디합작법인대웅인피온최우수바이오제약사상수상,http://www.ekn.kr/news/article.html?no=274747
502,2017-03-17,양정현건국대의료원장대웅병원경영혁신대상수상,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201703170216
503,2017-03-17,건국대병원양정현의료원장제11회대웅병원경영혁신대상수상,http://www.viva100.com/main/view.php?key=20170317010006225
504,2017-03-17,대웅인피온인도네시아최우수바이오제약사상수상,http://www.mdtoday.co.kr/mdtoday/index.html?no=281413
505,2017-03-17,대웅인피온인도네시아최우수바이오제약사상수상,http://www.kpanews.co.kr/article/show.asp?idx=182049&table=article&category=D
506,2017-03-17,최기남대웅제약대외협력실장모친,http://www.dailypharm.com/Users/News/TodayFocus.html?mode=View&nKind=3&ID=14978
507,2017-03-17,대웅인피온인도네시아서최우수바이오제약사상수상,http://www.kormedi.com/news/news/drug_dist/1222445_2906.html
508,2017-03-17,양정현건국대의료원장대웅병원경영혁신대상,http://www.doctorsnews.co.kr/news/articleView.html?idxno=115917
509,2017-03-17,건국대병원양정현의료원장대웅병원경영혁신대상수상,http://www.fnnews.com/news/201703171527415901
510,2017-03-17,건국대병원양정현의료원장대웅병원경영혁신대상,http://www.medical-tribune.co.kr/news/articleView.html?idxno=71802
511,2017-03-17,대웅인피온인도네시아서최우수바이오제약사상수상,http://www.newsis.com/view/?id=NISX20170317_0014771723&cID=10434&pID=13000
512,2017-03-17,대웅제약대웅인피온인도네시아최우수바이오제약사상수상,http://ilyo.co.kr/?ac=article_view&entry_id=237722
513,2017-03-17,대웅제약대웅인피온인도네시아최우수바이오제약사상수상,http://www.kukinews.com/news/article.html?no=440283
514,2017-03-17,대웅인피온인도네시아최우수바이오제약사상받아,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201703171716002&code=900303
515,2017-03-18,동구바이오대웅제약알리톡퍼스트제네릭개발돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=281459
516,2017-03-18,양정현건국대병원의료원장대웅병원경영혁신상대상수상,http://www.asiatoday.co.kr/view.php?key=20170318010011525
517,2017-03-19,양정현의료원장대웅병원경영혁신대상,http://www.dailymedi.com/detail.php?number=816841&thread=22r02
518,2017-03-20,대웅제약임팩타민프리미엄정판매업무정지15일처분,http://www.bosa.co.kr/news/articleView.html?idxno=2057151
519,2017-03-20,ET투자뉴스대웅제약_거래비중기관2413외국인243,http://www.etnews.com/20170320000044
520,2017-03-20,대웅제약중동베트남에보톨리눔톡신나보타공급계약,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201703200135
521,2017-03-20,대웅제약나보타중동베트남수출길오른다,http://www.sedaily.com/NewsView/1ODFZFVG9M
522,2017-03-20,대웅제약보톡스나보타중동베트남에수출,http://www.ebn.co.kr/news/view/882557
523,2017-03-20,대웅제약보툴리눔톡신제제나보타중동베트남진출,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=204482
524,2017-03-20,대웅제약보툴리눔톡신나보타중동베트남수출,http://medipana.com/news/news_viewer.asp?NewsNum=196739&MainKind=A&NewsKind=5&vCount=12&vKind=1
525,2017-03-20,대웅제약보툴리눔톡신제제나보타중동과베트남시장에수출,http://www.fnnews.com/news/201703201016334287
526,2017-03-20,대웅제약나보타중동베트남진출,http://www.medical-tribune.co.kr/news/articleView.html?idxno=71814
527,2017-03-20,대웅제약자체개발보툴리눔톡신제제나보타중동베트남진출,http://biz.chosun.com/site/data/html_dir/2017/03/20/2017032000981.html
528,2017-03-20,대웅제약보툴리눔톡신제제나보타중동베트남수출,http://www.newsway.co.kr/view.php?tp=1&ud=2017032010235154438
529,2017-03-20,대웅제약주름개선생의약품나보타베트남중동수출,http://news1.kr/articles/?2940939
530,2017-03-20,대웅제약보툴리눔톡신나보타중동베트남진출,https://cnbc.sbs.co.kr/article_hub/10000851767?division=NAVER
531,2017-03-20,대웅제약나보타중동베트남진출,http://stock.hankyung.com/news/app/newsview.php?aid=2017032020786
532,2017-03-20,대웅제약보톡스나보타베트남중동진출,http://www.mt.co.kr/view/mtview.php?type=1&no=2017032010190655879&outlink=1
533,2017-03-20,대웅제약보톡스나보타중동베트남수출,http://view.asiae.co.kr/news/view.htm?idxno=2017032010525985036
534,2017-03-20,대치동비타민대웅제약임팩타민24일부터15일간판매정지,http://www.sisaweek.com/news/articleView.html?idxno=88756
535,2017-03-20,대웅제약나보타중동베트남공략,http://www.m-i.kr/news/articleView.html?idxno=297554
536,2017-03-20,대웅제약나보타중동베트남진출,http://www.viva100.com/main/view.php?key=20170320010006802
537,2017-03-20,대웅제약보툴리눔톡신제제나보타중동베트남수출,http://www.newsis.com/view/?id=NISX20170320_0014775510&cID=10402&pID=13000
538,2017-03-20,대웅제약보툴리눔톡신제제중동베트남진출,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170320069800017&did=1195m
539,2017-03-20,대웅제약보툴리눔톡신제제나보타중동베트남수출,http://www.hankyung.com/news/app/newsview.php?aid=201703202191i
540,2017-03-20,대웅제약나보타중동베트남진출,http://www.bosa.co.kr/news/articleView.html?idxno=2057192
541,2017-03-20,대웅제약나보타중동베트남진출,http://www.monews.co.kr/news/articleView.html?idxno=99101
542,2017-03-20,양정현의료원장대웅병원경영혁신대상수상,http://www.monews.co.kr/news/articleView.html?idxno=99108
543,2017-03-20,대웅제약나보타중동베트남시장진출,http://www.dailypharm.com/News/223381
544,2017-03-20,남미동남아진출대웅제약나보타중동베트남,http://www.dailymedi.com/detail.php?number=816883&thread=22r05
545,2017-03-20,대웅제약임팩타민프리미엄약사법위반판매업무정지15일,http://www.mdtoday.co.kr/mdtoday/index.html?no=281564
546,2017-03-20,대웅제약보툴리눔톡신나보타중동베트남진출,http://www.mdtoday.co.kr/mdtoday/index.html?no=281558
547,2017-03-20,대웅제약나보타중동베트남진출,http://www.sportsseoul.com/news/read/493443
548,2017-03-20,대웅제약보툴리눔톡신나보타중동베트남진출,http://www.kukinews.com/news/article.html?no=440696
549,2017-03-20,대웅제약나보타중동베트남진출,http://www.newstomato.com/ReadNews.aspx?no=739696
550,2017-03-20,대웅제약나보타중동과베트남등8개국수출,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1040283
551,2017-03-20,대웅제약나보타중동베트남진출,http://www.newscj.com/news/articleView.html?idxno=412892
552,2017-03-20,대웅제약보톡스나보타중동베트남진출,http://www.enewstoday.co.kr/news/articleView.html?idxno=1027400
553,2017-03-20,대웅제약보툴리눔톡신나보타중동베트남수출,http://www.dt.co.kr/contents.html?article_no=2017032002109976029004
554,2017-03-20,대웅제약보툴리눔톡신제제중동베트남진출,http://www.asiatoday.co.kr/view.php?key=20170320010012597
555,2017-03-20,대웅제약내년중동서보툴리눔톡신제제나보타발매,http://www.newspim.com/news/view/20170320000247
556,2017-03-20,대웅제약나보타중동베트남수출,http://www.joseilbo.com/news/news_read.php?uid=319572&class=27&grp=
557,2017-03-20,대웅제약나보타중동베트남시장진출임박,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017032017358047232&outlink=1
558,2017-03-20,대웅제약보툴리눔톡신제제나보타중동베트남진출,http://www.metroseoul.co.kr/news/newsview?newscd=2017032000155
559,2017-03-20,대웅제약자체개발보톡스제제나보타중동베트남시장에수출,http://www.ekn.kr/news/article.html?no=275365
560,2017-03-20,대웅제약임팩타민프리미엄약사법위반으로15일판매정지,http://www.ekn.kr/news/article.html?no=275358
561,2017-03-20,대웅제약중동과베트남으로보톡스수출확대,http://www.businesspost.co.kr/news/articleView.html?idxno=45235
562,2017-03-20,대웅제약보톡스나보타중동베트남수출,http://www.finomy.com/news/articleView.html?idxno=43604
563,2017-03-20,대웅제약나보타중동베트남에수출,http://www.fnnews.com/news/201703201957592883
564,2017-03-20,대웅제약보톡스나보타중동베트남수출이룬다,http://www.ajunews.com/view/20170320135339539
565,2017-03-21,대웅제약나보타중동베트남수출길오른다,http://www.sedaily.com/NewsView/1ODGFVXIG5
566,2017-03-21,제약소식대웅제약진통제이지엔6지난해매출3위점프,http://www.viva100.com/main/view.php?key=20170319010006093
567,2017-03-21,의료단신대웅제약보툴리눔톡신제제중동베트남수출,http://www.yeongnam.com/mnews/newsview.do?mode=newsView&newskey=20170321.010200746000001
568,2017-03-21,ET투자뉴스대웅제약_주요매물구간인68200원선이지지대로작용,http://www.etnews.com/20170321000075
569,2017-03-21,대웅제약임팩타민프리미엄정판매업무정지15일행정처분,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=204554
570,2017-03-21,한미약품대웅제약종근당올해도1000억원이상RD투자한다,http://www.ekn.kr/news/article.html?no=275534
571,2017-03-22,대웅제약우루사간건강지킴이반세기12國서호평,http://news.mk.co.kr/newsRead.php?&year=2017&no=192899
572,2017-03-22,균주출처논란대웅제약글로벌시장서주름펼까,http://www.etoday.co.kr/news/section/newsview.php?idxno=1470694
573,2017-03-22,한올대웅바이오글루코파지XR제네릭우판권획득,http://medipana.com/news/news_viewer.asp?NewsNum=196892&MainKind=A&NewsKind=5&vCount=12&vKind=1
574,2017-03-22,한올대웅바이오메트포르민1000mg우판권획득,http://www.dailypharm.com/News/223488
575,2017-03-22,한올대웅바이오메트포르민고용량특허회피에이어우판권확보,http://www.mdtoday.co.kr/mdtoday/index.html?no=281800
576,2017-03-23,기업분석대웅제약작년영업이익최근5년중최저판관비율37로最高,http://www.ekn.kr/news/article.html?no=275902
577,2017-03-23,더벨대웅출신임원들타제약사CEO로승승장구,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201703220100042730002618
578,2017-03-23,특허피한대웅바이오한올글루코파지XR제네릭독점판매,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1040425
579,2017-03-23,보톡스분쟁대웅제약메디톡스희비엇갈려,http://www.finomy.com/news/articleView.html?idxno=43697
580,2017-03-24,서울제약대웅출신사내이사3명선임,http://www.kormedi.com/news/news/drug_dist/1222560_2906.html
581,2017-03-24,대웅1주액면가500원주식분할결정,http://www.dailypharm.com/News/223585
582,2017-03-24,임팩타민병용효과CJ대웅안플라그서방정경합,http://www.dailypharm.com/News/223575
583,2017-03-24,대웅2500원→500원액면분할결정,http://www.newstomato.com/ReadNews.aspx?no=741054
584,2017-03-24,대웅대웅제약글로벌역량강화‥RD지속투자,http://medipana.com/news/news_viewer.asp?NewsNum=197028&MainKind=A&NewsKind=5&vCount=12&vKind=1
585,2017-03-24,대웅윤재승대표재선임자사주액면분할결의,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=204656
586,2017-03-24,대웅액면가2500원에서500원으로주식분할,http://www.sedaily.com/NewsView/1ODHV1ETBJ
587,2017-03-24,대웅제약주총서양윤선메디포스트대표사외이사선임대웅은자사주액면가분할,http://biz.chosun.com/site/data/html_dir/2017/03/24/2017032401764.html
588,2017-03-24,주총대웅1주당2500원→500원액면분할최종확정,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017032413333268124
589,2017-03-24,주총대웅자사주액면분할단행주주가치최우선고려,http://news1.kr/articles/?2946265
590,2017-03-24,주총현장대웅윤재승대표이사재선임,http://www.ebn.co.kr/news/view/883510
591,2017-03-24,슈퍼주총데이대웅자사주분할안결의주식거래활성화로주식가치제고”,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017032414208092770&outlink=1
592,2017-03-24,제약사주총대웅자사주액면분할1주당액면가2500원서500원으로,http://www.kukinews.com/news/article.html?no=442064
593,2017-03-24,윤재춘대웅제약대표올해도주주친화적기업경영및RD투자에집중할것,http://www.ekn.kr/news/article.html?no=276330
594,2017-03-24,주총현장대웅주식분할현금배당승인,http://news.mk.co.kr/newsRead.php?&year=2017&no=200967
595,2017-03-24,주총대웅자사주액면분할결의2500원→500원,http://www.newsway.co.kr/view.php?tp=1&ud=2017032414393192092
596,2017-03-24,대웅제약사외이사로양윤선메디포스트대표이사선임,http://www.mdtoday.co.kr/mdtoday/index.html?no=281987
597,2017-03-24,대웅제약양윤선사외이사신규선임,http://www.mt.co.kr/view/mtview.php?type=1&no=2017032415092088776&outlink=1
598,2017-03-24,대웅주총서주식배당안건부결,http://www.mt.co.kr/view/mtview.php?type=1&no=2017032415124048029&outlink=1
599,2017-03-24,대웅주총서주식배당안건부결,http://www.sedaily.com/NewsView/1ODHV20UOD
600,2017-03-24,대웅제약글로벌헬스케어다짐지난해악조건속실적견조,http://www.bosa.co.kr/news/articleView.html?idxno=2057600
601,2017-03-24,주총윤재춘대웅대표RD투자로매출성장이끌것,http://www.newsis.com/view/?id=NISX20170324_0014786590&cID=10408&pID=13000
602,2017-03-24,대웅제약줄기세포전문가영입세포치료제강화,http://view.asiae.co.kr/news/view.htm?idxno=2017032417164819516
603,2017-03-24,대웅윤재승대표이사재선임자사주액면분할,http://www.kormedi.com/news/news/drug_dist/1222573_2906.html
604,2017-03-24,대웅2500원→500원액면분할최종확정,http://www.rapportian.com/news/articleView.html?idxno=102798
605,2017-03-24,유한양행대웅제약일동제약등제약사주총개최,http://www.asiatoday.co.kr/view.php?key=20170324010016222
606,2017-03-24,대웅대웅제약제57기정기주주총회개최,http://www.newscj.com/news/articleView.html?idxno=413940
607,2017-03-24,대웅자사주2500원→500원액면분할주식거래활성화기대,http://www.viva100.com/main/view.php?key=20170324020019447
608,2017-03-27,흩어진대웅제약출신별제약사경영성공할까,http://www.kpanews.co.kr/article/show.asp?idx=182232&table=article&category=D
609,2017-03-27,fnRASSI대웅제약069620현재569↑,http://www.fnnews.com/news/201703271005167255
610,2017-03-27,ET투자뉴스대웅제약_주요매물구간인68200원선이지지대로작용,http://www.etnews.com/20170327000080
611,2017-03-27,대웅인도네시아산학관네트워킹활발,http://www.kpanews.co.kr/article/show.asp?idx=182329&table=article&category=D
612,2017-03-27,대웅인도네시아서산학관비즈니스미팅,http://www.dailypharm.com/News/223652
613,2017-03-27,대웅제약인도네시아정부현지기업과협력방안논의,http://www.fnnews.com/news/201703271049469411
614,2017-03-27,대웅제약인도네시아에서오픈콜라보레이션기회모색,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=204693
615,2017-03-27,대웅제약인도네시아진출박차산학관네트워크구축,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017032710578031624&outlink=1
616,2017-03-27,대웅제약인니진출본격화상호협력확대,http://www.m-i.kr/news/articleView.html?idxno=299303
617,2017-03-27,대웅제약印尼서산학관네트워크구축오픈콜라보레이션모색,http://www.newsis.com/view/?id=NISX20170327_0014790389&cID=10402&pID=13000
618,2017-03-27,대웅인니서오픈콜라보레이션기회모색,http://www.monews.co.kr/news/articleView.html?idxno=99444
619,2017-03-27,대웅제약인도네시아진출탄력‥네트워크구축,http://medipana.com/news/news_viewer.asp?NewsNum=197131&MainKind=A&NewsKind=5&vCount=12&vKind=1
620,2017-03-27,대웅제약인도네시아바이오의약품산업활성화협력강화,http://www.kukinews.com/news/article.html?no=442532
621,2017-03-27,유한녹십자대웅종근당한미화두글로벌기업,http://www.dailymedi.com/detail.php?number=817103&thread=22r05
622,2017-03-27,대웅인니정부학계산업계와협력확대모색,http://www.dailymedi.com/detail.php?number=817107&thread=22r05
623,2017-03-27,대웅제약인니바이오의약품산업육성박차,http://www.enewstoday.co.kr/news/articleView.html?idxno=1032204
624,2017-03-27,fnRASSI대웅제약069620현재645↑,http://www.fnnews.com/news/201703271331505776
625,2017-03-27,대웅제약인도네시아에바이오韓流깃발,http://view.asiae.co.kr/news/view.htm?idxno=2017032709174191902
626,2017-03-27,대웅제약인도네시아발판삼아해외바이오시장공략,http://news20.busan.com/controller/newsController.jsp?newsId=20170327000148
627,2017-03-27,대웅제약바이오메카인도네시아진출본격화,http://www.bosa.co.kr/news/articleView.html?idxno=2057757
628,2017-03-27,대웅제약인도네시아현지정부기관과네트워킹및협력추진,http://www.mdtoday.co.kr/mdtoday/index.html?no=282110
629,2017-03-27,이종욱대웅제약부회장바이오메카인도네시아서산학관협력방안모색,http://www.newsway.co.kr/view.php?tp=1&ud=2017032715262321689
630,2017-03-27,대웅제약인도네시아산학관바이오네트워크구축,http://www.dt.co.kr/contents.html?article_no=2017032702109976029005
631,2017-03-27,대웅제약인도네시아진출잰걸음,http://www.kormedi.com/news/news/drug_dist/1222598_2906.html
632,2017-03-27,리베이트비용줄어드나대웅제약등제약주급등,http://stock.hankyung.com/news/app/newsview.php?aid=2017032717401
633,2017-03-27,대웅제약印尼바이오산업육성협력,http://www.fnnews.com/news/201703272003224269
634,2017-03-27,대웅제약인도네시아바이오파르마와차세대EPO제제개발논의,http://www.viva100.com/main/view.php?key=20170327020019457
635,2017-03-27,대웅제약인도네시아에서산학관협력방안논의,http://www.newscj.com/news/articleView.html?idxno=414457
636,2017-03-28,대웅제약나보타중동베트남진출시작,http://www.newspim.com/news/view/20170328000049
637,2017-03-28,빅데이터MSI시장심리톱5한화코웨이무학SKC대웅제약,http://www.newsis.com/view/?id=NISX20170328_0014792507&cID=10401&pID=10400
638,2017-03-28,ET투자뉴스대웅제약나보타보툴리눔톡신매수유지토러스투자증권,http://www.etnews.com/20170328000073
639,2017-03-28,대웅제약인도네시아진출시동,http://www.foodtvnews.com/view.php?ud=20170328114149471914101_11
640,2017-03-29,투자부동산유한양행1014억대웅제약977억원,http://medipana.com/news/news_viewer.asp?NewsNum=197226&MainKind=A&NewsKind=5&vCount=12&vKind=1
641,2017-03-29,대웅제약나보타바이오의약품허가신청예상미국진출가시화,http://www.asiatoday.co.kr/view.php?key=20170329010018712
642,2017-03-30,대웅제약연이은해외수출계약호실적기대신영證,http://www.seoulfn.com/news/articleView.html?idxno=275769
643,2017-03-30,서울제약대웅제약출신임원영입한이유,http://www.kormedi.com/news/news/drug_dist/1222644_2906.html
644,2017-03-30,대웅국제피부미용성형학회나보타우수성알려,http://www.kpanews.co.kr/article/show.asp?idx=182423&table=article&category=D
645,2017-03-30,대웅제약국제피부미용성형학회에서나보타우수성알려,http://www.asiatoday.co.kr/view.php?key=20170330010019908
646,2017-03-30,대웅제약국제피부미용성형학회서나보타소개,http://www.g-enews.com/ko-kr/news/article/news_all/20170330104835717e6a49afa8d_1/article.html
647,2017-03-30,대웅국제피부미용성형학회서나보타소개,http://www.dailypharm.com/News/223811
648,2017-03-30,대웅제약국제피부미용성형학회서나보타우수성알려,http://www.bosa.co.kr/news/articleView.html?idxno=2058054
649,2017-03-30,대웅제약국제학회에서나보타우수성알려,http://medipana.com/news/news_viewer.asp?NewsNum=197315&MainKind=A&NewsKind=5&vCount=12&vKind=1
650,2017-03-30,대웅제약국제피부미용성형학회에서나보타우수성알려,http://www.mdtoday.co.kr/mdtoday/index.html?no=282438
651,2017-03-30,메로페넴나보타장착한대웅제약글로벌도약날갯짓,http://www.enewstoday.co.kr/news/articleView.html?idxno=1033999
652,2017-03-30,대웅제약국제피부미용성형학회참가,http://www.newstomato.com/ReadNews.aspx?no=742604
653,2017-03-30,대웅제약해외의료진에나보타우수성소개,http://www.kukinews.com/news/article.html?no=443577
654,2017-03-30,대웅IMCAS서나보타우수성알려,http://www.monews.co.kr/news/articleView.html?idxno=99597
655,2017-03-30,대웅제약국제피부미용성형학회서나보타우수성알려,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=204838
656,2017-03-30,대웅제약나보타로국제피부미용성형학회참가,http://news.mk.co.kr/newsRead.php?&year=2017&no=216764
657,2017-03-30,대웅제약국제피부미용성형학회에서나보타우수성소개,http://www.ekn.kr/news/article.html?no=277807
658,2017-03-30,한올바이오파마대웅제약인수후첫세무조사착수,http://www.tfnews.co.kr/news/article.html?no=32402
659,2017-03-30,대웅제약국제피부미용성형학회서나보타우수성알려,http://www.joseilbo.com/news/news_read.php?uid=320611&class=27&grp=
660,2017-03-30,대웅제약나보타국제피부미용성형학회소개,http://www.dailymedi.com/detail.php?number=817249&thread=22r05
661,2017-03-31,작년임상승인대웅제약한국릴리종근당順,http://www.monews.co.kr/news/articleView.html?idxno=99637
662,2017-03-31,대웅제약떠나보낸글리아티린제네릭허가받아,http://www.dailypharm.com/News/223862
663,2017-03-31,대웅제약글리아티린후속글리아스타허가왜,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1040746
664,2017-03-31,지난해임상건수살펴보니바이오항암제가키워드대웅제약서울대병원최다,http://biz.chosun.com/site/data/html_dir/2017/03/31/2017033102273.html
665,2017-03-31,대웅제약글리아티린제네릭글리아스타허가,http://www.mdtoday.co.kr/mdtoday/index.html?no=282594
666,2017-03-31,대웅제약보톡스제품나보타우수성중남미에소개,http://www.foodtvnews.com/view.php?ud=20170331142840194408901_11
667,2017-03-31,대웅제약나보타국제피부미용성형학회에서우수성알려,http://www.newscj.com/news/articleView.html?idxno=415408
668,2017-04-01,대웅바이오글라아타민포장단위유효기간등변경,http://www.kpanews.co.kr/article/show.asp?idx=182499&table=article&category=B
669,2017-04-02,두바이서조우한앙숙대웅제약메디톡스,http://www.finomy.com/news/articleView.html?idxno=43879
670,2017-04-03,사연많은글리아타민대웅vs종근당한판승부,http://www.dailymedi.com/detail.php?number=817327&thread=22r05
671,2017-04-03,대웅인수한올바이오줄퇴사,http://www.newstomato.com/ReadNews.aspx?no=743001
672,2017-04-03,제약톡톡글리아티린뺏긴대웅제네릭으로복수혈전,http://news.heraldcorp.com/view.php?ud=20170403000196
673,2017-04-03,대웅동국제약등중소형제약사주목골든브릿지,http://www.choicenews.co.kr/news/articleView.html?idxno=32497
674,2017-04-03,대웅제약나보타150U,http://www.medical-tribune.co.kr/news/articleView.html?idxno=72067
675,2017-04-03,대웅나보타150U출시,http://www.monews.co.kr/news/articleView.html?idxno=99698
676,2017-04-03,대웅제약나보타150U출시보험최대70지원,http://www.rapportian.com/news/articleView.html?idxno=103007
677,2017-04-03,대웅뇌졸중상지근육경직치료나보타150출시,http://medipana.com/news/news_viewer.asp?NewsNum=197461&MainKind=A&NewsKind=5&vCount=12&vKind=1
678,2017-04-03,대웅제약나보타150U출시의료비절감기대,http://www.dailypharm.com/News/223924
679,2017-04-03,쌍둥이제품전략쏠쏠했나대웅다품목허가가속화,http://medipana.com/news/news_viewer.asp?NewsNum=197452&MainKind=A&NewsKind=5&vCount=12&vKind=1
680,2017-04-03,대웅제약뇌졸중후상지근육경직환자용나보타150U출시,http://www.kpanews.co.kr/article/show.asp?idx=182538&table=article&category=D
681,2017-04-03,대웅제약뇌졸중후상지근육경직치료나보타150U출시,http://www.bosa.co.kr/news/articleView.html?idxno=2058188
682,2017-04-03,대웅제약상지근육경직환자위한나보타150U출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=282737
683,2017-04-04,대웅제약뇌졸중후상지근육경직치료용나보타150U출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1040848
684,2017-04-04,종근당․대웅제약글리아티린둘러싸고경쟁본격화,http://www.sisafocus.co.kr/news/articleView.html?idxno=159313
685,2017-04-04,대웅제약중남미고위관료에최첨단생산설비소개,http://medipana.com/news/news_viewer.asp?NewsNum=197510&MainKind=A&NewsKind=5&vCount=12&vKind=1
686,2017-04-04,중남미보건의료고위관계자대웅오송공장방문,http://www.kpanews.co.kr/article/show.asp?idx=182570&table=article&category=D
687,2017-04-04,대웅제약중남미고위관계자에게오송공장소개,http://stock.hankyung.com/news/app/newsview.php?aid=2017040425986
688,2017-04-04,대웅제약중남미보건의료고위관료에게오송공장의약품생산설비소개,http://biz.chosun.com/site/data/html_dir/2017/04/04/2017040400759.html
689,2017-04-04,대웅제약오송공장중남미보건의료관계자에게생산설비소개,http://news.mk.co.kr/newsRead.php?&year=2017&no=226956
690,2017-04-04,대웅제약중남미6개국보건의료고위관계자에게최첨단의약품생산시설소개,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017040409268019273&outlink=1
691,2017-04-04,대웅제약오송공장중남미보건의료고위관계자들에게최첨단의약품생산설비소개,http://www.viva100.com/main/view.php?key=20170404010000966
692,2017-04-04,중남미보건의료관계자대웅오송공장견학,http://www.edaily.co.kr/news/newspath.asp?newsid=02341926615892840
693,2017-04-04,대웅제약중남미6개국정부관계자오송공장방문,http://www.sedaily.com/NewsView/1OEILI2UQ4
694,2017-04-04,대웅제약오송공장에중남미국가들관심,http://www.dailypharm.com/News/223956
695,2017-04-04,대웅제약중남미관계자들에게최첨단의약품생산설비소개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=204938
696,2017-04-04,중남미보건의료공무원대웅제약공장견학,http://www.dailymedi.com/detail.php?number=817392&thread=22r05
697,2017-04-04,대웅제약중남미고위관계자에오송공장소개,http://www.newsis.com/view/?id=NISX20170404_0014807903&cID=10402&pID=13000
698,2017-04-04,대웅제약오송공장국내의료생산기지한류역할기대,http://www.ekn.kr/news/article.html?no=278735
699,2017-04-04,대웅제약중남미관계자에게오송공장첨단설비소개,http://www.dt.co.kr/contents.html?article_no=2017040402109976029003
700,2017-04-04,중남미6개국보건의료관계자대웅제약방문,http://www.joseilbo.com/news/news_read.php?uid=320944&class=27&grp=
701,2017-04-04,대웅오송공장에중남미관계자방문,http://www.medical-tribune.co.kr/news/articleView.html?idxno=72096
702,2017-04-04,대웅제약오송공장중남미보건의료고위관계자방문,http://www.m-i.kr/news/articleView.html?idxno=301507
703,2017-04-04,중남미보건의료고위관계자들대웅제약오송공장견학,http://www.mdtoday.co.kr/mdtoday/index.html?no=282817
704,2017-04-04,중남미보건의료고위관계자들대웅제약오송공장찾은이유,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017040410142135147
705,2017-04-04,대웅제약오송공장중남미보건의료관계자견학,http://www.bosa.co.kr/news/articleView.html?idxno=2058278
706,2017-04-04,대웅중남미고위관계자에생산설비소개,http://www.monews.co.kr/news/articleView.html?idxno=99756
707,2017-04-04,대웅제약중남미보건의료방문단에오송공장소개,http://www.seoulfn.com/news/articleView.html?idxno=276129
708,2017-04-04,ET투자뉴스대웅_업종평균에비해서변동성대비성과가좋지않아,http://www.etnews.com/20170404000141
709,2017-04-04,대웅제약뇌졸중후근육경직환자위한나보타150U출시,http://www.viva100.com/main/view.php?key=20170404020019532
710,2017-04-04,대웅오송공장찾은중남미고위관료제약산업위상↑,http://www.enewstoday.co.kr/news/articleView.html?idxno=1037504
711,2017-04-04,대웅제약중남미보건의료관계자들에의약품생산설비소개,http://www.ebn.co.kr/news/view/885300
712,2017-04-04,대웅제약공장에관심보이는중남미보건의료관계자들,http://www.breaknews.com/sub_read.html?uid=502206§ion=sc3
713,2017-04-04,대웅제약중남미6개국정부관계자에오송공장소개,http://www.newstomato.com/ReadNews.aspx?no=743783
714,2017-04-04,중남미국가보건의료고위관계자대웅제약최첨단의약품생산설비견학,http://ilyo.co.kr/?ac=article_view&entry_id=240695
715,2017-04-04,아파야챙길래보령제약대웅제약메디포스트,http://www.g-enews.com/ko-kr/news/article/news_all/201704041546196168e6a49afa8d_1/article.html
716,2017-04-04,중남미6개국보건당국관계자대웅제약오송공장견학,http://www.rapportian.com/news/articleView.html?idxno=103040
717,2017-04-04,원조약뺏긴대웅제약복제약으로설욕전,http://www.sisaweek.com/news/articleView.html?idxno=89446
718,2017-04-04,일동대웅보령습윤드레싱재신제품출시로메디폼아성에도전,http://www.viva100.com/main/view.php?key=20170404020019544
719,2017-04-04,대웅제약오송공장중남미고위관계자들최첨단의약품생산설비견학,http://www.newscj.com/news/articleView.html?idxno=416300
720,2017-04-05,대웅제약12세대영업자존심진검승부촉각,http://www.ajunews.com/view/20170330130032513
721,2017-04-05,대웅제약우루사국내전문간장약매출1위내줘,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170404155200017&did=1195m
722,2017-04-05,대웅우루사간장약전문의약품1위자리내줬다,http://news.heraldcorp.com/view.php?ud=20170405000076
723,2017-04-05,대웅제약우루사간장약1위자리뺐겼다,http://www.ebn.co.kr/news/view/885404
724,2017-04-05,대웅제약우루사셀트리온고덱스에전문의약품매출1위자리내줘,http://www.etoday.co.kr/news/section/newsview.php?idxno=1476736
725,2017-04-05,대웅제약우루사국내간장약전문의약품매출1위내줘,http://www.newsway.co.kr/view.php?tp=1&ud=2017040509162088273
726,2017-04-05,대웅제약중국심양약대와5건의협력연구및대웅연구실설립,http://www.viva100.com/main/view.php?key=20170405010001440
727,2017-04-05,대웅제약중국심양약대내대웅연구실설립키로,http://www.asiatoday.co.kr/view.php?key=20170405010002731
728,2017-04-05,대웅제약중국서신약개발연구가속화,http://www.edaily.co.kr/news/newspath.asp?newsid=02174646615893168
729,2017-04-05,대웅중국심양약대에대웅연구실설립키로,http://www.kpanews.co.kr/article/show.asp?idx=182615&table=article&category=D
730,2017-04-05,대웅제약중국공략오픈콜라보레이션가속화,http://www.dailypharm.com/News/223987
731,2017-04-05,대웅제약중국심양약대와협력연구5건계약체결,http://www.fnnews.com/news/201704050940243219
732,2017-04-05,대웅제약중국심양약대와협력연구계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=282925
733,2017-04-05,고창소방선운사대웅전서현장적응훈련실시,http://www.jeonmin.co.kr/news/articleView.html?idxno=167499
734,2017-04-05,대웅제약中심양약대와알츠하이머치료제공동연구,http://www.newspim.com/news/view/20170405000097
735,2017-04-05,대웅제약중국심양약대에연구실설립협력연구계약체결,http://www.dt.co.kr/contents.html?article_no=2017040502109976029005
736,2017-04-05,대웅제약중국심양약대와신약5건협력연구계약체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=204972
737,2017-04-05,아파야챙길래대웅제약동화약품동국제약,http://www.g-enews.com/ko-kr/news/article/news_all/201704051006526828e6a49afa8d_1/article.html
738,2017-04-05,대웅제약중국심양약대에대웅연구실설립,http://www.newsis.com/view/?id=NISX20170405_0014810529&cID=10402&pID=13000
739,2017-04-05,대웅제약중국심양약대와협력연구5건계약체결,http://medipana.com/news/news_viewer.asp?NewsNum=197589&MainKind=A&NewsKind=5&vCount=12&vKind=1
740,2017-04-05,대웅제약중국심양약대와협력연구,http://www.medical-tribune.co.kr/news/articleView.html?idxno=72121
741,2017-04-05,대웅제약中심양대약대와신약개발연구협력맺어,http://www.rapportian.com/news/articleView.html?idxno=103055
742,2017-04-05,대웅제약심양약대와손잡고중국시장공략,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017040511118057961&outlink=1
743,2017-04-05,대웅제약中협업다각화에속도낸다,http://www.enewstoday.co.kr/news/articleView.html?idxno=1038078
744,2017-04-05,대웅제약중국심양약대와신약공동개발,http://www.newstomato.com/ReadNews.aspx?no=744016
745,2017-04-05,자존심상한대웅제약우루사고덱스에간장치료제1위내줘,http://www.shinailbo.co.kr/news/articleView.html?idxno=569389
746,2017-04-05,대웅제약中심양약대와공동연구계약,http://www.dailymedi.com/detail.php?number=817435&thread=22r05
747,2017-04-05,대웅제약중국심양약대내연구실설립키로,http://www.bosa.co.kr/news/articleView.html?idxno=2058370
748,2017-04-05,메디톡스휴젤대웅보툴리눔삼각편대글로벌시장뜬다,http://www.kormedi.com/news/news/drug_dist/1222741_2906.html
749,2017-04-05,대웅中심양약대에연구실설립,http://www.monews.co.kr/news/articleView.html?idxno=99810
750,2017-04-05,대웅제약심양약대등과신약개발협력,http://www.doctorsnews.co.kr/news/articleView.html?idxno=116239
751,2017-04-05,대웅제약中심양약대와협력연구계약체결,http://www.kukinews.com/news/article.html?no=444926
752,2017-04-05,대웅제약중국심양약대과함께연구개발콜라보레이션가속화,http://www.ekn.kr/news/article.html?no=279098
753,2017-04-05,대웅제약우루사셀트리온제약에간장약1위내줘,http://www.seoulfn.com/news/articleView.html?idxno=276241
754,2017-04-05,대웅제약中오픈콜라보레이션가속화,http://www.m-i.kr/news/articleView.html?idxno=301924
755,2017-04-05,대웅제약중국심양약대와5건의협력연구과제추진,http://www.newsway.co.kr/view.php?tp=1&ud=2017040514462966562
756,2017-04-05,대웅제약中심양약대에대웅연구실설립,http://news20.busan.com/controller/newsController.jsp?newsId=20170405000191
757,2017-04-05,대웅제약中심양약대와협력연구계약체결및대웅연구실설립키로,http://ilyo.co.kr/?ac=article_view&entry_id=240968
758,2017-04-05,셀트리온대웅제약꺾고간치료제전문의약품서1위,http://news.mk.co.kr/newsRead.php?&year=2017&no=231613
759,2017-04-05,대웅제약중국선양대와신약개발추진,http://www.finomy.com/news/articleView.html?idxno=43985
760,2017-04-05,대웅제약중국심양약대와협력연구5건계약체결,http://sports.hankooki.com/lpage/life/201704/sp20170405175600136800.htm
761,2017-04-05,대웅제약中심양약대와협력연구계약,http://www.seoulfn.com/news/articleView.html?idxno=276278
762,2017-04-05,대웅제약중국심양약대와협력연구계약체결,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201704051828002&code=900303
763,2017-04-06,클릭e종목대웅제약나보타기대감극대화,http://view.asiae.co.kr/news/view.htm?idxno=2017040607331045649
764,2017-04-06,대웅제약나보타기대감극대화전망목표가↑NH,http://stock.hankyung.com/news/app/newsview.php?aid=2017040687766
765,2017-04-06,대웅제약나보타가치상승목표주가상향NH,http://www.mt.co.kr/view/mtview.php?type=1&no=2017040607564963642&outlink=1
766,2017-04-06,대웅제약나보타FDA허가신청목표주가↑,http://www.asiatoday.co.kr/view.php?key=20170406010003461
767,2017-04-06,대웅제약나보타FDA허가신청기대목표주가↑NH투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017040608105692282
768,2017-04-06,NH투자대웅제약글로벌고성장지속목표가↑,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170406033000008&did=1195m
769,2017-04-06,HotLine대웅제약글로벌고성장지속목표가↑,http://news.mk.co.kr/newsRead.php?&year=2017&no=232828
770,2017-04-06,대웅제약나보타미국가치상승목표가↑NH투자증권,http://www.edaily.co.kr/news/newspath.asp?newsid=01836806615893496
771,2017-04-06,NH투자증권대웅제약글로벌고성장”목표가올려,http://www.viva100.com/main/view.php?key=20170406010001900
772,2017-04-06,ET투자뉴스대웅제약FDA허가신청으로매수유지NH투자증권,http://www.etnews.com/20170406000090
773,2017-04-06,대웅제약의약품수출호조로올해실적늘듯,http://www.businesspost.co.kr/news/articleView.html?idxno=46574
774,2017-04-06,함양수동면대웅축산장학금200만원기탁,http://www.gnnews.co.kr/news/articleView.html?idxno=295271
775,2017-04-07,함양대웅축산재영농장장학회에200만원씩,http://www.knnews.co.kr/news/articleView.php?idxno=1211106
776,2017-04-07,코오롱생명과학대웅영진파이프라인기대감에주가상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=283161
777,2017-04-07,신약RD③대웅제약리버스이노베이션에서답을찾다,http://www.seoulfn.com/news/articleView.html?idxno=276463
778,2017-04-10,기획아버지의그림자를지워라동아대웅JW중외제일,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1041045
779,2017-04-10,대웅제약지난해기간제근로자증가율240제약업계최고,http://www.ceoscoredaily.com/news/article.html?no=28664
780,2017-04-10,대웅제약업계최초NCS일학습병행제시행,http://medipana.com/news/news_viewer.asp?NewsNum=197775&MainKind=A&NewsKind=5&vCount=12&vKind=1
781,2017-04-10,대웅업계최초의약품영업NCS일학습병행제도입,http://www.kpanews.co.kr/article/show.asp?idx=182773&table=article&category=D
782,2017-04-10,대웅제약업계최초의약품영업NCS일학습병행제시행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=205099
783,2017-04-10,대웅의약품영업NCS일학습병행제시행,http://www.monews.co.kr/news/articleView.html?idxno=100011
784,2017-04-10,대웅제약의약품영업NCS일학습병행제도입,http://www.newsis.com/view/?id=NISX20170410_0014820951&cID=10402&pID=13000
785,2017-04-10,대웅제약업계최초의약품영업NCS일학습병행제시행,http://news.mk.co.kr/newsRead.php?&year=2017&no=242015
786,2017-04-10,대웅최초의약품영업NCS일학습병행제,http://www.bosa.co.kr/news/articleView.html?idxno=2058676
787,2017-04-10,대웅제약업계최초NCS일학습병행제시행,http://news.mt.co.kr/view/mtview.php?no=2017041011242753728&outlink=1
788,2017-04-10,대웅제약NCS일학습병행제로영업전문가육성,http://www.newsway.co.kr/view.php?tp=1&ud=2017041011492697832
789,2017-04-10,대웅제약업계최초의약품영업NCS일학습병행제시행영업전문가육성,http://www.viva100.com/main/view.php?key=20170410010003187
790,2017-04-10,대웅제약직원37명공인의약품영업교육수료,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1041063
791,2017-04-10,대웅제약업계첫NCS일학습병행제운영,http://www.dailymedi.com/detail.php?number=817592&thread=22r05
792,2017-04-10,대웅제약업계최초의약품영업NCS일학습병행제시행,http://www.g-enews.com/ko-kr/news/article/news_all/201704101317562811e6a49afa8d_1/article.html
793,2017-04-10,대웅의약품영업NCS일학습병행시행,http://www.dailypharm.com/News/224155
794,2017-04-10,대웅제약의약품영업NCS일학습병행제실시,http://news20.busan.com/controller/newsController.jsp?newsId=20170410000161
795,2017-04-10,대웅제약업계최초의약품영업NCS일학습병행제시행,http://www.asiatoday.co.kr/view.php?key=20170410010006056
796,2017-04-10,대웅제약의약품영업국가직무능력표준일학습병행제시행,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017041016088010837&outlink=1
797,2017-04-10,대웅제약의약품영업NCS일학습병행제시행으로전문가육성,http://sports.hankooki.com/lpage/life/201704/sp20170410162045136800.htm
798,2017-04-10,대웅제약업계최초의약품영업NCS일학습병행제시행,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017041015342129054
799,2017-04-10,브랜드아카데미함께한대웅제약이지덤상처치료엔이지덤”인식남겨,http://www.hankyung.com/news/app/newsview.php?aid=201704109200a
800,2017-04-10,대웅제약업계최초의약품영업NCS일학습병행제시행,http://ilyo.co.kr/?ac=article_view&entry_id=241779
801,2017-04-10,대웅제약의약품영업NCS일학습병행제로영업전문가육성,http://www.mdtoday.co.kr/mdtoday/index.html?no=283330
802,2017-04-10,대웅제약업계최초의약품영업NCS일학습병행제시행,http://www.newscj.com/news/articleView.html?idxno=417421
803,2017-04-11,제약株1분기낮아진눈높이충족대웅제약최선호유진,http://stock.hankyung.com/news/app/newsview.php?aid=2017041199646
804,2017-04-11,대웅제약업계최초영업전문가육성,http://www.kormedi.com/news/news/drug_dist/1222840_2906.html
805,2017-04-12,더벨대웅제약세엘진GSK등과기술수출논의,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201704110100018740001133
806,2017-04-12,BIOKOREA2017영상글로벌네트워크기반헬스케어산업을리딩하는대웅제약,http://kr.aving.net/news/view.php?articleId=1377343&Branch_ID=kr&rssid=naver&mn_name=news
807,2017-04-13,CJ헬스5천억대웅바이오2천억휴텍스1천억돌파,http://www.dailypharm.com/News/224290
808,2017-04-13,빅데이터MSI시장심리톱5CJ한국전력대웅제약OCI한국가스공사,http://www.newsis.com/view/?id=NISX20170413_0014828455&cID=10427&pID=10400
809,2017-04-13,대웅등바이오제약5개기업연구기관복지부표창,http://medipana.com/news/news_viewer.asp?NewsNum=197963&MainKind=A&NewsKind=5&vCount=12&vKind=1
810,2017-04-13,대웅제약김도영팀장등복지부장관상수상,http://www.medicaltimes.com/News/1111181
811,2017-04-13,대웅제약김도영팀장장관표창안국약품수출계약,http://www.dailypharm.com/News/224313
812,2017-04-13,CJ헬스케어대웅바이오한국휴텍스등비상장제약사급성장눈길,http://www.mdtoday.co.kr/mdtoday/index.html?no=283639
813,2017-04-14,대웅제약해외법인손실눈덩이10곳중7곳적자허덕,http://www.ceoscoredaily.com/news/article.html?no=28770
814,2017-04-17,전자식흡연욕구저하제시장매출기대↓광동대웅등사업철수하나,http://www.mdtoday.co.kr/mdtoday/index.html?no=283834
815,2017-04-18,직원건강이우선대웅제약건강하자캠페인진행,http://medipana.com/news/news_viewer.asp?NewsNum=198161&MainKind=A&NewsKind=5&vCount=12&vKind=1
816,2017-04-18,직원건강이우선대웅제약건강하자캠페인눈길,http://www.kpanews.co.kr/article/show.asp?idx=183043&table=article&category=D
817,2017-04-18,대웅제약임직원건강캠페인진행,http://www.sedaily.com/NewsView/1OEP1FHPBQ
818,2017-04-18,직원건강이우선”대웅제약건강하자캠페인눈길,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=205366
819,2017-04-18,대웅제약직원건강부터건강하자캠페인,http://www.bosa.co.kr/news/articleView.html?idxno=2059241
820,2017-04-18,대웅제약건강하자캠페인으로임직원건강챙긴다,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017041810538053910&outlink=1
821,2017-04-18,대웅제약건강하자캠페인진행직원건강이우선,http://news.mk.co.kr/newsRead.php?&year=2017&no=261818
822,2017-04-18,대웅제약직원대상건강캠페인진행,http://www.rapportian.com/news/articleView.html?idxno=103301
823,2017-04-18,대웅글로벌도약은직원건강이먼저,http://www.dailypharm.com/News/224477
824,2017-04-18,대웅제약건강하자캠페인눈길건강지킴이프로그램도입,http://www.etnews.com/20170418000161
825,2017-04-18,아파야챙길래광동제약대웅제약,http://www.g-enews.com/ko-kr/news/article/news_all/201704181344335902e6a49afa8d_1/article.html
826,2017-04-18,대웅제약체계화된건강하자캠페인운영,http://www.m-i.kr/news/articleView.html?idxno=304970
827,2017-04-18,대웅제약직원건강지킴이프로그램도입,http://www.kukinews.com/news/article.html?no=448035
828,2017-04-18,대웅제약건강하자캠페인눈길,http://www.joseilbo.com/news/news_read.php?uid=322240&class=27&grp=
829,2017-04-18,대웅제약임직원위한건강하자캠페인,http://www.mdtoday.co.kr/mdtoday/index.html?no=283927
830,2017-04-18,대웅제약건강하자캠페인눈길,http://www.newscj.com/news/articleView.html?idxno=418949
831,2017-04-18,대웅제약직원건강챙기는건강하자캠페인눈길,http://sports.hankooki.com/lpage/life/201704/sp20170418164852136800.htm
832,2017-04-19,유한양행녹십자대웅제약제약사1분기매출순풍,http://www.ajunews.com/view/20170418125917021
833,2017-04-19,대웅제약항생제메로페넴미국시장진출,http://medipana.com/news/news_viewer.asp?NewsNum=198234&MainKind=A&NewsKind=5&vCount=12&vKind=1
834,2017-04-19,대웅제약항생제메로페넴미국출시,http://www.viva100.com/main/view.php?key=20170419010006635
835,2017-04-19,대웅제약국산복제약최초메로페넴美시판,http://news1.kr/articles/?2971192
836,2017-04-19,대웅제약항생제메로페넴미국시장서발매,http://www.rapportian.com/news/articleView.html?idxno=103333
837,2017-04-19,대웅제약항생제메로페넴미국출시한국제네릭최초진출,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1041436
838,2017-04-19,대웅제약항생제메로페넴미국시장진출,http://www.newsway.co.kr/view.php?tp=1&ud=2017041910582994599
839,2017-04-19,대웅제약항생제메로페넴미국수출,http://www.ebn.co.kr/news/view/887773
840,2017-04-19,대웅제약메노페넴국산제네릭최초미국수출,http://www.sedaily.com/NewsView/1OEPH5GMZF
841,2017-04-19,대웅제약항생제메로페넴미국출시韓복제약중최초,http://stock.hankyung.com/news/app/newsview.php?aid=2017041911546
842,2017-04-19,대웅제약항생제메로페넴으로미국시장뚫었다,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=101&oid=050&aid=0000044038
843,2017-04-19,대웅제약항생제메로페넴미국출시,http://www.bosa.co.kr/news/articleView.html?idxno=2059327
844,2017-04-19,대웅제약항생제메로페넴미국시장출시,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170419085000017&did=1195m
845,2017-04-19,대웅제약항생제메로페넴미국출시,http://www.etnews.com/20170419000128
846,2017-04-19,대웅제약항생제메로페넴미국정식발매,http://www.dt.co.kr/contents.html?article_no=2017041902109976029003
847,2017-04-19,대웅제약메로페넴국산제네릭최초美발매,http://view.asiae.co.kr/news/view.htm?idxno=2017041911255282445
848,2017-04-19,대웅제약항생제메로페넴미국출시국산복제약중최초”,http://biz.chosun.com/site/data/html_dir/2017/04/19/2017041901343.html
849,2017-04-19,대웅제약항생제메로페넴美출시,http://www.m-i.kr/news/articleView.html?idxno=305312
850,2017-04-19,대웅제약항생제메로페넴미국출시국산복제약첫진출,http://www.ajunews.com/view/20170419112513220
851,2017-04-19,대웅항생제메로페넴미국서판다한국제네릭첫진출,http://www.kpanews.co.kr/article/show.asp?idx=183085&table=article&category=D
852,2017-04-19,대웅제약첫FDA승인제네릭항생제메로페넴미국시장출시,http://www.ekn.kr/news/article.html?no=282252
853,2017-04-19,대웅제약메로페넴美출시韓복제약최초,http://www.enewstoday.co.kr/news/articleView.html?idxno=1045765
854,2017-04-19,대웅제약항생제메로페넴美출시,http://www.medical-tribune.co.kr/news/articleView.html?idxno=72344
855,2017-04-19,대웅제약항생제메로페넴미국출시,http://www.medigatenews.com/news/2341832154
856,2017-04-19,대웅항생제메로페넴미국출시,http://www.monews.co.kr/news/articleView.html?idxno=100393
857,2017-04-19,대웅제약메로페넴국산복제약사상첫美판매,http://news.mt.co.kr/view/mtview.php?no=2017041913371349935&outlink=1
858,2017-04-19,의료바이오대웅제약미국항생제시장첫진출,http://www.etnews.com/20170419000265
859,2017-04-19,대웅제약항생제메로페넴미국시장출시,http://www.asiatoday.co.kr/view.php?key=20170419010012184
860,2017-04-19,대웅제약항생제메로페넴미국출시국산제네릭최초,http://www.mdtoday.co.kr/mdtoday/index.html?no=284020
861,2017-04-19,대웅제약항생제메로페넴미국출시,http://www.kukinews.com/news/article.html?no=448338
862,2017-04-19,대웅제약메로페넴국산제네릭최초미국수출,http://www.sedaily.com/NewsView/1OEPHBO3KY
863,2017-04-19,대웅제약미국시장에제네릭의약품메로페넴발매,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=103&oid=014&aid=0003805187
864,2017-04-19,대웅제약제네릭항생제메로페넴미국수출,http://www.newsis.com/view/?id=NISX20170419_0014841232&cID=10434&pID=13000
865,2017-04-19,대웅제약항생제메로페넴미국첫수출,http://biz.newdaily.co.kr/news/article.html?no=10130653
866,2017-04-19,아파야챙길래JW중외제약대웅제약동구바이오제약,http://www.g-enews.com/ko-kr/news/article/news_all/201704191505409001e6a49afa8d_1/article.html
867,2017-04-19,대웅한국제네릭의약품최초미국시장진출,http://www.dailymedi.com/detail.php?number=817918&thread=22r05
868,2017-04-19,대웅제약항생제메로페넴미국출시한국제네릭최초,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017041914200619904
869,2017-04-19,대웅제약항생제메로페넴미국출시,http://www.sportsseoul.com/news/read/504459
870,2017-04-19,대웅제약항생제메로페넴미국출시,http://www.newstomato.com/ReadNews.aspx?no=747745
871,2017-04-19,3월처방액종근당유한한미늘고대웅동아줄었다,http://www.sisajournal-e.com/biz/article/167829
872,2017-04-19,대웅제약항생제메로페넴美출시,http://www.joseilbo.com/news/news_read.php?uid=322394&class=27&grp=
873,2017-04-19,대웅제약항생제메로페넴美진출,http://news.mk.co.kr/newsRead.php?&year=2017&no=266324
874,2017-04-19,대웅제약제네릭항생제메로페넴美진출,http://news20.busan.com/controller/newsController.jsp?newsId=20170419000211
875,2017-04-19,대웅제약미국서항생제메로페넴출시,http://www.newspim.com/news/view/20170419000312
876,2017-04-19,대웅제약항생제메로페넴미국출시,http://sports.hankooki.com/lpage/life/201704/sp20170419173320136800.htm
877,2017-04-19,대웅제약복제약항생제메로페넴미국출시,http://www.hankyung.com/news/app/newsview.php?aid=2017041924021
878,2017-04-19,대웅제약메로페넴한국제네릭의약품최초미국시장진출,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017041918318035981&outlink=1
879,2017-04-19,대웅제약항생제메로페넴미국시장발매外,http://sports.donga.com/3/all/20170419/83948420/1
880,2017-04-19,대웅복제약메로페넴美진출비결해외콜라보덕분,http://news1.kr/articles/?2971934
881,2017-04-19,대웅제약항생제메로페넴미국출시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1482293
882,2017-04-19,대웅제약항생제메로페넴미국출시,http://www.newscj.com/news/articleView.html?idxno=419294
883,2017-04-20,해설대웅제약메로페넴美발매의미,http://www.bosa.co.kr/news/articleView.html?idxno=2059351
884,2017-04-20,대웅제약항생제메로페넴미국출시,https://cnbc.sbs.co.kr/article_hub/10000855981?division=NAVER
885,2017-04-20,대웅제약항생제메로페넴미국진출,http://www.edaily.co.kr/news/newspath.asp?newsid=01748246615898088
886,2017-04-20,대웅제약메로페넴한국제네릭최초미국출시,http://www.kormedi.com/news/news/drug_dist/1222994_2906.html
887,2017-04-20,美입성대웅제약메로페넴향후성장가능성은,http://www.enewstoday.co.kr/news/articleView.html?idxno=1046503
888,2017-04-20,국산복제약미국시장첫진출대웅메로페넴14일시판,http://www.newstomato.com/ReadNews.aspx?no=748040
889,2017-04-20,대웅제약이제네릭으로미국시장진출한이유는,http://www.doctorsnews.co.kr/news/articleView.html?idxno=116535
890,2017-04-20,대웅에데인식약처대조약선정기준손질,http://www.medicaltimes.com/News/1111317
891,2017-04-21,대웅두달만에글리아티린대조약지위상실할듯,http://www.dailypharm.com/News/224597
892,2017-04-21,초점미국진출국산제네릭1호만든대웅제약의전략은,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1041515
893,2017-04-21,대웅글리아티린대조약논란종지부식약처고시개정,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1041527
894,2017-04-21,대웅올1분기글리아티린시장종근당에승勝,http://www.dailymedi.com/detail.php?number=817989&thread=22r05
895,2017-04-21,美시장두드리는대웅제약나보타균주출처변수로,http://biz.newdaily.co.kr/news/article.html?no=10130876
896,2017-04-21,뇌기능개선제글리아티린대조약다시대웅제약→종근당,http://news1.kr/articles/?2973201
897,2017-04-21,美항생제시장공략나선대웅제약의속도전눈길항생제제네릭최초수출,http://biz.chosun.com/site/data/html_dir/2017/04/21/2017042102429.html
898,2017-04-21,대웅제약상처만남은글리아티린수싸움,http://www.sisaweek.com/news/articleView.html?idxno=90221
899,2017-04-22,상위제약사임원영입활발대웅출신최다,http://www.dailymedi.com/detail.php?number=817997&thread=22r05
900,2017-04-24,대웅자회사기업가치상승목표가↑골든브릿지,http://stock.hankyung.com/news/app/newsview.php?aid=2017042417606
901,2017-04-24,특징주대웅자회사벨류에이션상승전망에상승세,http://www.dailian.co.kr/news/view/628306/?sc=naver
902,2017-04-24,특징주대웅8일째상승자회사가치부각,http://stock.hankyung.com/news/app/newsview.php?aid=2017042420496
903,2017-04-24,대웅대웅제약기업가치크게상승할가능성,http://www.choicenews.co.kr/news/articleView.html?idxno=32919
904,2017-04-24,대웅자회사들가치부각에연일오름세,http://www.newsprime.co.kr/news/article.html?no=372606
905,2017-04-24,대웅제약상반기공채실시,http://www.edaily.co.kr/news/newspath.asp?newsid=02187766615899400
906,2017-04-24,대웅그룹상반기신입경력사원150명공개채용,http://www.jobnjoy.com/portal/jobnews/medium_company_view.jsp?nidx=205713&depth1=1&depth2=1&depth3=6
907,2017-04-24,대웅그룹2017년상반기신입경력사원150명공개채용,http://www.newsis.com/view/?id=NISX20170424_0014850462&cID=10409&pID=13000
908,2017-04-24,대웅2017년상반기신입∙경력사원공개채용실시,http://medipana.com/news/news_viewer.asp?NewsNum=198449&MainKind=A&NewsKind=5&vCount=12&vKind=1
909,2017-04-24,대웅제약신입경력직150명공개채용,http://view.asiae.co.kr/news/view.htm?idxno=2017042410250989045
910,2017-04-24,대웅제약2017년상반기신입및경력사원공채,http://www.sedaily.com/NewsView/1OERSCF8HD
911,2017-04-24,대웅150여명규모신입∙경력사원공개채용,http://www.kpanews.co.kr/article/show.asp?idx=183218&table=article&category=D
912,2017-04-24,대웅그룹2017년상반기신입경력사원공개채용실시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017042410150955142
913,2017-04-24,대웅그룹2017년상반기신입경력공개채용실시,http://www.viva100.com/main/view.php?key=20170424010008314
914,2017-04-24,대웅그룹2017년상반기신입∙경력사원공개채용실시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=205502
915,2017-04-24,대웅신입경력사원공개채용실시,http://www.bosa.co.kr/news/articleView.html?idxno=2059615
916,2017-04-24,대웅그룹상반기신입및경력사원150여명채용,http://news.mt.co.kr/view/mtview.php?no=2017042410150305536&outlink=1
917,2017-04-24,대웅제약상반기신입및경력공채실시,http://www.g-enews.com/ko-kr/news/article/news_all/201704241127132180e6a49afa8d_1/article.html
918,2017-04-24,대웅그룹2017년상반기신입경력150명공채,http://www.dailypharm.com/News/224711
919,2017-04-24,대웅그룹2017상반기신입경력사원공채실시,http://www.m-i.kr/news/articleView.html?idxno=306471
920,2017-04-24,대한민국이좋다대웅그룹관계사시지바이오미혼모건강관리제품전달,http://www.m-i.kr/news/articleView.html?idxno=306491
921,2017-04-24,대웅그룹2017년상반기신입경력사원공개채용150여명규모,http://www.newsway.co.kr/view.php?tp=1&ud=2017042411275158850
922,2017-04-24,대웅제약계열사시지바이오임신부에튼살관리제품,http://www.medical-tribune.co.kr/news/articleView.html?idxno=72412
923,2017-04-24,대웅그룹2017년상반기공채실시,http://www.monews.co.kr/news/articleView.html?idxno=100570
924,2017-04-24,대웅2017년상반기신입경력150명채용,http://news1.kr/articles/?2975649
925,2017-04-24,대웅그룹신입경력사원150여명공개채용,http://www.hankyung.com/news/app/newsview.php?aid=201704242867i
926,2017-04-24,대웅그룹상반기신입경력사원공개채용,http://news.heraldcorp.com/view.php?ud=20170424000681
927,2017-04-24,대웅그룹2017년상반기신입경력사원공개채용,http://www.seoulfn.com/news/articleView.html?idxno=277601
928,2017-04-24,대웅그룹상반기신입경력사원150명채용,http://www.etoday.co.kr/news/section/newsview.php?idxno=1483732
929,2017-04-24,대웅그룹2017년상반기신입경력사원공개채용,http://ilyo.co.kr/?ac=article_view&entry_id=244225
930,2017-04-24,대웅그룹상반기공개채용실시150여명규모,http://www.etnews.com/20170424000264
931,2017-04-24,대웅제약새얼굴찾습니다150여명규모공채실시,http://ciobiz.etnews.com/20170424120022
932,2017-04-24,대웅그룹신입경력직150여명공채실시,http://www.rapportian.com/news/articleView.html?idxno=103424
933,2017-04-24,대웅그룹2017년상반기신입경력사원150여명공개채용,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017042416318022870&outlink=1
934,2017-04-24,대웅그룹올상반기신입∙경력사원공채,http://www.joseilbo.com/news/news_read.php?uid=322846&class=27&grp=
935,2017-04-24,대웅그룹상반기신입경력사원공개채용실시,http://www.sportsseoul.com/news/read/506191
936,2017-04-24,대웅그룹2017년상반기신입경력공채실시,http://www.metroseoul.co.kr/news/newsview?newscd=2017042400077
937,2017-04-24,대웅그룹신입경력사원공채실시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1041614
938,2017-04-24,대웅제약150명공개채용해외법인직원국내모집,http://news.mk.co.kr/newsRead.php?&year=2017&no=277660
939,2017-04-24,대웅그룹2017년상반기신입경력사원공개채용실시,http://sports.hankooki.com/lpage/life/201704/sp20170424175520136800.htm
940,2017-04-24,Job뉴스대웅그룹상반기신입경력사원공채,http://news.kmib.co.kr/article/view.asp?arcid=0923735878&code=11151400&cp=nv
941,2017-04-24,대웅그룹2017년상반기신입경력사원공개채용,http://www.newscj.com/news/articleView.html?idxno=420211
942,2017-04-25,대웅그룹상반기공채,http://sports.donga.com/3/all/20170424/84049213/3
943,2017-04-25,대웅그룹2017상반기신입경력사원공개채용,http://www.newspim.com/news/view/20170425000047
944,2017-04-25,자회사실적훈풍대웅신진에스엠주목,http://news.heraldcorp.com/view.php?ud=20170425000084
945,2017-04-25,자회사실적훈풍대웅신진에스엠기지개,http://news.heraldcorp.com/view.php?ud=20170425000474
946,2017-04-25,분석대웅제약은왜인도네시아로갔나바이오집중공략,http://biz.newdaily.co.kr/news/article.html?no=10131106
947,2017-04-25,대웅그룹2017년상반기신입경력사원공개채용,http://www.kukinews.com/news/article.html?no=449904
948,2017-04-26,대웅제약복제약메로페넴미국시장상륙주목,http://www.ajunews.com/view/20170425105819364
949,2017-04-26,사설대웅제약의글로벌도전방식에거는기대,http://www.dailypharm.com/News/224787
950,2017-04-26,직원성장이먼저다인재를아끼는대웅제약,http://news.heraldcorp.com/view.php?ud=20170425000176
951,2017-04-26,영인프런티어대웅제약에14억원규모정보화시스템판매,http://www.mt.co.kr/view/mtview.php?type=1&no=2017042611402022416&outlink=1
952,2017-04-26,영인프런티어대웅제약과144억규모실험실정보화시스템공급계약체결,http://news.heraldcorp.com/view.php?ud=20170426000613
953,2017-04-26,영인프런티어대웅제약과14억4700만원규모공급계약,http://www.newstomato.com/ReadNews.aspx?no=749356
954,2017-04-26,일하기좋은기업대웅제약,http://www.metroseoul.co.kr/news/newsview?newscd=2017042600025
955,2017-04-26,영인프런티어대웅제약실험실정보화시스템공급계약,http://www.etoday.co.kr/news/section/newsview.php?idxno=1484813
956,2017-04-26,영인프런티어LIMS솔루션사업가속화대웅제약과계약체결,http://stock.hankyung.com/news/app/newsview.php?aid=2017042695106
957,2017-04-26,영인프런티어대웅제약실험실정보화시스템공급계약체결상보,http://www.newstomato.com/ReadNews.aspx?no=749384
958,2017-04-26,영인프런티어대웅제약과14억LIMS구축계약,http://www.mt.co.kr/view/mtview.php?type=1&no=2017042613231248822&outlink=1
959,2017-04-26,특징주영인프런티어대웅제약실험실정보화시스템공급수주에상승세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1484832
960,2017-04-26,영인프런티어대웅제약실험실정보화시스템공급,http://www.edaily.co.kr/news/newspath.asp?newsid=03358726615900056
961,2017-04-26,영인프런티어대웅제약과14억규모LIMS공급계약,http://www.newsis.com/view/?id=NISX20170426_0014856390&cID=10401&pID=10400
962,2017-04-26,대웅제약5월8일월까지신입및경력사원공개채용,http://www.ekn.kr/news/article.html?no=283878
963,2017-04-26,글리아티린대조약지정대웅제약반발식약처문제없어,http://medipana.com/news/news_viewer.asp?NewsNum=198541&MainKind=A&NewsKind=5&vCount=12&vKind=1
964,2017-04-27,대웅글리아티린등대조약251개목록무더기삭제,http://www.kpanews.co.kr/article/show.asp?idx=183336&table=article&category=D
965,2017-04-27,대웅제약점심시간은자기계발시간자율타임제만족도높네,http://www.edaily.co.kr/news/newspath.asp?newsid=03011046615900384
966,2017-04-27,대웅제약플렉서블자율타임제성공적운영,http://medipana.com/news/news_viewer.asp?NewsNum=198652&MainKind=A&NewsKind=5&vCount=12&vKind=1
967,2017-04-27,대웅바이오글리아타민등치매관련제네릭4개품목블록버스터등극,http://www.mdtoday.co.kr/mdtoday/index.html?no=284696
968,2017-04-27,대웅제약점심시간에어학공부하러가요,http://www.bosa.co.kr/news/articleView.html?idxno=2059891
969,2017-04-27,대웅제약플렉서블자율타임제정착,http://sports.hankooki.com/lpage/life/201704/sp20170427115828136800.htm
970,2017-04-27,근무제부터직급제까지싹다바꾼대웅제약,http://www.mt.co.kr/view/mtview.php?type=1&no=2017042615334074866&outlink=1
971,2017-04-27,국산제네릭쾌거대웅제약美진출본격화,http://www.g-enews.com/ko-kr/news/article/news_all/201704271413258260e6a49afa8d_1/article.html
972,2017-04-27,대웅제약플렉서블자율타임제운영,http://news.mk.co.kr/newsRead.php?&year=2017&no=286323
973,2017-04-27,점심시간에어학공부대웅제약플렉서블자율타임제운영,http://www.g-enews.com/ko-kr/news/article/news_all/201704271425362570e6a49afa8d_1/article.html
974,2017-04-27,대웅제약자기주도플렉서블자율타임제정착,http://www.dailypharm.com/News/224885
975,2017-04-27,대웅제약플렉서블자율타임제정착,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=205619
976,2017-04-27,대웅제약플렉서블자율타임제정착,http://www.etnews.com/20170427000546
977,2017-04-27,대웅제약플렉서블자율타임제정착점심시간활용해어학공부해요,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017042718150521709
978,2017-04-28,외자사판권회수반전시킨CJ대웅유한제네릭,http://www.dailymedi.com/detail.php?number=818204&thread=22r05
979,2017-04-28,대웅제약에는직급이없다직원경쟁력강화에올인,http://www.sisaon.co.kr/news/articleView.html?idxno=56140
980,2017-04-28,대웅제약플렉서블자율타임제정착,http://www.newscj.com/news/articleView.html?idxno=421182
981,2017-04-29,대웅제약알리톡제품수급문제없다약국공급안정적,http://www.kpanews.co.kr/article/show.asp?idx=183453&table=article&category=D
982,2017-04-29,유한녹십자한미종근당대웅1분기실적껑충,http://www.dailymedi.com/detail.php?number=818247&thread=22r05
983,2017-04-30,美印尼中삼각편대로글로벌진출가속대웅제약메로페넴미출시,http://news.kmib.co.kr/article/view.asp?arcid=0923739269&code=14130000&cp=nv
984,2017-05-01,채용이베이코리아14일까지인턴웹디벨로퍼경력직대웅그룹8일까지신입경력사원각각접수,http://www.nextdaily.co.kr/news/article.html?id=20170430800010
985,2017-05-01,대웅제약우루사에프연질캡슐효능인정못받아,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170430022500017&did=1195m
986,2017-05-01,대웅CJ등판권회수에도선전하는국내제약사제네릭이오리지날넘었다,http://www.mdtoday.co.kr/mdtoday/index.html?no=284823
987,2017-05-01,항암신약개발사업단장에박영환전대웅연구본부장,http://www.dailypharm.com/News/224999
988,2017-05-01,대웅글리아타린연질캡슐급여삭제,http://www.dailypharm.com/News/225003
989,2017-05-01,제2기항암신약개발사업단장에박영환전대웅연구본부장,http://www.sportsseoul.com/news/read/508624
990,2017-05-01,식약처대웅제약우루사1개제품효능효과불인정,http://www.asiatoday.co.kr/view.php?key=20170501010000051
991,2017-05-01,대웅제약우루사1개제품효능효과불인정,https://cnbc.sbs.co.kr/article_hub/10000857450?division=NAVER
992,2017-05-01,국가항암신약개발단장에전대웅제약박영환박사,http://www.medicaltimes.com/News/1111506
993,2017-05-01,식약처대웅글리아티린등251개대조약대거삭제,http://www.dailypharm.com/News/225016
994,2017-05-01,대웅제미글로연매출1000억원기대,http://www.dailypharm.com/News/225018
995,2017-05-01,대웅제약우루사1개제품효능효과불인정,http://news.mk.co.kr/newsRead.php?&year=2017&no=293703
996,2017-05-01,식약청대웅제약우루사연질캡슐효능의문제기,http://daily.hankooki.com/lpage/economy/201705/dh20170501150216138080.htm
997,2017-05-01,대웅제약우루사1개제품효능효과불인정,http://www.sportsseoul.com/news/read/508689
998,2017-05-01,녹십자대웅제약부광약품삼성제약간기능개선일부제품식약처재평가결과효능효과불인정,http://sports.khan.co.kr/news/sk_index.html?art_id=201705011555003&sec_id=561801&pt=nv
999,2017-05-01,국가항암신약개발사업단장에박영환전대웅제약본부장,http://www.hankyung.com/news/app/newsview.php?aid=201705011042i
1000,2017-05-01,식약처대웅제약우루사1개제품효능효과불인정,http://news.mk.co.kr/newsRead.php?&year=2017&no=294142
1001,2017-05-01,국가항암신약개발사업단출범단장에박영환前대웅제약본부장,http://news.kmib.co.kr/article/view.asp?arcid=0923740100&code=11132000&cp=nv
1002,2017-05-01,국가항암신약개발사업단출범단장에박영환전대웅제약본부장,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201705010232
1003,2017-05-01,식약처대웅제약우루사1개제품효능효과불인정,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201705010233
1004,2017-05-02,식약처대웅제약우루사에프연질캡슐효능효과불인정,http://www.sisaweek.com/news/articleView.html?idxno=90704
1005,2017-05-04,대웅나보타주위조제품발견사용주의,http://www.medical-tribune.co.kr/news/articleView.html?idxno=72571
1006,2017-05-04,대웅제약보톨리눔주사제나보타위조품국내유통경찰일당적발,http://www.newsis.com/view/?id=NISX20170504_0014873981&cID=10434&pID=13000
1007,2017-05-04,대웅제약보툴리눔톡신나보타짝퉁주의보,http://www.mt.co.kr/view/mtview.php?type=1&no=2017050416545260661&outlink=1
1008,2017-05-04,醫藥사건사고대웅제약나보타주가짜제품국내유통정황포착,http://www.econovill.com/news/articleView.html?idxno=314313
1009,2017-05-05,대웅제약보톡스나보타주가짜제품유통식약처사용주의당부,http://www.ntoday.co.kr/news/articleView.html?idxno=52808
1010,2017-05-05,대웅제약나보타위조품만든중국일당검거국내유통가능성은희박,http://biz.chosun.com/site/data/html_dir/2017/05/05/2017050501023.html
1011,2017-05-05,나보타위조품논란진화나선대웅제약,http://www.dailymedi.com/detail.php?number=818383&thread=22r05
1012,2017-05-05,대웅제약나보타위조품중국만유통국내전거래처진품확인할것,http://www.sportsseoul.com/news/read/509614
1013,2017-05-05,대웅나보타위조품은中에서만유통,http://www.medical-tribune.co.kr/news/articleView.html?idxno=72574
1014,2017-05-05,대웅제약나보타위조품국내유통확률없어,http://www.newscj.com/news/articleView.html?idxno=422555
1015,2017-05-05,대웅제약나보타위조품국내유통가능성낮다”,http://www.newsway.co.kr/view.php?tp=1&ud=2017050515320127971
1016,2017-05-05,대웅제약나보타위조품국내유통확률없어,http://view.asiae.co.kr/news/view.htm?idxno=2017050518473832496
1017,2017-05-05,대웅제약나보타위조품국내유통가능성거의없어,http://medipana.com/news/news_viewer.asp?NewsNum=198868&MainKind=A&NewsKind=5&vCount=12&vKind=1
1018,2017-05-06,코스피신고가업종별분석⑩의약품작년말대비674↑대웅제약1위,http://www.newsis.com/view/?id=NISX20170505_0014875708&cID=10403&pID=10400
1019,2017-05-06,식약처나보타주위조제품주의대웅제약진품여부학인해야”,http://www.kukinews.com/news/article.html?no=451932
1020,2017-05-07,대웅제약나보타위조품국내유통안됐다,http://www.edaily.co.kr/news/newspath.asp?newsid=01380886615926624
1021,2017-05-07,대웅제약나보타위조품국내유통가능성거의없다,http://www.g-enews.com/ko-kr/news/article/news_all/201705071013304714e6a49afa8d_1/article.html
1022,2017-05-07,대웅나보타위조품국내에는유통안돼,http://www.dailypharm.com/News/225120
1023,2017-05-07,짝퉁나보타조심하세요대웅제약확인서비스시행,http://www.hankyung.com/news/app/newsview.php?aid=2017050721491
1024,2017-05-08,대웅제약나보타위조품적발수사기관통해조사,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=205719
1025,2017-05-08,대웅제약나보타위조품중국에만유통최선의조치취할것”,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017050809068053536&outlink=1
1026,2017-05-08,대웅제약나보타위조품중국유통국내정품여부확인,http://www.seoulfn.com/news/articleView.html?idxno=278334
1027,2017-05-08,fnRASSI대웅제약전일대비502상승,http://www.fnnews.com/news/201705081005525358
1028,2017-05-08,대웅제약나보타위조품일당검거중국에유통사실확인조금의의심도남지않도록최선”,http://www.sedaily.com/NewsView/1OFUDK5UZL
1029,2017-05-08,나보타위조품대웅제약중국서만유통확인,http://www.kormedi.com/news/news/drug_dist/1223219_2906.html
1030,2017-05-08,​식약처대웅제약우루사제품효능인정불가,http://www.sisafocus.co.kr/news/articleView.html?idxno=160719
1031,2017-05-08,대웅제약보툴리눔톡신나보타위조품중국서만유통”,http://www.viva100.com/main/view.php?key=20170508020019825
1032,2017-05-09,나보타위조품유통충격대웅중국만유통확인,http://www.monews.co.kr/news/articleView.html?idxno=101040
1033,2017-05-10,ET투자뉴스대웅제약전세계4번째로미STRONGBUY상향토러스투자증권,http://www.etnews.com/20170510000103
1034,2017-05-11,주름편보톡스주다윗메디톡스vs골리앗대웅제약승자는,http://www.kukinews.com/news/article.html?no=452634
1035,2017-05-12,대웅제약나보타현재까지국내유통된위조품없다,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=205858
1036,2017-05-12,대웅나보타위조품국내유통없다,http://www.monews.co.kr/news/articleView.html?idxno=101229
1037,2017-05-12,대웅전수조사결과나보타위조품유통안돼,http://www.dailypharm.com/News/225261
1038,2017-05-12,대웅제약나보타위조품국내유통안돼,http://www.asiatoday.co.kr/view.php?key=20170512010005249
1039,2017-05-12,대웅제약나보타위조품국내유통없었다”전수조사결과발표,http://www.newsway.co.kr/view.php?tp=1&ud=2017051210363469321
1040,2017-05-12,대웅제약나보타위조품전수조사결과발표국내유통안됐다”,http://biz.chosun.com/site/data/html_dir/2017/05/12/2017051201202.html
1041,2017-05-12,대웅제약짝퉁나보타국내유통없다”,http://www.edaily.co.kr/news/newspath.asp?newsid=02384566615928264
1042,2017-05-12,대웅제약나보타위조품국내유통없다전수조사결과발표,http://www.g-enews.com/ko-kr/news/article/news_all/201705121057112110e6a49afa8d_1/article.html
1043,2017-05-12,대웅제약나보타위조품국내발견사례없다,http://view.asiae.co.kr/news/view.htm?idxno=2017051210583775482
1044,2017-05-12,대웅제약보톡스나보타짝퉁국내엔유통안돼,http://www.ebn.co.kr/news/view/891245
1045,2017-05-12,대웅제약국내유통된나보타위조품없다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017051210320559029
1046,2017-05-12,대웅제약국내유통된가짜보톡스없다,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170512064000017&did=1195m
1047,2017-05-12,대웅제약짝퉁나보타국내엔유통안돼,http://www.mt.co.kr/view/mtview.php?type=1&no=2017051210270691303&outlink=1
1048,2017-05-12,대웅제약나보타현재까지국내유통된위조품없다,http://news.mk.co.kr/newsRead.php?&year=2017&no=317732
1049,2017-05-12,대웅제약국내유통된가짜보톡스없어,http://www.viva100.com/main/view.php?key=20170512010003788
1050,2017-05-12,대웅제약나보타위조품국내유통안돼,http://www.kukinews.com/news/article.html?no=453212
1051,2017-05-12,대웅제약가짜나보타국내유통없었다,http://www.enewstoday.co.kr/news/articleView.html?idxno=1056904
1052,2017-05-12,대웅나보타위조픔국내에없다경찰중국유통수사중,http://www.kpanews.co.kr/article/show.asp?idx=183661&table=article&category=D
1053,2017-05-12,대웅제약나보타위조품유통여부현재까지안심,http://www.newscj.com/news/articleView.html?idxno=423858
1054,2017-05-12,대웅제약나보타국내유통된가짜제품없다,http://www.sisajournal-e.com/biz/article/168784
1055,2017-05-12,대웅제약나보타위조품유통여부전수조사결과발표,http://www.m-i.kr/news/articleView.html?idxno=310213
1056,2017-05-12,대웅제약나보타위조품국내유통없어,http://www.etnews.com/20170512000160
1057,2017-05-12,대웅제약나보타국내유통안돼,http://www.newstomato.com/ReadNews.aspx?no=752180
1058,2017-05-12,대웅제약짝퉁나보타국내서유통안돼,http://www.mediapen.com/news/view/266008
1059,2017-05-12,대웅제약짝퉁보톡스제품국내유통안됐다”,http://www.breaknews.com/sub_read.html?uid=508779§ion=sc3
1060,2017-05-12,대웅제약나보타위조품유통우려철저대비,http://www.dailymedi.com/detail.php?number=818575&thread=22r05
1061,2017-05-12,대웅제약국내나보타위조품유통없어”,http://www.mdtoday.co.kr/mdtoday/index.html?no=285521
1062,2017-05-12,대웅제약보툴리눔톡신나보타위조품국내유통안돼,http://www.newsis.com/view/?id=NISX20170512_0014890225&cID=10434&pID=13000
1063,2017-05-12,대웅제약가짜보톡스국내유통안됐다,http://ciobiz.etnews.com/20170512120012
1064,2017-05-12,대웅제약나보타국내유통안됐다,http://www.seoulfn.com/news/articleView.html?idxno=278680
1065,2017-05-12,대웅제약나보타위조품국내유통없다,http://www.newspim.com/news/view/20170512000289
1066,2017-05-12,대웅제약나보타위조품국내유통안돼”,http://www.joseilbo.com/news/news_read.php?uid=324300&class=27&grp=
1067,2017-05-12,대웅제약국내유통된가짜나보타없다,http://www.dt.co.kr/contents.html?article_no=2017051202109976029003
1068,2017-05-12,대웅제약전수조사결과나보타위조품국내유통안됐다”,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017051218038066372&outlink=1
1069,2017-05-12,대웅제약나보타위조품전수조사국내유통사실없어”,http://ilyo.co.kr/?ac=article_view&entry_id=247432
1070,2017-05-14,대웅제약가짜보톡스국내에없다,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0300&key=20170514.99002003349
1071,2017-05-15,대웅제약매출증가에도기부적은이유광동제약기부최고,http://www.ceoscoredaily.com/news/article.html?no=29359
1072,2017-05-15,대웅제약나보타위조품국내에는유통안된것으로확인,http://www.rapportian.com/news/articleView.html?idxno=103699
1073,2017-05-15,전성수전대웅제약고문515,http://www.dailypharm.com/Users/News/TodayFocus.html?mode=View&nKind=3&ID=15103
1074,2017-05-16,부고전성수씨전대웅제약고문별세,http://news1.kr/articles/?2994311
1075,2017-05-16,한화투자증권대웅제약마케팅비용감소로수익성개선,http://www.newsprime.co.kr/news/article.html?no=374762
1076,2017-05-16,부고전성수전대웅제약고문씨별세,http://www.newsis.com/view/?id=NISX20170516_0014897200&cID=10904&pID=16000
1077,2017-05-16,ET투자뉴스대웅제약마케팅비용감소로매수유지한화투자증권,http://www.etnews.com/20170516000527
1078,2017-05-16,부음전성수씨전대웅제약고문별세,http://news.mk.co.kr/newsRead.php?&year=2017&no=327338
1079,2017-05-16,대웅제약우루사1977년연질캡슐혁신50년장수간기능개선제명성,http://www.dt.co.kr/contents.html?article_no=2017051702101222813002
1080,2017-05-16,대웅제약나보타美허가신청내년말출시,http://news1.kr/articles/?2995265
1081,2017-05-17,대웅제약나보타美판매허가신청주가에긍정적KB,http://stock.hankyung.com/news/app/newsview.php?aid=2017051748356
1082,2017-05-17,대웅제약나보타美출시가시화매수KB證,http://www.mt.co.kr/view/mtview.php?type=1&no=2017051708042225839&outlink=1
1083,2017-05-17,ET투자뉴스대웅제약2017년은모멘텀매수유지KB증권,http://www.etnews.com/20170517000017
1084,2017-05-17,대웅제약나보타미국출시가시화KB,http://biz.chosun.com/site/data/html_dir/2017/05/17/2017051700778.html
1085,2017-05-17,대웅제약올해는모멘텀에서실적으로이어지는구간,http://daily.hankooki.com/lpage/economy/201705/dh20170517102551138110.htm
1086,2017-05-17,WhoIs이종욱대웅제약부회장,http://www.businesspost.co.kr/news/articleView.html?idxno=49313
1087,2017-05-17,가정의달특집대웅제약임팩타민,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201705171531015&code=900303
1088,2017-05-18,대웅진통CJ안정바이엘임금갈등님문화현모습,http://medipana.com/news/news_viewer.asp?NewsNum=200335&MainKind=A&NewsKind=5&vCount=12&vKind=1
1089,2017-05-18,대웅제약미국FDA에나보타판매허가신청,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1042285
1090,2017-05-18,ET투자뉴스대웅1분기실적호조매수유지골든브릿지투자증권,http://www.etnews.com/20170518000051
1091,2017-05-18,대웅주식거래재개액면분할완료,http://www.g-enews.com/ko-kr/news/article/news_all/201705181029581734e6a49afa8d_1/article.html
1092,2017-05-18,㈜대웅액면분할완료”18일부터거래재개,http://www.newsway.co.kr/view.php?tp=1&ud=2017051810351398552
1093,2017-05-18,대웅18일부터주식거래재개액면분할완료”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=206069
1094,2017-05-18,대웅18일부터거래재개액면분할완료,http://www.dailypharm.com/News/226492
1095,2017-05-18,㈜대웅18일부터거래재개액면분할완료”,http://sports.hankooki.com/lpage/economy/201705/sp20170518103708137020.htm
1096,2017-05-18,대웅18일부터거래재개액면분할완료,http://medipana.com/news/news_viewer.asp?NewsNum=200369&MainKind=A&NewsKind=5&vCount=12&vKind=1
1097,2017-05-18,대웅18일부터거래재개액면분할완료,http://www.seoulfn.com/news/articleView.html?idxno=279048
1098,2017-05-18,㈜대웅18일부터거래재개액면분할완료,http://www.bosa.co.kr/news/articleView.html?idxno=2061104
1099,2017-05-18,대웅액면분할완료18일부터거래재개,http://www.kpanews.co.kr/article/show.asp?idx=183841&table=article&category=D
1100,2017-05-18,대웅액면분할완료18일부터거래재개,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201705180186
1101,2017-05-18,대웅18일부터주식거래재개액면분할완료,http://www.rapportian.com/news/articleView.html?idxno=103782
1102,2017-05-18,대웅이달18일거래재개액면분할완료”,http://www.dailymedi.com/detail.php?number=818750&thread=22r05
1103,2017-05-18,대웅주식거래재개액면분할완료,http://www.newsis.com/view/?id=NISX20170518_0014903050&cID=10401&pID=10400
1104,2017-05-18,대웅18일부터거래재개액면분할완료,http://www.mdtoday.co.kr/mdtoday/index.html?no=285975
1105,2017-05-18,대웅18일부터거래재개액면분할완료,http://www.m-i.kr/news/articleView.html?idxno=311862
1106,2017-05-18,대웅제약이지덤팬모여라”이지덤대학생마케팅서포터즈공식출범,http://www.hankyung.com/news/app/newsview.php?aid=201705189308a
1107,2017-05-18,대웅18일거래재개액면분할완료,http://www.ceoscoredaily.com/news/article.html?no=29461
1108,2017-05-18,㈜대웅18일부터거래재개액면분할완료,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017051813393292846
1109,2017-05-18,대웅제약17조원미국보톡스시장출사표,http://www.newstomato.com/ReadNews.aspx?no=753557
1110,2017-05-18,㈜대웅18일부터거래재개액면분할완료”,http://www.viva100.com/main/view.php?key=20170518010006212
1111,2017-05-18,액면분할완료대웅거래재개,http://www.monews.co.kr/news/articleView.html?idxno=101488
1112,2017-05-18,대웅18일부터거래재개액면분할완료,http://www.joseilbo.com/news/news_read.php?uid=324872&class=27&grp=
1113,2017-05-18,㈜대웅액면분할완료18일부터거래재개,http://www.anewsa.com/detail.php?number=1169288&thread=10r03
1114,2017-05-18,수출로매출1조원이룰까해외시장노리는대웅제약,http://www.sisajournal-e.com/biz/article/169082
1115,2017-05-18,대웅액면분할완료주식거래재개유통주식수확대로변동성축소”,http://biz.chosun.com/site/data/html_dir/2017/05/18/2017051802557.html
1116,2017-05-18,㈜대웅18일부터거래재개액면분할완료,http://www.newscj.com/news/articleView.html?idxno=425215
1117,2017-05-19,대웅액면분할완료18일부터거래재개,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1042313
1118,2017-05-19,대웅제약나보타FDA품목허가신청美진출한걸음전진,http://www.mdtoday.co.kr/mdtoday/index.html?no=285996
1119,2017-05-19,대웅제약우루사모델윤종신과함께신인뮤지션기회의장TakeaChance개최,http://sports.hankooki.com/lpage/life/201705/sp20170519103913136800.htm
1120,2017-05-19,대웅우루사모델윤종신과신인뮤지션발굴,http://www.dailypharm.com/News/226540
1121,2017-05-19,대웅제약우루사모델윤종신과함께신인뮤지션기회의장열어,http://www.sportsseoul.com/news/read/513912
1122,2017-05-19,대웅제약신인뮤지션에기회의장제공,http://www.bosa.co.kr/news/articleView.html?idxno=2061187
1123,2017-05-19,대웅제약신인뮤지션기획의장TakeaChance개최,http://www.m-i.kr/news/articleView.html?idxno=312140
1124,2017-05-19,대웅제약신인뮤지션위한TakeaChance개최,http://www.joseilbo.com/news/news_read.php?uid=324981&class=27&grp=
1125,2017-05-19,아파야챙길래한미약품대웅제약동아쏘시오外,http://www.g-enews.com/ko-kr/news/article/news_all/201705191538071248e6a49afa8d_1/article.html
1126,2017-05-19,대웅제약1분기전년비매출70영업이익341증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=206122
1127,2017-05-19,대웅제약우루사모델윤종신과함께신인뮤지션기회의장TakeaChance개최,http://www.newscj.com/news/articleView.html?idxno=425454
1128,2017-05-21,대웅제약나보타美향해한발더,http://www.enewstoday.co.kr/news/articleView.html?idxno=1061718
1129,2017-05-21,주간추천종목GS건설대웅제약테스유한양행,http://www.fnnews.com/news/201705211917166306
1130,2017-05-22,대웅글리아티린보험급여삭제이어반품조치시작,http://www.kpanews.co.kr/article/show.asp?idx=183901&table=article&category=D
1131,2017-05-22,봄건강지킴이대웅제약임팩타민,http://view.asiae.co.kr/news/view.htm?idxno=2017052210330916075
1132,2017-05-23,美시장진출준비대웅vs메디톡스희비엇갈려,http://www.monews.co.kr/news/articleView.html?idxno=101611
1133,2017-05-23,fnRASSI대웅52주신고가1469↑,http://www.fnnews.com/news/201705231301423470
1134,2017-05-23,대웅여름시즌한정이지듀DWEGF크림출시,http://www.dailypharm.com/News/226682
1135,2017-05-23,정원웅대웅건설주대표태안소원초모교저소득학생에장학금전달,http://www.daejonilbo.com/news/newsitem.asp?pk_no=1265202
1136,2017-05-23,정원웅대웅건설주대표이사남다른모교사랑눈길,http://www.chungnamilbo.com/news/articleView.html?idxno=403353
1137,2017-05-24,대웅제약나보타수출기대감유효매수유지KTB,http://www.mt.co.kr/view/mtview.php?type=1&no=2017052409585623389&outlink=1
1138,2017-05-24,ET투자뉴스대웅제약_업종지수와비교해서변동폭대비성과좋지않아,http://www.etnews.com/20170524000265
1139,2017-05-25,fnRASSI대웅52주신고가464↑,http://www.fnnews.com/news/201705251452215244
1140,2017-05-25,스톡인사이드美시장노크보톡스제왕꿈꾸는대웅제약,http://www.sedaily.com/NewsView/1OG28CZDZF
1141,2017-05-26,더벨일양약품백혈병치료제대웅영업력에도안되네,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201705250100038550002352
1142,2017-05-29,대웅제약바이오벤처대학과손잡고글로벌연구네트워크구축,http://news.mk.co.kr/newsRead.php?&year=2017&no=357958
1143,2017-05-30,1초4개팔렸다는대웅이지듀홈쇼핑시장기린아,http://www.dailypharm.com/News/226868
1144,2017-05-30,CEO경영파일③제약계이단아대웅제약윤재승회장,http://www.ajunews.com/view/20170528120334864
1145,2017-05-30,대웅제약간기능개선제우루사8주복용후80가피로회복,http://www.viva100.com/main/view.php?key=20170530020020010
1146,2017-05-31,fnRASSI대웅00309052주신고가463↑,http://www.fnnews.com/news/201705311002515409
1147,2017-05-31,그것이사고싶다지금사도될까삼성물산현대그린푸드AP시스템대웅만도外,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017053116004253881
1148,2017-05-31,관심주대웅제약미국생물의약품품목허가신청완료,https://cnbc.sbs.co.kr/article_hub/10000860952?division=NAVER
1149,2017-06-01,BioKorea대웅제약이지에프새살연고난치성상처에도효과,http://biz.chosun.com/site/data/html_dir/2017/05/31/2017053102124.html
1150,2017-06-01,대웅제약판매관리비RD비분리공시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=206423
1151,2017-06-01,대웅제약생산부터영업까지직원들전문역량키운다,http://news1.kr/articles/?3009161
1152,2017-06-01,대웅판매졸레드론산주사골다공증시장서승승장구,http://www.dailypharm.com/News/227064
1153,2017-06-01,대웅제약이판관비연구개발비분리한까닭은,http://www.sisajournal-e.com/biz/article/169735
1154,2017-06-02,해외로가는대웅제약매출1조클럽성큼,http://www.newspim.com/news/view/20170602000089
1155,2017-06-02,소비자와소통넓히는대웅제약이지덤뷰티,http://www.hankyung.com/news/app/newsview.php?aid=201706027989a
1156,2017-06-05,대웅이지덤습윤드레싱부문고객충성브랜드1위,http://www.dailypharm.com/News/227158
1157,2017-06-05,대웅제약이지덤브랜드고객충성도대상습윤드레싱부문1위수상,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017060510261613648
1158,2017-06-05,ET투자뉴스대웅제약_투심과거래량은보통현재주가는강세,http://www.etnews.com/20170605000124
1159,2017-06-05,대웅제약이지덤고객충성도1위,http://www.finomy.com/news/articleView.html?idxno=45104
1160,2017-06-05,대웅제약이지덤브랜드고객충성도대상습윤드레싱부문1위수상,http://sports.hankooki.com/lpage/life/201706/sp20170605110749136800.htm
1161,2017-06-05,대웅제약이지덤브랜드고객충성도대상습윤드레싱부문1위,http://news.mk.co.kr/newsRead.php?&year=2017&no=375635
1162,2017-06-05,대웅제약이지덤브랜드고객충성도대상1위수상,http://www.joseilbo.com/news/news_read.php?uid=326483&class=27&grp=
1163,2017-06-05,대웅제약브랜드고객충성도습윤드레싱부문1위,http://www.mdtoday.co.kr/mdtoday/index.html?no=287250
1164,2017-06-05,아파야챙길래대웅제약동국제약일양약품外,http://www.g-enews.com/ko-kr/news/article/news_all/201706051348419424e6a49afa8d_1/article.html
1165,2017-06-05,제약산업소식대웅제약이지덤브랜드고객충성도대상습윤드레싱1위수상外,http://www.kukinews.com/news/article.html?no=458723
1166,2017-06-05,대웅제약이지덤습윤드레싱부문1위,http://www.medical-tribune.co.kr/news/articleView.html?idxno=72969
1167,2017-06-05,대웅제약이지덤브랜드고객충성도대상습윤드레싱부문1위수상,http://www.m-i.kr/news/articleView.html?idxno=316312
1168,2017-06-05,대웅제약이지덤고객충성도습윤드레싱부문1위수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=206554
1169,2017-06-05,대웅제약이지덤브랜드고객충성도대상1위,http://www.seoulfn.com/news/articleView.html?idxno=280398
1170,2017-06-05,대웅제약이지덤브랜드고객충성도습윤드레싱부문1위,http://www.dailian.co.kr/news/view/637897/?sc=naver
1171,2017-06-05,대웅제약이지덤브랜드고객충성도대상습윤드레싱부문1위수상,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017060515468011321&outlink=1
1172,2017-06-05,대웅제약이지덤브랜드고객충성도대상습윤드레싱부문1위수상,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201706051600002&code=900303
1173,2017-06-05,대웅제약이지덤브랜드고객충성도대상습윤드레싱부문1위수상,http://news20.busan.com/controller/newsController.jsp?newsId=20170605000227
1174,2017-06-05,대웅제약이지덤브랜드고객충성도대상습윤드레싱부문1위수상,http://www.newscj.com/news/articleView.html?idxno=428518
1175,2017-06-06,대웅제약이지덤브랜드고객충성도대상서1위,http://www.enewstoday.co.kr/news/articleView.html?idxno=1070705
1176,2017-06-07,제약바이오의료기기업계이모저모대웅습윤드레싱이지덤고객충성도1위,http://news.heraldcorp.com/view.php?ud=20170607000426
1177,2017-06-07,대웅제약일반의약품품질업,http://view.asiae.co.kr/news/view.htm?idxno=2017060710570008262
1178,2017-06-08,대웅제약듀어클리어제뉴에어이상반응협심증추가,http://www.mdtoday.co.kr/mdtoday/index.html?no=287422
1179,2017-06-08,대웅제약67조원印尼시장잡아라,http://www.edaily.co.kr/news/newspath.asp?newsid=01567846615959752
1180,2017-06-08,대웅제약알리톡만성손습진환자에완치희망쐈다,http://www.bosa.co.kr/news/articleView.html?idxno=2062448
1181,2017-06-08,ET투자뉴스대웅지분변동윤재승외8명044p감소4111보유,http://www.etnews.com/20170608000337
1182,2017-06-08,ET투자뉴스대웅제약17년1분기실적발표당기순이익187억원전년동기대비4101,http://www.etnews.com/20170608000355
1183,2017-06-10,대웅제약차세대항궤양신약DWP140122상진입,http://www.dailypharm.com/News/227333
1184,2017-06-11,메디톡스휴젤대웅제약미국보톡스시장진출경쟁치열,http://www.businesspost.co.kr/news/articleView.html?idxno=51147
1185,2017-06-12,대웅제약보톡스적응증따라잡기적응증추가잰걸음,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1043121
1186,2017-06-13,대웅제약차세대항궤양제식약처임상2상시험승인,http://www.fnnews.com/news/201706130917266777
1187,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://www.asiatoday.co.kr/view.php?key=20170613010006648
1188,2017-06-13,대웅제약항궤양제2상임상승인,http://www.medigatenews.com/news/1037172153
1189,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://www.dailypharm.com/News/227422
1190,2017-06-13,대웅제약차세대항궤양제개발박차2상승인,http://medipana.com/news/news_viewer.asp?NewsNum=202526&MainKind=A&NewsKind=5&vCount=12&vKind=1
1191,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017061309304630267
1192,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://www.joseilbo.com/news/news_read.php?uid=327171&class=27&grp=
1193,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=206718
1194,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://sports.hankooki.com/lpage/life/201706/sp20170613095021136800.htm
1195,2017-06-13,대웅제약하루1번위궤양약임상2상승인,http://news1.kr/articles/?3019005
1196,2017-06-13,대웅제약항궤양제후보물질임상2상추진,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170613056600017&did=1195m
1197,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://www.dailymedi.com/detail.php?number=819545&thread=22r05
1198,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://www.sportsseoul.com/news/read/521914
1199,2017-06-13,대웅위궤양치료후보물질임상2상허가,http://www.edaily.co.kr/news/newspath.asp?newsid=02138566615961392
1200,2017-06-13,대웅제약항궤양제신약임상2상승인받아,http://www.mt.co.kr/view/mtview.php?type=1&no=2017061309363010445&outlink=1
1201,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://www.ebn.co.kr/news/view/896131
1202,2017-06-13,대웅제약항궤양제후보물질임상2상추진,http://view.asiae.co.kr/news/view.htm?idxno=2017061310291083936
1203,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://news.mk.co.kr/newsRead.php?&year=2017&no=394018
1204,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=101&oid=050&aid=0000044539
1205,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://www.g-enews.com/ko-kr/news/article/news_all/201706131037051542e6a49afa8d_1/article.html
1206,2017-06-13,대웅제약항궤양신약국내2상승인21개병원,http://www.medicaltimes.com/News/1112204
1207,2017-06-13,대웅차세대항궤양제내달국내2상임상돌입,http://www.medical-tribune.co.kr/news/articleView.html?idxno=73069
1208,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://news.hankyung.com/news/app/newsview.php?aid=201706130878i
1209,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://www.newsis.com/view/?id=NISX20170613_0000010721&cID=13001&pID=13000
1210,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://www.kormedi.com/news/news/drug_dist/1223662_2906.html
1211,2017-06-13,대웅제약차세대항궤양제2상승인,http://www.newstomato.com/ReadNews.aspx?no=758822
1212,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://www.m-i.kr/news/articleView.html?idxno=318079
1213,2017-06-13,대웅제약차세대항궤양제임상2상승인,http://www.doctorsnews.co.kr/news/articleView.html?idxno=117294
1214,2017-06-13,대웅제약PPI대체기대항궤양제2상임상승인받아,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1043171
1215,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://www.bosa.co.kr/news/articleView.html?idxno=2062730
1216,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://www.kpanews.co.kr/article/show.asp?idx=184547&table=article&category=D
1217,2017-06-13,대웅제약차세대항궤양제개발청신호,http://www.monews.co.kr/news/articleView.html?idxno=102382
1218,2017-06-13,대웅제약차세대항궤양후보물질국내임상2상승인,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201706130153
1219,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://www.seoulfn.com/news/articleView.html?idxno=280895
1220,2017-06-13,대웅제약차세대항궤양제국내임상2상시험승인,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017061313558078697&outlink=1
1221,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://stock.hankyung.com/news/app/newsview.php?aid=2017061313416
1222,2017-06-13,대웅제약차세대항궤양제임상2상승인받아,http://www.finomy.com/news/articleView.html?idxno=45279
1223,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://ciobiz.etnews.com/20170613120011
1224,2017-06-13,中서토종보톡스닻올린메디톡스뒤쫓는휴젤대웅휴온스,http://www.ebn.co.kr/news/view/896193
1225,2017-06-13,대웅제약항궤양제신약후보물질임상2상승인,http://www.rapportian.com/news/articleView.html?idxno=104242
1226,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://www.ceoscoredaily.com/news/article.html?no=30009
1227,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://health.chosun.com/site/data/html_dir/2017/06/13/2017061301743.html
1228,2017-06-13,대웅제약항궤양제DWP140122상임상시험승인,http://www.kukinews.com/news/article.html?no=460403
1229,2017-06-13,대웅제약차세대항궤양제후보물질임상2상돌입,http://www.dt.co.kr/contents.html?article_no=2017061302109976029003
1230,2017-06-13,대웅제약항궤양제국내임상2상승인,http://www.newspim.com/news/view/20170613000227
1231,2017-06-13,대웅제약차세대항궤양제국내임상2상추진,http://www.ekn.kr/news/article.html?no=293184
1232,2017-06-13,대웅제약차세대항궤양제국내임상2상승인,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201706131646002&code=900303
1233,2017-06-13,613제약한줄뉴스대웅제약녹십자MSSCM생명과학갈더마코리아,http://www.koreahealthlog.com/news/articleView.html?idxno=21668
1234,2017-06-13,대웅제약차세대항궤양제DWP14012국내임상2상승인,http://biz.chosun.com/site/data/html_dir/2017/06/13/2017061302282.html
1235,2017-06-13,대웅제약항궤양제국내임상2상승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=287926
1236,2017-06-13,대웅제약차세대항궤양제DWP14012국내2상임상승인,http://www.viva100.com/main/view.php?key=20170613020020117
1237,2017-06-14,대웅제약메디톡스보톡스해외시장진출놓고팽팽한신경전,http://www.rapportian.com/news/articleView.html?idxno=104254
1238,2017-06-14,유한양행대웅휴젤순현금보유많아골든브릿지,http://www.choicenews.co.kr/news/articleView.html?idxno=33874
1239,2017-06-14,박현진대웅제약개발본부장유리천장은스스로만드는것여성들도목표의식가져야,http://news.hankyung.com/news/app/newsview.php?aid=2017061454151
1240,2017-06-15,메디톡스미국서대웅제약에소송보톡스도용주장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170614158200017&did=1195m
1241,2017-06-15,메디톡스대웅제약상대소송제기결론도출시주가에긍정적하나,http://www.edaily.co.kr/news/newspath.asp?newsid=01892566615962048
1242,2017-06-15,메디톡스미국에서대웅상대로보톡스도용소송,http://news.heraldcorp.com/view.php?ud=20170615000098
1243,2017-06-15,특징주대웅제약대웅메디톡스보톡스소송에하락,http://www.mt.co.kr/view/mtview.php?type=1&no=2017061509104382372&outlink=1
1244,2017-06-15,메디톡스美서대웅제약에소송보톡스균주도용당했다”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1502992
1245,2017-06-15,메디톡스미국서대웅제약에보툴리눔도용소송제기,http://www.dt.co.kr/contents.html?article_no=2017061502109976029001
1246,2017-06-15,특징주대웅제약메디톡스보톡스소송에급락,http://www.edaily.co.kr/news/newspath.asp?newsid=02020486615962048
1247,2017-06-15,특징주대웅제약메디톡스보톡스소송에급락,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170615054000008&did=1195m
1248,2017-06-15,메디톡스미국서대웅제약에소송보톡스도용주장종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170614158251017&did=1195m
1249,2017-06-15,특징주어쩌나대웅제약메디톡스보톡스도용소송에하락세,http://view.asiae.co.kr/news/view.htm?idxno=2017061509244799508
1250,2017-06-15,메디톡스美서대웅제약에소송보톡스균주도용,http://view.asiae.co.kr/news/view.htm?idxno=2017061509353398383
1251,2017-06-15,특징주대웅제약보톡스도용소송피소에약세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1503062
1252,2017-06-15,특징주보톡스도용소송소식에대웅제약↓메디톡스↑,http://www.mediapen.com/news/view/277224
1253,2017-06-15,특징주대웅제약메디톡스보톡스소송소식에급락,http://www.newsway.co.kr/view.php?tp=1&ud=2017061509474281062
1254,2017-06-15,메디톡스대웅제약상대로보톡스균주훔쳐갔다소송제기,http://www.edaily.co.kr/news/newspath.asp?newsid=02230406615962048
1255,2017-06-15,대웅제약메디톡스보톡스소송소식에급락,http://www.newsprime.co.kr/news/article.html?no=378132
1256,2017-06-15,메디톡스美서대웅제약상대로보톡스도용소송,http://news.mk.co.kr/newsRead.php?&year=2017&no=400470
1257,2017-06-15,메디톡스美서대웅제약에소송보톡스도용당했다주장,http://health.chosun.com/site/data/html_dir/2017/06/15/2017061500994.html
1258,2017-06-15,특징주대웅제약메디톡스소송에7대하락,http://www.dailian.co.kr/news/view/640182/?sc=naver
1259,2017-06-15,메디톡스美서대웅제약에소송보톡스도용주장,http://www.seoulfn.com/news/articleView.html?idxno=281057
1260,2017-06-15,메디톡스미국서대웅제약상대로소송제기보톡스제조공정도용,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201706150108
1261,2017-06-15,메디톡스대웅제약보톡스기술놓고국제소송,http://www.ebn.co.kr/news/view/896519
1262,2017-06-15,대웅제약이보툴리눔균주도용했다메디톡스미국서소송제기,http://www.rapportian.com/news/articleView.html?idxno=104281
1263,2017-06-15,메디톡스美서대웅제약에소송보톡스도용으로지재권침해,http://daily.hankooki.com/lpage/economy/201706/dh20170615104714138080.htm
1264,2017-06-15,메디톡스미국서대웅제약상대소송보툴리눔균주도용주장,http://www.newsis.com/view/?id=NISX20170615_0000012945&cID=13001&pID=13000
1265,2017-06-15,특징주대웅제약메디톡스소송에약세,http://www.newstomato.com/ReadNews.aspx?no=759402
1266,2017-06-15,ET투자뉴스대웅제약메디톡스소송에대매수NH투자증권,http://www.etnews.com/20170615000148
1267,2017-06-15,균주논란2R美보톡스소송에메디톡스↑대웅제약↓,http://www.mt.co.kr/view/mtview.php?type=1&no=2017061509504871835&outlink=1
1268,2017-06-15,메디톡스美서대웅제약에보톡스도용소송제기,http://www.nocutnews.co.kr/news/4799782
1269,2017-06-15,메디톡스대웅제약에보톡스도용소송,http://www.naeil.com/news_view/?id_art=240709
1270,2017-06-15,메디톡스vs대웅보툴리눔톡신균주논란재점화,http://www.dailymedi.com/detail.php?number=819632&thread=22r05
1271,2017-06-15,대웅과보툴리눔톡신논란미국에옮겨간메디톡스,http://www.dailypharm.com/News/227544
1272,2017-06-15,메디톡스대웅제약미국소송의미없이끝날듯NH투자증권,http://www.kukinews.com/news/article.html?no=461079
1273,2017-06-15,보톨리눔톡신균주갈등재점화메디톡스미국서대웅제약에소송,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017061510352196709
1274,2017-06-15,메디톡스대웅제약분쟁점입가경이번엔美서소송전,http://www.sisajournal-e.com/biz/article/170268
1275,2017-06-15,메디톡스대웅제약美서보톡스소송전,http://www.munhwa.com/news/view.html?no=2017061501031921086001
1276,2017-06-15,메디톡스미국서대웅제약에소송제기대웅제약7↓,http://stock.hankyung.com/news/app/newsview.php?aid=2017061577106
1277,2017-06-15,메디톡스美서대웅제약에소송보톡스균주도용”,http://www.newsway.co.kr/view.php?tp=1&ud=2017061514231103593
1278,2017-06-15,보툴리눔톡신균주도용”메디톡스美에대웅제약상대소송제기,http://www.mdtoday.co.kr/mdtoday/index.html?no=288114
1279,2017-06-15,대웅제약메디톡스주장사실무근나보타美진출문제없어”,http://www.newsway.co.kr/view.php?tp=1&ud=2017061514520912505
1280,2017-06-15,대웅제약메디톡스의지속적인음해에대응가치못느껴”,http://www.kukinews.com/news/article.html?no=461141
1281,2017-06-15,나보타둘러싼공방대웅제약메디톡스美소송주장해외진출방해위한허위,http://www.g-enews.com/ko-kr/news/article/news_all/201706151458178458e6a49afa8d_1/article.html
1282,2017-06-15,대웅美진출문제없어메디톡스모든책임물을것,http://www.dailypharm.com/News/227552
1283,2017-06-15,메디톡스대웅제약보톡스공방미국소송전으로번져,http://www.asiatoday.co.kr/view.php?key=20170615010008438
1284,2017-06-15,종합메디톡스미국서대웅제약상대소송보툴리눔균주도용주장,http://www.newsis.com/view/?id=NISX20170615_0000013493&cID=13001&pID=13000
1285,2017-06-15,메디톡스대웅제약2차전이번엔미국서민사소송,http://www.medicaltimes.com/News/1112260
1286,2017-06-15,대웅메디톡스美소송허위고음해다,http://www.bosa.co.kr/news/articleView.html?idxno=2062909
1287,2017-06-15,메디톡스대웅제약보툴리눔톡신논란미국으로확대,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1043302
1288,2017-06-15,보톡스美소송휘말린대웅제약미국진출문제없다,http://www.m-i.kr/news/articleView.html?idxno=318907
1289,2017-06-15,대웅제약나보타美진출문제없다소송과정서밝힐것,http://www.kpanews.co.kr/article/show.asp?idx=184645&table=article&category=D
1290,2017-06-15,대웅제약메디톡스균주도용주장사실무근법적책임묻겠다,http://www.rapportian.com/news/articleView.html?idxno=104296
1291,2017-06-15,메디톡스미국서대웅제약에소송보톡스균주도용주장종합2보,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170614158252017&did=1195m
1292,2017-06-15,터질게터졌다메디톡스미국서대웅제약과소송전,http://www.kormedi.com/news/news/drug_dist/1223687_2906.html
1293,2017-06-15,메디톡스대웅제약보툴리눔톡신균주싸움美서2라운드,http://biz.newdaily.co.kr/news/article.html?no=10134484
1294,2017-06-15,메디톡스대웅제약보톡스균주출처공방美서또,http://www.enewstoday.co.kr/news/articleView.html?idxno=1074960
1295,2017-06-15,메디톡스주장은허구대웅제약법적조치예고,http://www.monews.co.kr/news/articleView.html?idxno=102525
1296,2017-06-15,메디톡스대웅이보툴리눔균주도둑질美서소송,http://www.mt.co.kr/view/mtview.php?type=1&no=2017061515465988989&outlink=1
1297,2017-06-15,대웅제약보툴리눔균주도용사실무근법적책임물을것,http://www.ceoscoredaily.com/news/article.html?no=30078
1298,2017-06-15,메디톡스대웅제약이보톡스도용vs대웅제약사실무근법적책임물을것,http://news.mk.co.kr/newsRead.php?&year=2017&no=402125
1299,2017-06-15,대웅제약메디톡스측주장허구소송서철저히입증할것,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017061516253344149
1300,2017-06-15,메디톡스미국서대웅제약에소송제기보톡스균주도용주장,http://ciobiz.etnews.com/20170615120025
1301,2017-06-15,대웅제약메디톡스美보톡스소송에휘청,http://www.mt.co.kr/view/mtview.php?type=1&no=2017061514495850213&outlink=1
1302,2017-06-15,대웅제약美소송으로주가7↓나보타FDA허가지연가능,http://www.etnews.com/20170615000333
1303,2017-06-15,대웅제약나보타美진출문제없어메디톡스주장사실무근모든법적책임물을것”,http://sports.hankooki.com/lpage/life/201706/sp20170615164245136800.htm
1304,2017-06-15,대웅제약나보타美진출문제없어,http://www.seoulfn.com/news/articleView.html?idxno=281108
1305,2017-06-15,보톡스균주도용”메디톡스美법원에서소송제기대웅제약美진출방해의도”,http://biz.chosun.com/site/data/html_dir/2017/06/15/2017061502548.html
1306,2017-06-15,대웅제약메디톡스주장사실무근나보타美진출문제없어,http://view.asiae.co.kr/news/view.htm?idxno=2017061516582902803
1307,2017-06-15,메디톡스美소송제기대웅제약강력반발,http://www.dailymedi.com/detail.php?number=819644&thread=22r05
1308,2017-06-15,메디톡스미국에서대웅제약상대보톡스소송제기,http://www.businesspost.co.kr/news/articleView.html?idxno=51502
1309,2017-06-15,대웅제약나보타미국진출문제없다”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=206836
1310,2017-06-15,메디톡스vs대웅제약글로벌보톡스전쟁미국서민사소송으로격돌,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017061517048063480&outlink=1
1311,2017-06-15,보톡스균주기술빼갔다메디톡스미국서대웅제약에소송,http://news.hankyung.com/news/app/newsview.php?aid=2017061586001
1312,2017-06-15,메디톡스美법원에대웅제약상대로보톡스균주도용소송,http://www.mhj21.com/sub_read.html?uid=107186§ion=sc243
1313,2017-06-15,메디톡스대웅제약美서보툴리눔균주놓고공방,http://www.metroseoul.co.kr/news/newsview?newscd=2017061500098
1314,2017-06-15,메디톡스의발목잡기대웅제약상대로이번엔美소송,http://news1.kr/articles/?3022014
1315,2017-06-15,대웅제약나보타美진출문제없어메디톡스법적책임물을것,http://www.sportsseoul.com/news/read/522941
1316,2017-06-15,메디톡스美서대웅제약상대로소송의약품도용,http://www.sisafocus.co.kr/news/articleView.html?idxno=162478
1317,2017-06-15,메디톡스대웅제약이균주훔쳤다결국소송,http://www.doctorsnews.co.kr/news/articleView.html?idxno=117349
1318,2017-06-15,대웅제약나보타美진출문제없어,http://www.newscj.com/news/articleView.html?idxno=430801
1319,2017-06-16,메디톡스VS대웅제약보톡스국제소송戰3가지포인트,http://www.ebn.co.kr/news/view/896723
1320,2017-06-16,메디톡스대웅이직원매수해기밀자료와균훔쳤다종합,http://www.edaily.co.kr/news/newspath.asp?newsid=01118486615962376
1321,2017-06-16,대웅제약불확실성장기화가리스크KTB,http://stock.hankyung.com/news/app/newsview.php?aid=2017061693846
1322,2017-06-16,클릭e종목대웅제약美파트너사계약파기가능성은낮아,http://view.asiae.co.kr/news/view.htm?idxno=2017061607353946304
1323,2017-06-16,대웅제약美알페온계약파기없을것불확실성장기화KTB,http://www.mt.co.kr/view/mtview.php?type=1&no=2017061607414420917&outlink=1
1324,2017-06-16,더벨메디톡스대웅제약미국간보톡스논란점입가경,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201706150100027140001647
1325,2017-06-16,ET투자뉴스대웅제약균주논란재점화매수KTB투자증권,http://www.etnews.com/20170616000022
1326,2017-06-16,미국서소송전으로번진메디톡스대웅제약보툴리눔균주논란,http://www.rapportian.com/news/articleView.html?idxno=104302
1327,2017-06-16,특징주대웅제약균주관련피소에이틀째약세,http://view.asiae.co.kr/news/view.htm?idxno=2017061609080784726
1328,2017-06-16,대웅제약미국소송이슈장기화전망파트너社계약파기는없을것,http://www.polinews.co.kr/news/article.html?no=317441
1329,2017-06-16,오늘의종목대웅제약내년5월까지불확실성이어갈듯,http://www.sedaily.com/NewsView/1OH7YUB4T0
1330,2017-06-16,대웅제약피소에이틀연속하락세,http://www.sedaily.com/NewsView/1OH7YVCFC8
1331,2017-06-16,특징주대웅제약메디톡스민사소송제기에약세,http://www.viva100.com/main/view.php?key=20170616010005788
1332,2017-06-16,대웅제약메디톡스소송제기에이틀째약세,http://www.newsprime.co.kr/news/article.html?no=378311
1333,2017-06-16,특징주대웅제약균주도용피소소식에이틀째하락세,http://biz.chosun.com/site/data/html_dir/2017/06/16/2017061600902.html
1334,2017-06-16,BioS메디톡스가소장서주장한대웅보툴리눔균주도용전말은,http://www.etoday.co.kr/news/section/newsview.php?idxno=1503545
1335,2017-06-16,대웅제약메디톡스소송주장은허구해외진출방해시도,https://cnbc.sbs.co.kr/article_hub/10000862902?division=NAVER
1336,2017-06-16,대웅美진출문제없어메디톡스주장사실무근,http://medipana.com/news/news_viewer.asp?NewsNum=202699&MainKind=A&NewsKind=5&vCount=12&vKind=1
1337,2017-06-16,ET투자뉴스대웅제약향후발생할수있매수KB증권,http://www.etnews.com/20170616000092
1338,2017-06-16,대웅제약메디톡스보툴리눔균주진흙탕싸움,http://www.sisafocus.co.kr/news/articleView.html?idxno=162503
1339,2017-06-16,대웅제약주가이틀연속급락보톡스미국판매지연불가피,http://www.businesspost.co.kr/news/articleView.html?idxno=51610
1340,2017-06-16,메디톡스대웅제약美법정싸움과정은패소시피해막중,http://biz.newdaily.co.kr/news/article.html?no=10134563
1341,2017-06-16,KTB투자증권대웅제약메디톡스소송장기화가위험요인투자의견매수”,http://www.kukinews.com/news/article.html?no=461344
1342,2017-06-17,대웅제약와신상담매출회복으로판권회수극복,http://www.medicaltimes.com/News/1112290
1343,2017-06-18,대웅제약글로벌2020비전순항,http://www.fnnews.com/news/201706181916186661
1344,2017-06-19,대웅제약vs메디톡스보톡스전쟁마이너스섬치닫나,http://www.m-i.kr/news/articleView.html?idxno=319283
1345,2017-06-19,대웅제약보톡스분쟁이슈로주가하락할이유없어토러스,http://biz.chosun.com/site/data/html_dir/2017/06/19/2017061900574.html
1346,2017-06-19,보톡스소송논란대웅제약주가하락매수기회로삼아야토러스,http://www.edaily.co.kr/news/newspath.asp?newsid=01620326615963360
1347,2017-06-19,대웅제약보톡스프리미엄에주목강력매수토러스,http://www.cstimes.com/?mod=news&act=articleView&idxno=248387
1348,2017-06-19,토러스증권대웅제약보톡스소송논란을저가매수기회로”,http://www.fnnews.com/news/201706190902227830
1349,2017-06-19,특징주대웅제약하락과했나3일만에반등,http://www.newstomato.com/ReadNews.aspx?no=760012
1350,2017-06-19,특징주보톡스분쟁대웅제약사흘만에상승,http://www.edaily.co.kr/news/newspath.asp?newsid=01918806615963360
1351,2017-06-19,특징주대웅제약피소뒤3거래일째반등성공,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170619044100008&did=1195m
1352,2017-06-19,대웅제약이틀만반등,http://www.sedaily.com/NewsView/1OH9C72N3T
1353,2017-06-19,특징주주가하락은매수기회전망에대웅제약3거래일만의반등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1504241
1354,2017-06-19,대웅제약미국소송영향크지않을듯하태기,http://www.choicenews.co.kr/news/articleView.html?idxno=33964
1355,2017-06-19,ET투자뉴스대웅제약보톡스프리미엄전STRONGBUY유지토러스투자증권,http://www.etnews.com/20170619000085
1356,2017-06-19,ET투자뉴스대웅제약주가영향은제한적매수유지골든브릿지투자증권,http://www.etnews.com/20170619000120
1357,2017-06-19,메디톡스대웅제약보톡스도용고소경찰수사중,http://stock.hankyung.com/news/app/newsview.php?aid=2017061953326
1358,2017-06-19,메디톡스대웅제약이보톡스균훔쳐갔다경찰에수사의뢰,http://www.edaily.co.kr/news/newspath.asp?newsid=03358726615963360
1359,2017-06-19,제약주주가꼬집기③메디톡스대웅제약의보톡스전쟁,http://www.newsway.co.kr/view.php?tp=1&ud=2017061616401554077
1360,2017-06-19,보톡스쇼크대웅제약미국진출먹구름,http://www.sisajournal-e.com/biz/article/170464
1361,2017-06-19,대웅한샘2020클럽10곳주목하라,http://news.mk.co.kr/newsRead.php?&year=2017&no=410737
1362,2017-06-20,CEOUPDOWN365이종욱대웅제약부회장오너보좌형CEO굴레벗을까,http://www.ebn.co.kr/news/view/897137
1363,2017-06-20,1000억에서4조시장으로해외진출가속화하는메디톡스휴젤대웅제약,http://news.heraldcorp.com/view.php?ud=20170620000102
1364,2017-06-20,대웅제약메디톡스휴젤美보톡스시장진출러시,http://news.heraldcorp.com/view.php?ud=20170620000527
1365,2017-06-20,대웅고급인재양성으로시장선도기술개발,http://news.mk.co.kr/newsRead.php?&year=2017&no=413085
1366,2017-06-21,대웅제약OTC탈모약모바렌승인판시딜에도전,http://www.dailypharm.com/News/227753
1367,2017-06-21,대웅vs메디톡스보톡스전쟁어디까지가나,http://www.sportsseoul.com/news/read/524545
1368,2017-06-21,메디톡스대웅제약에도용소송제기보툴리눔균주출처논란재점화,http://www.ntoday.co.kr/news/articleView.html?idxno=53561
1369,2017-06-22,대웅제약탈모약ETCOTC로한걸음직진,http://www.mdtoday.co.kr/mdtoday/index.html?no=288684
1370,2017-06-22,대웅제약당뇨시장서킹메이커재기성공,http://www.mt.co.kr/view/mtview.php?type=1&no=2017062214302199537&outlink=1
1371,2017-06-24,대웅AZ엔토코트양도양수통해국내판권확보,http://www.dailypharm.com/News/227906
1372,2017-06-25,대웅제약한올바이오협업강화,http://www.newstomato.com/ReadNews.aspx?no=761273
1373,2017-06-26,대웅제약비타민DUDCA복합제썬팩타민발매,http://medipana.com/news/news_viewer.asp?NewsNum=203124&MainKind=A&NewsKind=5&vCount=12&vKind=1
1374,2017-06-26,대웅제약비타민D복합제썬팩타민연질캡슐출시,http://www.newsway.co.kr/view.php?tp=1&ud=2017062609361702683
1375,2017-06-26,대웅제약비타민D복합제썬팩타민출시,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170626047200017&did=1195m
1376,2017-06-26,대웅제약비타민DUDCA복합제썬팩타민출시,http://www.dt.co.kr/contents.html?article_no=2017062602109976029002&ref=naver
1377,2017-06-26,대웅제약비타민DUDCA복합제썬팩타민,http://www.medical-tribune.co.kr/news/articleView.html?idxno=73253
1378,2017-06-26,대웅제약비타민D•UDCA복합제썬팩타민연질캡슐출시,http://www.kpanews.co.kr/article/show.asp?idx=184929&table=article&category=D
1379,2017-06-26,대웅비타민DUDCA복합썬팩타민출시,http://www.kpinews.co.kr/news/articleView.html?idxno=45391
1380,2017-06-26,아파야챙길래대웅제약보령제약제일약품,http://www.g-enews.com/ko-kr/news/article/news_all/20170626101914455e6a49afa8d_1/article.html
1381,2017-06-26,대웅제약비타민D복합제썬팩타민연질캡슐출시,http://www.ebn.co.kr/news/view/898049
1382,2017-06-26,대웅제약비타민D복합제썬팩타민출시,http://www.fnnews.com/news/201706261104486191
1383,2017-06-26,대웅제약비타민D복합제썬팩타민출시,http://news.hankyung.com/article/201706262326i
1384,2017-06-26,대웅제약비타민D복합제썬팩타민출시,http://www.newspim.com/news/view/20170626000123
1385,2017-06-26,대웅제약비타민DUDCA복합제썬팩타민연질캡슐출시,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017062611288026813&outlink=1
1386,2017-06-26,이번엔비타민D대웅복합제썬팩타민출시,http://www.dailypharm.com/News/227971
1387,2017-06-26,대웅제약비타민DUDCA복합제썬팩타민출시,http://biz.chosun.com/site/data/html_dir/2017/06/26/2017062601361.html
1388,2017-06-26,비타민D복합제썬팩타민대웅제약,http://www.bosa.co.kr/news/articleView.html?idxno=2063589
1389,2017-06-26,대웅제약비타민DUDCA복합제썬팩타민출시,http://www.bosa.co.kr/news/articleView.html?idxno=2063588
1390,2017-06-26,대웅제약비타민DUDCA복합제썬팩타민출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=207136
1391,2017-06-26,대웅제약비타민D복합제썬팩타민출시,http://www.m-i.kr/news/articleView.html?idxno=321330
1392,2017-06-26,대웅제약비타민DUDCA복합제썬팩타민출시,http://www.joseilbo.com/news/news_read.php?uid=328414&class=27&grp=
1393,2017-06-26,제약신제품대웅제약비타민DUDCA복합제선팩타민출시外,http://www.kukinews.com/news/article.html?no=463819
1394,2017-06-26,대웅제약비타민D복합제썬팩타민출시,http://news20.busan.com/controller/newsController.jsp?newsId=20170626000109
1395,2017-06-26,대웅제약비타민D복합제썬팩타민출시,http://www.newstomato.com/ReadNews.aspx?no=761602
1396,2017-06-26,대웅제약비타민DUDCA복합제썬팩타민출시,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201706260232
1397,2017-06-26,대웅제약이지덤밴드허위과대광고논란,http://www.etnews.com/20170626000270
1398,2017-06-26,대웅제약비타민D복합제썬팩타민출시,http://www.asiatoday.co.kr/view.php?key=20170626010013351
1399,2017-06-26,대웅제약비타민DUDCA복합제썬팩타민출시,http://www.viva100.com/main/view.php?key=20170626020020214
1400,2017-06-26,대웅제약비타민DUDCA복합제썬팩타민연질캡슐출시,http://www.newscj.com/news/articleView.html?idxno=432800
1401,2017-06-27,대웅제약이지덤서포터즈로고객소통강화,http://www.sportsseoul.com/news/read/526197
1402,2017-06-27,대웅제약이지덤서포터즈와고객소통강화,http://medipana.com/news/news_viewer.asp?NewsNum=203192&MainKind=A&NewsKind=5&vCount=12&vKind=1
1403,2017-06-27,대웅제약이지덤대학생서포터즈로상생추구,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017062709058099915&outlink=1
1404,2017-06-27,대웅이지덤대학생서포터즈로고객소통강화,http://www.dailypharm.com/News/228022
1405,2017-06-27,대웅이지덤서포터즈와소통강화통한가치제고,http://www.kpanews.co.kr/article/show.asp?idx=184991&table=article&category=D
1406,2017-06-27,아파야챙길래대웅제약메디톡스광동제약外,http://www.g-enews.com/ko-kr/news/article/news_all/201706270954138121e6a49afa8d_1/article.html
1407,2017-06-27,대웅이지덤서포터즈고객소통강화가치제고,http://www.bosa.co.kr/news/articleView.html?idxno=2063659
1408,2017-06-27,대웅제약이지덤서포터즈와고객소통강화,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201706270108
1409,2017-06-27,대웅제약이지덤서포터즈와고객소통강화,http://www.m-i.kr/news/articleView.html?idxno=321516
1410,2017-06-27,대웅제약이지덤서포터즈로고객소통강화,http://www.joseilbo.com/news/news_read.php?uid=328521&class=27&grp=
1411,2017-06-27,대웅제약이지덤서포터즈와고객소통강화,http://www.seoulfn.com/news/articleView.html?idxno=281895
1412,2017-06-27,대웅제약비타민DUDCA복합제썬팩타민연질캡슐출시,http://sports.hankooki.com/lpage/life/201706/sp20170627112931136800.htm
1413,2017-06-27,대웅제약이지덤서포터즈와고객소통강화를통한가치제고,http://www.newscj.com/news/articleView.html?idxno=432941
1414,2017-06-27,대웅제약이지덤서포터즈와고객소통강화통한가치제고,http://sports.hankooki.com/lpage/life/201706/sp20170627145811136800.htm
1415,2017-06-27,대웅제약이지덤서포터즈와고객소통강화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=207184
1416,2017-06-27,대웅제약이지덤서포터즈운영,http://www.newstomato.com/ReadNews.aspx?no=761963
1417,2017-06-27,대웅제약이지덤대학생서포터즈운영고객소통강화통한가치제고,http://sports.khan.co.kr/news/sk_index.html?art_id=201706271746003&sec_id=561801&pt=nv
1418,2017-06-28,여름건강을지키자대웅제약신약개발박차항궤양제안구건조증치료제임상본격화,http://www.newsis.com/view/?id=NISX20170627_0000024598&cID=13001&pID=13000
1419,2017-06-28,대웅제약자회사손실무려600↑한올바이오파마또적자전환,http://www.ceoscoredaily.com/news/article.html?no=30308
1420,2017-06-28,제약산업소식대웅제약이지덤서포터즈와고객소통강화外,http://www.kukinews.com/news/article.html?no=464577
1421,2017-06-29,대웅제약나를고소하라,http://www.mt.co.kr/view/mtview.php?type=1&no=2017062812085613879&outlink=1
1422,2017-06-29,더벨대웅제약RD비중136신약개발박차,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201706280100051110003075
1423,2017-06-29,대웅제약맞춤형해외진출로글로벌제약사도약,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017062910368025863&outlink=1
1424,2017-07-02,대웅제약이지덤즐거운야외활동상처걱정은이제그만,http://news.kmib.co.kr/article/view.asp?arcid=0923775573&code=14130000&cp=nv
1425,2017-07-03,대웅제약연이은악재에휘청,http://www.kormedi.com/news/news/drug_dist/1223864_2906.html
1426,2017-07-05,LG화학제미글로월처방액60억돌파대웅제약공동판매효과,http://news1.kr/articles/?3039620
1427,2017-07-05,대웅제약공동마케팅으로LG화학제미글로월처방액60억원돌파,http://www.fnnews.com/news/201707051155551310
1428,2017-07-05,사노피에서대웅으로바뀌니제미글로700억대블록버스터기대↑,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1044045
1429,2017-07-05,대웅제약당뇨신약제미글로월처방액60억돌파,http://ciobiz.etnews.com/20170705120023
1430,2017-07-05,대웅제약제미글로월처방액60억돌파,http://www.newstomato.com/ReadNews.aspx?no=763720
1431,2017-07-05,대웅제약당뇨병치료제제미글로월처방액60억원돌파,http://www.sedaily.com/NewsView/1OICW3GANT
1432,2017-07-05,75제약한줄뉴스보령제약대웅제약바이오리더스,http://www.koreahealthlog.com/news/articleView.html?idxno=21767
1433,2017-07-06,대웅제약이인수한한올바이오파마승자의독배되나,http://www.ebn.co.kr/news/view/899533
1434,2017-07-07,대웅JW중외녹십자60조인도제약시장뚫을까,http://www.dailymedi.com/detail.php?number=820343&thread=22r05
1435,2017-07-10,전문약생산은녹십자일반약은대웅제약강세,http://www.bosa.co.kr/news/articleView.html?idxno=2064406
1436,2017-07-10,클릭e종목대웅제약양호한실적전망목표가↑,http://www.asiae.co.kr/news/view.htm?idxno=2017071007260718359
1437,2017-07-10,대웅제약양호한2분기실적전망목표가↑NH,http://news.hankyung.com/article/2017071064076
1438,2017-07-10,대웅제약2Q양호한실적목표가↑NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01594086615993208
1439,2017-07-10,NH투자대웅제약2분기영업익78증가매수기회,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170710034400008&did=1195m
1440,2017-07-10,대웅제약2분기양호한실적상승세,http://www.newsprime.co.kr/news/article.html?no=380889
1441,2017-07-10,대웅동화동국일반약역시최강자동국태극새강자,http://www.kpanews.co.kr/article/show.asp?idx=185396&table=article&category=D
1442,2017-07-10,대웅제약2분기매출2106억원으로예측돼,http://www.kpinews.co.kr/news/articleView.html?idxno=46967
1443,2017-07-11,일반의약품매출최강자대웅동화동국順,http://news.heraldcorp.com/view.php?ud=20170711000307
1444,2017-07-11,매출오른대웅제약성장배경은,http://www.mdtoday.co.kr/mdtoday/index.html?no=288454
1445,2017-07-12,대웅제약동화약품동국제약국내일반의약품시장강자,http://news.heraldcorp.com/view.php?ud=20170712000363
1446,2017-07-12,대웅보령계열사실적신통치않네,http://www.seoulfn.com/news/articleView.html?idxno=283095
1447,2017-07-13,수익성갈수록떨어지는대웅제약멀어지는AA급,http://news.hankyung.com/article/2017071373301
1448,2017-07-16,대웅제약식의약가족테니스대회우승,http://www.bosa.co.kr/news/articleView.html?idxno=2064881
1449,2017-07-17,ET투자뉴스대웅제약나보타단계별로우매수유지하이투자증권,http://www.etnews.com/20170717000133
1450,2017-07-17,ET투자뉴스대웅제약_거래비중기관192외국인1734,http://www.etnews.com/20170717000251
1451,2017-07-17,㈜대웅제약성남시도촌종합사회복지관에사랑의손길전해,http://www.bzeronews.com/news/articleView.html?idxno=310457
1452,2017-07-17,국고처최승욱종목상담대웅제약069620,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201707150044
1453,2017-07-18,대웅제약해외지사우수인재국내서역량강화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=207887
1454,2017-07-18,대웅제약해외지사우수인재국내서역량강화,http://www.dailian.co.kr/news/view/647543/?sc=naver
1455,2017-07-18,대웅제약해외지사인재역량강화,http://www.medical-tribune.co.kr/news/articleView.html?idxno=73623
1456,2017-07-18,대웅제약해외지사우수인재국내서역량강화,http://www.dt.co.kr/contents.html?article_no=2017071802109976029001&ref=naver
1457,2017-07-18,대웅해외지사우수인재국내서역량강화,http://www.dailypharm.com/News/228859
1458,2017-07-18,대웅해외지사우수인재국내서역량강화,http://www.kpanews.co.kr/article/show.asp?idx=185650&table=article&category=D
1459,2017-07-18,대웅제약해외지사우수인재국내서역량강화,http://www.bosa.co.kr/news/articleView.html?idxno=2065030
1460,2017-07-18,대웅제약해외지사우수인재초청워크샵,http://news.hankyung.com/article/201707187765f
1461,2017-07-18,대웅제약해외지사우수인재국내서역량강화,http://medipana.com/news/news_viewer.asp?NewsNum=204229&MainKind=A&NewsKind=5&vCount=12&vKind=1
1462,2017-07-18,대웅제약해외지사우수인재초청워크숍진행,http://www.rapportian.com/news/articleView.html?idxno=104905
1463,2017-07-18,일반약잇따른허가대웅처방용약국용투트랙전략,http://www.kpanews.co.kr/article/show.asp?idx=185661&table=article&category=D
1464,2017-07-18,대웅제약해외지사우수인재국내서키운다,http://www.monews.co.kr/news/articleView.html?idxno=103751
1465,2017-07-18,대웅제약해외지사외국인직원본사초청워크샵진행,http://www.edaily.co.kr/news/newspath.asp?newsid=02925766615995832
1466,2017-07-18,대웅제약해외지사우수인재워크숍개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1044524
1467,2017-07-18,대웅제약해외지사우수인재국내서역량강화,http://www.asiae.co.kr/news/view.htm?idxno=2017071813093976701
1468,2017-07-18,대웅제약청주수해지역복구작업지원,http://www.dailypharm.com/News/228885
1469,2017-07-18,대웅제약청주수해지역약국교품‥복구작업지원,http://medipana.com/news/news_viewer.asp?NewsNum=204254&MainKind=A&NewsKind=5&vCount=12&vKind=1
1470,2017-07-18,대웅제약청주수해지역약국교품복구작업지원,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=207917
1471,2017-07-18,대웅제약청주수해약국에복구지원,http://www.enewstoday.co.kr/news/articleView.html?idxno=1088037
1472,2017-07-18,대웅제약청주수해지역약국교품복구작업지원,http://www.newsis.com/view/?id=NISX20170718_0000044045&cID=13001&pID=13000
1473,2017-07-18,대웅청주수해지역약국복구작업지원,http://www.medigatenews.com/board/people/view/469
1474,2017-07-18,대웅제약청주수해지역약국교품복구작업지원,http://news.hankyung.com/article/201707189008f
1475,2017-07-18,대웅제약청주수해지역약국의약품교환복구작업지원,http://www.rapportian.com/news/articleView.html?idxno=104910
1476,2017-07-18,아파야챙길래광동제약동국제약대웅제약外,http://www.g-enews.com/ko-kr/news/article/news_all/201707181502095235e6a49afa8d_1/article.html
1477,2017-07-18,대웅제약해외지사인재역량강화,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201707180204
1478,2017-07-18,대웅청주수해지역약국대상복구지원,http://www.mt.co.kr/view/mtview.php?type=1&no=2017071814193030729&outlink=1
1479,2017-07-18,대웅제약청주수해지역약국교품복구작업실시,http://www.getnews.co.kr/view.php?ud=20170718150404484254b3c2d373_16
1480,2017-07-18,대웅제약청주수해지역복구작업지원,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201707180210
1481,2017-07-18,대웅제약청주수해지역약국의약품교환복구작업도지원,http://www.kukinews.com/news/article.html?no=469825
1482,2017-07-18,대웅제약청주지역침수피해의약품교환및복구작업지원,http://www.fnnews.com/news/201707181515215956
1483,2017-07-18,대웅제약청주수해지역약국교품복구작업지원,http://www.bosa.co.kr/news/articleView.html?idxno=2065074
1484,2017-07-18,대한민국이좋다대웅제약청주시약국대상수해복구지원,http://www.m-i.kr/news/articleView.html?idxno=327419
1485,2017-07-18,대웅제약해외지사우수인재국내서역량강화,http://sports.hankooki.com/lpage/life/201707/sp20170718162820136800.htm
1486,2017-07-18,대웅제약청주수해지역의약품교환및복구작업지원,http://news20.busan.com/controller/newsController.jsp?newsId=20170718000166
1487,2017-07-18,대웅제약청주수해지역약국교품복구작업지원,http://sports.hankooki.com/lpage/life/201707/sp20170718163610136800.htm
1488,2017-07-18,대웅제약청주수해지역약국의약품교환및복구지원,http://biz.chosun.com/site/data/html_dir/2017/07/18/2017071802416.html
1489,2017-07-18,대웅제약수마휩쓴청주지역약국지원,http://www.monews.co.kr/news/articleView.html?idxno=103780
1490,2017-07-18,대웅제약청주수해지역약국복구작업지원,http://www.sedaily.com/NewsView/1OIIUO02DE
1491,2017-07-18,대웅제약청주수해지역약국의약품교환복구작업지원,http://www.dt.co.kr/contents.html?article_no=2017071802109976029006&ref=naver
1492,2017-07-18,대웅제약청주수해지역약국교품복구작업지원,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017071818064034212
1493,2017-07-18,대웅제약해외지사우수인재국내서역량강화,http://www.newscj.com/news/articleView.html?idxno=437325
1494,2017-07-18,대웅제약청주수해지역약국교품복구작업지원,http://www.newscj.com/news/articleView.html?idxno=437318
1495,2017-07-18,대웅제약청주수해지역약국의약품교환및복구작업지원,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017071818258047584&outlink=1
1496,2017-07-18,대웅제약청주수해지역약국교품복구작업지원,http://www.viva100.com/main/view.php?key=20170718020020432
1497,2017-07-19,대웅제약청주수해지역약국교품및복구지원나서,http://www.dailian.co.kr/news/view/647731/?sc=naver
1498,2017-07-19,대웅제약청주수해지역약국교품복구작업지원,http://www.kpanews.co.kr/article/show.asp?idx=185693&table=article&category=D
1499,2017-07-19,대웅해외지사우수인재국내서역량강화,http://www.kpinews.co.kr/news/articleView.html?idxno=47827
1500,2017-07-19,대웅제약임팩트남긴No마케팅전략,http://www.m-i.kr/news/articleView.html?idxno=327773
1501,2017-07-19,대웅제약관계사바이오알파ATC지원사업선정,http://www.m-i.kr/news/articleView.html?idxno=327825
1502,2017-07-20,비슷한이름있었다고대웅본플러스상표무효화이유는,http://www.kpanews.co.kr/article/show.asp?idx=185702&table=article&category=D
1503,2017-07-20,대웅바이오순위급상승위임제네릭통했다,http://www.dailypharm.com/News/228942
1504,2017-07-20,전문약우루사대웅제약이꺼내든비장의카드는,http://www.medicaltimes.com/News/1112847
1505,2017-07-20,대웅제약나보타미국시장순풍‥FDA허가접수,http://medipana.com/news/news_viewer.asp?NewsNum=204363&MainKind=A&NewsKind=5&vCount=12&vKind=1
1506,2017-07-20,대웅제약보툴리눔톡신나보타美FDA허가접수,http://www.dailypharm.com/News/228988
1507,2017-07-20,ET투자뉴스대웅_주가거래량투심모두적정주순,http://www.etnews.com/20170720000060
1508,2017-07-20,대웅제약미국 진출 첫 단추 뀄다나보타FDA허가신청완료,http://www.kpinews.co.kr/news/articleView.html?idxno=48033
1509,2017-07-20,대웅제약나보타미국FDA허가접수,http://www.dt.co.kr/contents.html?article_no=2017072002109976029003&ref=naver
1510,2017-07-20,대웅제약보톡스나보타미국FDA허가신청,http://www.medicaltimes.com/News/1112865
1511,2017-07-20,대웅제약나보타해외진출준비착착,http://www.monews.co.kr/news/articleView.html?idxno=103892
1512,2017-07-20,대웅제약나보타미국FDA허가신청,http://www.dt.co.kr/contents.html?article_no=2017072102101122813001&ref=naver
1513,2017-07-21,위임제네릭으로성장이루는대웅바이오,http://www.mdtoday.co.kr/mdtoday/index.html?no=291215
1514,2017-07-21,더벨전승호본부장글로벌대웅제약이끈다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201707190100036230002156
1515,2017-07-21,대웅제약나보타미국시장순항중FDA허가신청완료,http://www.mdtoday.co.kr/mdtoday/index.html?no=291197
1516,2017-07-21,단독대웅제약주름개선나보타유럽도판매허가신청,http://news1.kr/articles/?3054466
1517,2017-07-21,대웅제약나보타미국이어유럽시장진출성큼,http://medipana.com/news/news_viewer.asp?NewsNum=204454&MainKind=A&NewsKind=5&vCount=12&vKind=1
1518,2017-07-21,대웅제약나보타유럽판매허가신청완료,http://www.newsis.com/view/?id=NISX20170721_0000047354&cID=13001&pID=13000
1519,2017-07-21,대웅제약나보타미FDA허가신청,http://www.newsis.com/view/?id=NISX20170721_0000047368&cID=13001&pID=13000
1520,2017-07-21,대웅제약보툴리눔톡신나보타EMA허가신청,http://www.dailypharm.com/News/229057
1521,2017-07-21,대웅나보타미국유럽서허가신청접수,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1044660
1522,2017-07-21,대웅제약나보타미FDA허가신청안정성인정받아,http://www.getnews.co.kr/view.php?ud=20170721151934411654b3c2d373_16
1523,2017-07-21,대웅제약나보타미국이어유럽서판매허가신청,http://www.rapportian.com/news/articleView.html?idxno=105011
1524,2017-07-21,721제약한줄뉴스대웅제약알테오젠대한뉴팜,http://www.koreahealthlog.com/news/articleView.html?idxno=21828
1525,2017-07-21,대웅제약나보타EMA허가신청접수완료,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=208080
1526,2017-07-23,대웅제약나보타미국이어유럽까지판매허가신청,http://www.mdtoday.co.kr/mdtoday/index.html?no=291306
1527,2017-07-24,제약톡톡대웅제약나보타미국유럽시장먼저노크,http://news.heraldcorp.com/view.php?ud=20170724000125
1528,2017-07-24,대웅바이오센터장에전복환전제넥신부사장선임,http://medipana.com/news/news_viewer.asp?NewsNum=204531&MainKind=A&NewsKind=5&vCount=12&vKind=1
1529,2017-07-24,대웅바이오센터장에전복환전제넥신부사장,http://www.dailypharm.com/News/229129
1530,2017-07-24,대웅제약전복환前제넥신부사장대웅바이오센터장선임,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=208106
1531,2017-07-24,대웅바이오센터센터장에전복환씨선임,http://www.asiatoday.co.kr/view.php?key=20170724010011725
1532,2017-07-24,인사대웅제약,http://www.shinailbo.co.kr/news/articleView.html?idxno=592897
1533,2017-07-24,대웅바이오센터장에전복환전제넥신부사장선임,http://www.medicaltimes.com/News/1112915
1534,2017-07-24,대웅제약대웅바이오센터센터장에전복환前제넥신부사장선임,http://sports.hankooki.com/lpage/life/201707/sp20170724105831136800.htm
1535,2017-07-24,대웅바이오센터센터장에전복환전제넥신부사장선임,http://www.metroseoul.co.kr/news/newsview?newscd=2017072400016
1536,2017-07-24,대웅바이오센터센터장에전복환前제넥신부사장선임,http://www.kpanews.co.kr/article/show.asp?idx=185833&table=article&category=D
1537,2017-07-24,인사대웅제약,http://www.fnnews.com/news/201707241116351513
1538,2017-07-24,대웅바이오센터센터장에전복환전제넥신부사장선임,http://www.mt.co.kr/view/mtview.php?type=1&no=2017072411152550166&outlink=1
1539,2017-07-24,대웅제약바이오센터장에전복환전제넥신부사장임명,http://www.mediapen.com/news/view/286853
1540,2017-07-24,대웅제약대웅바이오센터장에전복환씨,http://www.sedaily.com/NewsView/1OILLW33BT
1541,2017-07-24,대웅바이오센터장에전복환前제넥신부사장,http://www.medical-tribune.co.kr/news/articleView.html?idxno=73715
1542,2017-07-24,대웅바이오센터장에전복환전제넥신부사장선임,http://www.newsis.com/view/?id=NISX20170724_0000049045&cID=13001&pID=13000
1543,2017-07-24,대웅바이오센터센터장에전복환전제넥신부사장,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1044714
1544,2017-07-24,대웅바이오센터장에전복환전제넥신부사장선임,http://www.medigatenews.com/board/people/view/473
1545,2017-07-24,대웅제약바이오센터장에전복환전제넥신부사장선임,http://news.hankyung.com/article/201707248313f
1546,2017-07-24,인사대웅제약,http://www.etnews.com/20170724000238
1547,2017-07-24,인사국방부신라대대경일보대웅제약,http://www.businesspost.co.kr/news/articleView.html?idxno=54657
1548,2017-07-24,대웅제약전복환바이오센터장선임,http://www.dt.co.kr/contents.html?article_no=2017072402109976029003&ref=naver
1549,2017-07-24,대웅제약바이오센터센터장에전복환前제넥신부사장선임,http://www.viva100.com/main/view.php?key=20170724010008667
1550,2017-07-24,대웅제약전복환신임바이오센터장선임,https://cnbc.sbs.co.kr/article_hub/10000867865?division=NAVER
1551,2017-07-24,대웅제약바이오센터장에전복환전제넥신부사장,http://www.asiae.co.kr/news/view.htm?idxno=2017072414231237108
1552,2017-07-24,대웅제약바이오센터장에전복환전제넥신부사장선임,http://biz.chosun.com/site/data/html_dir/2017/07/24/2017072401810.html
1553,2017-07-24,대웅바이오센터장에전복환前제넥신부사장선임,http://www.bosa.co.kr/news/articleView.html?idxno=2065473
1554,2017-07-24,대웅제약바이오센터장에전복환제넥신부사장영입,http://www.rapportian.com/news/articleView.html?idxno=105040
1555,2017-07-24,대웅제약전복환전제넥신부사장바이오센터장에선임,http://www.edaily.co.kr/news/newspath.asp?newsid=03076646615997800
1556,2017-07-24,대웅바이오센터전복환신임센터장선임,http://www.monews.co.kr/news/articleView.html?idxno=103994
1557,2017-07-24,인사대웅제약,http://www.seoulfn.com/news/articleView.html?idxno=284008
1558,2017-07-24,대웅제약바이오센터센터장에전복환前제넥신부사장선임,http://www.ceoscoredaily.com/news/article.html?no=30970
1559,2017-07-24,대웅제약바이오센터장에전복환전제넥신부사장,http://www.newspim.com/news/view/20170724000145
1560,2017-07-24,대웅바이오센터장에전복환前제넥신부사장,http://www.kormedi.com/news/news/drug_dist/1224094_2906.html
1561,2017-07-24,대웅바이오센터센터장에전복환전제넥신부사장선임,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017072417325444766
1562,2017-07-24,대웅제약바이오센터장에전복환전제넥신부사장,http://www.seoulfn.com/news/articleView.html?idxno=284020
1563,2017-07-24,인사대웅제약;국방부;농림축산식품부등,http://news.hankyung.com/article/2017072499001
1564,2017-07-24,대웅제약바이오센터장에전복환前제넥신부사장선임,http://news1.kr/articles/?3056868
1565,2017-07-24,대웅제약센터장에전복환전제넥신부사장선임,http://www.newscj.com/news/articleView.html?idxno=438661
1566,2017-07-25,제약산업소식대웅제약대웅바이오센터장에전복환씨선임外,http://www.kukinews.com/news/article.html?no=471575
1567,2017-07-25,글로벌제네릭탄생시킨휴온스대웅전략은다르다,http://medipana.com/news/news_viewer.asp?NewsNum=204613&MainKind=A&NewsKind=5&vCount=12&vKind=1
1568,2017-07-25,ET투자뉴스대웅_현재주가근처인13500원대에주요매물대가존재,http://www.etnews.com/20170725000189
1569,2017-07-25,대웅제약2Q영업익140억전년비125증가,http://www.mt.co.kr/view/mtview.php?type=1&no=2017072516135155181&outlink=1
1570,2017-07-25,대웅제약2017년2분기영업이익140억원전년比125증가,http://biz.chosun.com/site/data/html_dir/2017/07/25/2017072502039.html
1571,2017-07-25,대웅제약2Q영업익140억원전년비126증가1보,http://news1.kr/articles/?3057831
1572,2017-07-25,대웅제약2분기영업익140억전년비12556↑,http://www.asiae.co.kr/news/view.htm?idxno=2017072516222341109
1573,2017-07-25,대웅제약2분기영업익1398억전년비12556↑,http://news.heraldcorp.com/view.php?ud=20170725000879
1574,2017-07-25,대웅제약2Q영업익139억원전년동기比12556,http://www.etoday.co.kr/news/section/newsview.php?idxno=1519192
1575,2017-07-25,대웅제약2Q영업익1398억전년比125↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03621126615998128
1576,2017-07-25,대웅제약2분기영업익140억원125성장,http://www.dailypharm.com/News/229212
1577,2017-07-25,대웅제약2분기영업익140억원전년비126증가,http://www.dailian.co.kr/news/view/649343/?sc=naver
1578,2017-07-25,ET투자뉴스대웅제약전분기比매출액영업이익동반상승,http://www.etnews.com/20170725000361
1579,2017-07-25,대웅제약상반기매출4277억영업익전년비103증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=208187
1580,2017-07-25,대웅제약2분기매출2225억영업익140억기록,http://www.rapportian.com/news/articleView.html?idxno=105085
1581,2017-07-25,대웅제약2Q영업익140억판매품목확대한덕분상보,http://news1.kr/articles/?3057912
1582,2017-07-25,대웅제약2분기영업익140억원작년보다126증가,http://www.dt.co.kr/contents.html?article_no=2017072502109976029007&ref=naver
1583,2017-07-25,대웅제약2분기영업익140억전년비2배껑충,http://www.newspim.com/news/view/20170725000225
1584,2017-07-25,더벨대웅제약미국유럽보톡스메디톡스제칠수있을까,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201707210100042500002532
1585,2017-07-25,대웅제약2분기영업이익139억8500만원전년比12556↑,http://www.nspna.com/news/?mode=view&newsid=233468
1586,2017-07-25,실적발표휴젤고영대웅제약,http://www.businesspost.co.kr/news/articleView.html?idxno=54831
1587,2017-07-25,대웅제약옛명성찾나‥작년과다른실적호조세,http://medipana.com/news/news_viewer.asp?NewsNum=204639&MainKind=A&NewsKind=5&vCount=12&vKind=1
1588,2017-07-26,대웅제약이익늘고비용줄어서프라이즈목표가↑하이,http://www.edaily.co.kr/news/newspath.asp?newsid=01443206615998456
1589,2017-07-26,대웅제약2Q깜짝실적목표가↑미래에셋대우,http://www.mt.co.kr/view/mtview.php?type=1&no=2017072608114054650&outlink=1
1590,2017-07-26,대웅제약2분기영업익전년比126증가,http://www.asiatoday.co.kr/view.php?key=20170726010012875
1591,2017-07-26,대웅제약2분기깜짝영업이익달성미래에셋대우,http://www.sedaily.com/NewsView/1OIMHSAYQV
1592,2017-07-26,대웅제약안정적인수익성계속될것한화,http://biz.chosun.com/site/data/html_dir/2017/07/26/2017072600621.html
1593,2017-07-26,대웅제약2분기실적기대치웃돌아성장세지속한화,http://news.hankyung.com/article/2017072651666
1594,2017-07-26,HotLine대웅제약올해연간영업익477억원예상목표가↑,http://news.mk.co.kr/newsRead.php?year=2017&no=500621
1595,2017-07-26,더벨대웅제약반기매출첫4000억돌파연1조가시화,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201707250100048720002915
1596,2017-07-26,클릭e종목대웅제약신제품시장안착으로깜짝영업이익달성목표가↑,http://www.asiae.co.kr/news/view.htm?idxno=2017072608554749561
1597,2017-07-26,특징주대웅제약2분기깜짝실적에상승,http://news.hankyung.com/article/2017072653726
1598,2017-07-26,특징주대웅제약어닝서프라이즈에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=01866326615998456
1599,2017-07-26,특징주대웅제약2분기호실적에상승,http://www.viva100.com/main/view.php?key=20170726010009584
1600,2017-07-26,한화투자증권대웅제약2Q호실적안적정수익성이어갈것,http://www.newsprime.co.kr/news/article.html?no=382757
1601,2017-07-26,어닝서프라이즈대웅제약주가도활짝,http://www.newsprime.co.kr/news/article.html?no=382767
1602,2017-07-26,ET투자뉴스대웅제약2Q17마케팅비용매수유지미래에셋대우,http://www.etnews.com/20170726000112
1603,2017-07-26,fnRASSI대웅003090현재806,http://www.fnnews.com/news/201707261044401429
1604,2017-07-26,ET투자뉴스대웅제약실적도보톡스도잘매수유지동부증권,http://www.etnews.com/20170726000192
1605,2017-07-26,녹십자독감백신대웅릭시아나2분기실적견인효자,http://www.kpanews.co.kr/article/show.asp?idx=185921&table=article&category=D
1606,2017-07-26,ET투자뉴스대웅제약신규전문의약품의매수유지한화투자증권,http://www.etnews.com/20170726000207
1607,2017-07-26,ET투자뉴스대웅제약_투심과거래량은보통현재주가는강세,http://www.etnews.com/20170726000208
1608,2017-07-26,ET투자뉴스대웅제약전사업부문매출매수유지NH투자증권,http://www.etnews.com/20170726000238
1609,2017-07-26,ET투자뉴스대웅제약매출성장과비용매수유지하이투자증권,http://www.etnews.com/20170726000253
1610,2017-07-26,ET투자뉴스대웅제약나보타소송이슈에매수KTB투자증권,http://www.etnews.com/20170726000255
1611,2017-07-26,대웅제약고혈압고지혈증치료제수익성견인,http://www.m-i.kr/news/articleView.html?idxno=329677
1612,2017-07-26,대웅제약2분기에도성장그래프ETCOTC안정적캐쉬카우역할,http://www.mdtoday.co.kr/mdtoday/index.html?no=291647
1613,2017-07-26,fnRASSI장마감거래소상승종목대웅1282↑,http://www.fnnews.com/news/201707261541564576
1614,2017-07-26,제약사2분기실적순항셀트리온녹십자대웅고공행진,http://www.sportsseoul.com/news/read/535936
1615,2017-07-26,ET투자뉴스대웅제약3분기영업이익1매수유지신한금융투자,http://www.etnews.com/20170726000435
1616,2017-07-26,이종목은왜오늘의특징주집중분석LG생활건강삼성에스디에스대웅제약,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017072616115279740
1617,2017-07-27,녹십자대웅제약올해반기실적보고하며웃었다,http://www.dailypharm.com/News/229259
1618,2017-07-27,BioS고른사업포트폴리오대웅제약의위기관리테크닉,http://www.etoday.co.kr/news/section/newsview.php?idxno=1519943
1619,2017-07-27,깜짝실적대웅제약관건은나보타소송,http://news.heraldcorp.com/view.php?ud=20170727000187
1620,2017-07-27,빅데이터MSI시장심리톱5녹십자고려아연대웅제약호텔신라LG이노텍,http://www.newsis.com/view/?id=NISX20170727_0000052223&cID=10401&pID=10400
1621,2017-07-27,2분기제약사들장사잘했네녹십자대웅제약최대매출,http://www.sisajournal-e.com/biz/article/171925
1622,2017-07-28,대웅수성총력일동유한한미시장잠식,http://www.dailymedi.com/detail.php?number=821032&thread=22r05
1623,2017-07-28,녹십자대웅등주요제약사들상반기실적어닝서프라이즈,http://www.rapportian.com/news/articleView.html?idxno=105135
1624,2017-07-28,ET투자뉴스대웅제약실적성장으로나보매수신규골든브릿지투자증권,http://www.etnews.com/20170728000384
1625,2017-07-28,판권잃고고전했던대웅제약부활날갯짓,http://www.bizwatch.co.kr/pages/view.php?uid=32468
1626,2017-07-30,대웅제약녹십자깜짝실적,http://news.hankyung.com/article/2017073090921
1627,2017-07-31,이종웅대웅제약부회장제약업계CEO중재임기간세번째,http://www.ceoscoredaily.com/news/article.html?no=31150
1628,2017-07-31,대웅제약글로벌2020비전순항중전문역량강화본격화,http://www.g-enews.com/ko-kr/news/article/news_all/201707311055472944e6a49afa8d_1/article.html
1629,2017-07-31,WhoIs윤재승대웅제약회장,http://www.businesspost.co.kr/news/articleView.html?idxno=55241
1630,2017-07-31,대웅제약여름휴가철상비약은꼭챙겨야,http://www.metroseoul.co.kr/news/newsview?newscd=2017073100075
1631,2017-07-31,대웅제약윤재승회장직원의성장에도움안된다면,http://www.kormedi.com/news/news/drug_dist/1224171_2906.html
1632,2017-07-31,대웅제약윤재승회장직원과함께성장할방안당부,http://www.viva100.com/main/view.php?key=20170731010011881
1633,2017-07-31,대웅제약윤재승회장소통경영직원성장최우선,http://www.medicaltimes.com/News/1113041
1634,2017-07-31,대웅제약한중인니글로벌삼각편대활짝,http://www.newspim.com/news/view/20170731000237
1635,2017-08-01,특허만료됐지만年처방600억대웅알비스,http://www.dailymedi.com/detail.php?number=821120&thread=22r05
1636,2017-08-01,대웅제약이지덤이지엔6씨콜드베아제등휴가철상비약인기,http://www.seoul.co.kr/news/newsView.php?id=20170731500135&wlog_tag3=naver
1637,2017-08-01,대웅제약윤재승호국가별맞춤형전략통했다,http://www.dailypharm.com/News/229440
1638,2017-08-01,대웅제약글로벌생산네트워크강화,http://www.mt.co.kr/view/mtview.php?type=1&no=2017080114281167222&outlink=1
1639,2017-08-01,대웅제약윤재승호글로벌생산네트워크완성,http://medipana.com/news/news_viewer.asp?NewsNum=204948&MainKind=A&NewsKind=5&vCount=12&vKind=1
1640,2017-08-01,대웅제약윤재승호한국중국인니에생산네트워크구축,http://www.viva100.com/main/view.php?key=20170801020020548
1641,2017-08-02,줄기세포힘주는대웅제약잇따른전문가영입눈길,http://biz.newdaily.co.kr/news/article.html?no=10138101
1642,2017-08-02,글로벌인재키우는제약업계동아대웅등열심,http://www.dt.co.kr/contents.html?article_no=2017080202109976029005&ref=naver
1643,2017-08-02,대웅제약국가별특화전략으로글로벌제약사도약,http://www.m-i.kr/news/articleView.html?idxno=331524
1644,2017-08-03,대웅푸루나졸부동의1위스포라녹스이트라각축,http://www.kpanews.co.kr/article/show.asp?idx=185965&table=article&category=D
1645,2017-08-03,더벨LG화학신약제미로우대웅제약과또파트너맺을까,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201708020100003550000211
1646,2017-08-04,녹십자한미대웅깜짝실적,http://www.medigatenews.com/news/3319284775
1647,2017-08-05,삼진플래리스대웅글리아타민종근당리피로우호조,http://www.dailymedi.com/detail.php?number=821249&thread=22r05
1648,2017-08-06,대웅제약국내외인재육성으로글로벌경쟁력강화,http://news.kmib.co.kr/article/view.asp?arcid=0923793197&code=14130000&cp=nv
1649,2017-08-07,fnRASSI대웅52주신고가354↑,http://www.fnnews.com/news/201708071014028275
1650,2017-08-07,일반약선두까스활명수아로나민대웅5개최다,http://www.dailymedi.com/detail.php?number=821286&thread=22r05
1651,2017-08-08,LG화학대웅제약제미로우맞손가능성솔솔,http://www.m-i.kr/news/articleView.html?idxno=332617
1652,2017-08-08,ET투자뉴스대웅_외국인의매수세유입이후주가가탄력받나현재182,http://www.etnews.com/20170808000031
1653,2017-08-09,대웅친인척윤재훈윤석호씨18만1114주장내매도,http://www.edaily.co.kr/news/newspath.asp?newsid=03709686616025680
1654,2017-08-09,공시대웅윤재훈윤석호18만1114주장내매도,http://www.newsway.co.kr/view.php?tp=1&ud=2017080916510162110
1655,2017-08-09,대웅윤재훈윤석호씨18만주장내매도,http://www.asiae.co.kr/news/view.htm?idxno=2017080917015234051
1656,2017-08-09,ET투자뉴스대웅지분변동윤재승외8명061p감소405보유,http://www.etnews.com/20170809000389
1657,2017-08-09,대웅시지바이오흡수성체내용지혈용품이지스탑출시,http://www.viva100.com/main/view.php?key=20170809020020609
1658,2017-08-11,대웅제약간질환포트폴리오강화,http://www.mdtoday.co.kr/mdtoday/index.html?no=292926
1659,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=208629
1660,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://www.kpanews.co.kr/article/show.asp?idx=186225&table=article&category=D
1661,2017-08-11,대웅제약정맥질환개선제출시,http://www.newstomato.com/ReadNews.aspx?no=771508
1662,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://www.mediapen.com/news/view/291535
1663,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://www.asiatoday.co.kr/view.php?key=20170811010005203
1664,2017-08-11,대웅제약정맥질환개선제센테라이트출시,http://news1.kr/articles/?3072143
1665,2017-08-11,대웅제약정맥질환개선제센테라이트출시,http://medipana.com/news/news_viewer.asp?NewsNum=205327&MainKind=A&NewsKind=5&vCount=12&vKind=1
1666,2017-08-11,대웅제약정맥질환개선제센테라이트출시,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170811049300017&did=1195m
1667,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://news.kmib.co.kr/article/view.asp?arcid=0011676724&code=61171911&cp=nv
1668,2017-08-11,대웅정맥질환개선제센테라이트출시,http://www.dailypharm.com/News/229703
1669,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://www.bosa.co.kr/news/articleView.html?idxno=2066553
1670,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://www.kpinews.co.kr/news/articleView.html?idxno=50479
1671,2017-08-11,대웅제약정맥질환개선제센테라이트론칭,http://www.medicaltimes.com/News/1113211
1672,2017-08-11,대웅제약정맥질환개선제센테라이트,http://www.medical-tribune.co.kr/news/articleView.html?idxno=73982
1673,2017-08-11,대웅제약정맥질환개선제센테라이트출시,http://www.fnnews.com/news/201708111009071042
1674,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://biz.chosun.com/site/data/html_dir/2017/08/11/2017081100982.html
1675,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://www.mt.co.kr/view/mtview.php?type=1&no=2017081109531077089&outlink=1
1676,2017-08-11,대웅제약정맥질환치료제센테라이트정출시,http://news.mk.co.kr/newsRead.php?year=2017&no=539192
1677,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://www.medicaltimes.com/News/1113215
1678,2017-08-11,대웅정맥질환개선제센테라이트출시,http://www.dailymedi.com/detail.php?number=821436&thread=22r05
1679,2017-08-11,정맥질환개선제센테라이트정대웅제약,http://www.bosa.co.kr/news/articleView.html?idxno=2066564
1680,2017-08-11,대웅제약정맥질환개선제센테라이트출시,http://www.rapportian.com/news/articleView.html?idxno=105414
1681,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=292960
1682,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://news.hankyung.com/article/201708117678f
1683,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1097016
1684,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://www.metroseoul.co.kr/news/newsview?newscd=2017081100011
1685,2017-08-11,아파야챙길래대웅제약한미약품동화약품,http://www.g-enews.com/ko-kr/news/article/news_all/201708111438572854e6a49afa8d_1/article.html
1686,2017-08-11,대웅제약정맥질환치료제시장확대나서,http://www.m-i.kr/news/articleView.html?idxno=334101
1687,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://www.newsis.com/view/?id=NISX20170811_0000065947&cID=13001&pID=13000
1688,2017-08-11,대웅제약정맥질환개선제센테라이트출시,http://www.finomy.com/news/articleView.html?idxno=46823
1689,2017-08-11,대웅제약정맥질환개선제센테라이트출시,http://www.fnnews.com/news/201708111733126800
1690,2017-08-11,대웅제약정맥질환개선제센테라이트출시,http://www.seoulfn.com/news/articleView.html?idxno=285443
1691,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://www.newsprime.co.kr/news/article.html?no=384648
1692,2017-08-11,복지부진흥원대웅JW중외등국내제약기업10곳해외진출지원,http://www.viva100.com/main/view.php?key=20170811020020623
1693,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201708110284
1694,2017-08-11,대웅제약정맥질환개선제센테라이트정출시,http://www.newscj.com/news/articleView.html?idxno=442438
1695,2017-08-12,대웅제약정맥질환개선제센테라이트정출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1045438
1696,2017-08-12,대웅제약정맥질환개선제센테라이트정출시,http://www.ftoday.co.kr/news/articleView.html?idxno=78958
1697,2017-08-14,CEOUP대웅제약상반기매출4277억1조클럽성큼,http://www.ajunews.com/view/20170813121350846
1698,2017-08-14,ET투자뉴스대웅제약나보타미국진출과매수유지KB증권,http://www.etnews.com/20170814000014
1699,2017-08-14,대웅제약하반기나보타미국진출실적개선기대감,http://www.nspna.com/news/?mode=view&newsid=236026
1700,2017-08-14,대웅제약정맥질환개선제센테라이트정출시,http://sports.hankooki.com/lpage/life/201708/sp20170814122917136800.htm
1701,2017-08-16,상장제약반기실적대체로양호대웅3위로껑충,http://www.dailypharm.com/News/229786
1702,2017-08-16,대웅제약신경병증성통증치료제리카프리출시,http://www.kpanews.co.kr/article/show.asp?idx=186278&table=article&category=D
1703,2017-08-16,대웅제약신경병증성통증치료제리카프리출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=208754
1704,2017-08-16,대웅신경병증통증치료제리카프리출시,http://www.dailypharm.com/News/229800
1705,2017-08-16,대웅우루사효능효과서소화불량식욕부진삭제,http://www.mt.co.kr/view/mtview.php?type=1&no=2017081609493568860&outlink=1
1706,2017-08-16,대웅제약신경병증성통증치료제리카프리출시,http://www.bosa.co.kr/news/articleView.html?idxno=2066715
1707,2017-08-16,대웅제약신경병증성통증치료제리카프리출시,http://www.medicaltimes.com/News/1113251
1708,2017-08-16,대웅제약우루사의약품재평가통해간기능장애에의한육체피로전신권태인정받아,http://sports.hankooki.com/lpage/life/201708/sp20170816102258136800.htm
1709,2017-08-16,대웅우루사간기능장애육체피로전신권태인정반색,http://www.kpanews.co.kr/article/show.asp?idx=186289&table=article&category=D
1710,2017-08-16,대웅우루사의약품재평가로효능재입증,http://www.dailymedi.com/detail.php?number=821537&thread=22r05
1711,2017-08-16,원기소시판금지대웅제약우루사는효능축소,http://www.cstimes.com/?mod=news&act=articleView&idxno=253443
1712,2017-08-16,대웅제약우루사간기능장애육체피로전신권태인정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=208760
1713,2017-08-16,대웅제약우루사육체피로전신권태효과재인정,http://news.hankyung.com/article/201708169483f
1714,2017-08-16,대웅우루사간기능장애육체피로전신권태인정,http://www.sisajournal-e.com/biz/article/172763
1715,2017-08-16,대웅제약신경병증성통증치료제리카프리출시,http://www.rapportian.com/news/articleView.html?idxno=105482
1716,2017-08-16,아파야챙길래한미약품대웅제약유유제약外,http://www.g-enews.com/ko-kr/news/article/news_all/201708161047348428e6a49afa8d_1/article.html
1717,2017-08-16,대웅신경병증성통증치료제리카프리출시,http://www.monews.co.kr/news/articleView.html?idxno=104510
1718,2017-08-16,대웅제약우루사의약품재평가로효과인정,http://www.monews.co.kr/news/articleView.html?idxno=104517
1719,2017-08-16,대웅제약우루사의약품재평가통해피로및간기능개선효과입증,http://www.newsis.com/view/?id=NISX20170816_0000068906&cID=13001&pID=13000
1720,2017-08-16,대웅제약신경병증성통증치료제리카프리출시,http://medipana.com/news/news_viewer.asp?NewsNum=205467&MainKind=A&NewsKind=5&vCount=12&vKind=1
1721,2017-08-16,대웅제약신경병증성통증치료제리카프리,http://www.medical-tribune.co.kr/news/articleView.html?idxno=74020
1722,2017-08-16,대웅제약신경병증성통증치료제리리카제네릭출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1045575
1723,2017-08-16,대웅제약간질약리리카복제약경쟁합류,http://www.mt.co.kr/view/mtview.php?type=1&no=2017081611303283181&outlink=1
1724,2017-08-16,대웅제약우루사피로회복효과재입증,http://www.m-i.kr/news/articleView.html?idxno=334924
1725,2017-08-16,대웅제약우루사육체피로개선효과재입증,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017081614428030224&outlink=1
1726,2017-08-16,대웅제약우루사간기능장애육체피로효과인정받아,http://www.newstomato.com/ReadNews.aspx?no=772133
1727,2017-08-16,식약처원기소등26개의약품판매금지대웅제약우루사일부효능삭제,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=520081
1728,2017-08-16,대웅제약우루사의약품재평가로효능재입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=293237
1729,2017-08-16,500억리리카시장대웅제약제네릭첫출시,http://www.kormedi.com/news/news/drug_dist/1224331_2906.html
1730,2017-08-16,대웅제약우루사의약품재평가서피로회복효과재입증,http://news.mk.co.kr/newsRead.php?year=2017&no=549203
1731,2017-08-16,대웅제약우루사의약품재평가로효과입증,http://www.dailian.co.kr/news/view/654266/?sc=naver
1732,2017-08-16,대웅제약통증치료제리카프리출시,http://www.enewstoday.co.kr/news/articleView.html?idxno=1098509
1733,2017-08-16,대웅제약신경병증성통증치료제리카프리출시,http://www.viva100.com/main/view.php?key=20170816020020644
1734,2017-08-16,대웅제약우루사피로간기능개선효과임상실험으로입증,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201708161748002&code=900303
1735,2017-08-16,대웅제약우루사육체피로전신권태개선효과재인정,http://www.techholic.co.kr/news/articleView.html?idxno=170732
1736,2017-08-16,대웅제약우루사의약품재평가통해간기능육체피로에효과입증,http://www.newscj.com/news/articleView.html?idxno=443439
1737,2017-08-17,대웅제약우루사간기능장애육체피로효과인정받아,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017081615373529709
1738,2017-08-17,대웅제약우루사간장용제1위,http://www.newstomato.com/ReadNews.aspx?no=772285
1739,2017-08-17,대웅제약이져버린약속의무게,http://www.doctorsnews.co.kr/news/articleView.html?idxno=118332
1740,2017-08-17,대웅도입품목성장에함박웃음릭시아나돌풍,http://www.dailypharm.com/News/229862
1741,2017-08-17,윤재훈석호씨대웅162만주장내매도,http://www.mt.co.kr/view/mtview.php?type=1&no=2017081717430157062&outlink=1
1742,2017-08-17,대웅자궁근종치료제DWJ107J첫임상곧개시,http://www.dailypharm.com/News/229897
1743,2017-08-18,대웅제약코프로모션품목상승에미소,http://www.mdtoday.co.kr/mdtoday/index.html?no=293398
1744,2017-08-18,대웅제약신규TV광고캠페인방영,http://www.enewstoday.co.kr/news/articleView.html?idxno=1099131
1745,2017-08-18,대웅제약신규TV광고캠페인방영,http://www.newstomato.com/ReadNews.aspx?no=772523
1746,2017-08-18,대웅제약신규TV광고캠페인우루사의힘편방영,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=208868
1747,2017-08-18,대웅제약우루사의힘신규광고전개,http://www.dailypharm.com/News/229904
1748,2017-08-18,대웅제약신규TV광고캠페인우루사의힘방영,http://medipana.com/news/news_viewer.asp?NewsNum=205557&MainKind=A&NewsKind=5&vCount=12&vKind=1
1749,2017-08-18,대웅제약신규광고우루사의힘방영,http://news.hankyung.com/article/201708187238f
1750,2017-08-18,제약단신대웅제약우루사신규광고캠페인방영나서外,http://www.newsis.com/view/?id=NISX20170818_0000071123&cID=13001&pID=13000
1751,2017-08-18,대웅제약신규TVCF우루사의힘편방영,http://www.bosa.co.kr/news/articleView.html?idxno=2066885
1752,2017-08-18,아파야챙길래대웅제약보령제약JW중외제약外,http://www.g-enews.com/ko-kr/news/article/news_all/201708181105182858e6a49afa8d_1/article.html
1753,2017-08-18,대웅제약우루사새TV광고방영,http://www.seoulfn.com/news/articleView.html?idxno=285852
1754,2017-08-18,제약산업이모저모대웅제약우루사의힘신규광고진행外,http://www.kukinews.com/news/article.html?no=477667
1755,2017-08-18,대웅제약상반기매출10영업익순익60이상증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=208866
1756,2017-08-18,대웅제약새로운TV광고우루사의힘방영,http://news.mk.co.kr/newsRead.php?year=2017&no=554563
1757,2017-08-18,대웅제약신규TV광고우루사의힘방영,http://www.metroseoul.co.kr/news/newsview?newscd=2017081800023
1758,2017-08-18,대웅제약신규TV광고캠페인우루사의힘편방영,http://sports.hankooki.com/lpage/life/201708/sp20170818152052136800.htm
1759,2017-08-18,대웅제약신규광고캠페인우루사의힘방영,http://www.mdtoday.co.kr/mdtoday/index.html?no=293444
1760,2017-08-18,효능논란벗어난대웅제약우루사소화제오명벗고자양강장제인정,http://news.hankyung.com/article/2017081891791
1761,2017-08-18,대웅제약신규TV광고캠페인우루사의힘편방영,http://www.newscj.com/news/articleView.html?idxno=444024
1762,2017-08-19,대웅제약자궁근종치료제임상1상허가,http://www.mdtoday.co.kr/mdtoday/index.html?no=293434
1763,2017-08-19,대웅제약신규TV광고캠페인우루사의힘편방영,http://www.kpanews.co.kr/article/show.asp?idx=186398&table=article&category=D
1764,2017-08-20,대웅제약신규TV광고캠페인방영,http://www.m-i.kr/news/articleView.html?idxno=335765
1765,2017-08-21,오늘의종목대웅계열사지분가치상승,http://www.sedaily.com/NewsView/1OJU52AW8K
1766,2017-08-21,골든브릿지대웅자회사지분가치상승목표가↑,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20170821025900008&did=1195m
1767,2017-08-21,대웅자회사지분가치상승목표가↑골든브릿지,http://www.seoulfn.com/news/articleView.html?idxno=285960
1768,2017-08-21,ET투자뉴스대웅자회사지분가치상매수유지골든브릿지투자증권,http://www.etnews.com/20170821000039
1769,2017-08-21,메디톡스대웅제약보톡스미국진출누가웃을까,http://www.etnews.com/20170821000178
1770,2017-08-21,제약소식대웅제약신규TV광고캠페인우루사의힘편방영外,http://www.kukinews.com/news/article.html?no=478356
1771,2017-08-23,영업활동으로인한현금흐름‥유한786억대웅408억,http://medipana.com/news/news_viewer.asp?NewsNum=205721&MainKind=A&NewsKind=5&vCount=12&vKind=1
1772,2017-08-23,대웅제약복약편의성높인인플루엔자치료제타미빅트발매,http://www.viva100.com/main/view.php?key=20170823010008148
1773,2017-08-23,대웅제약복약편의성높인인플루엔자치료제타미빅트발매,http://www.kpanews.co.kr/article/show.asp?idx=186476&table=article&category=D
1774,2017-08-23,대웅제약인플루엔자치료제타미빅트발매,http://www.enewstoday.co.kr/news/articleView.html?idxno=1100768
1775,2017-08-23,대웅제약인플루엔자치료제타미빅트출시,http://news1.kr/articles/?3081123
1776,2017-08-23,대웅제약복약편의성높인인플루엔자치료제타미빅트발매,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209016
1777,2017-08-23,대웅제약복약편의성높인인플루엔자치료제타미빅트발매,http://www.sportsseoul.com/news/read/544430
1778,2017-08-23,대웅제약타미플루제네릭타미빅트출시,http://www.dailypharm.com/News/230053
1779,2017-08-23,대웅제약복용편의성높인독감치료제타미빅트출시,http://www.sedaily.com/NewsView/1OJV30S0NU
1780,2017-08-23,대웅제약편의성높인독감치료제타미빅트발매,http://www.dt.co.kr/contents.html?article_no=2017082302109976029001&ref=naver
1781,2017-08-23,대웅제약인플루엔자치료제타미빅트출시,http://www.joseilbo.com/news/news_read.php?uid=333636&class=27&grp=
1782,2017-08-23,대웅소아복용편의개선독감약타미빅트출시,http://medipana.com/news/news_viewer.asp?NewsNum=205739&MainKind=A&NewsKind=5&vCount=12&vKind=1
1783,2017-08-23,대웅제약복약편의성높인인플루엔자치료제타미빅트출시,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201708230076
1784,2017-08-23,대웅제약소아환자복약편의성높인인플루엔자치료제타미빅트발매,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017082310068052298&outlink=1
1785,2017-08-23,대웅제약소아복용편의개선독감약타미빅트,http://www.asiae.co.kr/news/view.htm?idxno=2017082310085528483
1786,2017-08-23,대웅제약독감치료제타미빅트출시쓴맛없애소아환자복약편의성높여”,http://biz.chosun.com/site/data/html_dir/2017/08/23/2017082301064.html
1787,2017-08-23,대웅제약소아환자도복용하기쉬운인플루엔자치료제출시,http://www.kpinews.co.kr/news/articleView.html?idxno=51735
1788,2017-08-23,제약단신대웅제약인플루엔자치료제타미빅트출시外,http://www.newsis.com/view/?id=NISX20170823_0000074875&cID=13001&pID=13000
1789,2017-08-23,대웅제약인플루엔자치료제타미빅트발매,http://www.mt.co.kr/view/mtview.php?type=1&no=2017082309420147779&outlink=1
1790,2017-08-23,아파야챙길래대웅제약메디톡스JW중외제약外,http://www.g-enews.com/ko-kr/news/article/news_all/201708231050243750e6a49afa8d_1/article.html
1791,2017-08-23,대웅타미플루제네릭타미빅트출시,http://www.medigatenews.com/news/1825751111
1792,2017-08-23,대웅제약인플루엔자치료제타미빅트출시,http://www.metroseoul.co.kr/news/newsview?newscd=2017082300026
1793,2017-08-23,대웅제약쓴맛개선한타미플루복제약타미빅트발매,http://news.hankyung.com/article/201708231980f
1794,2017-08-23,대웅제약독감치료제타미빅트출시,http://www.rapportian.com/news/articleView.html?idxno=105637
1795,2017-08-23,대웅인플루엔자치료제타미빅트출시,http://www.monews.co.kr/news/articleView.html?idxno=104790
1796,2017-08-23,대웅제약직원퇴사율30사실아냐,http://www.dailypharm.com/News/230064
1797,2017-08-23,대웅제약크레딧잡에공개된퇴사율사실과달라,http://medipana.com/news/news_viewer.asp?NewsNum=205748&MainKind=A&NewsKind=5&vCount=12&vKind=1
1798,2017-08-23,대웅제약복약편의성높인인플루엔자치료제타미빅트출시,http://www.fnnews.com/news/201708231209390481
1799,2017-08-23,직원10명중3명이퇴사대웅제약발끈,http://www.bosa.co.kr/news/articleView.html?idxno=2067184
1800,2017-08-23,대웅제약인플루엔자치료제타미빅트발매,http://www.newstomato.com/ReadNews.aspx?no=773288
1801,2017-08-23,대웅제약쓴맛없앤독감치료제타미빅트발매,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1045815
1802,2017-08-23,대웅제약인플루엔자치료제타미빅트발매,http://www.m-i.kr/news/articleView.html?idxno=336768
1803,2017-08-23,대웅제약복약편의성높인인플루엔자치료제타미빅트출시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017082311291717967
1804,2017-08-23,대웅제약복약편의성높인타미빅트출시,http://health.chosun.com/site/data/html_dir/2017/08/23/2017082301838.html
1805,2017-08-23,823제약한줄뉴스JW중외제약메디톡스대웅제약,http://www.koreahealthlog.com/news/articleView.html?idxno=21930
1806,2017-08-23,대웅제약글로벌맞춤형생산공장구축,http://www.newstomato.com/ReadNews.aspx?no=773404
1807,2017-08-23,그것이사고싶다대웅한국항공우주현대차한국콜마홀딩스LG화학,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017082315340117086
1808,2017-08-23,대웅제약인플루엔자백신타미빅트출시,http://www.kormedi.com/news/news/drug_dist/1224403_2906.html
1809,2017-08-23,대웅제약인플루엔자치료제타미빅트출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=293831
1810,2017-08-23,대웅제약복약편의성높인인플루엔자치료제타미빅트발매,http://www.techholic.co.kr/news/articleView.html?idxno=170818
1811,2017-08-23,대웅제약소아용인플루엔자치료제타미빅트출시,http://www.seoulfn.com/news/articleView.html?idxno=286230
1812,2017-08-23,대웅제약복약편의성높인인플루엔자치료제타미빅트발매,http://www.newscj.com/news/articleView.html?idxno=445089
1813,2017-08-24,대웅제약복약편의성높인인플루엔자치료제타미빅트출시,https://cnbc.sbs.co.kr/article_hub/10000871723?division=NAVER
1814,2017-08-24,대웅제약임직원자녀위한리틀베어여름성장캠프진행,http://www.enewstoday.co.kr/news/articleView.html?idxno=1101197
1815,2017-08-24,대웅제약임직원자녀위한리틀베어여름성장캠프열어,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209062
1816,2017-08-24,대웅제약임직원자녀여름성장캠프개최,http://medipana.com/news/news_viewer.asp?NewsNum=205811&MainKind=A&NewsKind=5&vCount=12&vKind=1
1817,2017-08-24,대한민국이좋다대웅제약리틀베어여름성장캠프개최,http://www.m-i.kr/news/articleView.html?idxno=336954
1818,2017-08-24,대웅제약임직원자녀위한리틀베어여름성장캠프열어,http://www.kpanews.co.kr/article/show.asp?idx=186520&table=article&category=D
1819,2017-08-24,대웅제약임직원자녀위한리틀베어여름성장캠프진행,http://www.dt.co.kr/contents.html?article_no=2017082402109976029002&ref=naver
1820,2017-08-24,대웅제약임직원자녀위한리틀베어여름성장캠프,http://news.heraldcorp.com/view.php?ud=20170824000262
1821,2017-08-24,대웅제약리틀베어여름성장캠프개최,http://www.bosa.co.kr/news/articleView.html?idxno=2067262
1822,2017-08-24,대웅제약임직원자녀위한리틀베어여름성장캠프,http://www.ebn.co.kr/news/view/906587
1823,2017-08-24,대웅제약임직원자녀위한리틀베어여름성장캠프진행,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201708240087
1824,2017-08-24,대웅제약리틀베어여름성장캠프진행,http://www.newsprime.co.kr/news/article.html?no=385744
1825,2017-08-24,대웅임직원자녀위한리틀베어여름성장캠프,http://www.dailypharm.com/News/230114
1826,2017-08-24,아파야챙길래동아제약대웅제약현대약품,http://www.g-enews.com/ko-kr/news/article/news_all/201708241225251886e6a49afa8d_1/article.html
1827,2017-08-24,대웅제약임직원자녀위한리틀베어여름성장캠프진행,http://www.metroseoul.co.kr/news/newsview?newscd=2017082400021
1828,2017-08-24,대웅제약복약편의성높인인플루엔자치료제타미빅트발매,http://sports.hankooki.com/lpage/life/201708/sp20170824135658136800.htm
1829,2017-08-24,대웅제약임직원자녀위한리틀베어여름성장캠프”열어,http://sports.hankooki.com/lpage/life/201708/sp20170824144329136800.htm
1830,2017-08-24,대웅제약임직원자녀대상리틀베어여름성장캠프개최,http://news.hankyung.com/article/201708246257f
1831,2017-08-24,제약신제품대웅제약인플루엔자치료제타미빅트출시外,http://www.kukinews.com/news/article.html?no=479197
1832,2017-08-24,대웅제약임직원자녀초청여름성장캠프가져,http://www.rapportian.com/news/articleView.html?idxno=105684
1833,2017-08-24,대웅제약임직원자녀위한리틀베어여름성장캠프개최,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017082417401233843
1834,2017-08-24,대웅제약임직원자녀위한과학캠프로소통창구활짝,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201708241758002&code=900303
1835,2017-08-24,대웅제약일과가정의양립위한리틀베어여름성장캠프개최,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017082420238068298&outlink=1
1836,2017-08-24,대웅제약임직원자녀위한리틀베어여름성장캠프성료,http://www.newscj.com/news/articleView.html?idxno=445409
1837,2017-08-25,저력의대웅제약빅3복귀균형잡힌매출구조가힘,http://www.bosa.co.kr/news/articleView.html?idxno=2067271
1838,2017-08-25,대웅제약이지덤X대학생서포터즈스트레스날리는이벤트연다,http://news.hankyung.com/article/201708250455a
1839,2017-08-28,CJ대웅당뇨고지혈복합제허가신청LG와경쟁,http://www.dailypharm.com/News/230176
1840,2017-08-28,BioS바이오신약1호대웅제약의잠재력과정중동RD행보,http://www.etoday.co.kr/news/section/newsview.php?idxno=1531880
1841,2017-08-28,대웅이지덤티안나게빨리낫자이벤트개최,http://www.kpanews.co.kr/article/show.asp?idx=186581&table=article&category=D
1842,2017-08-28,대웅제약대학생들이기획한이지덤뷰티홍보이벤트개최,http://news.mk.co.kr/newsRead.php?year=2017&no=574998
1843,2017-08-28,대웅제약이지덤서포터즈와함께청춘응원,http://medipana.com/news/news_viewer.asp?NewsNum=205921&MainKind=A&NewsKind=5&vCount=12&vKind=1
1844,2017-08-28,대웅제약마라톤대회서습윤드레싱홍보활동,http://www.rapportian.com/news/articleView.html?idxno=105725
1845,2017-08-28,제약단신대웅제약이지덤뷰티현장이벤트개최外,http://www.newsis.com/view/?id=NISX20170828_0000078689&cID=13001&pID=13000
1846,2017-08-28,대웅제약티안나게빨리낫자이벤트진행,http://www.newsprime.co.kr/news/article.html?no=386026
1847,2017-08-28,대웅제약이지덤티안나게빨리낫자이벤트,http://www.bosa.co.kr/news/articleView.html?idxno=2067444
1848,2017-08-28,대웅제약티안나게빨리낫자이색이벤트개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=294175
1849,2017-08-28,대웅제약이지덤티안나게빨리낫자이벤트열어,http://www.metroseoul.co.kr/news/newsview?newscd=2017082800008
1850,2017-08-28,대웅이지덤뷰티이색마라톤현장서홍보이벤트,http://www.dailypharm.com/News/230205
1851,2017-08-28,아파야챙길래대웅제약SK케미칼한미약품,http://www.g-enews.com/ko-kr/news/article/news_all/201708281142384917e6a49afa8d_1/article.html
1852,2017-08-28,대웅제약이지덤서포터즈와함께청춘응원티안나게빨리낫자이벤트개최,http://sports.hankooki.com/lpage/life/201708/sp20170828115244136800.htm
1853,2017-08-28,대웅제약초대형판권회수아픔극복빅3복귀,http://www.dailymedi.com/detail.php?number=821880&thread=22r05
1854,2017-08-28,대웅제약이지덤서포터즈와티안나게빨리낫자이벤트개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1102339
1855,2017-08-28,대한민국이좋다대웅제약이지덤서포터즈티안나게빨리낫자이벤트,http://www.m-i.kr/news/articleView.html?idxno=337930
1856,2017-08-28,대웅제약컬러미라드서울서이지덤뷰티홍보,http://www.seoulfn.com/news/articleView.html?idxno=286511
1857,2017-08-28,한용해대웅제약본부장외부평가통해글로벌시장노크,http://www.kpinews.co.kr/news/articleView.html?idxno=52031
1858,2017-08-28,대웅제약이지덤서포터즈와청춘응원,http://www.newscj.com/news/articleView.html?idxno=446082
1859,2017-08-29,CJ헬스케어대웅공동개발한당뇨고지혈증복합제각각허가신청,http://www.mdtoday.co.kr/mdtoday/index.html?no=294258
1860,2017-08-29,fnRASSI대웅032오르며거래량증가,http://www.fnnews.com/news/201708290925232584
1861,2017-08-29,한올바이오대웅제약과시너지본격화HL036미국임상IND신청,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209185
1862,2017-08-29,한올바이오대웅제약美에바이오베터2상신청,http://medipana.com/news/news_viewer.asp?NewsNum=205978&MainKind=A&NewsKind=5&vCount=12&vKind=1
1863,2017-08-29,의약품판권에서위기겪었던대웅제약의귀환,http://news.hankyung.com/article/201708290220A
1864,2017-08-29,특징주대웅자회사지분가치성장↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03007766616032240
1865,2017-08-29,한올바이오파마대웅제약과공동개발안구건조증치료제美임상2상신청,http://biz.chosun.com/site/data/html_dir/2017/08/29/2017082902187.html
1866,2017-08-29,한올바이오파마대웅제약공동개발안구건조증치료제미임상신청,http://www.edaily.co.kr/news/newspath.asp?newsid=04218086616032240
1867,2017-08-30,글리아티린과비슷하다대웅바이오글리아타민상표권패소,http://www.kpanews.co.kr/article/show.asp?idx=186613&table=article&category=D
1868,2017-08-30,한올바이오파마대웅제약과공동경영3년차올해부터시너지본격,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1046035
1869,2017-08-30,fnRASSI대웅제약06962052주신고가경신195↑,http://www.fnnews.com/news/201708301523213132
1870,2017-08-30,대웅글리아타민상표무효패소상고할것,http://www.medicaltimes.com/News/1113519
1871,2017-08-30,대웅바이오글리아타민글리아티린상표유사성없다상고,http://www.kpanews.co.kr/article/show.asp?idx=186674&table=article&category=D
1872,2017-08-30,DailyPharma대웅제약우루사처방량웃고매출액울고,http://www.econovill.com/news/articleView.html?idxno=321683
1873,2017-08-30,대웅바이오글라아타민상표권패소에즉시상고,http://medipana.com/news/news_viewer.asp?NewsNum=206088&MainKind=A&NewsKind=5&vCount=12&vKind=1
1874,2017-08-30,대웅바이오글리아타민상표무효소송패소즉시상고할것,http://www.g-enews.com/ko-kr/news/article/news_all/201708301547058702e6a49afa8d_1/article.html
1875,2017-08-30,대웅바이오글리아타민글리아티린상표유사성없다”상고,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209262
1876,2017-08-30,대웅바이오글리아타밍무효소송패소즉시상고할것,http://www.enewstoday.co.kr/news/articleView.html?idxno=1103378
1877,2017-08-30,대웅바이오글리아타민상표권소송패소즉시상고할것,http://www.mediapen.com/news/view/296340
1878,2017-08-30,대웅바이오글리아타민상표소송상고,http://www.newstomato.com/ReadNews.aspx?no=774744
1879,2017-08-30,글리아타민상표소송서패소한대웅즉시상고,http://www.dailypharm.com/News/230317
1880,2017-08-30,대웅바이오글리아타민글리아티린상표와유사성없다”상고할것,http://www.fnnews.com/news/201708301629352241
1881,2017-08-30,대웅바이오글리아타민글리아티린상표와유사성없다”즉시상고,http://sports.hankooki.com/lpage/life/201708/sp20170830170116136800.htm
1882,2017-08-30,대웅바이오글리아타민상표유사성분쟁상고,http://www.m-i.kr/news/articleView.html?idxno=338791
1883,2017-08-30,대웅바이오글리아타민글리아티린상표와유사성없다,http://www.newsprime.co.kr/news/article.html?no=386405
1884,2017-08-30,대웅바이오복제약글리아타민상표무효판결에즉시상고,http://news.mk.co.kr/newsRead.php?year=2017&no=582324
1885,2017-08-30,대웅바이오글리아타민상표소송상고,http://news.hankyung.com/article/201708306761f
1886,2017-08-30,대웅바이오글리아타민글리아티린상표무효소송즉시상고,http://www.kukinews.com/news/article.html?no=480990
1887,2017-08-30,대웅바이오글리아타민글리아티린상표와유사성없어상고할것,http://www.newsis.com/view/?id=NISX20170830_0000081866&cID=13001&pID=13000
1888,2017-08-30,대웅바이오글리아타민상표소송패소에즉시상고,http://www.metroseoul.co.kr/news/newsview?newscd=2017083000108
1889,2017-08-30,대웅바이오글리아타민상표소송패소에즉시상고,http://www.newspim.com/news/view/20170830000224
1890,2017-08-30,대웅바이오글리아티민상표권패소하자대법상고결정,http://news1.kr/articles/?3087844
1891,2017-08-30,대웅바이오글리아타민글리아티린과상표유사성없다”즉시상고,http://www.viva100.com/main/view.php?key=20170830020020754
1892,2017-08-31,월드클래스300기업제약화장품대웅제약콜마최고,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209139
1893,2017-08-31,특허법원글리아타민글리아티린유사하다대웅패소,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1046076
1894,2017-08-31,글리아티린상표권분쟁대웅바이오즉시상고할것,http://www.ftoday.co.kr/news/articleView.html?idxno=79622
1895,2017-08-31,대웅바이오글리아타민글리아티린과무슨상관,http://www.bosa.co.kr/news/articleView.html?idxno=2067718
1896,2017-08-31,대웅임팩타민2017K디자인어워드브론즈위너수상,http://www.kpanews.co.kr/article/show.asp?idx=186699&table=article&category=D
1897,2017-08-31,대웅제약임팩타민디자인어워드브론즈위너수상,http://medipana.com/news/news_viewer.asp?NewsNum=206119&MainKind=A&NewsKind=5&vCount=12&vKind=1
1898,2017-08-31,대웅임팩타민K디자인어워드브론즈위너수상,http://www.dailypharm.com/News/230350
1899,2017-08-31,특허법원글리아타민상표등록무효판결대웅제약즉시상고,http://www.rapportian.com/news/articleView.html?idxno=105861
1900,2017-08-31,대웅제약임팩타민패키지2017K디자인어워드브론즈위너수상,http://www.enewstoday.co.kr/news/articleView.html?idxno=1103647
1901,2017-08-31,대웅제약임팩타민패키지로2017K디자인어워드브론즈위너수상,http://sports.hankooki.com/lpage/life/201708/sp20170831104809136800.htm
1902,2017-08-31,대웅제약임팩타민패키지K디자인어워드브론즈위너,http://www.medical-tribune.co.kr/news/articleView.html?idxno=74245
1903,2017-08-31,대웅제약임팩타민K디자인어워드서브론즈위너상수상,http://www.sedaily.com/NewsView/1OJYQVC042
1904,2017-08-31,대웅제약임팩타민2017K디자인어워드수상,http://news.hankyung.com/article/201708319324f
1905,2017-08-31,대웅제약임팩타민패키지2017K디자인어워드브론즈위너수상,http://news.mk.co.kr/newsRead.php?year=2017&no=584155
1906,2017-08-31,대웅제약임팩타민패키지로2017K디자인어워드수상,http://www.metroseoul.co.kr/news/newsview?newscd=2017083100043
1907,2017-08-31,대웅제약임팩타민2017K디자인어워드브론즈위너수상,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201708310147
1908,2017-08-31,대웅제약임팩타민패키지2017K디자인어워드브론즈위너수상,http://www.m-i.kr/news/articleView.html?idxno=339057
1909,2017-08-31,대웅바이오글리아타민상표권소송패소,http://www.kormedi.com/news/news/drug_dist/1224494_2906.html
1910,2017-08-31,아파야챙길래대웅제약일동제약메디톡스,http://www.g-enews.com/ko-kr/news/article/news_all/201708311206182946e6a49afa8d_1/article.html
1911,2017-08-31,약품이름더이상베끼기안된다대웅바이오패소,http://www.newsworks.co.kr/news/articleView.html?idxno=136327
1912,2017-08-31,대웅제약임팩타민패키지K디자인어워드브론즈위너수상,http://www.newsprime.co.kr/news/article.html?no=386566
1913,2017-08-31,얄궂은악연종근당에도입약품뺏긴대웅제약소송도패해,http://news.mk.co.kr/newsRead.php?year=2017&no=584717
1914,2017-08-31,대웅제약임팩타민K디자인어워드브론즈위너상수상,http://www.viva100.com/main/view.php?key=20170831010011773
1915,2017-08-31,대웅제약임팩타민케이디자인어워드브론즈위너수상,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201708311647002&code=900303
1916,2017-08-31,글리아타민상표유사성없다대웅바이오상고방침,http://www.monews.co.kr/news/articleView.html?idxno=105096
1917,2017-08-31,대웅제약임팩타민패키지로2017K디자인어워드서수상,http://www.news2day.co.kr/91998
1918,2017-08-31,대웅제약임팩타민패키지로2017K디자인어워드브론즈위너수상,http://www.newscj.com/news/articleView.html?idxno=446934
1919,2017-09-01,대웅바이오글리아타민상표무효소송패소즉시상고”,http://www.mdtoday.co.kr/mdtoday/index.html?no=294609
1920,2017-09-01,ET투자뉴스대웅_주요투자주체는개인투자자,http://www.etnews.com/20170901000132
1921,2017-09-03,대웅제약또다시악재인지장애개선제글라아티린상표권침해소송패소,http://www.etnews.com/20170901000155
1922,2017-09-03,기업배틀당신의선택은대웅제약VS보령제약커리어쌓기좋은대웅경쟁스트레스없는보령,http://www.sedaily.com/NewsView/1OKVUKAWIB
1923,2017-09-04,체질개선한안국약품대웅제약영업이익액호조,http://www.medicaltimes.com/News/1113609
1924,2017-09-04,fnRASSI대웅제약52주신고가343↑,http://www.fnnews.com/news/201709041302163246
1925,2017-09-04,혁신형제약바이오기업을가다⑩대웅제약글로벌헬스케어그룹비전실현,http://www.metroseoul.co.kr/news/newsview?newscd=2017090400043
1926,2017-09-05,대웅제약상처받은청춘위한이지덤뷰티28초티빨드라마공모전개최,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017090508578060229&outlink=1
1927,2017-09-05,대웅제약이지덤뷰티28초드라마공모전개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1105267
1928,2017-09-05,대웅제약이지덤뷰티28초티빨드라마공모전,http://medipana.com/news/news_viewer.asp?NewsNum=206328&MainKind=A&NewsKind=5&vCount=12&vKind=1
1929,2017-09-05,대웅제약이지덤뷰티28초티빨드라마공모전개최,http://www.viva100.com/main/view.php?key=20170905010001354
1930,2017-09-05,대웅제약이지덤뷰티28초티빨드라마공모전개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209448
1931,2017-09-05,대웅제약이지덤뷰티28초드라마공모전개최,http://news.mk.co.kr/newsRead.php?year=2017&no=594518
1932,2017-09-05,대웅제약이지덤뷰티28초드라마공모전,http://news.hankyung.com/article/201709054121f
1933,2017-09-05,아파야챙길래대웅제약녹십자JW중외제약外,http://www.g-enews.com/ko-kr/news/article/news_all/20170905101525884e6a49afa8d_1/article.html
1934,2017-09-05,대웅이지덤뷰티28초드라마공모전,http://www.bosa.co.kr/news/articleView.html?idxno=2067985
1935,2017-09-05,대웅제약이지덤뷰티28초영상드라마공모,http://www.dailypharm.com/News/230540
1936,2017-09-05,대웅제약이지덤뷰티28초티빨드라마공모전열어,http://www.metroseoul.co.kr/news/newsview?newscd=2017090500011
1937,2017-09-05,대웅제약이지덤뷰티28초티빨드라마공모전진행,http://www.newsprime.co.kr/news/article.html?no=387036
1938,2017-09-05,대웅제약이지덤뷰티28초티빨드라마공모전개최,http://sports.hankooki.com/lpage/life/201709/sp20170905123750136800.htm
1939,2017-09-05,대웅제약이지덤뷰티28초티빨드라마공모전,http://www.m-i.kr/news/articleView.html?idxno=340365
1940,2017-09-05,대웅제약이지덤뷰티28초티빨드라마공모전개최,http://www.wolyo.co.kr/news/articleView.html?idxno=45005
1941,2017-09-05,대웅제약이지덤뷰티28초티빨드라마공모전개최,http://www.newscj.com/news/articleView.html?idxno=447946
1942,2017-09-06,공모행사대웅제약28초티빨드라마,http://www.munhwa.com/news/view.html?no=2017090601032103000001
1943,2017-09-06,대웅나보타치료용보툴리눔톡신영역공략나서,http://www.dailypharm.com/News/230588
1944,2017-09-06,대웅제약10월2일임시공휴일전사휴무결정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209521
1945,2017-09-06,대웅제약10월2일임시공휴일전사휴무결정,http://www.rapportian.com/news/articleView.html?idxno=106017
1946,2017-09-06,대웅제약10월2일임시공휴일전사휴무결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=295020
1947,2017-09-06,대웅제약10월2일임시공휴일전사휴무결정,http://www.dailypharm.com/News/230601
1948,2017-09-07,대웅제약대학병원피부과전문의대상이지톡심포지엄개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1106190
1949,2017-09-07,대웅제약피부과전문의대상이지톡심포지엄개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209543
1950,2017-09-07,대웅제약피부질환치료최신지견공유의장이지톡심포지엄개최,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017090709108017959&outlink=1
1951,2017-09-07,대웅제약피부과대상이지톡심포지엄개최,http://medipana.com/news/news_viewer.asp?NewsNum=206459&MainKind=A&NewsKind=5&vCount=12&vKind=1
1952,2017-09-07,대웅제약쉬운피부질환치료이야기이지톡심포지엄개최,http://www.viva100.com/main/view.php?key=20170907010002425
1953,2017-09-07,대웅제약피부과전문의대상이지톡심포지엄개최,http://www.asiae.co.kr/news/view.htm?idxno=2017090709474106877
1954,2017-09-07,대웅제약피부과전문의대상이지톡심포지움개최,http://www.sportsseoul.com/news/read/549123
1955,2017-09-07,대웅제약이지덤뷰티28초티빨드라마공모전개최,http://www.kpanews.co.kr/article/show.asp?idx=186902&table=article&category=D
1956,2017-09-07,대웅제약피부과전문의대상이지톡심포지엄개최,http://sports.hankooki.com/lpage/life/201709/sp20170907102208136800.htm
1957,2017-09-07,대웅제약피부과전문의대상이지톡심포지엄개최,http://www.sisajournal-e.com/biz/article/173610
1958,2017-09-07,대웅제약이지톡심포지엄개최,http://www.newstomato.com/ReadNews.aspx?no=776112
1959,2017-09-07,아파야챙길래대웅제약동화약품보령제약外,http://www.g-enews.com/ko-kr/news/article/news_all/201709071116198796e6a49afa8d_1/article.html
1960,2017-09-07,대웅제약피부과전문의대상이지톡심포지엄개최,http://www.kpanews.co.kr/article/show.asp?idx=186913&table=article&category=D
1961,2017-09-07,대웅제약피부과전문의대상이지톡심포지엄개최,http://www.m-i.kr/news/articleView.html?idxno=341093
1962,2017-09-07,대웅제약이지톡심포지엄개최최신지견공유,http://www.newsprime.co.kr/news/article.html?no=387334
1963,2017-09-07,대웅제약이지톡심포지엄개최,http://www.monews.co.kr/news/articleView.html?idxno=105356
1964,2017-09-07,대웅제약피부과전문의대상이지톡심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2068189
1965,2017-09-07,대웅제약피부과전문의대상이지톡심포지엄개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=295103
1966,2017-09-07,대웅제약피부과전문의대상이지톡심포지엄열어,http://www.metroseoul.co.kr/news/newsview?newscd=2017090700040
1967,2017-09-07,대웅제약피부과의사대상이지톡심포지엄개최,http://www.seoulfn.com/news/articleView.html?idxno=287421
1968,2017-09-07,대웅제약피부과전문의대상이지톡심포지엄개최,http://www.newscj.com/news/articleView.html?idxno=448504
1969,2017-09-08,대웅안국국내사코프로모션성공모델,http://www.dailymedi.com/detail.php?number=822258&thread=22r05
1970,2017-09-08,대웅제약나보타150U랜딩진행휴젤메디톡스긴장,http://www.mdtoday.co.kr/mdtoday/index.html?no=295172
1971,2017-09-08,대웅제약업무효율증진성과창출기여스마트오피스구축,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209596
1972,2017-09-08,대웅제약스마트오피스도입해업무효율높여,http://www.fnnews.com/news/201709081107476511
1973,2017-09-08,대웅제약스마트오피스구축‥200평공간재탄생,http://medipana.com/news/news_viewer.asp?NewsNum=206525&MainKind=A&NewsKind=5&vCount=12&vKind=1
1974,2017-09-08,대웅제약본사한강변보이는스마트오피스변신,http://www.dailypharm.com/News/230676
1975,2017-09-08,대웅제약업무효율성높인스마트오피스구축,http://www.kpinews.co.kr/news/articleView.html?idxno=53397
1976,2017-09-08,대웅제약스마트오피스구축,http://www.m-i.kr/news/articleView.html?idxno=341419
1977,2017-09-08,대웅제약업무효율성강화스마트오피스마련,http://www.rapportian.com/news/articleView.html?idxno=106065
1978,2017-09-08,대웅제약스마트오피스구축미래경쟁력강화,http://www.newsprime.co.kr/news/article.html?no=387495
1979,2017-09-08,대웅제약일하기좋은환경스마트오피스구축,http://www.bosa.co.kr/news/articleView.html?idxno=2068252
1980,2017-09-08,대웅제약본사9층에스마트오피스구축자율좌석제집중업무공간구성,http://biz.chosun.com/site/data/html_dir/2017/09/08/2017090801410.html
1981,2017-09-08,대웅제약직원들자율성업무효율위한스마트오피스구축,http://www.mdtoday.co.kr/mdtoday/index.html?no=295216
1982,2017-09-08,대웅제약혁신형사무공간스마트오피스구축,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017090813368061476&outlink=1
1983,2017-09-08,아파야챙길래JW중외제약대웅제약한국다케다제약,http://www.g-enews.com/ko-kr/news/article/news_all/201709081410506615e6a49afa8d_1/article.html
1984,2017-09-08,대웅제약피부과전문의대상이지톡심포지엄개최,http://health.chosun.com/site/data/html_dir/2017/09/08/2017090801737.html
1985,2017-09-08,대웅제약업무효율향상스마트오피스구축,http://www.dt.co.kr/contents.html?article_no=2017090802109976029001&ref=naver
1986,2017-09-08,대웅제약스마트오피스구축으로자율적업무몰입환경조성,http://www.techholic.co.kr/news/articleView.html?idxno=171009
1987,2017-09-08,대웅제약스마트오피스구축업무효율증대,http://www.finomy.com/news/articleView.html?idxno=47480
1988,2017-09-08,대웅제약업무효율증진스마트오피스구축,http://www.newscj.com/news/articleView.html?idxno=448703
1989,2017-09-08,대웅제약본사스마트오피스로재탄생,http://www.newspim.com/news/view/20170908000227
1990,2017-09-08,대웅제약스마트오피스구축자율성과몰입통해업무효율높여,http://www.news2day.co.kr/92271
1991,2017-09-08,대웅제약미래경쟁력강화위한스마트오피스마련,http://www.k-health.com/news/articleView.html?idxno=31250
1992,2017-09-08,대웅제약똑똑한사무실꾸며미래경쟁력강화,http://www.seoulfn.com/news/articleView.html?idxno=287540
1993,2017-09-08,대웅제약자율성업무몰입도높이는스마트오피스구축,http://www.viva100.com/main/view.php?key=20170908020020857
1994,2017-09-09,제약업계역대급효자제품⑥고난의현대사와함께한대웅제약우루사,http://www.cnbnews.com/news/article.html?no=356879
1995,2017-09-09,대웅제약스마트오피스구축,http://www.enewstoday.co.kr/news/articleView.html?idxno=1107050
1996,2017-09-11,대웅제약스마트오피스혁신형사무공간구축,http://www.kpanews.co.kr/article/show.asp?idx=186991&table=article&category=D
1997,2017-09-11,이정수기자의헬스전망대대웅제약제품효능논란벗을까,http://www.ajunews.com/view/20170910104206058
1998,2017-09-11,ET투자뉴스대웅제약_주가와거래량은보통투자심리는강세,http://www.etnews.com/20170911000156
1999,2017-09-11,대웅두타겟알보젠티로진등알약모양표식변경,http://www.dailypharm.com/News/230738
2000,2017-09-12,대웅제약부산경남수해지역약국교품복구작업지원,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209715
2001,2017-09-12,대웅제약부산경남수해지역약국교품복구작업지원,http://www.enewstoday.co.kr/news/articleView.html?idxno=1107919
2002,2017-09-12,대웅제약부산경남수해지역약국복구작업지원,http://www.sedaily.com/NewsView/1OKZYFFY7N
2003,2017-09-12,뉴스투데이E대웅제약부산경남수해지역약국교품및복구지원나서,http://www.news2day.co.kr/92374
2004,2017-09-12,대웅부산경남지역침수약국의약품교환,http://www.dailypharm.com/News/230788
2005,2017-09-12,대웅제약부산경남수해지역약국교품‥복구지원,http://medipana.com/news/news_viewer.asp?NewsNum=206689&MainKind=A&NewsKind=5&vCount=12&vKind=1
2006,2017-09-12,대웅제약부산경남수해지역약국에제품교환복구지원키로,http://news.mk.co.kr/newsRead.php?year=2017&no=612318
2007,2017-09-12,대웅제약부산경남수해지역약국교품복구작업지원,http://www.newsprime.co.kr/news/article.html?no=387887
2008,2017-09-12,대웅제약부산경남수해지역약국복구작업나서,http://www.g-enews.com/ko-kr/news/article/news_all/201709121459229083d20c4c13e9_1/article.html
2009,2017-09-12,대웅제약부산경남수해지역복구지원,http://www.dailymedi.com/detail.php?number=822383&thread=22r05
2010,2017-09-12,대웅한의원전기석원장사회복지유공보건복지부장관상수상,http://www.dtnews24.com/news/article.html?no=433843
2011,2017-09-12,전기석대웅한의원장사회복지유공보건복지부장관상수상,http://www.anewsa.com/detail.php?number=1218700&thread=09r02
2012,2017-09-12,대웅제약부산경남수해지역약국복구작업지원,http://www.metroseoul.co.kr/news/newsview?newscd=2017091200077
2013,2017-09-12,대웅제약부산경남수해지역약국복구지원,http://www.medical-tribune.co.kr/news/articleView.html?idxno=74441
2014,2017-09-12,대웅제약자회사항체신약2종中제약사에대규모기술수출,http://www.ebn.co.kr/news/view/909239
2015,2017-09-12,대웅제약부산경남수해지역약국복구작업지원,http://news20.busan.com/controller/newsController.jsp?newsId=20170912000172
2016,2017-09-12,대전대웅한의원전기석원장사회복지유공장관상,http://news1.kr/articles/?3099275
2017,2017-09-12,대웅제약부산및경남수해지역의약품교환작업지원,http://www.newsis.com/view/?id=NISX20170912_0000093478&cID=13001&pID=13000
2018,2017-09-12,대웅제약부산및경남침수피해약국의약품교환및복구작업지원,http://www.fnnews.com/news/201709121639205438
2019,2017-09-12,대웅제약부산경남수해지역약국복구작업지원,http://www.getnews.co.kr/view.php?ud=2017091216450310954b3c2d373_16
2020,2017-09-12,대웅제약집중호우부산경남약국복구지원,http://www.seoulfn.com/news/articleView.html?idxno=287788
2021,2017-09-12,대웅제약부산경남서의약품교환및복구작업지원,http://www.mediapen.com/news/view/299580
2022,2017-09-12,대웅한의원전기석원장사회복지유공보건복지부장관상수상,http://ilyo.co.kr/?ac=article_view&entry_id=268879
2023,2017-09-12,대웅제약부산경남수해지역약국지원,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017091217398059555&outlink=1
2024,2017-09-12,대전대덕구대웅한의원전기석원장보건복지부장관상,http://www.goodmorningcc.com/news/articleView.html?idxno=72142
2025,2017-09-12,대웅제약부산및경남수해지역약국교품복구작업지원,http://sports.hankooki.com/lpage/economy/201709/sp20170912201522137000.htm
2026,2017-09-12,대웅제약부산및경남수해지역약국교품복구작업지원,http://www.newscj.com/news/articleView.html?idxno=449450
2027,2017-09-13,대웅제약부산경남수해지역약국교품등지원,http://www.bosa.co.kr/news/articleView.html?idxno=2068516
2028,2017-09-13,대웅제약부산경남수해지역약국복구작업지원,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1046516
2029,2017-09-13,뉴스투데이E대웅제약우루사신규광고간상눈길,http://www.news2day.co.kr/92417
2030,2017-09-13,대웅제약우루사신규광고캠페인간상공개,http://medipana.com/news/news_viewer.asp?NewsNum=206719&MainKind=A&NewsKind=5&vCount=12&vKind=1
2031,2017-09-13,대웅제약동영상채널통해우루사신규광고캠페인공개,http://www.enewstoday.co.kr/news/articleView.html?idxno=1108225
2032,2017-09-13,대웅제약우루사신규광고캠페인간상肝相공개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209742
2033,2017-09-13,대웅제약부산및경남수해지역약국복구작업지원,http://www.ftoday.co.kr/news/articleView.html?idxno=80021
2034,2017-09-13,대웅제약우루사신규광고간건강캠페인간상肝相공개,http://www.lawissue.co.kr/news/articleView.html?idxno=20170913092849110841d0c69529_12
2035,2017-09-13,대웅우루사새광고통해해독노폐물배출기능홍보,http://www.dailypharm.com/News/230819
2036,2017-09-13,대웅제약우루사신규광고간상공개,http://www.metroseoul.co.kr/news/newsview?newscd=2017091300005
2037,2017-09-13,대웅제약우루사신규광고캠페인간상편공개,http://www.newsway.co.kr/view.php?tp=1&ud=2017091310463934771
2038,2017-09-13,대웅제약우루사신규광고공개,http://www.sedaily.com/NewsView/1OL0FDKRGD
2039,2017-09-13,대웅제약우루사신규광고캠페인공개,http://www.m-i.kr/news/articleView.html?idxno=342628
2040,2017-09-13,대웅제약우루사신규광고캠페인공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=295556
2041,2017-09-13,대웅제약우루사신규광고간상공개,http://www.sisajournal-e.com/biz/article/173841
2042,2017-09-13,아파야챙길래삼진제약대웅제약현대약품外,http://www.g-enews.com/ko-kr/news/article/news_all/20170913114158267d20c4c13e9_1/article.html
2043,2017-09-13,대웅제약우루사신규광고캠페인간상肝相공개,http://health.chosun.com/site/data/html_dir/2017/09/13/2017091301485.html
2044,2017-09-13,우루사에웃고글리아타민에우는대웅제약,http://www.sportsseoul.com/news/read/551086
2045,2017-09-13,대웅제약우루사신규광고캠페인간상肝相공개,http://www.newsprime.co.kr/news/article.html?no=388073
2046,2017-09-13,대웅제약우루사간건강관리중요신규광고캠페인간상肝相공개,http://sports.hankooki.com/lpage/life/201709/sp20170913180525136800.htm
2047,2017-09-13,대웅제약우루사TV광고교체,http://www.seoulfn.com/news/articleView.html?idxno=287915
2048,2017-09-13,대웅제약우루사신규광고캠페인공개,http://www.newscj.com/news/articleView.html?idxno=449676
2049,2017-09-14,대웅제약1500억시장B형간염약테노포비르제네릭우판권획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209809
2050,2017-09-14,대웅제약B형간염치료제비리헤파우선판매권획득,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=101&oid=050&aid=0000045375
2051,2017-09-14,대웅제약B형간염치료제비리헤파우판권획득내달1일출시,http://www.lawissue.co.kr/news/articleView.html?idxno=20170914092015863741d0c69529_12
2052,2017-09-14,대웅제약비리어드제네릭비리헤파내달출시,http://www.dailypharm.com/News/230871
2053,2017-09-14,B형간염치료제비리헤파대웅제약우선판매권획득,http://www.dt.co.kr/contents.html?article_no=2017091402109976029001&ref=naver
2054,2017-09-14,대웅제약B형간염치료제비리헤파우판권획득,http://news.hankyung.com/article/201709146219f
2055,2017-09-14,대웅제약B형간염치료제비리헤파우선판매권획득,http://www.metroseoul.co.kr/news/newsview?newscd=2017091400012
2056,2017-09-14,대웅제약1500억원규모B형간염치료제시장진출,http://www.kpinews.co.kr/news/articleView.html?idxno=53960
2057,2017-09-14,대웅제약B형간염치료제비리헤파우선판매권한,http://www.asiae.co.kr/news/view.htm?idxno=2017091409311767821
2058,2017-09-14,대웅제약B형간염치료제비리헤파우선판매권획득,http://www.rapportian.com/news/articleView.html?idxno=106193
2059,2017-09-14,간질환의약품전문회사대웅제약B형간염치료제비리헤파우선판매권획득,http://sports.hankooki.com/lpage/life/201709/sp20170914101342136800.htm
2060,2017-09-14,1500억비리어드시장먼저잠식대웅비리헤파우선판매권획득,http://news.mk.co.kr/newsRead.php?year=2017&no=617419
2061,2017-09-14,대웅비리어드제네릭내달출시,http://www.medigatenews.com/news/2536636570
2062,2017-09-14,대웅제약B형간염치료제비리헤파우선판매권한,http://www.enewstoday.co.kr/news/articleView.html?idxno=1108742
2063,2017-09-14,대웅한올신약공동개발가속화,http://www.newstomato.com/ReadNews.aspx?no=777269
2064,2017-09-14,대웅제약B형간염치료제비리헤파우판권획득,http://www.sisajournal-e.com/biz/article/173902
2065,2017-09-14,대웅제약B형간염치료제비리헤파우판권획득,http://www.newsprime.co.kr/news/article.html?no=388184
2066,2017-09-14,중국진출10년대웅제약현지화로승부수,http://www.asiatoday.co.kr/view.php?key=20170914010006779
2067,2017-09-14,대웅제약B형간염제네릭비리헤파우선판매,http://www.mt.co.kr/view/mtview.php?type=1&no=2017091409345530591&outlink=1
2068,2017-09-14,대웅제약B형간염치료제비리헤파식약처우선판매권한받아,http://www.fnnews.com/news/201709141043313404
2069,2017-09-14,제약산업단신대웅제약우루사신규광고간상肝相공개外,http://www.kukinews.com/news/article.html?no=484863
2070,2017-09-14,대웅제약B형간염치료제비리헤파우선판매권획득9개월간제네릭시장선점,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017091410438083746&outlink=1
2071,2017-09-14,대웅제약B형간염약비리헤파식약처로부터우선판매권획득,http://www.kukinews.com/news/article.html?no=484874
2072,2017-09-14,B형간염시장뛰어든대웅비리헤파출시,http://www.monews.co.kr/news/articleView.html?idxno=105654
2073,2017-09-14,대웅제약B형간염치료제비리헤파우판권획득,http://www.m-i.kr/news/articleView.html?idxno=342985
2074,2017-09-14,대웅제약B형간염치료제비리헤파우판권획득,http://www.bosa.co.kr/news/articleView.html?idxno=2068650
2075,2017-09-14,대웅제약B형간염치료제비리헤파우판권획득,http://medipana.com/news/news_viewer.asp?NewsNum=206800&MainKind=A&NewsKind=5&vCount=12&vKind=1
2076,2017-09-14,대웅제약B형간염치료제비리헤파내달출시,http://www.finomy.com/news/articleView.html?idxno=47627
2077,2017-09-14,아파야챙길래대웅제약LG화학대원제약外,http://www.g-enews.com/ko-kr/news/article/news_all/20170914114038755e6a49afa8d_1/article.html
2078,2017-09-14,대웅제약B형간염치료제비리헤파우판권획득,http://www.medicaltimes.com/News/1113865
2079,2017-09-14,대웅제약1500억시장B형간염테노포비르제네릭우선판매권획득,http://www.etnews.com/20170914000137
2080,2017-09-14,대웅제약B형간염치료제시장진출,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201709140184
2081,2017-09-14,대웅제약비리헤파로B형간염치료제시장진출,http://www.kormedi.com/news/news/drug_dist/1224636_2906.html
2082,2017-09-14,대웅제약B형간염치료제시장진출비리헤파우선판매권획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017091413552487867
2083,2017-09-14,제약한줄뉴스테라젠이텍스LG화학대웅제약,http://www.koreahealthlog.com/news/articleView.html?idxno=22001
2084,2017-09-14,대웅제약B형간염치료제비리헤파우판권획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=295692
2085,2017-09-14,CoverStory대웅제약연매출액10이상RD에투자,http://news.hankyung.com/article/2017091458791
2086,2017-09-14,일하기좋은최적의사무실대웅제약스마트오피스구축,http://www.nextdaily.co.kr/news/article.html?id=20170914800050
2087,2017-09-14,CoverStory대웅제약해외현지제약산업육성하며성장한국형사업모델만들것,http://news.hankyung.com/article/2017091458781
2088,2017-09-14,CoverStory대웅제약연간910명6개월현장언어문화실무교육,http://news.hankyung.com/article/2017091458771
2089,2017-09-14,CoverStory대웅제약문재인케어로의료수요확대기대약제비총액관리제영향은지켜봐야,http://news.hankyung.com/article/2017091458871
2090,2017-09-14,CoverStory대웅제약주름개선의약품나보타해외진출눈앞3분기호好실적예고,http://news.hankyung.com/article/2017091458881
2091,2017-09-14,CoverStory대웅제약대웅제약신약개발네트워크구축글로벌제약사꿈꾼다,http://news.hankyung.com/article/2017091458951
2092,2017-09-14,대웅제약B형간염치료제비리헤파우판권획득,http://www.joseilbo.com/news/news_read.php?uid=335441&class=27&grp=
2093,2017-09-14,뉴스투데이E대웅제약B형간염치료제비리헤파발매예정,http://www.news2day.co.kr/92502
2094,2017-09-14,대웅제약B형간염치료제비리헤파우판권획득,http://www.kpanews.co.kr/article/show.asp?idx=187148&table=article&category=D
2095,2017-09-14,대웅제약B형간염치료제비리헤파우판권획득,http://www.newscj.com/news/articleView.html?idxno=449871
2096,2017-09-14,대웅제약B형간염치료제비리헤파우선판매권획득,http://www.viva100.com/main/view.php?key=20170914020020904
2097,2017-09-15,특허회피대웅제약B형간염시장진출,http://www.dailymedi.com/detail.php?number=822471&thread=22r05
2098,2017-09-15,대웅제약비리어드무염제품비리헤파10월발매,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1046653
2099,2017-09-15,대웅제약B형간염치료제비리헤파우선판매권획득,http://www.munhwa.com/news/view.html?no=20170915MW151852778389
2100,2017-09-15,대웅제약1500억원대B형간염치료제시장진출,http://www.techholic.co.kr/news/articleView.html?idxno=171089
2101,2017-09-15,대웅제약우루사후계자비리헤파10월1일발매,http://www.seoulfn.com/news/articleView.html?idxno=288120
2102,2017-09-16,모사프리드오리지널업체대웅서방제제개발완료,http://www.dailypharm.com/News/230964
2103,2017-09-17,대웅제약우루사수고많았던간에전하는최고의선물,http://news.kmib.co.kr/article/view.asp?arcid=0923817345&code=14130000&cp=nv
2104,2017-09-18,대웅제약영업실적개선추세지속골든브릿지,http://www.sedaily.com/NewsView/1OL2P7UBWP
2105,2017-09-18,대웅제약확률적으로배팅해볼시기,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017091809022535799
2106,2017-09-18,ET투자뉴스대웅제약지금은확률적으로매수유지골든브릿지투자증권,http://www.etnews.com/20170918000034
2107,2017-09-18,대웅제약퇴직사우모임웅비회소통과화합의장성료,http://sports.hankooki.com/lpage/life/201709/sp20170918100943136800.htm
2108,2017-09-18,대웅제약영업실적개선추세는이어질전망,http://www.newsworks.co.kr/news/articleView.html?idxno=139218
2109,2017-09-18,대웅제약퇴직사우모임웅비회소통과화합의장성료,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=209909
2110,2017-09-18,아파야챙길래대웅제약CJ헬스케어한국MSD,http://www.g-enews.com/ko-kr/news/article/news_all/201709181033044255e6a49afa8d_1/article.html
2111,2017-09-18,대웅제약퇴직사우모임웅비회소통과화합의장마련,http://medipana.com/news/news_viewer.asp?NewsNum=206931&MainKind=A&NewsKind=5&vCount=12&vKind=1
2112,2017-09-18,대웅퇴직사우모임웅비회소통과화합의장,http://www.dailypharm.com/News/231007
2113,2017-09-18,대웅제약퇴직사우모임웅비회화합의장,http://www.bosa.co.kr/news/articleView.html?idxno=2068846
2114,2017-09-18,대웅제약퇴직사우모임웅비회성료,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1046734
2115,2017-09-18,대웅제약퇴직사우모임웅비회소통과화합의장성료,http://www.enewstoday.co.kr/news/articleView.html?idxno=1110012
2116,2017-09-18,대웅제약퇴직사우모임웅비회행사성료,http://www.newsis.com/view/?id=NISX20170918_0000098576&cID=13001&pID=13000
2117,2017-09-18,대웅제약퇴직사우모임웅비회소통과화합의장성료,http://www.lawissue.co.kr/news/articleView.html?idxno=20170918142622232541d0c69529_12
2118,2017-09-18,대웅퇴직사우모임웅비회소통화합의장성료,http://www.kpanews.co.kr/article/show.asp?idx=187216&table=article&category=D
2119,2017-09-18,대웅제약전현직대웅인소통과화합의장마련,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017091814308065970&outlink=1
2120,2017-09-18,대웅제약퇴직사우모임웅비회성료,http://www.mdtoday.co.kr/mdtoday/index.html?no=295938
2121,2017-09-18,뉴스투데이E대웅제약퇴직사우모임웅비회진행,http://www.news2day.co.kr/92604
2122,2017-09-18,대웅제약퇴직사우모임웅비회소통과화합의장마련,http://www.dt.co.kr/contents.html?article_no=2017091802109976029005&ref=naver
2123,2017-09-18,대웅제약퇴직사우모임웅비회진행,http://www.m-i.kr/news/articleView.html?idxno=343956
2124,2017-09-18,대웅제약전현직임직원모임웅비회성료,http://www.getnews.co.kr/view.php?ud=20170918211219379254b3c2d373_16
2125,2017-09-18,대웅제약퇴직사우모임웅비회소통과화합의장성료,http://www.newscj.com/news/articleView.html?idxno=450516
2126,2017-09-19,비바100대웅제약중국제약시장진출10년성공적안착,http://www.viva100.com/main/view.php?key=20170918010006246
2127,2017-09-19,fnRASSI대웅제약06962052주신고가39↑,http://www.fnnews.com/news/201709191051319730
2128,2017-09-19,대웅제약웅비회열어퇴직사우와소통,http://www.seoulfn.com/news/articleView.html?idxno=288287
2129,2017-09-19,대웅제약우루사로간기능개선,http://www.asiae.co.kr/news/view.htm?idxno=2017091813515408922
2130,2017-09-19,메디톡스vs대웅제약보톡스균주도둑질공방,http://www.insightkorea.co.kr/news/articleView.html?idxno=14492
2131,2017-09-20,대웅제약가스모틴서방제제임상3상완료시장진입다가서다,http://www.mdtoday.co.kr/mdtoday/index.html?no=295979
2132,2017-09-21,RD와투자의힘내외에서주목받는두제약사대웅제약중국진출10년현지화의모범으로,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201709210900085&code=900303
2133,2017-09-21,fnRASSI대웅제약52주신고가409↑,http://www.fnnews.com/news/201709210913329915
2134,2017-09-21,대웅제약이지엔6대학생서포터즈이지엔젤2기발대식개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=210068
2135,2017-09-21,대웅제약대학생서포터스이지엔젤2기발대식개최,http://www.sedaily.com/NewsView/1OL43ZDWG0
2136,2017-09-21,대웅이지엔6대학생서포터즈발대식,http://www.medical-tribune.co.kr/news/articleView.html?idxno=74600
2137,2017-09-21,대웅제약이지엔6서포터즈출범생리통바로알기캠페인기획키로,http://news.mk.co.kr/newsRead.php?year=2017&no=634260
2138,2017-09-21,대웅제약이지엔6대학생서포터즈이지엔젤2기발대식개최,http://www.lawissue.co.kr/view.php?ud=20170921105051138741d0c69529_12
2139,2017-09-21,대웅제약이지엔6대학생서포터즈2기발대식,http://www.bosa.co.kr/news/articleView.html?idxno=2069156
2140,2017-09-21,대웅콜린알포대조약소송유감반론기회못얻어,http://www.dailypharm.com/News/231168
2141,2017-09-21,대웅제약종근당행정심판원소송판결수용못해,http://medipana.com/news/news_viewer.asp?NewsNum=207142&MainKind=A&NewsKind=5&vCount=12&vKind=1
2142,2017-09-21,글리아티린대조약대웅→종근당변경의견조회,http://medipana.com/news/news_viewer.asp?NewsNum=207139&MainKind=A&NewsKind=5&vCount=12&vKind=1
2143,2017-09-21,대웅제약제약사도대조약공고다툴권리가있다,http://www.kpanews.co.kr/article/show.asp?idx=187335&table=article&category=D
2144,2017-09-21,콜린알포세레이트대조약지위포기못해대웅제약항소의지,http://www.medicaltimes.com/News/1114004
2145,2017-09-21,대웅제약이지엔6대학생서포터즈발대식개최,http://medipana.com/news/news_viewer.asp?NewsNum=207146&MainKind=A&NewsKind=5&vCount=12&vKind=1
2146,2017-09-21,대웅제약대조약변경공고는명백한처분법률상이익있다”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=210078
2147,2017-09-21,뉴스투데이E대웅제약이지엔6대학생서포터즈이지엔젤2기출범,http://www.news2day.co.kr/92776
2148,2017-09-21,대웅제약글리아티린대조약변경공고는명백한처분행위1심판결부당성적극다툴것”,http://biz.chosun.com/site/data/html_dir/2017/09/21/2017092101674.html
2149,2017-09-21,대웅제약이지엔6대학생서포터즈이지엔젤2기발대식,http://www.newscj.com/news/articleView.html?idxno=451055
2150,2017-09-21,대웅제약이지엔6대학생서포터즈이지엔젤2기발대식개최,http://sports.hankooki.com/lpage/life/201709/sp20170921130933136800.htm
2151,2017-09-21,대웅글리아티린대조약분쟁항소방침,http://www.dailymedi.com/detail.php?number=822681&thread=22r05
2152,2017-09-21,종근당에패소대웅제약글리아티린행정소송1심판결부당,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1046904
2153,2017-09-21,대웅제약진통제이지엔6소비자와만나다,http://news.hankyung.com/article/201709210858a
2154,2017-09-21,신약무한도전④대웅제약1호DNA를살려라,http://www.bizwatch.co.kr/pages/view.php?uid=33530
2155,2017-09-21,대웅제약생리통바로알기캠페인진통제복용법교육등,http://www.sisajournal-e.com/biz/article/174211
2156,2017-09-21,대웅제약대조약변경공고1심판결부당항소방침표명,http://www.lawissue.co.kr/view.php?ud=20170921150100307641d0c69529_12
2157,2017-09-21,대웅제약이지엔6대학생서포터즈발대식,http://www.dt.co.kr/contents.html?article_no=2017092102109976029002&ref=naver
2158,2017-09-21,대웅제약이지엔6대학생서포터즈이지엔젤2기발대식개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1111468
2159,2017-09-21,대웅제약글리아티린관련행정소송종근당일방적주장에만의존,http://www.g-enews.com/ko-kr/news/article/news_all/201709211600139624e6a49afa8d_1/article.html
2160,2017-09-21,대웅글리아티린대조약소송서변론기회못얻어,http://www.monews.co.kr/news/articleView.html?idxno=105906
2161,2017-09-21,글리아티린대조약지위못놓는대웅,http://www.medigatenews.com/news/3797425698
2162,2017-09-21,대웅제약이지엔젤2기발대식개최,http://www.m-i.kr/news/articleView.html?idxno=345063
2163,2017-09-21,대웅제약대조약변경공고1심판결부당함다툴것,http://www.m-i.kr/news/articleView.html?idxno=345080
2164,2017-09-21,우리가이지엔6마케터”대웅제약이지엔젤2기공식출범,http://news.hankyung.com/article/201709211602a
2165,2017-09-21,종근당글리아티린대조약분쟁대웅제약에판정승,http://www.finomy.com/news/articleView.html?idxno=47817
2166,2017-09-21,대웅제약제약사도대조약공고다툴권리있어,http://www.enewstoday.co.kr/news/articleView.html?idxno=1111570
2167,2017-09-21,대웅제약대학생서포터즈이지엔젤2기발대식개최,http://www.k-health.com/news/articleView.html?idxno=31530
2168,2017-09-22,대웅제약종근당행정심판소송판결수용불가,http://www.mdtoday.co.kr/mdtoday/index.html?no=296337
2169,2017-09-22,종근당대웅제약글리아티린대조약선정과정두고신경전,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1046924
2170,2017-09-22,뇌기능개선제글리아티린둘러싼갈등으로골치아픈대웅제약종근당,http://www.rapportian.com/news/articleView.html?idxno=106362
2171,2017-09-22,대웅글리아티린논쟁제네릭이무슨대조약,http://www.kpanews.co.kr/article/show.asp?idx=187362&table=article&category=D
2172,2017-09-22,종근당글리아티린대조약으로대웅문제있다,http://www.dailypharm.com/News/231200
2173,2017-09-22,대웅제약제네릭이무슨대조약인가,http://www.enewstoday.co.kr/news/articleView.html?idxno=1111839
2174,2017-09-22,대웅제약글리아티린대조약선정은특혜”주장,http://www.newsway.co.kr/view.php?tp=1&ud=2017092210193106175
2175,2017-09-22,대웅제약종근당글리아티린은대조약될수없다,http://medipana.com/news/news_viewer.asp?NewsNum=207186&MainKind=A&NewsKind=5&vCount=12&vKind=1
2176,2017-09-22,대웅제약식약처에반기대조약추진종근당글리아티린은제네릭”,http://www.sisajournal-e.com/biz/article/174239
2177,2017-09-22,치매치료제선두경쟁대웅제약종근당신경전,http://news.hankyung.com/article/201709224415f
2178,2017-09-22,대웅제약vs종근당글리아티린대조약선정갈등,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017092214508071369&outlink=1
2179,2017-09-22,변론기회조차얻지못했다대웅제약뿔난사연,http://www.kpinews.co.kr/news/articleView.html?idxno=54755
2180,2017-09-22,대웅종근당식약처글리아티린대조약분쟁에복제약개발스톱,http://news.mk.co.kr/newsRead.php?year=2017&no=638084
2181,2017-09-22,식약처가점화한대웅제약과종근당싸움글리아티린분쟁향배는,http://www.news2day.co.kr/92821
2182,2017-09-22,제약산업소식대웅제약이지엔6대학생서포터즈발대식外,http://www.kukinews.com/news/article.html?no=487097
2183,2017-09-23,주간추천종목KB증권포스코GS대웅제약,http://www.viva100.com/main/view.php?key=20170923010009115
2184,2017-09-24,주간추천종목KB증권POSCOGS대웅제약,http://www.g-enews.com/ko-kr/news/article/news_all/201709221802389081581e5800d6_1/article.html
2185,2017-09-24,주간추천종목KB증권POSCO대웅제약등,http://www.asiatoday.co.kr/view.php?key=20170924010011245
2186,2017-09-24,주간추천주POSCOGS대웅제약KB증권,http://www.dailian.co.kr/news/view/662917/?sc=naver
2187,2017-09-24,주간추천종목KB증권POSCOGS대웅제약,http://www.fntimes.com/paper/view.aspx?num=189436
2188,2017-09-25,대웅제약의대조약항쟁시장재진입노림수,http://www.medicaltimes.com/News/1114057
2189,2017-09-25,대웅제약종근당글리아티린대조약재지정은특혜행정,http://www.rapportian.com/news/articleView.html?idxno=106392
2190,2017-09-25,제약톡톡글리아티린놓고대웅제약종근당충돌,http://news.heraldcorp.com/view.php?ud=20170925000120
2191,2017-09-25,보톡스균주에글리아티린대조약분쟁까지대웅제약왜,http://www.newsway.co.kr/view.php?tp=1&ud=2017092511151091344
2192,2017-09-26,대웅제약우루사50년이상국민간건강지킨국민피로회복제,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201709260185
2193,2017-09-26,대웅제약추석선물임팩타민추천,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201709260184
2194,2017-09-26,대조약공방전두고대웅제약에꽂힌불편한시선,http://www.kpinews.co.kr/news/articleView.html?idxno=55058
2195,2017-09-26,대웅제약중국지사시장진출10년현지화성공안착,http://www.lawissue.co.kr/view.php?ud=20170926152034720641d0c69529_12
2196,2017-09-27,접전타미플루제네릭대웅유한더싸게승부수,http://www.monews.co.kr/news/articleView.html?idxno=106081
2197,2017-09-27,추석연휴체력관리필수품대웅제약임팩타민,http://www.econovill.com/news/articleView.html?idxno=323479
2198,2017-09-27,대웅제약이지덤씬인증샷SNS이벤트진행,http://www.dailypharm.com/News/231403
2199,2017-09-27,대웅제약이지덤씬구매인증이벤트실시,http://www.metroseoul.co.kr/news/newsview?newscd=2017092700022
2200,2017-09-27,대웅제약임펙타민으로비타민B군해결,http://www.mt.co.kr/view/mtview.php?type=1&no=2017092710334343633&outlink=1
2201,2017-09-27,대웅제약이지덤씬인증샷SNS이벤트진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=210304
2202,2017-09-27,대웅제약이지덤씬인증샷SNS이벤트진행,http://medipana.com/news/news_viewer.asp?NewsNum=207416&MainKind=A&NewsKind=5&vCount=12&vKind=1
2203,2017-09-27,대웅제약이지덤씬인증샷SNS이벤트,http://www.joseilbo.com/news/news_read.php?uid=336433&class=27&grp=
2204,2017-09-27,김영란법시행후접대비감소최다유한대웅,http://www.dailymedi.com/detail.php?number=822878&thread=22r05
2205,2017-09-27,대웅제약이지덤씬인증샷SNS이벤트진행,http://www.lawissue.co.kr/view.php?ud=20170927123631899341d0c69529_12
2206,2017-09-27,고혈압3제복합제일동가세대웅한미와경쟁,http://www.dailypharm.com/News/231365
2207,2017-09-27,이지덤으로치료하고직업체험하자대웅제약SNS이벤트나서,http://news.mk.co.kr/newsRead.php?year=2017&no=648438
2208,2017-09-27,대웅제약이지덤씬인증샷SNS이벤트,http://www.bosa.co.kr/news/articleView.html?idxno=2069561
2209,2017-09-27,한올바이오파마창업주일가대웅제약과결별수순,http://www.newspim.com/news/view/20170927000107
2210,2017-09-27,대웅제약이지덤씬인증샷SNS이벤트진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=296770
2211,2017-09-27,대웅제약우루사추석간건강지킨다과식과음지방간위험높여,http://www.viva100.com/main/view.php?key=20170927020021007
2212,2017-09-27,대웅제약비타민B군복합제임팩타민시리즈판매,http://www.businesspost.co.kr/BP?command=article_view&num=60012
2213,2017-09-27,대웅제약습윤드레싱이지덤씬인증샷SNS이벤트,http://biz.newdaily.co.kr/news/article.html?no=10142399
2214,2017-09-27,대웅제약이어린이의꿈과건강을응원합니다,http://www.k-health.com/news/articleView.html?idxno=31645
2215,2017-09-27,대웅제약이지덤씬인증샷SNS이벤트진행,http://www.newscj.com/news/articleView.html?idxno=452470
2216,2017-09-28,대조약지위가뭐길래”대웅제약종근당치열한법적공방,http://biz.chosun.com/site/data/html_dir/2017/09/28/2017092800438.html
2217,2017-09-28,대웅제약이지덤씬인증샷SNS이벤트진행,http://www.enewstoday.co.kr/news/articleView.html?idxno=1113777
2218,2017-09-28,뉴스투데이E대웅제약이지덤씬SNS인증샷올리고키자니아무료이용권받으세요”,http://www.news2day.co.kr/93018
2219,2017-09-28,경남인어려운이웃아낌없이후원이병호대웅건설회장,http://www.knnews.co.kr/news/articleView.php?idxno=1227817
2220,2017-09-28,대웅제약이지덤씬인증샷SNS이벤트진행,http://sports.hankooki.com/lpage/life/201709/sp20170928101543136800.htm
2221,2017-09-28,종근당대웅제약치매치료제주도권놓고치열한소송전,http://www.businesspost.co.kr/BP?command=article_view&num=60137
2222,2017-09-28,대웅제약치매치료제대조약분쟁숨은의도는,http://www.seoulfn.com/news/articleView.html?idxno=289186
2223,2017-09-29,대웅제약해외의사교류프로그램서나보타소개,http://medipana.com/news/news_viewer.asp?NewsNum=207530&MainKind=A&NewsKind=5&vCount=12&vKind=1
2224,2017-09-29,대웅해외피부성형전문의초청나보타시술교육,http://www.dailypharm.com/News/231516
2225,2017-09-29,대웅제약해외의사교류프로그램통해나보타우수성전파,http://www.dt.co.kr/contents.html?article_no=2017092902109976029001&ref=naver
2226,2017-09-29,대웅제약해외의사교류프로그램KMC통해나보타우수성전파,http://www.viva100.com/main/view.php?key=20170929010011756
2227,2017-09-29,대웅제약해외의사교류프로그램KMC통해나보타우수성전파,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=210395
2228,2017-09-29,대웅제약해외의사30명초청한나보타코리아마스터클래스성료,http://news.mk.co.kr/newsRead.php?year=2017&no=653913
2229,2017-09-29,대웅제약해외의사교류프로그램KMC통해나보타우수성전파,http://www.lawissue.co.kr/view.php?ud=20170929093624974541d0c69529_12
2230,2017-09-29,대웅제약해외의사교류KMC통해나보타우수성전파,http://www.kpanews.co.kr/article/show.asp?idx=187610&table=article&category=D
2231,2017-09-29,대웅제약해외의사교류프로그램KMC통해나보타우수성전파,http://www.enewstoday.co.kr/news/articleView.html?idxno=1114264
2232,2017-09-29,제약산업소식대웅제약이지덤씬인증샷SNS이벤트진행,http://www.kukinews.com/news/article.html?no=488819
2233,2017-09-29,대웅제약해외의사교류프로그램으로나보타전파,http://www.kpinews.co.kr/news/articleView.html?idxno=55334
2234,2017-09-29,아파야챙길래대웅제약광동제약대원제약外,http://www.g-enews.com/ko-kr/news/article/news_all/201709291103212455e6a49afa8d_1/article.html
2235,2017-09-29,대웅해외의사교류나보타우수성전파,http://www.bosa.co.kr/news/articleView.html?idxno=2069721
2236,2017-09-29,대웅제약해외의사교류프로그램KMC통해나보타우수성전파,http://sports.hankooki.com/lpage/life/201709/sp20170929114727136800.htm
2237,2017-09-29,대웅제약해외의사교류프로그램에서나보타우수성전파,http://www.techholic.co.kr/news/articleView.html?idxno=171308
2238,2017-09-29,제약산업소식대웅제약해외서나보타우수성전파,http://www.kukinews.com/news/article.html?no=488929
2239,2017-09-29,대웅제약해외의사교류프로그램KMC통해나보타우수성전파,http://www.newscj.com/news/articleView.html?idxno=452915
2240,2017-09-29,대웅제약해외의사교류프로그램통해나보타전파,http://www.metroseoul.co.kr/news/newsview?newscd=2017092900016
2241,2017-09-29,대웅제약해외의사교류프로그램통해나보타전파,http://www.metroseoul.co.kr/news/newsview?newscd=2017092900018
2242,2017-09-29,대웅제약미국에서내년상반기에보톡스품목허가받을듯,http://www.businesspost.co.kr/BP?command=article_view&num=60293
2243,2017-10-02,국내고혈압3제복합제시장대웅한미일동3파전,http://www.enewstoday.co.kr/news/articleView.html?idxno=1114924
2244,2017-10-02,뉴스투데이L대웅제약해외의사교류프로그램KMC통해나보타우수성전파,http://www.news2day.co.kr/93156
2245,2017-10-07,한심포지엄3개제품홍보대웅듀얼마케팅눈길,http://www.dailypharm.com/News/231570
2246,2017-10-09,대웅제약3분기도깜짝실적예약美진출앞둔보톡스,http://www.mt.co.kr/view/mtview.php?type=1&no=2017092915070948164&outlink=1
2247,2017-10-10,대웅제약연간450만바이알생산나보타제2공장구축,http://www.sportsseoul.com/news/read/557897
2248,2017-10-10,대웅제약나보타제2공장구축4조규모해외진출본격화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=210476
2249,2017-10-10,대웅제약보툴리눔톡신나보타제2공장KGMP획득,http://www.dailypharm.com/News/231638
2250,2017-10-10,대웅제약보툴리눔톡신나보타제2공장식약처KGMP승인,http://www.fnnews.com/news/201710100927238969
2251,2017-10-10,대웅제약나보타제2공장KGMP승인글로벌진출가속화,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017101009248069101&outlink=1
2252,2017-10-10,대웅제약나보타제2공장구축국내외진출본격화,http://www.newsway.co.kr/view.php?tp=1&ud=2017101009345600145
2253,2017-10-10,대웅제약나보타제2공장KGMP승인,http://www.mt.co.kr/view/mtview.php?type=1&no=2017101009265893664&outlink=1
2254,2017-10-10,대웅제약나보타제2공장KGMP승인생산능력10배로,http://news.mk.co.kr/newsRead.php?year=2017&no=667007
2255,2017-10-10,대웅제약나보타제2공장구축국내•외진출본격화,http://www.kpanews.co.kr/article/show.asp?idx=187711&table=article&category=D
2256,2017-10-10,대웅제약나보타2공장식약처승인美진출청신호,http://news.hankyung.com/article/201710105592f
2257,2017-10-10,대웅제약보툴리눔톡신나보타제2공장KGMP인증,http://news1.kr/articles/?3118954
2258,2017-10-10,대웅제약보톨리눔톡신나보타제2공장구축연간450만바이알규모,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017101009495435674
2259,2017-10-10,대웅제약보툴리눔톡신나보타제2공장구축4조규모해외진출본격화,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201710100087
2260,2017-10-10,대웅제약보툴리눔톡신나보타제2공장구축,http://www.dt.co.kr/contents.html?article_no=2017101002109976029003&ref=naver
2261,2017-10-10,대웅제약연간450만바이알규모나보타제2공장구축,http://www.newsis.com/view/?id=NISX20171010_0000112819&cID=13001&pID=13000
2262,2017-10-10,대웅제약연간450만병보툴리눔톡신생산2공장구축,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171010055800017&did=1195m
2263,2017-10-10,대웅제약4조원규모보툴리눔톡신시장본격진출,http://www.econovill.com/news/articleView.html?idxno=324023
2264,2017-10-10,대웅제약나보타글로벌진출위한제2공장구축,http://www.kpinews.co.kr/news/articleView.html?idxno=55810
2265,2017-10-10,대웅제약보툴리눔톡신나보타제2공장구축해외진출박차,http://www.asiae.co.kr/news/view.htm?idxno=2017101010253096187
2266,2017-10-10,대웅나보타제2공장KGMP승인,http://www.medigatenews.com/news/1094179016
2267,2017-10-10,대웅제약나보타제2공장구축국내외진출본격화,http://www.asiatoday.co.kr/view.php?key=20171010010001507
2268,2017-10-10,대웅제약나보타제2공장구축,http://www.bosa.co.kr/news/articleView.html?idxno=2069866
2269,2017-10-10,대웅제약자체개발보툴리눔톡신제제나보타2공장KGMP인증획득,http://biz.chosun.com/site/data/html_dir/2017/10/10/2017101001158.html
2270,2017-10-10,대웅제약연간450만바이알규모의나보타제2공장구축,http://sports.hankooki.com/lpage/life/201710/sp20171010105751136800.htm
2271,2017-10-10,대웅제약나보타제2공장KGMP획득연500만바이알생산,http://www.rapportian.com/news/articleView.html?idxno=106582
2272,2017-10-10,대웅제약연간450만바이알규모나보타제2공장구축,http://www.etoday.co.kr/news/section/newsview.php?idxno=1547091
2273,2017-10-10,대웅제약나보타제2공장구축시장확대본격화,http://www.metroseoul.co.kr/news/newsview?newscd=2017101000021
2274,2017-10-10,대웅나보타공장KGMP인증생산량확대,http://www.medical-tribune.co.kr/news/articleView.html?idxno=74814
2275,2017-10-10,주대웅5시간만에홍삼액추출가능한만능쿠커중탕기신제품출시,http://www.viva100.com/main/view.php?key=20171010001118027
2276,2017-10-10,대웅제약나보타제2공장구축,http://www.joseilbo.com/news/news_read.php?uid=336908&class=27&grp=
2277,2017-10-10,대웅제약향남2공장KGMP획득,http://www.doctorsnews.co.kr/news/articleView.html?idxno=119146
2278,2017-10-10,대웅제약연산450만바이알규모나보타제2공장구축,http://www.techholic.co.kr/news/articleView.html?idxno=171341
2279,2017-10-10,대웅제약나보타제2공장구축국내외진출본격화,http://www.medicaltimes.com/News/1114251
2280,2017-10-10,나보타드라이브대웅제약제2공장구축,http://www.monews.co.kr/news/articleView.html?idxno=106222
2281,2017-10-10,아파야챙길래대웅제약동국제약보령제약外,http://www.g-enews.com/ko-kr/news/article/news_all/201710101213179501e6a49afa8d_1/article.html
2282,2017-10-10,대웅제약연간450만바이알규모나보타제2공장구축,http://www.newscj.com/news/articleView.html?idxno=454197
2283,2017-10-10,대웅제약연간450만바이알규모의나보타제2공장구축국내외진출본격화,http://www.viva100.com/main/view.php?key=20171010010001354
2284,2017-10-10,대웅제약보툴리눔톡신제2공장구축승인美수출청신호,http://www.sisajournal-e.com/biz/article/174614
2285,2017-10-10,대웅제약나보타생산2공장KGMP인증획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1047394
2286,2017-10-10,대웅제약나보타2공장가동국내외진출본격화,http://www.kukinews.com/news/article.html?no=490120
2287,2017-10-10,대웅제약나보타제2공장구축국내외진출시동,http://www.m-i.kr/news/articleView.html?idxno=348067
2288,2017-10-10,대웅제약나보타제2공장구축해외진출가속화,http://www.mediapen.com/news/view/305611
2289,2017-10-10,대웅제약나보타제2공장구축국내•외진출본격화,http://www.lawissue.co.kr/view.php?ud=20171010125636507641d0c69529_12
2290,2017-10-10,대웅제약연간450만바이알규모나보타제2공장구축,http://www.newspost.kr/news/articleView.html?idxno=57477
2291,2017-10-10,대웅제약보툴리눔톡신나보타제2공장식약처승인,http://www.ebn.co.kr/news/view/912306
2292,2017-10-10,대웅제약나보타전용생산공장우수의약품제조시설인증획득,http://www.edaily.co.kr/news/newspath.asp?newsid=02978246616091608
2293,2017-10-10,대웅제약나보타2공장식약처승인받아,http://www.ftoday.co.kr/news/articleView.html?idxno=80678
2294,2017-10-10,대웅제약연간450만바이알규모나보타제2공장구축국내외진출본격화,http://www.enewstoday.co.kr/news/articleView.html?idxno=1115971
2295,2017-10-10,대웅제약나보타제2공장구축보툴리눔시장본격진출,http://sports.khan.co.kr/news/sk_index.html?art_id=201710101514003&sec_id=561801&pt=nv
2296,2017-10-10,대웅제약나보타제2공장구축,http://www.newstomato.com/ReadNews.aspx?no=780985
2297,2017-10-10,대웅제약나보타2공장식약처승인미국수출생산체계구축,http://www.etnews.com/20171010000416
2298,2017-10-10,대웅제약연간450만바이알규모나보타제2공장가동된다,http://www.mdtoday.co.kr/mdtoday/index.html?no=297470
2299,2017-10-10,대웅제약나보타제2공장식약처승인,http://www.seoulfn.com/news/articleView.html?idxno=289652
2300,2017-10-10,대웅제약보툴리눔톡신나보타제2공장식약처KGMP승인,http://news.mk.co.kr/newsRead.php?year=2017&no=668703
2301,2017-10-10,제약한줄뉴스리제네론SK케미칼대웅제약,http://www.koreahealthlog.com/news/articleView.html?idxno=22067
2302,2017-10-10,대웅제약보톡스나보타제2공장증설,http://www.sedaily.com/NewsView/1OM8ZVJSY1
2303,2017-10-10,대웅나보타2공장완비수출확대본격화,http://www.dailymedi.com/detail.php?number=823098&thread=22r05
2304,2017-10-10,대웅제약나보타제2공장본격가동,http://www.newspim.com/news/view/20171010000257
2305,2017-10-10,대웅제약세계4조보톡스시장공략채비마쳤다,http://news.hankyung.com/article/2017101080331
2306,2017-10-10,대웅제약나보타수출에날개,http://www.fnnews.com/news/201710101944415846
2307,2017-10-11,대웅제약보톡스나보타전용공장KGMP인증,https://cnbc.sbs.co.kr/article_hub/10000877254?division=NAVER
2308,2017-10-11,대웅제약나보타신공장KGMP승인성장세지속,http://www.nspna.com/news/?mode=view&newsid=244268
2309,2017-10-11,KB증권대웅제약성장세지속전망에목표주가↑,http://www.newsprime.co.kr/news/article.html?no=390690
2310,2017-10-11,대웅제약보톡스나보타생산수출확대목표가14만원↑하이투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1547490
2311,2017-10-11,대웅제약나보타2공장KGMP승인목표가상향하이투자,http://www.newstomato.com/ReadNews.aspx?no=781146
2312,2017-10-11,하이투자증권대웅제약나보타생산능력확장긍정적목표가상향”,http://www.g-enews.com/ko-kr/news/article/news_all/201710110853341245581e5800d6_1/article.html
2313,2017-10-11,대웅제약나보타매출확대전망하이투자증권,http://www.sedaily.com/NewsView/1OM9GAUZZE
2314,2017-10-11,대웅제약나보타생산수출확대목표가↑,http://www.asiatoday.co.kr/view.php?key=20171011010001967
2315,2017-10-11,특징주대웅제약나보타매출확대기대에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=01804006616091936
2316,2017-10-11,대웅산도스로부터골다공증치료제국내판권인수,http://www.dailypharm.com/News/231696
2317,2017-10-11,특징주대웅제약나보타제2공장KGMP승인소식에상승세,http://www.mt.co.kr/view/mtview.php?type=1&no=2017101109183444755&outlink=1
2318,2017-10-11,특징주대웅제약나보타식약처승인에급등,http://www.ebn.co.kr/news/view/912409
2319,2017-10-11,대웅제약나보타매출확대전망에급등,http://www.sedaily.com/NewsView/1OM9G6Q38N
2320,2017-10-11,대웅제약산도스골다공증치료제허가권판권인수,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=210538
2321,2017-10-11,ET투자뉴스대웅_기관과개인은순매도외국인은순매수한달누적,http://www.etnews.com/20171011000028
2322,2017-10-11,대웅제약골다공증치료제허가권및판권인수,http://www.newsis.com/view/?id=NISX20171011_0000113983&cID=13001&pID=13000
2323,2017-10-11,대웅제약골다공증치료제허가권및판권인수,http://www.asiatoday.co.kr/view.php?key=20171011010002018
2324,2017-10-11,대웅제약골다공증치료제허가권및판권인수,http://www.medicaltimes.com/News/1114268
2325,2017-10-11,대웅제약산도스골다공증약허가권판권인수,http://medipana.com/news/news_viewer.asp?NewsNum=207724&MainKind=A&NewsKind=5&vCount=12&vKind=1
2326,2017-10-11,대웅제약산도스골다공증치료제졸레드론산주국내판권및허가권인수,http://www.fnnews.com/news/201710110927022029
2327,2017-10-11,특징주대웅제약톡신생산2공장설립에강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171011053100008&did=1195m
2328,2017-10-11,특징주대웅제약나보타매출확대전망에상승,http://www.newspim.com/news/view/20171011000063
2329,2017-10-11,대웅제약1년에한번맞는골다공증주사제판권확보,http://www.edaily.co.kr/news/newspath.asp?newsid=01915526616091936
2330,2017-10-11,ET투자뉴스대웅제약나보타신공장KG매수유지KB증권,http://www.etnews.com/20171011000037
2331,2017-10-11,대웅골다공증약판권확보,http://www.medigatenews.com/news/2929165577
2332,2017-10-11,대웅제약보톡스새공장가동주가상승호재,http://www.businesspost.co.kr/BP?command=article_view&num=60690
2333,2017-10-11,대웅제약KGMP승인으로나보타실적늘어날듯,http://www.choicenews.co.kr/news/articleView.html?idxno=36573
2334,2017-10-11,대웅제약골다공증치료제졸레드론산판권인수,http://www.medical-tribune.co.kr/news/articleView.html?idxno=74844
2335,2017-10-11,대웅제약골다공증치료제허가권판권인수,http://www.kpinews.co.kr/news/articleView.html?idxno=55919
2336,2017-10-11,대웅제약골다공증치료제허가권및판권인수,http://news.hankyung.com/article/201710119930f
2337,2017-10-11,대웅제약골다공증치료제허가권및판권인수,http://www.bosa.co.kr/news/articleView.html?idxno=2069931
2338,2017-10-11,특징주대웅제약톡신생산2공장식약처승인소식강세,http://www.asiae.co.kr/news/view.htm?idxno=2017101110120107558
2339,2017-10-11,대웅제약산도스골다공증치료제국내허가권인수,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171011063300017&did=1195m
2340,2017-10-11,대웅제약골다공증치료제허가권및판권인수,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=101&oid=050&aid=0000045614
2341,2017-10-11,대웅제약골다공증치료제졸레드론산국내판권인수,http://www.econovill.com/news/articleView.html?idxno=324093
2342,2017-10-11,대웅제약골다공증치료제허가권및판권인수,http://www.viva100.com/main/view.php?key=20171011010001751
2343,2017-10-11,대웅제약골다공증치료제허가권인수,http://www.newstomato.com/ReadNews.aspx?no=781165
2344,2017-10-11,대웅제약산도스골다공증치료제졸레드론산국내허가권판권인수,http://biz.chosun.com/site/data/html_dir/2017/10/11/2017101101167.html
2345,2017-10-11,대웅제약보툴리눔톡신나보타세계공급력확보,http://www.ajunews.com/view/20171010125341034
2346,2017-10-11,대웅제약산도스골다공증치료제국내판권인수,http://news1.kr/articles/?3120193
2347,2017-10-11,대웅산도스골다공증약졸레드론산판권인수,http://www.dailymedi.com/detail.php?number=823120&thread=22r05
2348,2017-10-11,대웅제약한국산도스골다공증치료제판권허가권인수,http://www.rapportian.com/news/articleView.html?idxno=106600
2349,2017-10-11,대웅제약산도스골다공증치료제허가권판권인수,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201710110111
2350,2017-10-11,제약바이오의료기기업계이모저모대웅제약나보타제2공장식약처KGMP승인,http://news.heraldcorp.com/view.php?ud=20171011000444
2351,2017-10-11,대웅제약골다공증치료제허가권및판권인수,http://www.lawissue.co.kr/view.php?ud=20171011112945948441d0c69529_12
2352,2017-10-11,대웅제약골다공증치료제졸레드론산허가권판권인수,http://www.newsway.co.kr/view.php?tp=1&ud=2017101112083526023
2353,2017-10-11,대웅제약골다공증치료제졸레드론산주허가권판권인수,http://www.techholic.co.kr/news/articleView.html?idxno=171372
2354,2017-10-11,대웅제약나보타신공장승인수혜올해매출은,http://www.medicaltimes.com/News/1114272
2355,2017-10-11,대웅제약골다공증치료제허가권및판권인수,http://sports.hankooki.com/lpage/life/201710/sp20171011122810136800.htm
2356,2017-10-11,대웅제약산도스골다공증치료제국내판권허가권인수,http://www.metroseoul.co.kr/news/newsview?newscd=2017101100030
2357,2017-10-11,대웅제약산도스골다공증치료제국내허가권및판권인수,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017101112504521280
2358,2017-10-11,대웅제약골다공증치료제허가권및판권인수,http://news.kmib.co.kr/article/view.asp?arcid=0011814153&code=61171911&cp=nv
2359,2017-10-11,대웅골다공증치료제졸레드론산판권허가권인수,http://www.monews.co.kr/news/articleView.html?idxno=106286
2360,2017-10-11,대웅제약판매대행하던골다공증치료제허가권판권인수,http://news.mk.co.kr/newsRead.php?year=2017&no=670630
2361,2017-10-11,아파야챙길래대웅제약유한양행GSK,http://www.g-enews.com/ko-kr/news/article/news_all/201710111351194079e6a49afa8d_1/article.html
2362,2017-10-11,대웅제약골다공증치료제졸레드론산국내허가판권인수,http://www.kukinews.com/news/article.html?no=490493
2363,2017-10-11,ET투자뉴스대웅제약_주가거래량투심모두적정수준,http://www.etnews.com/20171011000250
2364,2017-10-11,대웅제약골다공증치료제졸레드론산판권인수,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1047437
2365,2017-10-11,대웅제약졸레드론산판권허가권인수,http://www.dt.co.kr/contents.html?article_no=2017101102109976029003&ref=naver
2366,2017-10-11,보톡스생산왕나야나대웅제약vs메디톡스보톡스대표기업맞짱,http://www.ebn.co.kr/news/view/912489
2367,2017-10-11,보톡스물량푸는대웅제약시장판도는,http://www.newstomato.com/ReadNews.aspx?no=781249
2368,2017-10-11,대웅제약골다공증치료제허가권판권인수,http://www.mdtoday.co.kr/mdtoday/index.html?no=297622
2369,2017-10-11,대웅제약나보타수출확대기대감에8대강세,http://www.newstomato.com/ReadNews.aspx?no=781291
2370,2017-10-11,대웅제약골다공증치료제허가권및판권인수,http://www.mediapen.com/news/view/305995
2371,2017-10-11,대웅제약산도스골다공증치료제판권인수,http://www.seoulfn.com/news/articleView.html?idxno=289758
2372,2017-10-11,대웅제약산도스골다공증치료제허가권판권인수,http://www.ciobiz.co.kr/news/article.html?id=20171011120023
2373,2017-10-11,대웅제약스위스골다공증약판매,http://news.mk.co.kr/newsRead.php?year=2017&no=671518
2374,2017-10-11,대웅제약골다공증치료제허가판권인수,http://www.newsprime.co.kr/news/article.html?no=390854
2375,2017-10-11,대웅제약골다공증치료제허가권및판권인수,http://www.newscj.com/news/articleView.html?idxno=454524
2376,2017-10-11,대웅제약골다공증치료제졸레드론산허가판권인수,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017101117408063474&outlink=1
2377,2017-10-11,대웅제약골다공증치료제허가권및판권인수,http://www.enewstoday.co.kr/news/articleView.html?idxno=1116413
2378,2017-10-11,특징주분석대웅제약생산공장증설과판권인수로주가급등,http://www.news2day.co.kr/93361
2379,2017-10-11,대웅제약산도스골다공증치료제판권인수,https://cnbc.sbs.co.kr/article_hub/10000877394?division=NAVER
2380,2017-10-12,빅데이터MSI시장심리톱5KB금융대웅제약삼성생명하이트진로현대미포조선,http://www.newsis.com/view/?id=NISX20171012_0000115119&cID=10401&pID=10400
2381,2017-10-12,빅데이터MSI오전10시시장심리톱5KB금융대웅제약CJ삼성생명하이트진로,http://www.newsis.com/view/?id=NISX20171012_0000115299&cID=10401&pID=10400
2382,2017-10-12,대웅제약올해첫회사채발행3년물900억,http://news.einfomax.co.kr/news/articleView.html?idxno=3415855
2383,2017-10-12,대웅제약골다공증치료제국내판권등인수,http://health.chosun.com/site/data/html_dir/2017/10/12/2017101202576.html
2384,2017-10-12,대웅제약골다공증치료제허가권및판권인수,http://www.kpanews.co.kr/article/show.asp?idx=187829&table=article&category=D
2385,2017-10-13,fnRASSI대웅제약52주신고가478↑,http://www.fnnews.com/news/201710130919153215
2386,2017-10-13,메디톡스대웅제약소송에美법원부적합결정,http://medipana.com/news/news_viewer.asp?NewsNum=207909&MainKind=A&NewsKind=5&vCount=12&vKind=1
2387,2017-10-13,美법원메디톡스소송부적합”결정대웅제약안도,http://www.newsway.co.kr/view.php?tp=1&ud=2017101312271406662
2388,2017-10-13,한숨돌린대웅제약미국보툴리눔소송부적합,http://www.medicaltimes.com/News/1114347
2389,2017-10-13,美법원메디톡스대웅제약상대소송부적합결정,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1047556
2390,2017-10-13,메디톡스대웅제약나보타소송에KO패,http://www.econovill.com/news/articleView.html?idxno=324295
2391,2017-10-13,메디톡스의대웅상대영업비밀침범訴美법원부적합,http://www.medical-tribune.co.kr/news/articleView.html?idxno=74897
2392,2017-10-13,美법원대웅제약영업비밀침해했다메디톡스소송부적합”결정,http://www.mdtoday.co.kr/mdtoday/index.html?no=297907
2393,2017-10-13,대웅제약주름개선제나보타美진출장애물사라졌다,http://www.ajunews.com/view/20171013131311769
2394,2017-10-13,대웅제약美법원이소송부적합결정VS메디톡스사실과달라,http://news.hankyung.com/article/2017101397036
2395,2017-10-13,더벨스플릿해소대웅제약올해첫회사채착수,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201710120100006890000393
2396,2017-10-13,대웅제약미국법원메디톡스소송부적합판정,http://www.finomy.com/news/articleView.html?idxno=48221
2397,2017-10-13,ET투자뉴스대웅_투심과거래량은보통현재주가는강세,http://www.etnews.com/20171013000199
2398,2017-10-13,대웅메디톡스나보타미국소송놓고입장엇갈려,http://www.dailypharm.com/News/231880
2399,2017-10-13,대웅제약미법원서메디톡스소송부적한판단,http://www.kpinews.co.kr/news/articleView.html?idxno=56242
2400,2017-10-13,대웅제약미법원승소메디톡스사실과달라,http://www.newsis.com/view/?id=NISX20171013_0000116984&cID=13001&pID=13000
2401,2017-10-13,아파야챙길래동화약품대웅제약메디톡스,http://www.g-enews.com/ko-kr/news/article/news_all/201710131430055175e6a49afa8d_1/article.html
2402,2017-10-13,美법원판결온도차대웅소송부적합결정VS메디톡스내년4월소송속개,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201710130216
2403,2017-10-13,대웅제약美법원메디톡스가제기한민사소송부적합”메디톡스내년4월美소송속개”,http://biz.chosun.com/site/data/html_dir/2017/10/13/2017101301859.html
2404,2017-10-13,메디톡스한국에서대웅제약에대해소송곧제기,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=210669
2405,2017-10-13,대웅제약VS메디톡스美보톡스분쟁한국으로넘어오나,http://www.ebn.co.kr/news/view/912866
2406,2017-10-13,대웅제약메디톡스보톡스균주출처갈등격화,http://www.newspim.com/news/view/20171013000182
2407,2017-10-13,대웅제약메디톡스美법원명령놓고다른해석갈등,http://www.asiae.co.kr/news/view.htm?idxno=2017101314520132338
2408,2017-10-13,대웅제약미법원소송부적합메디톡스사실아니다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017101314534326020
2409,2017-10-13,대웅제약메디톡스같은판결다른해석,http://www.edaily.co.kr/news/newspath.asp?newsid=03129126616092592
2410,2017-10-13,보툴리눔톡신진실공방대웅제약메디톡스입장엇갈려,http://www.dt.co.kr/contents.html?article_no=2017101302109976029005&ref=naver
2411,2017-10-13,대웅제약메디톡스나보타영업비밀소송전한국에서가린다,http://www.fnnews.com/news/201710131423330655
2412,2017-10-13,fnRASSI대웅제약나이스디앤비등30종목52주신고가경신,http://www.fnnews.com/news/201710131534482657
2413,2017-10-13,대웅제약vs메디톡스균주소송국내서먼저결론내나,http://biz.newdaily.co.kr/news/article.html?no=10143244
2414,2017-10-13,美캘리포니아법원메디톡스소송부적합”대웅제약승소,http://www.enewstoday.co.kr/news/articleView.html?idxno=1117179
2415,2017-10-13,대웅제약美법원메디톡스소송부적합판정VS메디톡스아니다열띤공방,http://www.starseoultv.com/news/articleView.html?idxno=475170
2416,2017-10-13,美법원메디톡스소송부적합결정대웅제약안도,http://www.ggilbo.com/news/articleView.html?idxno=411655
2417,2017-10-13,대웅제약메디톡스보톡스美법원판결두고충돌,http://www.newsway.co.kr/view.php?tp=1&ud=2017101314455251633
2418,2017-10-13,메디톡스vs대웅美균주공방한국서재연,http://www.mt.co.kr/view/mtview.php?type=1&no=2017101314345890441&outlink=1
2419,2017-10-13,메디톡스대웅제약나보타판결정면반박내년4월소송속개,http://www.enewstoday.co.kr/news/articleView.html?idxno=1117196
2420,2017-10-13,대웅제약vs메디톡스美소송국내법정싸움으로번지나,http://news1.kr/articles/?3123201
2421,2017-10-13,대웅제약메디톡스보톡스균주미국법정공방한국서2라운드돌입,http://www.asiatoday.co.kr/view.php?key=20171013010003698
2422,2017-10-13,대웅제약미국캘리포니아법원서메디톡스소송부적합결정,http://www.asiatime.co.kr/news/articleView.html?idxno=156560
2423,2017-10-13,美캘리포니아주법원메디톡스의대웅제약에대한소송18년4월13일9시속개”,http://www.lawissue.co.kr/view.php?ud=20171013172127123041d0c69529_12
2424,2017-10-13,대웅제약美법원메디톡스제기한민사소송부적합판정,http://www.rapportian.com/news/articleView.html?idxno=106670
2425,2017-10-13,아주종목분석대웅제약나보타2공장식약처승인에10급등,http://www.ajunews.com/view/20171013174620903
2426,2017-10-13,메디톡스대웅제약과한국서소송,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1047571
2427,2017-10-13,대웅제약메디톡스또신경전미법원결정놓고딴소리,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171013123300017&did=1195m
2428,2017-10-13,대웅제약글리아티린대조약변경공고집행정지됐다”,http://www.newsway.co.kr/view.php?tp=1&ud=2017101317485994511
2429,2017-10-13,뉴스투데이E美캘리포니아법원메디톡스소송부적합”결정에대웅제약메디톡스신경전계속,http://www.news2day.co.kr/93492
2430,2017-10-13,글리아티린대조약변경공고또제동대웅유지,http://medipana.com/news/news_viewer.asp?NewsNum=207934&MainKind=A&NewsKind=5&vCount=12&vKind=1
2431,2017-10-13,중앙행심위글리아티린대조약변경집행정지대웅제약환영,http://www.mdtoday.co.kr/mdtoday/index.html?no=297990
2432,2017-10-13,美법원메디톡스소송부적합판정대웅제약안도메디톡스사실아냐,http://www.anewsa.com/detail.php?number=1229791&thread=10r02
2433,2017-10-13,대웅제약메디톡스미법원명령문놓고동상이몽,http://www.mediapen.com/news/view/306608
2434,2017-10-13,메디톡스대웅제약국내법정에서보톡스균주논란이어간다,http://www.businesspost.co.kr/BP?command=article_view&num=60999
2435,2017-10-13,대웅글리아티린대조약기사회생집행정지인용,http://www.dailypharm.com/News/231907
2436,2017-10-13,메디톡스대웅제약미국판결제멋대로해석보톡스출처논쟁재점화,http://news.mk.co.kr/newsRead.php?year=2017&no=677987
2437,2017-10-13,대웅중앙행심위글리아티린대조약변경유지,http://www.kpanews.co.kr/article/show.asp?idx=187911&table=article&category=D
2438,2017-10-14,대웅제약메디톡스OC법원명령문놓고동상이몽,http://www.radiokorea.com/news/article.php?uid=271787
2439,2017-10-14,미법원명령문두고대웅메디톡스신경전첨예,http://www.kpanews.co.kr/article/show.asp?idx=187910&table=article&category=D
2440,2017-10-14,대웅제약중앙행심위글리아티린대조약변경유지종근당기술이전문제없어,http://www.enewstoday.co.kr/news/articleView.html?idxno=1117340
2441,2017-10-14,대웅제약메디톡스소송부적합결정”vs메디톡스사실과달라한국서소송”,http://www.mdtoday.co.kr/mdtoday/index.html?no=298017
2442,2017-10-15,美→韓넘어온대웅VS메디톡스보톡스소송,http://news.hankyung.com/article/201710153411A
2443,2017-10-15,대웅제약뇌기능개선제글리아티린대조약지위유지행심위식약처대조약변경공고집행정지”,http://biz.chosun.com/site/data/html_dir/2017/10/15/2017101500380.html
2444,2017-10-15,대웅메디톡스미국법원보톡스판결공방,http://www.newstomato.com/ReadNews.aspx?no=781805
2445,2017-10-15,대웅제약vs메디톡스아직끝나지않은독한싸움,http://www.sisaweek.com/news/articleView.html?idxno=97766
2446,2017-10-15,메디톡스대웅제약보톡스균주논란국내서도불거질까,http://www.kpinews.co.kr/news/articleView.html?idxno=56376
2447,2017-10-15,올해1조클럽주인공은누구유한녹십자확실한미재가입대웅종근당내년첫도전,http://biz.chosun.com/site/data/html_dir/2017/10/15/2017101501100.html
2448,2017-10-16,대웅제약vs메디톡스균주진실공방새국면,http://www.dailymedi.com/detail.php?number=823280&thread=22r05
2449,2017-10-16,메디톡스VS대웅제약균주소송진실은,http://www.edaily.co.kr/news/newspath.asp?newsid=01351366616093576
2450,2017-10-16,클릭e종목대웅제약균주리스크사실상해소,http://www.asiae.co.kr/news/view.htm?idxno=2017101607203017829
2451,2017-10-16,앙숙대웅제약메디톡스美소송판결놓고신경전,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1047616
2452,2017-10-16,대웅제약보툴리눔톡신균주논란사실상해소목표가↑KTB,http://news.hankyung.com/article/2017101651796
2453,2017-10-16,HotLine대웅제약보톡스균주리스크해소목표가↑,http://news.mk.co.kr/newsRead.php?year=2017&no=680795
2454,2017-10-16,대웅제약보툴리눔균주논란해소목표가↑KTB증권,http://www.dailian.co.kr/news/view/666962/?sc=naver
2455,2017-10-16,대웅제약소송리스크해소나보타가치상향,http://www.asiatoday.co.kr/view.php?key=20171016010004256
2456,2017-10-16,대웅제약균주논란리스크사실상해소목표가↑KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=01462886616093576
2457,2017-10-16,대웅제약vs메디톡스보툴리눔균주논란미국서국내법정으로,http://www.rapportian.com/news/articleView.html?idxno=106676
2458,2017-10-16,대웅제약보톡스미국유럽진출임박주가재평가기대한국투자證,http://www.mt.co.kr/view/mtview.php?type=1&no=2017101608191720223&outlink=1
2459,2017-10-16,KTB투자대웅제약균주논란사실상해소,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171016028000008&did=1195m
2460,2017-10-16,대웅제약美법원판결에보톡스균주논란리스크해소목표가15만원KTB투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1549427
2461,2017-10-16,美법원메디톡스민사소송부적합”대웅제약환영,http://www.kukinews.com/news/article.html?no=491772
2462,2017-10-16,오늘의종목대웅제약균주논란사실상해소”,http://www.sedaily.com/NewsView/1OMBQOLAA2
2463,2017-10-16,특징주대웅제약균주논란해소에상승,http://www.mt.co.kr/view/mtview.php?type=1&no=2017101609005614299&outlink=1
2464,2017-10-16,특징주대웅제약상승보툴리눔톡신균주논란해소,http://news.hankyung.com/article/2017101654626
2465,2017-10-16,특징주대웅제약보톡스균주논란리스크해소기대감에급등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1549444
2466,2017-10-16,ET투자뉴스대웅_외인의매도보다는기관의매수에집중할때현재2884일간상승,http://www.etnews.com/20171016000022
2467,2017-10-16,대웅제약주가오를듯미국유럽보톡스시장진출부각,http://www.businesspost.co.kr/BP?command=article_view&num=61078
2468,2017-10-16,특징주대웅제약균주분쟁해소평가에52주신고가,http://www.newsis.com/view/?id=NISX20171016_0000118349&cID=10401&pID=10400
2469,2017-10-16,특징주대웅제약보툴리늄톡신균주논란해소↑,http://www.seoulfn.com/news/articleView.html?idxno=290109
2470,2017-10-16,fnRASSI대웅제약06962052주신고가경신04↑,http://www.fnnews.com/news/201710161011040175
2471,2017-10-16,ET투자뉴스대웅제약미국으로불거졌던매수KTB투자증권,http://www.etnews.com/20171016000076
2472,2017-10-16,대웅메디톡스보툴리눔톡신진실공방,http://www.monews.co.kr/news/articleView.html?idxno=106490
2473,2017-10-16,대웅제약美에서불거졌던균주논란리스크사실상해소,http://www.newsworks.co.kr/news/articleView.html?idxno=143240
2474,2017-10-16,특징주대웅제약美EU시장선진출로차별화,http://www.sisaon.co.kr/news/articleView.html?idxno=63862
2475,2017-10-16,대웅제약보톡스개발보다어려운건美에보톡스파는것,http://www.newsworks.co.kr/news/articleView.html?idxno=143245
2476,2017-10-16,대웅글리아티린대조약지위유지,http://www.medigatenews.com/news/3632231303
2477,2017-10-16,대웅제약vs메디톡스보톡스소송전초읽기,http://www.ebn.co.kr/news/view/913092
2478,2017-10-16,대웅제약글리아티린대조약지위되찾아,http://www.kormedi.com/news/news/drug_dist/1224867_2906.html
2479,2017-10-16,버핏이라면대웅제약미국FDA의리스크제거효과분석필요,http://www.news2day.co.kr/93530
2480,2017-10-16,대웅제약메디톡스가제기한보톡스균주논란에서사실상벗어나,http://www.businesspost.co.kr/BP?command=article_view&num=61103
2481,2017-10-16,대웅제약메디톡스와美소송사실상종결된것,http://news.hankyung.com/article/2017101668716
2482,2017-10-16,대웅제약메디톡스영업비밀민사소송사실상미국소송종결,http://www.sportsseoul.com/news/read/560010
2483,2017-10-16,아파야챙길래종근당대웅제약서울제약,http://www.g-enews.com/ko-kr/news/article/news_all/201710161357421788e6a49afa8d_1/article.html
2484,2017-10-16,대웅제약미법원메디톡스소송한국서다툴문제,http://medipana.com/news/news_viewer.asp?NewsNum=208017&MainKind=A&NewsKind=5&vCount=12&vKind=1
2485,2017-10-16,취재수첩대웅제약은왜부적합이라는단어를썼나,http://biz.newdaily.co.kr/news/article.html?no=10143371
2486,2017-10-16,대웅미나보타소송한국서다툴문제사실상종결,http://www.kpanews.co.kr/article/show.asp?idx=187966&table=article&category=D
2487,2017-10-16,대웅제약vs메디톡스보톡스균주논란국내소송으로,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=521091
2488,2017-10-16,ET투자뉴스대웅제약전략적배팅에서확매수유지골든브릿지투자증권,http://www.etnews.com/20171016000229
2489,2017-10-16,대웅제약미국법원한국에서다툴문제사실상미국소송종결”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=210747
2490,2017-10-16,대웅제약메디톡스미국소송사실상종결선언,http://www.bosa.co.kr/news/articleView.html?idxno=2070274
2491,2017-10-16,대웅제약보톡스미국소송종결주장,http://www.newstomato.com/ReadNews.aspx?no=782095
2492,2017-10-16,대웅메디톡스와미국소송은사실상종결,http://www.dailypharm.com/News/231996
2493,2017-10-16,대웅제약미국법원사실상미국서소송종결”,http://www.dt.co.kr/contents.html?article_no=2017101602109976029010&ref=naver
2494,2017-10-16,대웅메디톡스美법원결정문에공방전,http://www.medical-tribune.co.kr/news/articleView.html?idxno=74935
2495,2017-10-16,메디톡스대웅제약에재반박국내소송즉시진행,http://www.dailypharm.com/News/232003
2496,2017-10-16,메디톡스대웅제약균주관련공개토론해야분쟁종결,http://www.m-i.kr/news/articleView.html?idxno=349935
2497,2017-10-16,대웅제약vs메디톡스또다른해석美소송종결이냐유보냐,http://biz.newdaily.co.kr/news/article.html?no=10143406
2498,2017-10-16,대웅제약미국서진행중인보톡스소송사실상종결,http://www.mediapen.com/news/view/307057
2499,2017-10-16,대웅미국소송종결”VS메디톡스한국서시작”,http://www.edaily.co.kr/news/newspath.asp?newsid=03863846616093576
2500,2017-10-16,메디톡스대웅제약상대로보톡스균주논란에강경대응태도,http://www.businesspost.co.kr/BP?command=article_view&num=61147
2501,2017-10-16,설전이어가는메디톡스대웅제약한국소송은초읽기,http://news.hankyung.com/article/201710167933f
2502,2017-10-16,대웅제약메디톡스와미국소송종결메디톡스한국서소송할것,http://www.ciobiz.co.kr/news/article.html?id=20171016120034
2503,2017-10-16,대웅제약vs메디톡스미국소송종결국내서재격돌,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017101617468026175&outlink=1
2504,2017-10-16,대웅제약vs메디톡스톡신전쟁어디로,http://www.kormedi.com/news/news/drug_dist/1224875_2906.html
2505,2017-10-16,대웅제약보톡스균주소송美법원명령문왜곡논란,http://www.insightkorea.co.kr/news/articleView.html?idxno=14633
2506,2017-10-16,대웅제약보톨리눔톡신美판결문논란에사실상소송종결”,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1047671
2507,2017-10-16,메디톡스대웅제약등당사자대상한국소송즉시진행,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=210766
2508,2017-10-16,대웅제약美불거진균주논란리스크해소KTB,http://www.mdtoday.co.kr/mdtoday/index.html?no=298247
2509,2017-10-16,대웅제약메디톡스제기미국소송사실상종결미법원한국에서다툴문제,http://www.newsis.com/view/?id=NISX20171016_0000119301&cID=13001&pID=13000
2510,2017-10-17,메디톡스대웅제약법정공방2라운드예고,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201710160425
2511,2017-10-17,대웅메디톡스보톡스혈투2R국내법정에서가린다,http://news.heraldcorp.com/view.php?ud=20171017000187
2512,2017-10-17,대웅제약메디톡스소송리스크해소로나보타가치↑,http://news.heraldcorp.com/view.php?ud=20171017000212
2513,2017-10-17,보톡스후발주자대웅제약美진출로역전노린다,http://www.asiae.co.kr/news/view.htm?idxno=2017101709531382739
2514,2017-10-17,단독메디톡스다음주대웅제약상대소송건다법무법인선정완료,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201710170086
2515,2017-10-17,아파야챙길래대웅제약동국제약GSK,http://www.g-enews.com/ko-kr/news/article/news_all/201710171103297358e6a49afa8d_1/article.html
2516,2017-10-17,대웅제약메디톡스소송리스크해소나보타가치상향,http://news.heraldcorp.com/view.php?ud=20171017000450
2517,2017-10-17,대웅제약vs메디톡스국내서재격돌미소송신경전심화,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017101710170119789
2518,2017-10-17,대웅제약SNS서효과적인여드름상처관리법소개,http://www.fnnews.com/news/201710171154030500
2519,2017-10-17,대웅제약이지덤뷰티효과적인여드름상처관리법소개,http://www.lawissue.co.kr/view.php?ud=20171017122039898241d0c69529_12
2520,2017-10-17,대웅제약미국법원한국에서다툴문제사실상미국에서의소송종결”,http://www.lawissue.co.kr/view.php?ud=2017101713091040941d0c69529_12
2521,2017-10-17,대웅제약이지덤뷰티효과적여드름상처관리법소개,http://www.bosa.co.kr/news/articleView.html?idxno=2070394
2522,2017-10-17,대웅제약이지덤뷰티광고통해효과적인여드름상처관리법소개,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017101713433891181
2523,2017-10-17,대웅제약이지덤뷰티광고로효과적인여드름상처관리법소개,http://www.enewstoday.co.kr/news/articleView.html?idxno=1118099
2524,2017-10-17,대웅제약유튜브스타포니출연한이지덤뷰티광고노출,http://news.mk.co.kr/newsRead.php?year=2017&no=685282
2525,2017-10-17,대웅제약이지덤뷰티효과적인여드름상처관리소개,http://www.kpanews.co.kr/article/show.asp?idx=188030&table=article&category=D
2526,2017-10-17,단독메디톡스대웅제약상대보톡스소송본격화,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201710170099
2527,2017-10-17,대웅제약이지덤뷰티광고진행여드름상처관리법소개,http://www.mdtoday.co.kr/mdtoday/index.html?no=298395
2528,2017-10-17,대웅제약17일부터이지덤뷰티유튜브페이스북인스타그램에광고선봬,http://sports.hankooki.com/lpage/life/201710/sp20171017174117136800.htm
2529,2017-10-17,뉴스투데이E대웅제약이지덤뷰티로여드름상처관리하세요”,http://www.news2day.co.kr/93631
2530,2017-10-17,대웅제약이지덤뷰티광고로효과적인여드름상처관리법소개,http://www.newscj.com/news/articleView.html?idxno=456028
2531,2017-10-17,대웅제약습윤드레싱이지덤뷰티새SNS광고선봬,http://www.viva100.com/main/view.php?key=20171017020021141
2532,2017-10-18,대웅알비스정등무더기판매업무정지공급차질우려,http://www.kpanews.co.kr/article/show.asp?idx=188042&table=article&category=B
2533,2017-10-18,대웅엘도스COPD악화기간감소효과입증,http://www.dailypharm.com/News/232113
2534,2017-10-18,대웅제약엘도스COPD악화기간감소효과입증,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017101809008054522&outlink=1
2535,2017-10-18,특징주대웅제약소송리스크해소로52주신고가,http://www.mt.co.kr/view/mtview.php?type=1&no=2017101809101102810&outlink=1
2536,2017-10-18,fnRASSI대웅제약52주신고가4↑,http://www.fnnews.com/news/201710180913590136
2537,2017-10-18,대웅제약엘도스거담제유일COPD악화감소,http://medipana.com/news/news_viewer.asp?NewsNum=208153&MainKind=A&NewsKind=5&vCount=12&vKind=1
2538,2017-10-18,대웅엘도스거담제로유일COPD악화기간감소효과입증,http://www.kpanews.co.kr/article/show.asp?idx=188050&table=article&category=D
2539,2017-10-18,대웅엘도스거담제유일COPD악화기간감소,http://www.dailymedi.com/detail.php?number=823400&thread=22r05
2540,2017-10-18,특징주대웅제약메디톡스소송리스크해소신고가,http://www.viva100.com/main/view.php?key=20171018010004576
2541,2017-10-18,ET투자뉴스대웅제약미국에진출한기업매수유지한국투자증권,http://www.etnews.com/20171018000029
2542,2017-10-18,대웅제약거담제엘도스임상시험유럽호흡기저널발표,http://www.fnnews.com/news/201710180933111490
2543,2017-10-18,대웅제약엘도스거담제유일COPD악화기간감소입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=210856
2544,2017-10-18,대웅제약유럽호흡기저널서거담제엘도스임상결과발표,http://www.newsis.com/view/?id=NISX20171018_0000120970&cID=13001&pID=13000
2545,2017-10-18,대웅엘도스COPD악화기간감소,http://www.medigatenews.com/news/3756154552
2546,2017-10-18,대웅제약의균주획득경위와전체유전체염기서열공개가곧분쟁의종결,http://www.ggilbo.com/news/articleView.html?idxno=412952
2547,2017-10-18,대웅제약vs메디톡스법적다툼점입가경,http://www.newsway.co.kr/view.php?tp=1&ud=2017101809354404785
2548,2017-10-18,대웅제약엘도스유럽임상서거담제중유일하게COPD악화기간감소,http://biz.chosun.com/site/data/html_dir/2017/10/18/2017101801086.html
2549,2017-10-18,아파야챙길래종근당대웅제약LG화학外,http://www.g-enews.com/ko-kr/news/article/news_all/201710181050432071e6a49afa8d_1/article.html
2550,2017-10-18,대웅제약엘도스대규모임상결과발표,http://www.newstomato.com/ReadNews.aspx?no=782542
2551,2017-10-18,대웅제약엘도스거담제로유일하게COPD악화기간감소효과입증,http://www.lawissue.co.kr/view.php?ud=20171018104415337141d0c69529_12
2552,2017-10-18,보톡스균주소송전美서국내로대웅사실상끝”메디톡스아직아냐”,http://news.heraldcorp.com/view.php?ud=20171018000361
2553,2017-10-18,대웅제약거담제엘도스다국적임상결과학술지에발표,http://www.rapportian.com/news/articleView.html?idxno=106746
2554,2017-10-18,대웅3D프린트제조업체일루미네이드자회사편입,http://www.mt.co.kr/view/mtview.php?type=1&no=2017101812491276661&outlink=1
2555,2017-10-18,대웅제약거담제엘도스COPD악화기간감소효과입증,http://www.newsprime.co.kr/news/article.html?no=391755
2556,2017-10-18,대웅일루미네이드자회사로편입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1550843
2557,2017-10-18,대웅3D프린팅기술확보위해일루미네이드자회사편입,http://www.sedaily.com/NewsView/1OMCOOMICK
2558,2017-10-18,공시대웅3D프린트제조업체일루미네이드자회사편입,http://www.fnnews.com/news/201710181325335112
2559,2017-10-18,대웅제약엘도스COPD악화기간감소효과입증,http://www.bosa.co.kr/news/articleView.html?idxno=2070494
2560,2017-10-18,대웅3D프린팅기술확보위해일루미네이드자회사편입,http://www.newsis.com/view/?id=NISX20171018_0000121365&cID=10401&pID=10400
2561,2017-10-18,대웅3D프린터업체일루미네이드자회사편입,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171018109000008&did=1195m
2562,2017-10-18,대웅3D프린트제조업체일루미네이드자회사편입,http://biz.chosun.com/site/data/html_dir/2017/10/18/2017101801677.html
2563,2017-10-18,대웅일루미네이드자회사편입,http://www.edaily.co.kr/news/newspath.asp?newsid=03263606616094232
2564,2017-10-18,대웅3D프린터제조업체일루미네이드자회사로편입,http://www.newspim.com/news/view/20171018000141
2565,2017-10-18,공시대웅3D프린터제조업체일루미네이드자회사편입,http://www.viva100.com/main/view.php?key=20171018010004784
2566,2017-10-18,대웅제약엘도스거담제유일COPD악화기간감소효과입증,http://www.mdtoday.co.kr/mdtoday/index.html?no=298495
2567,2017-10-18,헬스단신대전성모병원대림성모병원대웅제약,http://www.sportsseoul.com/news/read/560829
2568,2017-10-18,대웅거담제엘도스COPD악화기간감소,http://www.monews.co.kr/news/articleView.html?idxno=106626
2569,2017-10-18,대웅제약엘도스COPD악화기간감소입증,http://www.k-health.com/news/articleView.html?idxno=31931
2570,2017-10-18,대웅제약거담제엘도스RESTORE임상서COPD악화기간246단축,http://www.viva100.com/main/view.php?key=20171018020021149
2571,2017-10-18,대웅제약유럽호흡기저널서거담제엘도스임상결과발표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1550951
2572,2017-10-18,대웅제약엘도스거담제유일COPD악화기간감소효과입증,http://www.techholic.co.kr/news/articleView.html?idxno=171495
2573,2017-10-18,대웅제약엘도스만성폐쇄성폐질환악화기간감소입증,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201710180316
2574,2017-10-18,대웅제약엘도스거담제로유일하게COPD악화기간감소효과입증,http://sports.hankooki.com/lpage/life/201710/sp20171018184029136800.htm
2575,2017-10-18,대웅제약엘도스거담제최초로만성폐쇄성폐질환악화기간감소입증,http://news.mk.co.kr/newsRead.php?year=2017&no=689351
2576,2017-10-19,터치PeakBottom대웅제약美보톡스소송리스크해소로52주신고가,http://www.sedaily.com/NewsView/1OMD34NAP4
2577,2017-10-19,더벨대웅제약간판우루사美진출추진,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201710180100016860000997
2578,2017-10-19,대웅리리카제네릭리카프리출시,http://www.medigatenews.com/news/3741981506
2579,2017-10-19,메디톡스대웅같은판결다른해석,http://www.medigatenews.com/news/2061884630
2580,2017-10-19,대웅에한미일동유한도전장,http://www.medigatenews.com/news/1885143079
2581,2017-10-19,대웅제약엘도스매출성장이끌까,http://www.econovill.com/news/articleView.html?idxno=324722
2582,2017-10-19,단백질크림의귀환대웅제약이지듀DWEGF크림프리미엄출시,http://biz.chosun.com/site/data/html_dir/2017/10/19/2017101901233.html
2583,2017-10-19,대웅제약이지듀DWEGF크림프리미엄출시,http://sports.hankooki.com/lpage/life/201710/sp20171019111148136800.htm
2584,2017-10-19,대웅제약엘도스거담제로유일하게COPD악화기간감소효과입증,http://www.newscj.com/news/articleView.html?idxno=456528
2585,2017-10-19,대웅제약이지듀DWEGF크림프리미엄출시,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201710190391
2586,2017-10-19,대웅제약이지듀DWEGF크림프리미엄출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=298717
2587,2017-10-20,녹십자대웅제약신약美출시역사쓸까,http://www.ajunews.com/view/20171019125245704
2588,2017-10-20,뉴스줌인메디톡스대웅보톡스전쟁눈치보는휴젤,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201710200115
2589,2017-10-20,국제망신대웅제약메디톡스보톡스출처논쟁언제까지,http://news.mk.co.kr/newsRead.php?year=2017&no=694881
2590,2017-10-22,대웅제약나보타제2공장본격가동돌입해외공략박차,http://news.kmib.co.kr/article/view.asp?arcid=0923834240&code=14130000&cp=nv
2591,2017-10-23,대웅제약vs메디톡스보톡스균주출처소송전누가이길까,http://www.rapportian.com/news/articleView.html?idxno=106828
2592,2017-10-23,메디톡스이번주대웅소송증거쌓이고넘쳐,http://www.mt.co.kr/view/mtview.php?type=1&no=2017102010173677992&outlink=1
2593,2017-10-23,대웅家2세윤재훈윤재승각자도생시작,http://www.finomy.com/news/articleView.html?idxno=48472
2594,2017-10-23,더벨대웅제약등급불일치해소후수요예측성공,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201710200100020640001226
2595,2017-10-24,스마트컨슈머㈜대웅만능쿠커도자기중탕기5시간만에홍삼추출가능,http://news.donga.com/3/all/20171023/86905932/1
2596,2017-10-24,더벨윤재훈알피그룹회장㈜대웅지분전량처분,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201710230100023400001397
2597,2017-10-24,보톡스도둑질논란대웅메디톡스한판국내무대옮긴다,http://www.kpanews.co.kr/article/show.asp?idx=188320&table=article&category=D
2598,2017-10-24,메디톡스이번주대웅제약상대소장접수국내소송본격화,http://biz.newdaily.co.kr/news/article.html?no=10144171
2599,2017-10-25,대웅올로스타나보타등13개품목판매업무광고정지과징금,http://www.medical-tribune.co.kr/news/articleView.html?idxno=75121
2600,2017-10-25,대웅제약올로스타정등10품목판매업무정지45일행정처분,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211131
2601,2017-10-25,DataScore대웅제약연구개발비매출액의1271,http://www.ceoscoredaily.com/news/article.html?no=32856
2602,2017-10-25,대웅의료상李承奎간이식임상연구상에김기훈교수,http://medipana.com/news/news_viewer.asp?NewsNum=208554&MainKind=A&NewsKind=5&vCount=12&vKind=1
2603,2017-10-25,대웅제약나보타주등13품목약사법위반혐의로행정처분,http://www.sportsseoul.com/news/read/563214
2604,2017-10-25,제5회대웅의료상이승규간이식임상연구상에김기훈울산대교수,http://www.sedaily.com/NewsView/1OMFVWX1PP
2605,2017-10-25,대웅제약올로스타스멕타등13품목무더기행정처분,http://www.kpanews.co.kr/article/show.asp?idx=188382&table=article&category=D
2606,2017-10-25,대웅의료상李承奎간이식임상연구상에김기훈교수수상,http://www.newsprime.co.kr/news/article.html?no=392673
2607,2017-10-25,대웅재단대웅의료상이승규간이식임상•연구상김기훈교수수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211158
2608,2017-10-25,제5회대웅의료상울산의대김기훈교수수상,http://www.dailypharm.com/News/232552
2609,2017-10-25,대웅재단제5회대웅의료상이승규간이식임상∙연구상김기훈교수수상,http://www.lawissue.co.kr/view.php?ud=20171025104409404641d0c69529_12
2610,2017-10-25,대웅제약메디톡스미국진출난항겪자경쟁사음해도넘어섰다,http://www.g-enews.com/ko-kr/news/article/news_all/201710251117213206e6a49afa8d_1/article.html
2611,2017-10-25,대웅제약보톡스균주분쟁메디톡스출처부터증명해야”,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017102511218058500&outlink=1
2612,2017-10-25,대웅메디톡스균주출처증명더우선허구성입증할것,http://www.kpanews.co.kr/article/show.asp?idx=188394&table=article&category=D
2613,2017-10-25,대웅제약메디톡스균주출처증명이더우선구체적검증없어,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211169
2614,2017-10-25,대웅메디톡스먼저균주출처공개해야,http://www.dailypharm.com/Users/News/NewsView.html?ID=232560&REFERER=NP
2615,2017-10-25,대웅의료상에김기훈서울아산병원교수,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171025089600017&did=1195m
2616,2017-10-25,대웅제약의약품무더기판매정지과징금처분받아,http://www.insightkorea.co.kr/news/articleView.html?idxno=14831
2617,2017-10-25,김기훈교수대웅이승규상수상,http://www.doctorsnews.co.kr/news/articleView.html?idxno=119412
2618,2017-10-25,김기훈울산의대교수제5회대웅의료상수상,http://www.kpinews.co.kr/news/articleView.html?idxno=57452
2619,2017-10-25,김기훈교수제5회대웅의료상수상,http://news.kmib.co.kr/article/view.asp?arcid=0011849301&code=61171911&cp=nv
2620,2017-10-25,대웅균주국가기관검증국내소송걱정없다,http://medipana.com/news/news_viewer.asp?NewsNum=208581&MainKind=A&NewsKind=5&vCount=12&vKind=1
2621,2017-10-25,식약처대웅제약철퇴나보타등13품목약사법위반,http://www.seoulfn.com/news/articleView.html?idxno=290989
2622,2017-10-25,대웅의료상李承奎간이식임상연구상에김기훈교수,http://www.medical-tribune.co.kr/news/articleView.html?idxno=75132
2623,2017-10-25,대웅제약메디톡스음해관두고균주출처밝히라”,http://www.mhj21.com/sub_read.html?uid=109864§ion=sc243
2624,2017-10-25,제미글로3분기500억돌파대웅제약매출의핵심,http://www.dailypharm.com/News/232543
2625,2017-10-25,대웅제약나보타주광고위반과징금1억7천만원,http://www.econovill.com/news/articleView.html?idxno=325126
2626,2017-10-25,제5회대웅의료상김기훈교수수상,http://www.monews.co.kr/news/articleView.html?idxno=106927
2627,2017-10-25,제5회대웅의료상李承奎간이식임상연구상에김기훈교수,http://www.bosa.co.kr/news/articleView.html?idxno=2071007
2628,2017-10-25,대웅재단제5회대웅의료상이승규간이식임상연구상김기훈교수수상,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017102513230911531
2629,2017-10-25,대웅재단제5회대웅의료상李承奎간이식임상연구상시상식개최김기훈울산의대교수수상,http://www.nextdaily.co.kr/news/article.html?id=20171025800037
2630,2017-10-25,대웅제약메디톡스균주출처증명부터해야”,http://www.dt.co.kr/contents.html?article_no=2017102502109976029005&ref=naver
2631,2017-10-25,대웅재단대웅의료상이승규간이식임상연구상서울아산병원김기훈교수선정,http://www.kukinews.com/news/article.html?no=494783
2632,2017-10-25,대웅재단제5회대웅의료상이승규간이식임상연구상김기훈교수수상,http://www.enewstoday.co.kr/news/articleView.html?idxno=1120948
2633,2017-10-25,대웅의료상간이식연구상울산의대김기훈교수수상,http://www.medicaltimes.com/News/1114625
2634,2017-10-25,김기훈서울아산병원교수제5회대웅의료상이승규간이식임상연구상수상,http://www.viva100.com/main/view.php?key=20171025010007740
2635,2017-10-25,대웅제약살빠지는당뇨병치료제자체개발착수,http://news1.kr/articles/?3133995
2636,2017-10-25,간이식새지평김기훈교수대웅의료상,http://www.sedaily.com/NewsView/1OMFWQOQ3T
2637,2017-10-25,대웅의료상에김기훈교수수상,http://www.newsis.com/view/?id=NISX20171025_0000128123&cID=13001&pID=13000
2638,2017-10-25,김기훈서울아산병원교수대웅의료상이승규간이식임상연구상수상,http://news.mk.co.kr/newsRead.php?year=2017&no=705779
2639,2017-10-25,3분기원외처방액증가율1위는종근당동아에스티대웅제약↓,http://news.hankyung.com/article/201710251416f
2640,2017-10-25,대웅제약메디톡스의보툴리눔톡신균주출처불명확,http://www.rapportian.com/news/articleView.html?idxno=106916
2641,2017-10-25,대웅제약vs메디톡스균주소송갈수록점입가경,http://www.edaily.co.kr/news/newspath.asp?newsid=04024566616096528
2642,2017-10-25,아파야챙길래대웅제약일동제약한화제약,http://www.g-enews.com/ko-kr/news/article/news_all/201710251704182124e6a49afa8d_1/article.html
2643,2017-10-25,메디톡스대웅제약은소송본질왜곡하지말라”,http://www.dt.co.kr/contents.html?article_no=2017102502109976029010&ref=naver
2644,2017-10-25,메디톡스대웅제약은소송의본질을왜곡하지말라”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211186
2645,2017-10-25,메디톡스대웅제약은소송본질왜곡하지마라,http://medipana.com/news/news_viewer.asp?NewsNum=208595&MainKind=A&NewsKind=5&vCount=12&vKind=1
2646,2017-10-25,대웅제약vs메디톡스보톡스균주다툼장기화,http://www.enewstoday.co.kr/news/articleView.html?idxno=1121128
2647,2017-10-25,대웅의료상에김기훈울산의대교수,http://news.hankyung.com/article/2017102521821
2648,2017-10-25,빅데이터주식투자코스피대웅제약,http://www.leaders.kr/news/articleView.html?idxno=55391
2649,2017-10-25,대웅제약메디톡스소송보다균주출처부터밝히길,http://www.k-health.com/news/articleView.html?idxno=32145
2650,2017-10-25,김기훈서울아산병원간이식외과교수제5회대웅의료상수상,http://www.viva100.com/main/view.php?key=20171025020021229
2651,2017-10-25,메디톡스대웅제약소송본질은도용여부당당히공개토론하자,http://www.k-health.com/news/articleView.html?idxno=32146
2652,2017-10-25,대웅메디톡스먼저균주출처와검증필요,http://www.mdtoday.co.kr/mdtoday/index.html?no=299405
2653,2017-10-25,대웅재단제5회대웅의료상이승규간이식임상연구상김기훈교수수상,http://www.newscj.com/news/articleView.html?idxno=458194
2654,2017-10-25,hotissue메디톡스대웅제약은숨지말고공개토론해라”강력촉구,http://www.lawissue.co.kr/view.php?ud=201710252332206604d7f4c63cc6_12
2655,2017-10-26,대웅이승규간이식임상연구상김기훈울산의대교수,http://www.dailymedi.com/detail.php?number=823680&thread=22r03
2656,2017-10-26,대웅제약13개품목판매중지과징금등처분,http://www.medigatenews.com/news/913775843
2657,2017-10-26,대웅LG화학제미글로고공행진연매출700억원노려,http://www.mdtoday.co.kr/mdtoday/index.html?no=299380
2658,2017-10-26,대웅제약우루사글로벌화추진매출증가크게기여,http://www.ceoscoredaily.com/news/article.html?no=33391
2659,2017-10-26,대웅의반격메디톡스균주출처도검증하자,http://www.doctorsnews.co.kr/news/articleView.html?idxno=119421
2660,2017-10-26,㈜대웅멀티형포터기티앤쿡국내최초출시,http://www.viva100.com/main/view.php?key=20171026000857344
2661,2017-10-26,공개토론카드꺼낸메디톡스대웅제약떳떳하면나와라”,http://www.mhj21.com/sub_read.html?uid=109879§ion=sc243
2662,2017-10-26,대웅비리어드제네릭비리헤파가격확줄인다,http://www.dailypharm.com/News/232609
2663,2017-10-26,뉴스텔링메디톡스vs대웅제약보톡스전쟁2라운드염기서열공개가스모킹건,http://www.cnbnews.com/news/article.html?no=359617
2664,2017-10-26,살빠지는당뇨약시장에도전장던진대웅제약,http://medipana.com/news/news_viewer.asp?NewsNum=208641&MainKind=A&NewsKind=5&vCount=12&vKind=1
2665,2017-10-26,대웅올로스타판매정지등13품목행정처분,http://www.dailypharm.com/News/232614
2666,2017-10-26,한국소송앞두고대웅제약메디톡스서로비방눈살,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1048069
2667,2017-10-26,대웅제약나보타스멕타등무더기행정처분,http://news.hankyung.com/article/201710265203f
2668,2017-10-26,대웅제약메디톡스균주구체적인유래취득경위등검증없어,http://www.kukinews.com/news/article.html?no=495280
2669,2017-10-26,대웅제약주력제품약사법위반으로줄줄이행정처분,http://www.newsworks.co.kr/news/articleView.html?idxno=145199
2670,2017-10-26,설전오가는대웅제약vs메디톡스공개토론제안왜,http://biz.newdaily.co.kr/news/article.html?no=10144436
2671,2017-10-26,도약하는K바이오대웅제약씨콜드플러스정환절기불청객감기꼼짝마,http://www.sedaily.com/NewsView/1OMGDGJSRK
2672,2017-10-26,대웅제약출처더욱의심돼vs메디톡스본질왜곡그만,http://www.kpinews.co.kr/news/articleView.html?idxno=57521
2673,2017-10-26,대웅제약보툴리눔톡신두고정부와대립각,http://www.mhj21.com/sub_read.html?uid=109895§ion=sc243
2674,2017-10-27,대웅제약인재육성연구지원장학사업활발전개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211045
2675,2017-10-27,제약말말말②대웅VS메디톡스지겨운공방전,http://www.mdtoday.co.kr/mdtoday/index.html?no=299550
2676,2017-10-27,대웅제약복약편의성약가인하로B형간염치료제시장공략박차,http://www.mdtoday.co.kr/mdtoday/index.html?no=299553
2677,2017-10-27,대웅제약살빠지는당뇨병치료제DWP16001임상돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=299547
2678,2017-10-27,대웅제약올로스타나보타스멕타등13개품목행정처분,http://www.mdtoday.co.kr/mdtoday/index.html?no=299526
2679,2017-10-27,울산의대외과김기훈교수대웅의료상수상,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1048095
2680,2017-10-27,대웅그룹2017년하반기신입및주니어경력사원공개채용,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211250
2681,2017-10-27,대웅제약신입경력사원공개채용,http://www.newstomato.com/ReadNews.aspx?no=784636
2682,2017-10-27,대웅그룹11월6일까지신입경력공채진행,http://www.kpinews.co.kr/news/articleView.html?idxno=57733
2683,2017-10-27,대웅제약하반기신입및경력사원공채,http://www.sedaily.com/NewsView/1OMGSQ68KF
2684,2017-10-27,대웅제약하반기신입및경력사원공개채용,http://www.ebn.co.kr/news/view/914912
2685,2017-10-27,대웅그룹11월6일까지하반기신입및주니어경력자모집,http://www.fnnews.com/news/201710271053563989
2686,2017-10-27,자율적으로일하고도전으로성장하는대웅그룹,http://medipana.com/news/news_viewer.asp?NewsNum=208695&MainKind=A&NewsKind=5&vCount=12&vKind=1
2687,2017-10-27,대웅그룹하반기신입및주니어경력사원공개채용,http://www.jobnjoy.com/portal/job/hotnews_view.jsp?nidx=241990&depth1=1&depth2=1&depth3=2
2688,2017-10-27,대웅제약900억원무보증사채발행,http://www.dailypharm.com/News/232665
2689,2017-10-27,대웅그룹하반기신입및주니어경력사원공개채용,http://news.heraldcorp.com/view.php?ud=20171027000356
2690,2017-10-27,대웅제약타사제품비방등광고위반으로13품목행정처분,http://www.kukinews.com/news/article.html?no=495516
2691,2017-10-27,대웅그룹2017년하반기신입및경력사원,http://www.medical-tribune.co.kr/news/articleView.html?idxno=75193
2692,2017-10-27,대웅그룹하반기신입주니어경력자사원모집,http://www.newsprime.co.kr/news/article.html?no=393024
2693,2017-10-27,JOB속보대웅제약2017신입경력사원공채시작,http://www.news2day.co.kr/94195
2694,2017-10-27,대웅그룹하반기신입주니어경력사원공채자율적근무문화장점”,http://biz.chosun.com/site/data/html_dir/2017/10/27/2017102701539.html
2695,2017-10-27,대웅자율로일하고도전으로성장하는인재찾아,http://www.dailypharm.com/News/232670
2696,2017-10-27,대웅그룹하반기신입및주니어경력사원공개채용실시,http://www.asiatime.co.kr/news/articleView.html?idxno=157609
2697,2017-10-27,대웅제약이제메디톡스차례균주출처증빙공개해야”,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211261
2698,2017-10-27,대웅그룹2017년하반기신입및주니어경력사원공개채용,http://www.viva100.com/main/view.php?key=20171027010008705
2699,2017-10-27,대웅그룹2017년하반기신입및주니어경력사원공개채용,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017102713360487505
2700,2017-10-27,대웅메디톡스균주출처가장불명확먼저밝혀야,http://www.dailypharm.com/News/232679
2701,2017-10-27,대웅그룹2017년하반기공개채용,http://www.ajunews.com/view/20171027141858468
2702,2017-10-27,대웅제약한올바이오파마주식17만2192주장내매수,http://www.newsis.com/view/?id=NISX20171027_0000130717&cID=10401&pID=10400
2703,2017-10-27,대웅제약한올바이오파마株17만2192주매수,http://www.mt.co.kr/view/mtview.php?type=1&no=2017102714281036969&outlink=1
2704,2017-10-27,대웅제약하반기신입주니어경력사원공채,http://www.asiae.co.kr/news/view.htm?idxno=2017102714312108525
2705,2017-10-27,대웅그룹2017년하반기경력사원공채,http://www.monews.co.kr/news/articleView.html?idxno=107056
2706,2017-10-27,대웅그룹하반기신입주니어경력사원공개채용,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017102714308035368&outlink=1
2707,2017-10-27,대웅제약메디톡스균주국가검증부터받아야”,http://www.dt.co.kr/contents.html?article_no=2017102702109976029004&ref=naver
2708,2017-10-27,대웅그룹하반기신입주니어경력사원공개채용,http://www.newscj.com/news/articleView.html?idxno=458666
2709,2017-10-27,메디톡스30일대웅제약상대소장접수,http://biz.newdaily.co.kr/news/article.html?no=10144564
2710,2017-10-27,제약산업이모저모대웅그룹하반기신입경력사원공개채용실시外,http://www.kukinews.com/news/article.html?no=495590
2711,2017-10-27,대웅그룹하반기신입경력자공채실시,http://www.rapportian.com/news/articleView.html?idxno=106961
2712,2017-10-27,자율적으로일하고도전통해성장대웅그룹공개채용시작,http://www.g-enews.com/ko-kr/news/article/news_all/201710271536222522e6a49afa8d_1/article.html
2713,2017-10-27,대웅제약메디톡스균주출처증빙공개해라,http://medipana.com/news/news_viewer.asp?NewsNum=208713&MainKind=A&NewsKind=5&vCount=12&vKind=1
2714,2017-10-27,대웅제약2017년하반기신입주니어경력사원공개채용,http://www.mdtoday.co.kr/mdtoday/index.html?no=299633
2715,2017-10-27,아파야챙길래동아제약대웅제약한국릴리外,http://www.g-enews.com/ko-kr/news/article/news_all/20171027154704403e6a49afa8d_1/article.html
2716,2017-10-27,메디톡스vs대웅제약법정공방초읽기월요일30일소장접수,http://www.mhj21.com/sub_read.html?uid=109914§ion=sc243
2717,2017-10-27,대웅그룹올해하반기신입주니어경력사원공개채용,http://www.mt.co.kr/view/mtview.php?type=1&no=2017102716442028333&outlink=1
2718,2017-10-27,대웅제약메디톡스보톡스균주출처증빙공개해야메디톡스30일소송,http://biz.chosun.com/site/data/html_dir/2017/10/27/2017102702365.html
2719,2017-10-27,대웅제약메디톡스균주출처증빙공개하고검증받을차례”,http://www.mdtoday.co.kr/mdtoday/index.html?no=299630
2720,2017-10-27,대웅그룹내달6일까지하반기신입경력자채용,http://www.fnnews.com/news/201710271724447914
2721,2017-10-27,대웅그룹하반기신입경력사원채용,http://www.seoulfn.com/news/articleView.html?idxno=291236
2722,2017-10-27,대웅그룹다음달6일까지하반기신입경력사원공채접수,http://news.mk.co.kr/newsRead.php?year=2017&no=712569
2723,2017-10-27,대웅메디톡스균주출처공개검증받아야,http://www.kpanews.co.kr/article/show.asp?idx=188487&table=article&category=D
2724,2017-10-28,대웅제약무보증사채발행900억원공모,http://www.mdtoday.co.kr/mdtoday/index.html?no=299672
2725,2017-10-28,머니S토리메디톡스vs대웅제약보톡스전쟁3라운드,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017102620318094618&outlink=1
2726,2017-10-28,대웅그룹2017년하반기신입및주니어경력사원공개채용,http://www.enewstoday.co.kr/news/articleView.html?idxno=1122193
2727,2017-10-29,메디톡스대웅제약보톡스진흙탕싸움,http://www.newstomato.com/ReadNews.aspx?no=784738
2728,2017-10-29,대웅제약의반격메디톡스보툴리눔톡스균주출처증빙공개하라,http://www.newsis.com/view/?id=NISX20171029_0000131688&cID=13001&pID=13000
2729,2017-10-29,대웅제약vs메디톡스보톡스균주설전점입가경,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017102914064835836
2730,2017-10-30,대웅제약SGLT2당뇨병치료제임상1상진입,http://www.econovill.com/news/articleView.html?idxno=325351
2731,2017-10-30,대웅제약메디톡스보툴리눔톡스균주출처증빙공개하라,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1002993327
2732,2017-10-30,대웅그룹올하반기신입및주니어경력사원공개채용,http://www.nextdaily.co.kr/news/article.html?id=20171029800025
2733,2017-10-30,대웅제약대웅바이오독일CPhIWorldwide참가,http://medipana.com/news/news_viewer.asp?NewsNum=208763&MainKind=A&NewsKind=5&vCount=12&vKind=1
2734,2017-10-30,방신원대웅제약영업본부소장부친,http://www.dailypharm.com/Users/News/TodayFocus.html?mode=View&nKind=3&ID=15381
2735,2017-10-30,대웅제약대웅바이오독일세계의약품전시회참가,http://www.sportsseoul.com/news/read/565226
2736,2017-10-30,대웅글로벌파트너십강화CDMO사업공식화,http://www.dailypharm.com/News/232723
2737,2017-10-30,대웅제약영업본부방신원소장부친,http://medipana.com/news/news_viewer.asp?NewsNum=208777&MainKind=A&NewsKind=5&vCount=12&vKind=1
2738,2017-10-30,아파야챙길래대웅제약CJ헬스케어JW중외제약外,http://www.g-enews.com/ko-kr/news/article/news_all/201710301002596781e6a49afa8d_1/article.html
2739,2017-10-30,부음대웅제약영업본부방신원소장부친,http://www.yakup.com/news/index.html?mode=view&cat=meet&cat2=35&nid=1700141931
2740,2017-10-30,대웅제약대웅바이오원료의약품수탁개발•생산사업출범,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211320
2741,2017-10-30,대웅제약대웅바이오세계최대의약품전시회참가,http://www.kpinews.co.kr/news/articleView.html?idxno=57885
2742,2017-10-30,대웅제약대웅바이오글로벌파트너십강화독일CPhIWorldwide참가,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201710300121
2743,2017-10-30,대웅제약대웅바이오獨의약품전시회참가,http://www.medical-tribune.co.kr/news/articleView.html?idxno=75222
2744,2017-10-30,대웅제약CPhIWorldwide2017참가글로벌파트너십강화,http://www.newsprime.co.kr/news/article.html?no=393209
2745,2017-10-30,대웅제약국제의약품박람회참가해해외파트너십강화나서,http://news.mk.co.kr/newsRead.php?year=2017&no=716521
2746,2017-10-30,대웅세계의약품전시회참가,http://www.newstomato.com/ReadNews.aspx?no=784955
2747,2017-10-30,대웅대웅바이오CDMO사업공식출범,http://www.monews.co.kr/news/articleView.html?idxno=107094
2748,2017-10-30,메디톡스대웅제약국내서보톡스전쟁2라운드,http://www.asiae.co.kr/news/view.htm?idxno=2017103010515473402
2749,2017-10-30,대웅제약대웅바이오CPhIWorldwide2017참가CDMO사업공식화,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017103011221073759
2750,2017-10-30,대웅제약의약품개발생산대행사업출범,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171030085400017&did=1195m
2751,2017-10-30,대웅제약2017독일세계의약품전시회참가,http://www.dailymedi.com/detail.php?number=823800&thread=22r05
2752,2017-10-30,대웅제약대웅바이오CPhIWorldwide2017참가,http://www.bosa.co.kr/news/articleView.html?idxno=2071316
2753,2017-10-30,대웅제약원료의약품수탁개발생산사업출범,http://www.kormedi.com/news/news/drug_dist/1225003_2906.html
2754,2017-10-30,대웅제약대웅바이오독일프랑크프루트CPhIWorldwide2017참가,http://www.enewstoday.co.kr/news/articleView.html?idxno=1122553
2755,2017-10-30,대웅제약대웅바이오CPhIWorldwide2017서우수기술력소개해글로벌파트너십강화,http://sports.hankooki.com/lpage/life/201710/sp20171030140955136800.htm
2756,2017-10-30,대웅그룹하반기신입및주니어경력사원공개채용,http://www.sportsseoul.com/news/read/565315
2757,2017-10-30,대웅그룹2017년하반기신입및주니어경력사원공채11월6일원서마감,http://sports.hankooki.com/lpage/life/201710/sp20171030143417136800.htm
2758,2017-10-30,대웅제약대웅바이오독일프랑크프루트세계의약품전시회참가,http://www.metroseoul.co.kr/news/newsview?newscd=2017103000058
2759,2017-10-30,대웅제약상대메디톡스의보톡스균주소송정현호모아니면도,http://www.businesspost.co.kr/BP?command=article_view&num=62471
2760,2017-10-30,대웅제약원료의약품수탁생산시장출사표,http://www.techholic.co.kr/news/articleView.html?idxno=171632
2761,2017-10-30,제약산업소식대웅제약대웅바이오세계의약품전시회참가外,http://www.kukinews.com/news/article.html?no=496212
2762,2017-10-30,끊임없는물고뜯기대웅vs메디톡스보톡스전쟁,http://www.sportsseoul.com/news/read/565426
2763,2017-10-30,메디톡스보톡스균주절취혐의로대웅제약고소,http://www.insightkorea.co.kr/news/articleView.html?idxno=14960
2764,2017-10-30,메디톡스대웅제약상대서울지법에손배청구,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171030166100008&did=1195m
2765,2017-10-30,대웅제약대웅바이오독일프랑크프루트CPhIWorldwide2017참가,http://www.newscj.com/news/articleView.html?idxno=459258
2766,2017-10-30,메디톡스대웅이보툴리눔톡신균주절도손배소,http://www.mt.co.kr/view/mtview.php?type=1&no=2017103016563765505&outlink=1
2767,2017-10-30,대웅제약대웅바이오의약품개발생산대행사업나선다,http://www.asiae.co.kr/news/view.htm?idxno=2017103018071600913
2768,2017-10-30,메디톡스대웅제약상대로보톡스균주도용국내소송제기,http://news1.kr/articles/?3138486
2769,2017-10-30,메디톡스대웅대웅제약상대손해배상청구소장접수,http://biz.newdaily.co.kr/news/article.html?no=10144757
2770,2017-10-30,대웅제약의약품수탁개발생산사업진출,http://www.newspim.com/news/view/20171030000233
2771,2017-10-30,메디톡스대웅제약에손배소제기,http://www.mt.co.kr/view/mtview.php?type=1&no=2017103018330039892&outlink=1
2772,2017-10-30,대웅제약대웅바이오독일CPhIWorldwide2017참가,http://www.kpanews.co.kr/article/show.asp?idx=188534&table=article&category=D
2773,2017-10-30,메디톡스대웅제약상대손해배상청구,http://www.seoulfn.com/news/articleView.html?idxno=291415
2774,2017-10-30,메디톡스대웅제약상대서울지법에손배청구,http://www.asiae.co.kr/news/view.htm?idxno=2017103018420149170
2775,2017-10-30,대웅제약대웅바이오독일프랑크프루트CPhIWorldwide2017참가,http://www.lawissue.co.kr/view.php?ud=201710301838437957d7f4c63cc6_12
2776,2017-10-30,메디톡스대웅상대보툴리눔톡신균주출처국내소송제기,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201710300407
2777,2017-10-30,메디톡스vs대웅제약보톡스전쟁국내법원서결판종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171030166151008&did=1195m
2778,2017-10-30,메디톡스대웅제약상대서울지법에손배소청구,http://www.newsis.com/view/?id=NISX20171030_0000133074&cID=10401&pID=10400
2779,2017-10-30,메디톡스대웅제약상대서울지법에손배청구,http://www.viva100.com/main/view.php?key=20171030010009720
2780,2017-10-30,메디톡스대웅에영업비밀침해금지등소송제기,http://www.kpanews.co.kr/article/show.asp?idx=188541&table=article&category=C
2781,2017-10-30,메디톡스대웅제약대상영업비밀침해금지청구소제기,http://news.hankyung.com/article/201710308772f
2782,2017-10-30,메디톡스대웅제약에영업비밀침해금지소송제기,http://www.ekn.kr/news/article.html?no=320939
2783,2017-10-30,메디톡스대웅제약상대나보타균주소송,http://www.bizwatch.co.kr/pages/view.php?uid=34340
2784,2017-10-30,메디톡스대웅제약상대로서울지법에영업비밀침해금지손배소청구,http://www.lawissue.co.kr/view.php?ud=201710302047398779d7f4c63cc6_12
2785,2017-10-30,대웅제약독일2017세계의약품전시회참가글로벌파트너십모색,http://www.viva100.com/main/view.php?key=20171030020021283
2786,2017-10-30,메디톡스대웅제약에우리균주이용해만든제품폐기하라소송,http://www.edaily.co.kr/news/newspath.asp?newsid=03955686616098168
2787,2017-10-31,대웅윤재승회장24살장남부친경영권강화힘보탠다,http://www.newspim.com/news/view/20171030000177
2788,2017-10-31,메디톡스대웅제약에소송보툴리눔톡신균주논란재점화,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1048234
2789,2017-10-31,뉴스투데이E대웅제약대웅바이오독일프랑크프루트서열린CPhIWorldwide2017참가해,http://www.news2day.co.kr/94347
2790,2017-10-31,메디톡스vs대웅제약보톡스분쟁국내소송전돌입서울중앙지법서진실가린다,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017103108598016350&outlink=1
2791,2017-10-31,빅데이터MSI시장심리톱5기아차대웅제약호텔신라한미약품현대모비스,http://www.newsis.com/view/?id=NISX20171031_0000133334&cID=10401&pID=10400
2792,2017-10-31,대웅제약이공동판매한당뇨병약제미글로월처방액70억돌파,http://news.mk.co.kr/newsRead.php?year=2017&no=719614
2793,2017-10-31,LG화학대웅제약국산당뇨약제미글로연매출1000억가시화,http://www.ebn.co.kr/news/view/915359
2794,2017-10-31,ET투자뉴스대웅_주가거래량투심모두적정주순,http://www.etnews.com/20171031000063
2795,2017-10-31,아파야챙길래대웅제약JW중외제약녹십자外,http://www.g-enews.com/ko-kr/news/article/news_all/201710311044058249e6a49afa8d_1/article.html
2796,2017-10-31,당뇨신약제미글로월처방액70억돌파LG화학대웅제약공동마케팅효과,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017103111058033452&outlink=1
2797,2017-10-31,보톡스출처밝혀라메디톡스대웅제약에손배청구,http://www.sisajournal-e.com/biz/article/175540
2798,2017-10-31,대웅제약당뇨병치료제제미글로월처방액70억돌파,http://www.rapportian.com/news/articleView.html?idxno=107007
2799,2017-10-31,제약톡톡벼랑끝에선메디톡스vs대웅지는쪽은시장퇴출,http://news.heraldcorp.com/view.php?ud=20171031000659
2800,2017-10-31,법정으로가는보톡스전쟁메디톡스대웅제약에손해배상청구,http://www.nextdaily.co.kr/news/article.html?id=20171031800028
2801,2017-10-31,대웅제약과손잡은제미글로월원외처방액70억원돌파,http://www.mdtoday.co.kr/mdtoday/index.html?no=300015
2802,2017-11-01,보톡스분쟁점화메디톡스대웅상대로국내소송제기,http://www.mdtoday.co.kr/mdtoday/index.html?no=300026
2803,2017-11-01,사설메디톡스대웅제약품질과글로벌경쟁하라,http://www.dailypharm.com/News/232744
2804,2017-11-01,대웅제약목표주가올라보톡스미국진출가능성높아,http://www.businesspost.co.kr/BP?command=article_view&num=62699
2805,2017-11-01,대웅제약vs메디톡스보톡스진실게임점입가경,http://www.seoulfn.com/news/articleView.html?idxno=291560
2806,2017-11-01,메디톡스vs대웅벼랑끝보톡스전쟁,http://news.heraldcorp.com/view.php?ud=20171101000307
2807,2017-11-01,대웅제약3Q영업익145억전년比62↑,http://www.mt.co.kr/view/mtview.php?type=1&no=2017110112034149069&outlink=1
2808,2017-11-01,ET투자뉴스대웅제약17년3분기실적매출액영업이익상승,http://www.etnews.com/20171101000184
2809,2017-11-01,대웅제약3Q영업익145억전년비62증가1보,http://news1.kr/articles/?3140512
2810,2017-11-01,대웅제약3분기영업익145억전년비6198증가,http://www.newstomato.com/ReadNews.aspx?no=785639
2811,2017-11-01,대웅제약3분기매출2254억전년비영업익6198증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211503
2812,2017-11-01,대웅3분기영업익순이익80증가실적호조,http://www.dailypharm.com/News/232912
2813,2017-11-01,대웅제약3분기영업익145억원전년비61↑,http://news.hankyung.com/article/2017110157306
2814,2017-11-01,공시대웅제약3분기영업익145억3000만원전년比6198증가,http://www.newsway.co.kr/view.php?tp=1&ud=2017110113130881408
2815,2017-11-01,대웅제약3Q영업익145억전년比62↑,http://www.asiae.co.kr/news/view.htm?idxno=2017110113401114999
2816,2017-11-01,대웅제약3Q매출액2254억두자릿수성장상보,http://news1.kr/articles/?3140531
2817,2017-11-01,대웅제약3분기영업익145억원62증가,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171101111200008&did=1195m
2818,2017-11-01,대웅제약3분기영업이익145억원전년비62증가,http://www.sedaily.com/NewsView/1ONESFS0LV
2819,2017-11-01,대웅제약3분기영업이익145억전년比6198↑,http://www.newsworks.co.kr/news/articleView.html?idxno=146208
2820,2017-11-01,대웅제약3Q영업익145억전년比6198％껑충,http://www.mdtoday.co.kr/mdtoday/index.html?no=300114
2821,2017-11-01,대웅제약3분기영업익145억전년비62↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03424326616121456
2822,2017-11-01,대웅제약3분기영업이익145억원전년대비62↑,http://news.mk.co.kr/newsRead.php?year=2017&no=723479
2823,2017-11-01,대웅제약3분기영업이익145억원전년比6198↑,http://www.newsis.com/view/?id=NISX20171101_0000135350&cID=10401&pID=10400
2824,2017-11-01,대웅제약3Q영업익145억전년비6198↑,http://www.newspim.com/news/view/20171101000202
2825,2017-11-01,대웅제약3Q누계매출수익모두돋보인실적,http://medipana.com/news/news_viewer.asp?NewsNum=208999&MainKind=A&NewsKind=5&vCount=12&vKind=1
2826,2017-11-01,실적발표아이센스대웅제약디엔에이링크,http://www.businesspost.co.kr/BP?command=article_view&num=62756
2827,2017-11-01,대웅자회사대웅바이오추징금164억→11억,http://www.mt.co.kr/view/mtview.php?type=1&no=2017110115293656888&outlink=1
2828,2017-11-01,대웅제약3분기영업이익145억원전년대비6198껑충,http://www.econonews.co.kr/news/articleView.html?idxno=11998
2829,2017-11-01,대웅바이오국세청추징금153억원환급받아,http://www.dailypharm.com/News/232916
2830,2017-11-01,대웅바이오국세청추징금163억→10억으로153억원환급,http://www.mdtoday.co.kr/mdtoday/index.html?no=300132
2831,2017-11-01,대웅제약3분기영업익145억원전년비62증가,http://biz.chosun.com/site/data/html_dir/2017/11/01/2017110102474.html
2832,2017-11-01,대웅제약3분기영업이익145억원전년비62↑,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201711010334
2833,2017-11-01,대웅제약3분기영업이익145억3000만원전년比6198↑,http://www.ekn.kr/news/article.html?no=321577
2834,2017-11-02,대웅제약3분기개별영업익145억전년比61↑,http://www.ajunews.com/view/20171102005346946
2835,2017-11-02,대웅한미현대당뇨병치료제시장공략도전,http://www.mdtoday.co.kr/mdtoday/index.html?no=300171
2836,2017-11-02,대웅제약4분기에도호실적이어질것KTB,http://news.hankyung.com/article/2017110281156
2837,2017-11-02,대웅제약전사업부문고른성장NH,http://news.hankyung.com/article/2017110281436
2838,2017-11-02,대웅제약2분기연속높은실적기록중하이투자證,http://www.mt.co.kr/view/mtview.php?type=1&no=2017110207570460419&outlink=1
2839,2017-11-02,오늘의종목대웅제약2분기연속어닝서프라이즈전문의약품사업부12성장,http://www.sedaily.com/NewsView/1ONF93PXFS
2840,2017-11-02,클릭e종목대웅제약나보타신공장인증완료로4분기수출시작목표가↑,http://www.asiae.co.kr/news/view.htm?idxno=2017110208593162340
2841,2017-11-02,ET투자뉴스대웅제약비용통제로시장매수유지NH투자증권,http://www.etnews.com/20171102000026
2842,2017-11-02,특징주대웅제약3Q어닝서프라이즈소식에상승세,http://www.edaily.co.kr/news/newspath.asp?newsid=02102486616121784
2843,2017-11-02,빅데이터MSI오전10시시장심리톱5OCI대웅제약한미약품녹십자한국항공우주,http://www.newsis.com/view/?id=NISX20171102_0000136108&cID=10401&pID=10400
2844,2017-11-02,ET투자뉴스대웅제약구조적이익개선매수유지하이투자증권,http://www.etnews.com/20171102000047
2845,2017-11-02,대웅제약에서일하면어떨까유튜브에동영상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211535
2846,2017-11-02,대웅제약대웅제약서일하면어떨까영상선봬,http://medipana.com/news/news_viewer.asp?NewsNum=209042&MainKind=A&NewsKind=5&vCount=12&vKind=1
2847,2017-11-02,대웅제약에서일하면어떨까동영상유튜브에선보여,http://ilyo.co.kr/?ac=article_view&entry_id=277367
2848,2017-11-02,대웅제약기업문화소개동영상유튜브소개,http://www.newsprime.co.kr/news/article.html?no=393758
2849,2017-11-02,특징주대웅제약2분기연속이익개선흐름,http://www.sisaon.co.kr/news/articleView.html?idxno=64834
2850,2017-11-02,대웅대웅제약에서일하면어떨까영상유튜브에선보여,http://www.kpanews.co.kr/article/show.asp?idx=188691&table=article&category=D
2851,2017-11-02,대웅제약메디톡스도돌이표보톡스분쟁해외서다시국내로,http://www.ntoday.co.kr/news/articleView.html?idxno=55539
2852,2017-11-02,대웅제약에서일하면어떨까동영상유튜브선보여,http://www.bosa.co.kr/news/articleView.html?idxno=2071643
2853,2017-11-02,대웅제약에서일하면어떨까영상유튜브에공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=300250
2854,2017-11-02,대웅제약기업문화동영상유튜브에소개,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201711020167
2855,2017-11-02,대웅제약대웅제약에서일하면어떨까동영상유튜브선보여,http://www.enewstoday.co.kr/news/articleView.html?idxno=1124045
2856,2017-11-02,ET투자뉴스대웅제약실적호조지속매수KTB투자증권,http://www.etnews.com/20171102000216
2857,2017-11-02,아파야챙길래대웅제약JW중외제약녹십자外,http://www.g-enews.com/ko-kr/news/article/news_all/201711021446345155e6a49afa8d_1/article.html
2858,2017-11-02,대웅제약구직자눈길끄는대웅제약에서일하면어떨까동영상유튜브공개,http://sports.hankooki.com/lpage/life/201711/sp20171102145721136800.htm
2859,2017-11-02,ET투자뉴스대웅제약앞으로수익성이개매수유지한국투자증권,http://www.etnews.com/20171102000330
2860,2017-11-02,ET투자뉴스대웅제약처방의약품실적견매수유지한화투자증권,http://www.etnews.com/20171102000360
2861,2017-11-02,대웅제약대웅제약에서일하면어떨까동영상유튜브선보여,http://www.newscj.com/news/articleView.html?idxno=460127
2862,2017-11-02,대웅제약기업문화업무환경소개하는동영상선봬,http://news.mk.co.kr/newsRead.php?year=2017&no=727133
2863,2017-11-02,대웅제약대웅제약에서일하면어떨까동영상유튜브에선보여,http://www.lawissue.co.kr/view.php?ud=201711022139193497d7f4c63cc6_12
2864,2017-11-03,365대웅은그대의자랑그대는대웅의자랑,http://www.dailypharm.com/News/232976
2865,2017-11-03,클릭e종목대웅제약실적은좋은데밸류에이션부담,http://www.asiae.co.kr/news/view.htm?idxno=2017110307301605445
2866,2017-11-03,메디톡스대웅제약균주논란에정책개선요구왜,http://www.kpinews.co.kr/news/articleView.html?idxno=58283
2867,2017-11-03,대웅제약실적기대매수유지한국투자증권,http://www.sedaily.com/NewsView/1ONFP030S7
2868,2017-11-03,메디톡스대웅제약에국내소송제기,http://www.medigatenews.com/news/2001062626
2869,2017-11-03,대웅제약재미한국제약전문가와네트워킹강화,http://medipana.com/news/news_viewer.asp?NewsNum=209101&MainKind=A&NewsKind=5&vCount=12&vKind=1
2870,2017-11-03,대웅제약재미한국제약전문가들과글로벌네트워킹강화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211580
2871,2017-11-03,대웅제약재미한인제약인협회심포지엄참석,http://www.asiae.co.kr/news/view.htm?idxno=2017110310100911449
2872,2017-11-03,대웅재미한국제약전문가들과글로벌네트워킹강화,http://www.kpanews.co.kr/article/show.asp?idx=188722&table=article&category=D
2873,2017-11-03,대웅제약재미한국제약전문가들과글로벌네트워킹강화,http://www.kpinews.co.kr/news/articleView.html?idxno=58369
2874,2017-11-03,대웅제약재미한국제약전문가들과글로벌네트워킹강화,http://www.dt.co.kr/contents.html?article_no=2017110302109976029004&ref=naver
2875,2017-11-03,아파야챙길래대웅제약동국제약JW중외제약外,http://www.g-enews.com/ko-kr/news/article/news_all/201711031057597207e6a49afa8d_1/article.html
2876,2017-11-03,재미한국제약인과12년간인연잇는대웅제약,http://www.dailypharm.com/News/232999
2877,2017-11-03,대웅제약3분기실적기대치상회나보타모멘텀2018년부터본격화전망,http://nbntv.co.kr/news/view.php?idx=71553
2878,2017-11-03,대웅제약재미한국제약전문가들과교류글로벌네트워킹강화,http://www.mdtoday.co.kr/mdtoday/index.html?no=300369
2879,2017-11-03,ET투자뉴스대웅제약실적은좋은데밸류TRADINGBUY유지신한금융투자,http://www.etnews.com/20171103000163
2880,2017-11-03,대웅제약재미한국제약전문가네트워킹강화,http://www.techholic.co.kr/news/articleView.html?idxno=171707
2881,2017-11-03,대웅제약재미제약전문가네트워킹강화,http://www.monews.co.kr/news/articleView.html?idxno=107351
2882,2017-11-03,대웅제약2017KASBP추계심포지엄참석글로벌네트워킹강화,http://www.newsprime.co.kr/news/article.html?no=393964
2883,2017-11-03,대웅제약재미한국제약전문가교류강화,http://www.bosa.co.kr/news/articleView.html?idxno=2071744
2884,2017-11-03,대웅제약재미한국제약전문가들과글로벌네트워킹강화,http://www.newsis.com/view/?id=NISX20171103_0000137741&cID=13001&pID=13000
2885,2017-11-03,대웅제약재미한국제약전문가들과교류통해글로벌네트워킹강화,http://www.ftoday.co.kr/news/articleView.html?idxno=81673
2886,2017-11-03,대웅제약에서일하면어떨까,http://news.hankyung.com/article/201711032984A
2887,2017-11-03,뉴스투데이E대웅제약재미한인제약전문가들과글로벌네트워킹강화,http://www.news2day.co.kr/94576
2888,2017-11-03,대웅제약재미동포제약전문가들과교류해글로벌네트워크강화,http://news.mk.co.kr/newsRead.php?year=2017&no=729749
2889,2017-11-03,대웅제약재미한국제약전문가들과글로벌네트워킹강화,http://ilyo.co.kr/?ac=article_view&entry_id=277711
2890,2017-11-03,대웅제약재미한국제약전문가들과교류통해글로벌네트워킹강화,http://www.newscj.com/news/articleView.html?idxno=460463
2891,2017-11-03,대웅제약재미한국제약전문가들과교류통해글로벌네트워킹강화,http://www.lawissue.co.kr/view.php?ud=201711031924325703d7f4c63cc6_12
2892,2017-11-03,대웅제약재미한인제약인협회심포지엄서글로벌네트워크강화,http://www.viva100.com/main/view.php?key=20171103020021345
2893,2017-11-05,대웅제약재미한국제약전문가들과교류통해글로벌네트워킹강화,http://www.enewstoday.co.kr/news/articleView.html?idxno=1124932
2894,2017-11-06,블록버스터제조기유한대웅엔특별한것이있다,http://www.bosa.co.kr/news/articleView.html?idxno=2071777
2895,2017-11-06,클릭e종목대웅제약나보타미국출시기대감,http://www.asiae.co.kr/news/view.htm?idxno=2017110607541725915
2896,2017-11-06,ET투자뉴스대웅제약삶의질향상을선매수신규편입SK증권,http://www.etnews.com/20171106000018
2897,2017-11-06,대웅제약나보타미국의약품성분명프라보툴리눔톡신에이로등록,http://www.fnnews.com/news/201711060928380505
2898,2017-11-06,대웅제약나보타미국의약품성분명등록,http://medipana.com/news/news_viewer.asp?NewsNum=209164&MainKind=A&NewsKind=5&vCount=12&vKind=1
2899,2017-11-06,대웅제약나보타美상품명프라보툴리눔톡신A,http://www.mt.co.kr/view/mtview.php?type=1&no=2017110609355459190&outlink=1
2900,2017-11-06,대웅제약나보타미국의약품성분명등록미국진출청신호,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211627
2901,2017-11-06,대웅제약나보타미국의약품성분명등록현지진출가시화,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=101&oid=050&aid=0000045835
2902,2017-11-06,대웅제약나보타미국의약품성분명등록,http://www.enewstoday.co.kr/news/articleView.html?idxno=1125105
2903,2017-11-06,대웅제약나보타미국의약품성분명등록,http://www.dt.co.kr/contents.html?article_no=2017110602109976029002&ref=naver
2904,2017-11-06,대웅제약나보타미국에성분명등록완료,http://www.edaily.co.kr/news/newspath.asp?newsid=02023766616123096
2905,2017-11-06,대웅제약나보타미국성분명프라보툴리눔톡신에이로등록,http://news.mk.co.kr/newsRead.php?year=2017&no=733261
2906,2017-11-06,대웅제약나보타美의약품성분명등록,http://www.viva100.com/main/view.php?key=20171106010001876
2907,2017-11-06,대웅제약나보타미국의약품성분명등록,http://www.kpinews.co.kr/news/articleView.html?idxno=58548
2908,2017-11-06,대웅제약나보타미국성분명등록,http://www.newstomato.com/ReadNews.aspx?no=786493
2909,2017-11-06,대웅제약나보타美의약품성분명등록,http://www.newsis.com/view/?id=NISX20171106_0000139121&cID=13001&pID=13000
2910,2017-11-06,대웅제약녹십자등제약바이오주상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=300509
2911,2017-11-06,대웅나보타미국의약품성분명등록미국진출순항,http://www.econovill.com/news/articleView.html?idxno=325918
2912,2017-11-06,대웅제약보툴리눔톡신나보타미국서성분명등록,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171106072300017&did=1195m
2913,2017-11-06,대웅제약재미한국제약전문가들과신약개발관련교류가져,http://www.econovill.com/news/articleView.html?idxno=325924
2914,2017-11-06,대웅제약나보타美의약품성분명등록현지진출단계적성과,http://www.rapportian.com/news/articleView.html?idxno=107130
2915,2017-11-06,대웅제약나보타미국의약품성분명등록,http://www.medicaltimes.com/News/1114881
2916,2017-11-06,대웅제약보툴리눔톡신제제나보타美성분명등록,http://www.asiae.co.kr/news/view.htm?idxno=2017110611163326591
2917,2017-11-06,뉴스투데이E대웅제약나보타미국의약품성분명등록으로단계적인미국진출본격실시,http://www.news2day.co.kr/94653
2918,2017-11-06,대웅제약나보타美의약품성분명등록,http://www.dailymedi.com/detail.php?number=824048&thread=22r05
2919,2017-11-06,대웅제약보톡스나보타美서의약품성분명허가,http://www.ebn.co.kr/news/view/916280
2920,2017-11-06,대웅제약나보타美성분명PrabotulinumtoxinA등록,http://www.bosa.co.kr/news/articleView.html?idxno=2071867
2921,2017-11-06,대웅제약나보타미국의약품성분명등록,http://www.m-i.kr/news/articleView.html?idxno=356810
2922,2017-11-06,대웅제약보톡스제제나보타美의약품성분명등록,http://www.mhj21.com/sub_read.html?uid=110071§ion=sc243
2923,2017-11-06,대웅나보타美의약품성분명등록,http://www.monews.co.kr/news/articleView.html?idxno=107400
2924,2017-11-06,대웅제약나보타美성분명등록진출박차,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1048511
2925,2017-11-06,대웅제약나보타미국의약품성분명프라보툴리눔톡신에이로등록,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017110613285675671
2926,2017-11-06,대웅제약나보타미국의약품성분명등록미국진출준비,http://www.ftoday.co.kr/news/articleView.html?idxno=81758
2927,2017-11-06,대웅제약나보타미국의약품성분명등록단계적인미국진출준비밝혀,http://www.lawissue.co.kr/view.php?ud=201711061404245665d7f4c63cc6_12
2928,2017-11-06,대웅제약나보타미국의약품성분명프라보툴리눔톡신에이로등록,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201711060208
2929,2017-11-06,대웅제약메디톡스前직원에1억3천만원왜줬나,http://www.polinews.co.kr/news/article.html?no=334867
2930,2017-11-06,대웅제약나보타미국시장진출시동의약품성분명등록,http://www.techholic.co.kr/news/articleView.html?idxno=171730
2931,2017-11-06,대웅제약나보타미국의약품성분명등록,http://www.sportsseoul.com/news/read/567625
2932,2017-11-06,대웅나보타미국의약품성분명등록단계적미국진출준비,http://www.kpanews.co.kr/article/show.asp?idx=188798&table=article&category=D
2933,2017-11-06,대웅제약내년나보타美출시기대감,http://www.newsworks.co.kr/news/articleView.html?idxno=147095
2934,2017-11-06,대웅제약나보타미국의약품성분명등록미국진출단계적진행,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017110614228053768&outlink=1
2935,2017-11-06,대웅나보타성분명등록가까워지는미국진출,http://www.kormedi.com/news/news/drug_dist/1225082_2906.html
2936,2017-11-06,아파야챙길래대웅제약유유제약서울제약,http://www.g-enews.com/ko-kr/news/article/news_all/201711061513205755e6a49afa8d_1/article.html
2937,2017-11-06,대웅제약나보타미국의약품성분명등록,http://www.newsprime.co.kr/news/article.html?no=394180
2938,2017-11-06,대웅제약오픈콜라보레이션미래경영판도바꾼다,http://www.newsprime.co.kr/news/article.html?no=394149
2939,2017-11-06,대웅제약나보타美의약품성분명프라보툴리눔톡신에이로등록,http://www.mdtoday.co.kr/mdtoday/index.html?no=300579
2940,2017-11-06,대웅제약나보타미국의약품성분명등록단계적인미국진출준비,http://www.newscj.com/news/articleView.html?idxno=461143
2941,2017-11-06,대웅제약나보타미국의약품성분명등록美진출준비,http://ilyo.co.kr/?ac=article_view&entry_id=278087
2942,2017-11-06,대웅제약나보타미국의약품성분명등록,http://www.seoulfn.com/news/articleView.html?idxno=291985
2943,2017-11-06,대웅제약나보타글로벌진출청신호,http://www.fnnews.com/news/201711061924415380
2944,2017-11-07,대웅제약나보타美성분명칭등록,http://www.ajunews.com/view/20171106120923352
2945,2017-11-07,녹십자대웅제약등9개사ISO37001도입,http://www.fnnews.com/news/201711071928556476
2946,2017-11-08,영업력강하단평가받는대웅제약하지만영업사원들사이에서는,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1048495
2947,2017-11-08,대웅제약비리헤파제네릭최저가로약가인하,http://medipana.com/news/news_viewer.asp?NewsNum=209313&MainKind=A&NewsKind=5&vCount=12&vKind=1
2948,2017-11-08,녹십자대웅제약등9개제약사ISO윤리경영인증도입추진,http://www.dt.co.kr/contents.html?article_no=2017110702109976029005&ref=naver
2949,2017-11-08,마산한암자대웅전서불3500만원재산피해,http://news1.kr/articles/?3147001
2950,2017-11-08,fnRASSI대웅제약06962052주신고가경신769↑,http://www.fnnews.com/news/201711081525103000
2951,2017-11-08,특징주대웅제약종근당한미약품유한양행3분기´결실´,http://www.sisaon.co.kr/news/articleView.html?idxno=65127
2952,2017-11-09,마산봉암동대웅전서초넘어져불3천5백만원피해,http://fpn119.co.kr/sub_read.html?uid=86248§ion=sc72
2953,2017-11-09,Big5제약매출은유한양행수익성은대웅제약이최고,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211785
2954,2017-11-09,대웅제약생산본부전국품질분임조경진대회서대통령상수상,http://www.enewstoday.co.kr/news/articleView.html?idxno=1126531
2955,2017-11-09,뉴스투데이L대웅제약전국품질분임조경진대회처녀출전해수상싹쓸이,http://www.news2day.co.kr/94801
2956,2017-11-09,글리아티린대조약선정놓고대웅식약처종근당각축전,http://www.sportsseoul.com/news/read/568788
2957,2017-11-09,대웅제약생산본부전국품질분임조경진대회대통령상수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211792
2958,2017-11-09,대웅첫출전한전국품질분임조대회전원수상,http://www.dailypharm.com/News/233210
2959,2017-11-09,대웅제약전국품질분임조경진대회서금상2개은상1개휩쓸어,http://news.mk.co.kr/newsRead.php?year=2017&no=742307
2960,2017-11-09,대웅제약생산본부전국품질분임조경진대회대통령상수상,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017110909148045347&outlink=1
2961,2017-11-09,대웅바이오종근당글리아티린제네릭에불과해,http://www.medicaltimes.com/News/1114982
2962,2017-11-09,대웅바이오글리아티린오늘9일사용기한만료대조약종근당보다적합다국적사횡포바로잡아야,http://www.g-enews.com/ko-kr/news/article/news_all/201711091037505294e6a49afa8d_1/article.html
2963,2017-11-09,대웅종근당글리아티린아닌자사글리아타민대조약선정주장,http://www.sportsseoul.com/news/read/568833
2964,2017-11-09,대웅제약생산본부대통령상금상2팀은상1팀수상,http://medipana.com/news/news_viewer.asp?NewsNum=209387&MainKind=A&NewsKind=5&vCount=12&vKind=1
2965,2017-11-09,대웅제약전국품질분임조경진대회서금상은상수상,http://www.g-enews.com/ko-kr/news/article/news_all/201711091102045114e6a49afa8d_1/article.html
2966,2017-11-09,대웅글리아타민이대조약에선정돼야”,http://news.heraldcorp.com/view.php?ud=20171109000435
2967,2017-11-09,대웅바이오글리아티민대조약자격충분,http://www.bosa.co.kr/news/articleView.html?idxno=2072116
2968,2017-11-09,대웅바이오글리아타민대조약선정돼야,http://www.newspim.com/news/view/20171109000112
2969,2017-11-09,대웅제약종근당글리아티린은제네릭맹비난,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1048675
2970,2017-11-09,대웅제약동화약품녹십자신풍제약코스피시장제약주들52주신고가경신,http://www.mdtoday.co.kr/mdtoday/index.html?no=301013
2971,2017-11-09,글리아티린대조약논쟁새국면대웅글리아타민승부수,http://medipana.com/news/news_viewer.asp?NewsNum=209393&MainKind=A&NewsKind=5&vCount=12&vKind=1
2972,2017-11-09,대웅글리아티민이대조약합당종근당것부적절,http://www.dailypharm.com/News/233227
2973,2017-11-09,대조약공격나선대웅종근당원개발사품목아니다,http://www.kpanews.co.kr/article/show.asp?idx=188901&table=article&category=D
2974,2017-11-09,종근당부적합대웅글리아타민선정돼야,http://www.dailymedi.com/detail.php?number=824199&thread=22r05
2975,2017-11-09,대웅바이오종근당글리아티린복제약에불과”,http://www.mt.co.kr/view/mtview.php?type=1&no=2017110911394185286&outlink=1
2976,2017-11-09,현장스케치대웅자사제품글리아타민대조약선정돼야,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=521656
2977,2017-11-09,치매치료제글리아티린대조약놓고종근당대웅제약갈등,http://www.newsis.com/view/?id=NISX20171109_0000143211&cID=13001&pID=13000
2978,2017-11-09,대웅바이오글리아타민대조약선정돼야,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201711090142
2979,2017-11-09,글리아타민대조약지정요구하는대웅의속사정,http://www.monews.co.kr/news/articleView.html?idxno=107566
2980,2017-11-09,대웅종근당식약처치매치료제대조약지위두고갈등심화,http://www.ebn.co.kr/news/view/916889
2981,2017-11-09,대웅제약생산본부전국품질분임조경진대회서대통령상등수상,http://sports.hankooki.com/lpage/life/201711/sp20171109132259136800.htm
2982,2017-11-09,대웅제약생산본부업무혁신인정받아,http://www.bosa.co.kr/news/articleView.html?idxno=2072129
2983,2017-11-09,대웅식약처는제약업계정의수립에앞장서야,http://www.medical-tribune.co.kr/news/articleView.html?idxno=75476
2984,2017-11-09,대웅바이오종근당글리아티린원개발사품목아니다주장,http://www.fnnews.com/news/201711091341152521
2985,2017-11-09,대웅종근당제품은복제약불과”뇌기능개선제대조약선정논란,http://www.sisajournal-e.com/biz/article/175949
2986,2017-11-09,대웅바이오종근당글리아티린복제약에불과주장,http://www.ciobiz.co.kr/news/article.html?id=20171109120014
2987,2017-11-09,대웅바이오자사글리아티민대조약선정돼야종근당원개발사품목아냐,http://www.newsprime.co.kr/news/article.html?no=394538
2988,2017-11-09,대웅종근당글리아티린대조약자격없어,http://www.finomy.com/news/articleView.html?idxno=49034
2989,2017-11-09,자기주장만있는대웅의대조약논란,http://www.mediapen.com/news/view/312590
2990,2017-11-09,대웅제약종근당글리아티린은제네릭우리것이대조약”주장,http://www.newsway.co.kr/view.php?tp=1&ud=2017110915011449085
2991,2017-11-09,대웅제약종근당식약처와갈등대조약지위달라,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171109105000017&did=1195m
2992,2017-11-09,대웅제약종근당은제네릭일뿐대조약지위는부당”,http://www.mhj21.com/sub_read.html?uid=110161§ion=sc243
2993,2017-11-09,대웅제약9일부터글리아티린대조약없어글리아타민선정해야,http://news.mk.co.kr/newsRead.php?year=2017&no=743996
2994,2017-11-09,대웅제약전국품질분임조경진대회서대통령상수상,http://www.mdtoday.co.kr/mdtoday/index.html?no=301060
2995,2017-11-09,헬스케어이노베이션2017전복환대웅제약센터장스마트워크시스템연구협력으로혁신,http://biz.chosun.com/site/data/html_dir/2017/11/09/2017110902368.html
2996,2017-11-09,대웅제약대조약선정두고종근당식약처와갈등,http://www.dt.co.kr/contents.html?article_no=2017110902109976029004&ref=naver
2997,2017-11-09,의문만남긴대웅제약기자간담회질타쏟아져,http://www.mhj21.com/sub_read.html?uid=110163§ion=sc243
2998,2017-11-09,대웅바이오글리아타민이대조약에선정돼야,http://www.mdtoday.co.kr/mdtoday/index.html?no=301062
2999,2017-11-09,글리아타민이대조약돼야속내드러낸대웅,http://www.mt.co.kr/view/mtview.php?type=1&no=2017110912551558065&outlink=1
3000,2017-11-09,종합대웅바이오글리아타민이대조약으로선정돼야,http://www.newsis.com/view/?id=NISX20171109_0000143670&cID=13001&pID=13000
3001,2017-11-09,대조약지위가주는이익이뭐길래글리아티린두고대웅맹공격,http://www.econovill.com/news/articleView.html?idxno=326207
3002,2017-11-09,대웅제약식약처대조약지위날선공방,http://www.sedaily.com/NewsView/1ONII35RT3
3003,2017-11-09,대웅제약글리아티린대조약지위주장종근당과대립각,http://www.dailian.co.kr/news/view/672926/?sc=naver
3004,2017-11-09,대웅제약종근당향한대조약작심발언에도업계는싸늘,http://www.kpinews.co.kr/news/articleView.html?idxno=58931
3005,2017-11-09,대웅바이오글리아타민대조약에선정돼야,http://www.viva100.com/main/view.php?key=20171109010003752
3006,2017-11-09,대웅바이오종근당글리아티린대조약될수없어,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017110914151144254
3007,2017-11-09,취재수첩의도드러낸대웅제약의조급한기자간담회,http://biz.newdaily.co.kr/news/article.html?no=10145746
3008,2017-11-09,대웅종근당글리아티린은제네릭에불과대조약될수없어,http://www.rapportian.com/news/articleView.html?idxno=107215
3009,2017-11-09,대웅제약전국품질분임조경진대회서금상2팀은상1팀수상,http://www.newscj.com/news/articleView.html?idxno=462115
3010,2017-11-09,대웅제약vs종근당글리아티린대조약선정두고잡음,http://www.wolyo.co.kr/news/articleView.html?idxno=48490
3011,2017-11-09,대웅제약생산본부전국품질분임조경진대회서대통령상금상2팀은상1팀수상쾌거,http://www.lawissue.co.kr/view.php?ud=201711092051264495d7f4c63cc6_12
3012,2017-11-10,대조약진실게임종근당대웅이기술이전거부,http://www.medicaltimes.com/News/1114997
3013,2017-11-10,대웅제약종근당글리아티린은복제약”대조약논란점입가경,https://cnbc.sbs.co.kr/article_hub/10000881173?division=NAVER
3014,2017-11-10,종근당글리아티린제네릭말도안돼대웅바이오주장반박,http://www.kpanews.co.kr/article/show.asp?idx=188927&table=article&category=D
3015,2017-11-10,대웅트라젠타선행특허홀로깼지만빛바랜승리,http://www.dailypharm.com/News/233246
3016,2017-11-10,대웅제약VS식약처종근당글리아티린대조약둘러싼갈등커져,http://www.nextdaily.co.kr/news/article.html?id=20171110800001
3017,2017-11-10,식약처종근당대웅제약비판에어림없는소리,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1048721
3018,2017-11-10,글리아티린대조약지위놓고대웅제약vs종근당식약처갈등격화,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017111009181289983
3019,2017-11-10,대웅제약대조약문제제기제네릭제조사환자피해주장,http://www.seoulfn.com/news/articleView.html?idxno=292364
3020,2017-11-10,대웅제약VS식약처글리아티린대조약갈등재점화,http://news.hankyung.com/article/201711108356f
3021,2017-11-10,대웅제약전국품질분임조경진대회서생산본부대통령상수상,http://www.kukinews.com/news/article.html?no=499843
3022,2017-11-10,대웅제약석천나눔재단노인요양학술심포지엄성료,http://www.lawissue.co.kr/view.php?ud=201711102137448435d7f4c63cc6_12
3023,2017-11-11,대웅제약강공불구식약처종근당무대응,http://www.dailymedi.com/detail.php?number=824261&thread=22r05
3024,2017-11-12,대웅바이오글리아타민대조약만료에몽니,http://www.m-i.kr/news/articleView.html?idxno=358635
3025,2017-11-12,글리아티린대조약지위논란대웅제약종근당우리가오리지널”,http://biz.chosun.com/site/data/html_dir/2017/11/12/2017111200773.html
3026,2017-11-12,대웅석천나눔재단노인요양학술심포지엄성료,http://www.dailymedi.com/detail.php?number=824271&thread=22r05
3027,2017-11-13,대웅제약안국약품알비스D특허소송합의종결,http://www.dailypharm.com/News/233308
3028,2017-11-13,대웅트라젠타존속기간연장단독무효화,http://www.mdtoday.co.kr/mdtoday/index.html?no=301210
3029,2017-11-13,대웅제약불확실성해소상승할일만남았다토러스證,http://www.mt.co.kr/view/mtview.php?type=1&no=2017111308312905186&outlink=1
3030,2017-11-13,대웅제약불확실성해소목표가↑,http://www.newspim.com/news/view/20171113000027
3031,2017-11-13,대웅제약불확실성해소목표주가18만2000원토러스증권,http://www.sedaily.com/NewsView/1ONKAYIBBM
3032,2017-11-13,fnRASSI대웅00309052주신고가경신119↑,http://www.fnnews.com/news/201711130953488439
3033,2017-11-13,대웅동국씨트리제형차별화기반치매도전,http://www.dailymedi.com/detail.php?number=824305&thread=22r05
3034,2017-11-13,ET투자뉴스대웅제약불확실성해소이제매수하향토러스투자증권,http://www.etnews.com/20171113000141
3035,2017-11-14,대웅제약대웅인피온인도네시아보건복지부장관상수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=211954
3036,2017-11-14,대웅인피온인도네시아서보건복지부장관상수상,http://www.kpanews.co.kr/article/show.asp?idx=189009&table=article&category=D
3037,2017-11-14,인도네시아합작법인대웅인피온현지장관상수상,http://www.dailypharm.com/News/233389
3038,2017-11-14,대웅인피온인도네시아서복지부장관상수상,http://medipana.com/news/news_viewer.asp?NewsNum=210607&MainKind=A&NewsKind=5&vCount=12&vKind=1
3039,2017-11-14,대웅인피온印尼복지부장관상,http://www.medical-tribune.co.kr/news/articleView.html?idxno=75570
3040,2017-11-14,대웅제약대웅인피온인니복지부장관상수상,http://www.bosa.co.kr/news/articleView.html?idxno=2072411
3041,2017-11-14,대웅제약대웅인피온인도네시아서보건복지부장관상수상,http://www.g-enews.com/ko-kr/news/article/news_all/201711141119252361e6a49afa8d_1/article.html
3042,2017-11-14,대웅인피온인도네시아에서보건복지부장관상수상,http://www.viva100.com/main/view.php?key=20171114010005123
3043,2017-11-14,대웅제약대웅인피온인도네시아서보건복지부장관상수상,http://www.asiatime.co.kr/news/articleView.html?idxno=158875
3044,2017-11-14,대웅제약대웅인피온인도네시아에서보건복지부장관상수상,http://www.lawissue.co.kr/view.php?ud=201711141138085438d7f4c63cc6_12
3045,2017-11-14,대웅인피온인니보건복지부장관상수상,http://www.monews.co.kr/news/articleView.html?idxno=107718
3046,2017-11-14,fnRASSI대웅제약06962052주신고가경신412↑,http://www.fnnews.com/news/201711141313488016
3047,2017-11-14,뉴스투데이L대웅제약의대웅인피온인도네시아서기술성품질인정받아,http://www.news2day.co.kr/94985
3048,2017-11-14,대웅제약대웅인피온인도네시아보건복지부장관상수상,http://www.newsprime.co.kr/news/article.html?no=395012
3049,2017-11-14,대웅제약대웅인피온인도네시아에서보건복지부장관상수상,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017111414022460444
3050,2017-11-14,대웅제약합작법인대웅인피온인니보건복지부장관상,http://www.asiae.co.kr/news/view.htm?idxno=2017111414480600949
3051,2017-11-14,대웅제약인도네시아합작법인현지보건복지부장관상수상,http://news.mk.co.kr/newsRead.php?year=2017&no=754548
3052,2017-11-14,대웅제약대웅인피온인도네시아복지부장관상수상,http://www.mdtoday.co.kr/mdtoday/index.html?no=301511
3053,2017-11-14,대웅제약대웅인피온인도네시아보건복지부장관상수상,http://www.dt.co.kr/contents.html?article_no=2017111402109976029003&ref=naver
3054,2017-11-14,대웅제약대웅인피온인도네시아서보건복지부장관상수상,http://www.enewstoday.co.kr/news/articleView.html?idxno=1128291
3055,2017-11-14,대웅제약대웅인피온인도네시아보건복지부장관상수상,http://ilyo.co.kr/?ac=article_view&entry_id=279604
3056,2017-11-14,대웅인피온인도네시아복지부장관상수상,http://www.rapportian.com/news/articleView.html?idxno=107303
3057,2017-11-14,대웅제약대웅인피온인도네시아보건복지부장관상수상,http://www.techholic.co.kr/news/articleView.html?idxno=171843
3058,2017-11-14,대웅제약인도네시아합작법인현지보건복지부장관상,http://www.seoulfn.com/news/articleView.html?idxno=292626
3059,2017-11-14,대웅제약대웅인피온인도네시아보건복지부장관상,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201711140291
3060,2017-11-14,대웅제약대웅인피온인도네시아보건복지부장관상수상”,http://biz.chosun.com/site/data/html_dir/2017/11/14/2017111403338.html
3061,2017-11-14,대웅제약대웅인피온인도네시아에서보건복지부장관상수상,http://www.newscj.com/news/articleView.html?idxno=463099
3062,2017-11-15,대웅안국알비스D특허소송합의종결,http://www.mdtoday.co.kr/mdtoday/index.html?no=301554
3063,2017-11-15,대웅제약충북오송에세계규모新공장준공,http://www.anewsa.com/detail.php?number=1243461&thread=10r03
3064,2017-11-15,신한금융투자대웅제약우려불식시킨실적4분기최대매출기대,http://www.newsprime.co.kr/news/article.html?no=395143
3065,2017-11-15,2017년11월15일오늘의주요일정시도지사박원순서울시장이화여대강연남경필경기지사농업인의날행사이시종충북지사대웅제약오송공장준공식外,http://www.mediapen.com/news/view/313659
3066,2017-11-15,빅데이터MSI시장심리톱5동서대웅제약한국가스공사LG생활건강현대건설,http://www.newsis.com/view/?id=NISX20171115_0000148375&cID=10401&pID=10400
3067,2017-11-15,대웅제약오송에세계수준공장준공,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171115049800064&did=1195m
3068,2017-11-15,대웅대웅바이오등자회사실적주목골든브릿지,http://www.choicenews.co.kr/news/articleView.html?idxno=37401
3069,2017-11-15,헬스단신대웅제약고려대구로병원보건복지부,http://www.sportsseoul.com/news/read/570772
3070,2017-11-15,대웅제약충북오송에세계적수준의신공장준공,http://www.joongdo.co.kr/main/view.php?key=20171115010005993
3071,2017-11-15,대웅제약충북오송에cGMP스마트신공장준공,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=212014
3072,2017-11-15,대웅제약2천100억원투입오송에세계수준공장건설,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003011701
3073,2017-11-15,fnRASSI대웅00309052주신고가경신283↑,http://www.fnnews.com/news/201711151106210564
3074,2017-11-15,대웅제약청주오송에세계수준공장준공2100억원투자,http://www.newsis.com/view/?id=NISX20171115_0000148601&cID=10806&pID=10800
3075,2017-11-15,ET투자뉴스대웅제약_외국인투자자의거래참여활발거래비중1988,http://www.etnews.com/20171115000177
3076,2017-11-15,대웅제약충북오송에세계적수준의신新공장준공,http://www.viva100.com/main/view.php?key=20171115010005598
3077,2017-11-15,ET투자뉴스대웅기업가치대비저평매수유지골든브릿지투자증권,http://www.etnews.com/20171115000315
3078,2017-11-15,대웅제약오송에2100억공장건립,http://www.viva100.com/main/view.php?key=20171115010005542
3079,2017-11-15,대웅제약3분기누적매출액3위우뚝,http://www.newstomato.com/ReadNews.aspx?no=788660
3080,2017-11-15,대웅제약임원떠나고영업직원뒤숭숭,http://www.nongaek.com/news/articleView.html?idxno=30904
3081,2017-11-15,세계적수준의대웅제약新공장준공식충북오송서둥지,http://www.ggilbo.com/news/articleView.html?idxno=421153
3082,2017-11-15,대웅제약오송신공장준공식,http://www.ccdailynews.com/news/articleView.html?idxno=945161
3083,2017-11-15,대웅제약충북오송에세계적수준의新공장준공,http://www.bzeronews.com/news/articleView.html?idxno=329415
3084,2017-11-15,대웅제약충북오송에글로벌생산기지건립,http://www.nocutnews.co.kr/news/4877946
3085,2017-11-15,국내4위제약사대웅제약충북오송에둥지,http://www.newdaily.co.kr/news/article.html?no=361129
3086,2017-11-15,대웅제약충북오송에세계적수준신공장준공,http://news1.kr/articles/?3154130
3087,2017-11-15,대웅제약오송에세계수준공장준공,http://www.cctimes.kr/news/articleView.html?idxno=510441
3088,2017-11-15,대웅제약충북오송에최첨단공장준공,http://www.cctoday.co.kr/?mod=news&act=articleView&idxno=1098357
3089,2017-11-15,대웅제약오송에세계수준공장준공,http://www.ccdn.co.kr/news/articleView.html?idxno=486305
3090,2017-11-15,대웅제약오송신공장준공,http://www.ccdailynews.com/news/articleView.html?idxno=945189
3091,2017-11-15,대웅제약충북서웅비,http://www.inews365.com/news/article.html?no=515222
3092,2017-11-15,대웅제약청주오송세계수준공장설립,http://www.daejonilbo.com/news/newsitem.asp?pk_no=1285464
3093,2017-11-16,대웅제약최첨단스마트팩토리오송공장준공식개최,http://www.g-enews.com/ko-kr/news/article/news_all/201711161035482892e6a49afa8d_1/article.html
3094,2017-11-16,대웅제약최첨단시설cGMP수준오송공장준공,http://medipana.com/news/news_viewer.asp?NewsNum=210743&MainKind=A&NewsKind=5&vCount=12&vKind=1
3095,2017-11-16,대웅제약cGMP기준따라건설오송공장준공식개최,http://www.sportsseoul.com/news/read/571306
3096,2017-11-16,대웅제약식약처종근당에이어메디톡스와도전쟁,http://www.nongaek.com/news/articleView.html?idxno=30971
3097,2017-11-16,대웅제약최첨단시설cGMP수준오송공장준공식개최,http://www.fnnews.com/news/201711161107261446
3098,2017-11-16,대웅제약최첨단시설의cGMP수준오송공장준공식개최,http://www.viva100.com/main/view.php?key=20171116010006147
3099,2017-11-16,대웅제약첨단스마트팩토리오송공장준공식개최,http://www.sisajournal-e.com/biz/article/176191
3100,2017-11-16,대웅cGMP수준최첨단오송공장준공,http://www.dailymedi.com/detail.php?number=824422&thread=22r05
3101,2017-11-16,대웅제약최첨단cGMP수준오송공장준공,http://www.medigatenews.com/news/3037580044
3102,2017-11-16,대웅제약cGMP인증오송공장준공,http://www.mt.co.kr/view/mtview.php?type=1&no=2017111611175977182&outlink=1
3103,2017-11-16,대웅제약오송공장준공식개최cGMP수준의최첨단스마트팩토리,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017111611233422125
3104,2017-11-16,대웅제약최첨단시설의오송공장준공식개최,http://www.kpinews.co.kr/news/articleView.html?idxno=59479
3105,2017-11-16,대웅제약오송공장준공연간20억정내용고형제생산가능,http://www.rapportian.com/news/articleView.html?idxno=107348
3106,2017-11-16,대웅제약최첨단시설의cGMP수준오송공장준공식,http://www.bosa.co.kr/news/articleView.html?idxno=2072622
3107,2017-11-16,대웅제약최첨단시설의cGMP수준오송공장준공식개최,http://www.lawissue.co.kr/view.php?ud=201711161242247497d7f4c63cc6_12
3108,2017-11-16,대웅제약3분기누적전년비상품매출21RD비10증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=212059
3109,2017-11-16,대웅제약오송공장준공식개최,http://www.newstomato.com/ReadNews.aspx?no=788981
3110,2017-11-16,대웅제약2100억투입한최첨단오송공장준공,http://news.hankyung.com/article/201711167308f
3111,2017-11-16,기자수첩메디톡스vs대웅제약진흙탕싸움진실꼭밝혀지길,http://www.cnbnews.com/news/article.html?no=361309
3112,2017-11-16,대웅제약도입당뇨약딜레마,http://www.newstomato.com/ReadNews.aspx?no=788976
3113,2017-11-16,대웅제약최첨단스마트팩토리오송공장준공,http://www.newsprime.co.kr/news/article.html?no=395402
3114,2017-11-16,대웅제약오송에최첨단공장준공,http://www.edaily.co.kr/news/newspath.asp?newsid=03161926616126376
3115,2017-11-16,대웅제약cGMP인증오송공장준공식개최,http://www.ciobiz.co.kr/news/article.html?id=20171116120015
3116,2017-11-16,대웅제약세계수준최첨단오송공장준공,http://www.kormedi.com/news/news/drug_dist/1225186_2906.html
3117,2017-11-16,대웅제약최첨단시설오송공장준공식개최,http://news.heraldcorp.com/view.php?ud=20171116000678
3118,2017-11-16,대웅제약최첨단시설오송공장준공식개최,http://news.heraldcorp.com/view.php?ud=20171116000709
3119,2017-11-16,대웅제약cGMP수준스마트팩토리오송공장준공,http://news.mk.co.kr/newsRead.php?year=2017&no=761083
3120,2017-11-16,대웅제약첨단스마트팩토리오송공장준공글로벌헬스케어그룹도약발판,http://www.techholic.co.kr/news/articleView.html?idxno=171896
3121,2017-11-16,대웅제약오송공장준공,http://www.dt.co.kr/contents.html?article_no=2017111602109976029006&ref=naver
3122,2017-11-16,대웅제약글로벌진출목표로최첨단오송공장준공,http://www.econovill.com/news/articleView.html?idxno=326654
3123,2017-11-16,공시리포트제약주최선호셀트리온차선호대웅유한한화,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201711160275
3124,2017-11-16,대웅제약cGMP인증오송공장준공,http://www.seoulfn.com/news/articleView.html?idxno=292853
3125,2017-11-16,대웅제약최첨단시설cGMP수준오송공장준공식개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1129302
3126,2017-11-16,대웅제약최첨단오송공장준공,http://www.sedaily.com/NewsView/1ONLQ1NVKN
3127,2017-11-16,모바일한경홍보사관학교로거듭난대웅제약등,http://news.hankyung.com/article/2017111696121
3128,2017-11-16,대웅제약cGMP수준오송공장준공24시간IoT모니터링구축,http://biz.chosun.com/site/data/html_dir/2017/11/16/2017111603298.html
3129,2017-11-16,대웅제약최첨단시설의cGMP수준오송공장준공식개최,http://www.newscj.com/news/articleView.html?idxno=463786
3130,2017-11-16,대웅제약오송스마트팩토리완공,http://news.hankyung.com/article/2017111694181
3131,2017-11-16,대웅제약cGMP수준스마트팩토리오송공장준공,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=101&oid=050&aid=0000045930
3132,2017-11-17,포항지진대웅제약지진피해지역약국지원,http://www.ebn.co.kr/news/view/918053
3133,2017-11-17,대웅제약포항지진피해약국지원의약품교환신청가능,http://www.g-enews.com/ko-kr/news/article/news_all/201711170901578421e6a49afa8d_1/article.html
3134,2017-11-17,대웅제약포항지진피해지역약국지원,http://www.newsis.com/view/?id=NISX20171117_0000151007&cID=13001&pID=13000
3135,2017-11-17,대웅제약포항지진피해지역약국지원,http://www.newsway.co.kr/view.php?tp=1&ud=2017111709024202355
3136,2017-11-17,뉴스투데이L대웅제약포항지진피해지역약국지원손길,http://www.news2day.co.kr/95143
3137,2017-11-17,대웅제약포항지진피해지역약국지원,http://medipana.com/news/news_viewer.asp?NewsNum=210792&MainKind=A&NewsKind=5&vCount=12&vKind=1
3138,2017-11-17,대웅제약포항지진피해지역약국지원,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=212110
3139,2017-11-17,대웅제약포항지역지진피해약국의약품교환,http://www.dailypharm.com/News/233522
3140,2017-11-17,대웅제약지진피해포항약국제품교환지원,http://www.edaily.co.kr/news/newspath.asp?newsid=01777766616126704
3141,2017-11-17,대웅제약포항지역약국의지진피해복구지원나서,http://news.mk.co.kr/newsRead.php?year=2017&no=763022
3142,2017-11-17,대웅제약포항지진피해약국지원손상의약품교환,http://www.kukinews.com/news/article.html?no=501755
3143,2017-11-17,대웅제약포항지진피해지역약국지원,http://www.mt.co.kr/view/mtview.php?type=1&no=2017111709280292185&outlink=1
3144,2017-11-17,대웅제약최첨단IT시스템도입오송공장준공,http://www.asiae.co.kr/news/view.htm?idxno=2017111709541768272
3145,2017-11-17,대웅제약포항지진피해지역약국지원,http://www.asiae.co.kr/news/view.htm?idxno=2017111710062891493
3146,2017-11-17,대웅제약포항지진피해지역약국지원,http://www.newsprime.co.kr/news/article.html?no=395501
3147,2017-11-17,대웅제약완전자동화오송공장준공글로벌2020노린다,http://www.ajunews.com/view/20171117101755153
3148,2017-11-17,대웅제약포항지진피해지역약국지원,http://www.bosa.co.kr/news/articleView.html?idxno=2072700
3149,2017-11-17,대웅포항지진피해지역약국지원,http://www.medigatenews.com/news/997723134
3150,2017-11-17,대웅제약 포항지역지진피해약국지원,http://www.techholic.co.kr/news/articleView.html?idxno=171912
3151,2017-11-17,대웅제약포항지역지진피해약국지원나서,http://news20.busan.com/controller/newsController.jsp?newsId=20171117000071
3152,2017-11-17,대웅제약오송공장준공cGMP수준시설,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1049027
3153,2017-11-17,대웅제약포항지진피해약국지원,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1049067
3154,2017-11-17,대웅제약포항지진피해약국에의약품교환지원,http://www.rapportian.com/news/articleView.html?idxno=107378
3155,2017-11-17,대웅제약포항지진피해지역약국지원,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017111714082792654
3156,2017-11-17,대웅제약2100억원투자한청주오송공장준공,http://www.insightkorea.co.kr//news/articleView.html?idxno=20312
3157,2017-11-17,대웅제약포항지진약국에지원포항약국약쏟아지고벽갈라져,http://www.asiatime.co.kr/news/articleView.html?idxno=159181
3158,2017-11-17,대웅제약포항지진피해지역약국지원,http://www.dt.co.kr/contents.html?article_no=2017111702109976029003&ref=naver
3159,2017-11-17,대웅제약포항지진피해지역약국지원,http://www.lawissue.co.kr/view.php?ud=201711171519023005d7f4c63cc6_12
3160,2017-11-17,대웅최첨단시설의cGMP수준오송공장준공식,http://www.kpanews.co.kr/article/show.asp?idx=189122&table=article&category=D
3161,2017-11-17,대웅제약포항지진피해지역약국지원,http://news.hankyung.com/article/201711171139f
3162,2017-11-17,대웅제약포항지진피해지역약국지원,http://ilyo.co.kr/?ac=article_view&entry_id=280220
3163,2017-11-17,대웅제약cGMP수준첨단시설갖춘오송공장준공,http://www.kukinews.com/news/article.html?no=501958
3164,2017-11-17,대웅제약포항지진피해지역약국지원,http://www.newscj.com/news/articleView.html?idxno=463992
3165,2017-11-18,대웅제약포항지진피해지역약국지원,http://www.enewstoday.co.kr/news/articleView.html?idxno=1129789
3166,2017-11-19,글리아티린대조약전쟁종근당판정승대웅지위상실,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171118054300017&did=1195m
3167,2017-11-19,글리아티린대조약전쟁종근당판정승대웅지위상실,http://www.ekn.kr/news/article.html?no=325355
3168,2017-11-19,종근당vs대웅제약대조약2년전쟁승자는종근당,http://www.sedaily.com/NewsView/1ONN2J3XGD
3169,2017-11-19,글리아티린대조약전쟁대웅제약판정패로막내리나,http://www.mhj21.com/sub_read.html?uid=110378§ion=sc243
3170,2017-11-19,글리아티린대조약전쟁종근당판정승대웅지위상실,http://www.sportsseoul.com/news/read/572310
3171,2017-11-19,전운감도는메디톡스대웅제약불편한동거,http://www.jbnews.com/news/articleView.html?idxno=818763
3172,2017-11-19,대웅제약신약개발가속7개연구진행,http://news.kmib.co.kr/article/view.asp?arcid=0923850279&code=14130000&cp=nv
3173,2017-11-20,대웅제약지진덮친포항지역약국지원,http://www.monews.co.kr/news/articleView.html?idxno=107856
3174,2017-11-20,대웅cGMP수준오송공장준공식개최,http://www.monews.co.kr/news/articleView.html?idxno=107824
3175,2017-11-20,fnRASSI대웅00309052주신고가196↑,http://www.fnnews.com/news/201711201004281667
3176,2017-11-20,fnRASSI대웅52주신고가251↑,http://www.fnnews.com/news/201711201430485545
3177,2017-11-20,대웅제약치매치료제글리아티린대조약전쟁서종근당에敗,http://www.wolyo.co.kr/news/articleView.html?idxno=49028
3178,2017-11-21,대웅제약美심장학회서FirstinClass심장섬유화치료제효능발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=212200
3179,2017-11-21,대웅美심장학회FirstinClass심장섬유화치료효과발표,http://www.kpanews.co.kr/article/show.asp?idx=189191&table=article&category=D
3180,2017-11-21,fnRASSI대웅제약06962052주신고가경신106↑,http://www.fnnews.com/news/201711210940096013
3181,2017-11-21,대웅심장섬유화치료제전임상결과미국서공개,http://www.dailypharm.com/News/233637
3182,2017-11-21,대웅제약美심장학회서심장섬유화물질첫공개,http://medipana.com/news/news_viewer.asp?NewsNum=210949&MainKind=A&NewsKind=5&vCount=12&vKind=1
3183,2017-11-21,대웅제약美심장학회서심장섬유화치료제효능발표,http://www.mdtoday.co.kr/mdtoday/index.html?no=302298
3184,2017-11-21,대웅美학회서심장섬유화치료제전임상발표,http://www.medigatenews.com/news/1563348265
3185,2017-11-21,대웅제약미국심장학회서심장섬유화치료신약효능발표,http://www.dt.co.kr/contents.html?article_no=2017112102109976029002&ref=naver
3186,2017-11-21,대웅제약美심장학회서심장섬유화치료제효능발표,http://news.hankyung.com/article/201711212294f
3187,2017-11-21,대웅제약심장섬유증혁신신약개발동물실험서효능확인,http://news1.kr/articles/?3158694
3188,2017-11-21,대웅제약퍼스트인클래스심장섬유화치료제효능발표,http://www.bosa.co.kr/news/articleView.html?idxno=2072910
3189,2017-11-21,뉴스투데이E대웅제약美심장학회서심장섬유화치료제효능발표,http://www.news2day.co.kr/95290
3190,2017-11-21,대웅제약美심장학회서FirstinClass심장섬유화치료제효능발표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1130520
3191,2017-11-21,대웅제약미심장학회서심장섬유화치료제효능발표,http://www.asiatoday.co.kr/view.php?key=20171121010011114
3192,2017-11-21,대웅제약美심장학회서심장섬유화치료제효능입증,http://www.ebn.co.kr/news/view/918538
3193,2017-11-21,대웅제약美심장학회서심장섬유화치료제전임상결과발표,http://www.rapportian.com/news/articleView.html?idxno=107446
3194,2017-11-21,아파야챙길래동아제약대웅제약메디톡스外,http://www.g-enews.com/ko-kr/news/article/news_all/201711211148519224e6a49afa8d_1/article.html
3195,2017-11-21,대웅심장섬유화치료제전임상결과공개,http://www.doctorsnews.co.kr/news/articleView.html?idxno=119975
3196,2017-11-21,대웅제약심장섬유화치료제DWN12088전임상시험결과공개,http://www.newsprime.co.kr/news/article.html?no=395879
3197,2017-11-21,대웅제약혁신신약심장섬유증치료제효능입증美심장학회서발표,http://biz.chosun.com/site/data/html_dir/2017/11/21/2017112101517.html
3198,2017-11-21,대웅제약미국심장학회서심장섬유화치료제전임상결과발표,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017112112088087995&outlink=1
3199,2017-11-21,대웅제약심장섬유화치료제신약항섬유화항염증효능확인,http://www.techholic.co.kr/news/articleView.html?idxno=171958
3200,2017-11-21,대웅美심장학회서심장섬유화치료제전임상결과발표,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1049201
3201,2017-11-21,셀트리온제약대웅제약제치고간장약처방시장석권,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1049209
3202,2017-11-21,대웅AHA서심장섬유화치료제효능발표,http://www.monews.co.kr/news/articleView.html?idxno=107974
3203,2017-11-21,fnRASSI대웅52주신고가222↑,http://www.fnnews.com/news/201711211312259628
3204,2017-11-21,대웅제약美심장학회서FirstinClass심장섬유화치료제효능발표,http://www.lawissue.co.kr/view.php?ud=201711211357549642d7f4c63cc6_12
3205,2017-11-21,종근당vs대웅바이오3라운드식약처종근당에손,http://www.m-i.kr/news/articleView.html?idxno=361848
3206,2017-11-21,대웅제약심장섬유증치료제국제무대첫선,http://www.kormedi.com/news/news/drug_dist/1225229_2906.html
3207,2017-11-21,대웅제약미국심장학회서심장섬유화치료혁신신약전임상결과발표,http://news.mk.co.kr/newsRead.php?year=2017&no=771952
3208,2017-11-21,대웅제약심장섬유화치료제전임상서항섬유화및항염증효능입증,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017112115320782423
3209,2017-11-21,대웅제약미국학회서심장섬유화치료제전임상발표,http://www.newstomato.com/ReadNews.aspx?no=789790
3210,2017-11-21,대웅제약새홍보팀장영입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=212239
3211,2017-11-21,제약임상소식대웅제약美심장학회서심장섬유화치료제효능공개,http://www.kukinews.com/news/article.html?no=502860
3212,2017-11-21,대웅제약美심장학회서치료제연구결과발표,http://www.kpinews.co.kr/news/articleView.html?idxno=59795
3213,2017-11-21,대웅제약미심장학회서심장섬유화치료제효능발표,http://www.dailian.co.kr/news/view/675424/?sc=naver
3214,2017-11-21,대웅개발진행심장섬유화치료제전임상결과공개,http://www.dailymedi.com/detail.php?number=824573&thread=22r05
3215,2017-11-21,대웅제약美심장학회서FirstinClass심장섬유화치료제효능첫발표,http://ilyo.co.kr/?ac=article_view&entry_id=280740
3216,2017-11-21,대웅제약심장섬유화치료제동물임상서효능확인,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201711210260
3217,2017-11-21,대웅제약보톡스나보타美진출초읽기,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201711210150
3218,2017-11-21,대웅제약美심장학회서심장섬유화치료제효능발표,http://www.wolyo.co.kr/news/articleView.html?idxno=49070
3219,2017-11-21,대웅제약美심장학회서심장섬유화치료제효능발표,http://www.k-health.com/news/articleView.html?idxno=32678
3220,2017-11-21,대웅제약美심장학회서FirstinClass심장섬유화치료제효능발표,http://www.newscj.com/news/articleView.html?idxno=464925
3221,2017-11-21,대웅제약美심장학회심장섬유화치료제DWN12088전임상결과발표,http://www.viva100.com/main/view.php?key=20171121020021522
3222,2017-11-22,대웅제약심장섬유화치료제개발동물실험서효능확인,https://cnbc.sbs.co.kr/article_hub/10000882403?division=NAVER
3223,2017-11-22,대웅제약등제약업계1년새기간제근로자28감소,http://www.ceoscoredaily.com/news/article.html?no=34301
3224,2017-11-22,fnRASSI대웅제약06962052주신고가247↑,http://www.fnnews.com/news/201711220906131035
3225,2017-11-22,대웅이지엔6이브디지털영상캠페인전개,http://www.dailypharm.com/News/233701
3226,2017-11-22,대웅제약생리통엔이지엔6온라인캠페인,http://www.mt.co.kr/view/mtview.php?type=1&no=2017112210261054932&outlink=1
3227,2017-11-22,대웅제약여성위한이지엔6이브광고캠페인론칭,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=212272
3228,2017-11-22,아파야챙길래종근당동아제약대웅제약外,http://www.g-enews.com/ko-kr/news/article/news_all/201711221116313970e6a49afa8d_1/article.html
3229,2017-11-22,대웅제약액상형진통제이지엔6이브영상광고공개,http://news.mk.co.kr/newsRead.php?year=2017&no=774168
3230,2017-11-22,대웅제약여성위한이지엔6이브광고캠페인런칭,http://medipana.com/news/news_viewer.asp?NewsNum=212019&MainKind=A&NewsKind=5&vCount=12&vKind=1
3231,2017-11-22,대웅제약이지엔6이브영상캠페인,http://www.kpinews.co.kr/news/articleView.html?idxno=59856
3232,2017-11-22,대웅제약여성용이지엔6이브광고캠페인,http://www.bosa.co.kr/news/articleView.html?idxno=2073042
3233,2017-11-22,대웅제약여성을위한이지엔6이브광고캠페인전개,http://www.kpanews.co.kr/article/show.asp?idx=189245&table=article&category=D
3234,2017-11-22,대웅제약여성위한이지엔6이브캠페인론칭,http://www.dt.co.kr/contents.html?article_no=2017112202109976029004&ref=naver
3235,2017-11-22,헬스단신서울대치과병원대웅제약광동제약,http://www.sportsseoul.com/news/read/573612
3236,2017-11-22,대웅제약생리통엔이젠이지엔6영상캠페인전개,http://www.mdtoday.co.kr/mdtoday/index.html?no=302511
3237,2017-11-22,대웅제약이지엔6이브디지털영상캠페인진행생리통엔이젠이지엔6,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017112215355771066
3238,2017-11-22,대웅제약여성위한이지엔6이브광고캠페인런칭,http://www.enewstoday.co.kr/news/articleView.html?idxno=1131059
3239,2017-11-22,대웅제약여성을위한이지엔6이브광고캠페인런칭,http://www.newscj.com/news/articleView.html?idxno=465190
3240,2017-11-22,대웅제약액상형진통제이지엔6이브새온라인광고선봬,http://www.viva100.com/main/view.php?key=20171122020021534
3241,2017-11-22,대웅제약여성을위한이지엔6이브광고캠페인런칭,http://www.lawissue.co.kr/view.php?ud=201711221851195211d7f4c63cc6_12
3242,2017-11-23,대웅제약나보타공장FDA실사완료소송상관없이美수출추진,http://news.hankyung.com/article/201711227611f
3243,2017-11-23,대조약종근당글리아티린대웅글리아타민아성넘나,http://www.seoulfn.com/news/articleView.html?idxno=293411
3244,2017-11-24,청신호미국진출앞둔녹십자대웅FDA승인올해만49건,http://www.mdtoday.co.kr/mdtoday/index.html?no=302681
3245,2017-11-24,대웅제약나보타잠재가치주목,http://www.asiatoday.co.kr/view.php?key=20171124010013090
3246,2017-11-24,대웅제약나보타美진출가시화잠재가치커골든브릿지,http://biz.chosun.com/site/data/html_dir/2017/11/24/2017112400540.html
3247,2017-11-24,ET투자뉴스대웅제약영업실적호조나매수유지골든브릿지투자증권,http://www.etnews.com/20171124000008
3248,2017-11-24,HotLine대웅제약영업실적호조와나보타잠재가치에주목,http://news.mk.co.kr/newsRead.php?year=2017&no=779538
3249,2017-11-24,대웅겨울철비타민D썬팩타민으로,http://www.kpanews.co.kr/article/show.asp?idx=189310&table=article&category=D
3250,2017-11-24,대웅제약약사대상썬팩타민우수성홍보,http://medipana.com/news/news_viewer.asp?NewsNum=212153&MainKind=A&NewsKind=5&vCount=12&vKind=1
3251,2017-11-24,대웅제약썬팩타민제품설명회개최,http://www.bosa.co.kr/news/articleView.html?idxno=2073211
3252,2017-11-24,앙숙대웅제약메디톡스적응증확대경쟁도치열,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1049370
3253,2017-11-24,대웅제약나보타잠재적가치에주목,http://www.newsworks.co.kr/news/articleView.html?idxno=150997
3254,2017-11-24,대웅제약경남지역약사대상비타민D효능알려,http://www.techholic.co.kr/news/articleView.html?idxno=172036
3255,2017-11-24,대웅제약비타민D효능알리는썬팩타민제품설명회개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=302804
3256,2017-11-24,대웅제약비타민D의효능을알리는썬팩타민제품설명회개최,http://www.asiatime.co.kr/news/articleView.html?idxno=159716
3257,2017-11-24,대웅제약EGF크림이지듀DWEGF크림프리미엄홈쇼핑에서도홈런칠까,http://www.asiatoday.co.kr/view.php?key=20171124010013373
3258,2017-11-24,대웅제약시지바이오지혈제부작용33명환자재수술,http://www.newsway.co.kr/view.php?tp=1&ud=2017112416491035458
3259,2017-11-24,대웅제약썬팩타민제품설명회서비타민D필요성강조,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017112417070091640
3260,2017-11-24,식약처대웅제약관계사판매부작용지혈제회수조치,https://cnbc.sbs.co.kr/article_hub/10000882887?division=NAVER
3261,2017-11-24,대웅제약비타민D효능을알리는썬팩타민제품설명회개최,http://www.newscj.com/news/articleView.html?idxno=465922
3262,2017-11-25,대웅제약약사대상썬팩타민설명회개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1049416
3263,2017-11-26,대웅제약비타민D효능을알리는썬팩타민제품설명회개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1132281
3264,2017-11-27,가스티인CR견제용대웅제약특허심판심결각하,http://www.dailypharm.com/News/233847
3265,2017-11-27,대웅제약동아에스티보령제약해외법인투자나선다,http://www.mdtoday.co.kr/mdtoday/index.html?no=302848
3266,2017-11-27,제약업계비정규직백서대웅제약과셀트리온이서로다른1위차지,http://www.news2day.co.kr/95547
3267,2017-11-27,다빼고직무자격증만스펙다이어트로신입뽑은대웅제약,http://news.mk.co.kr/newsRead.php?year=2017&no=786059
3268,2017-11-28,대웅글리아타민복제약첫톱10진입대조약과경쟁심화,http://www.kpinews.co.kr/news/articleView.html?idxno=60351
3269,2017-11-28,대웅제약연구생산까지현지화하며글로벌비전2020잰걸음,http://news.mk.co.kr/newsRead.php?year=2017&no=788984
3270,2017-11-29,Bio의약대웅제약글로벌진출가속화2020년해외매출국내매출넘어선다,http://news.donga.com/3/all/20171128/87486156/1
3271,2017-11-29,ET투자뉴스대웅제약미국에서나보타선매수신규유안타증권,http://www.etnews.com/20171129000120
3272,2017-11-29,대웅제약나보타내년FDA시판허가가변수,http://www.choicenews.co.kr/news/articleView.html?idxno=37713
3273,2017-11-29,판박이광동대웅제약지배구조강화3종세트는,http://www.newspim.com/news/view/20171128000157
3274,2017-11-30,대웅제약FirstInClassBestInClass7개글로벌신약도전,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=212569
3275,2017-11-30,대웅제약맥널티등7곳상대알비스D특허소승소,http://www.dailypharm.com/News/233997
3276,2017-11-30,신약개발에속도붙는대웅제약‥RD성과는,http://medipana.com/news/news_viewer.asp?NewsNum=212418&MainKind=A&NewsKind=5&vCount=12&vKind=1
3277,2017-11-30,대웅제약나보타미국시판허가코앞업계초미관심,http://www.kpanews.co.kr/article/show.asp?idx=189463&table=article&category=D
3278,2017-11-30,대웅제약RD34년내가시적성과기대,http://www.bosa.co.kr/news/articleView.html?idxno=2073549
3279,2017-11-30,DB금융투자대웅제약나보타미국허가가능성높아목표가상향”,http://www.g-enews.com/ko-kr/news/article/news_all/201711300840469794581e5800d6_1/article.html
3280,2017-11-30,대웅제약나보타미국허가가능성높아목표가↑DB금융,http://www.newstomato.com/ReadNews.aspx?no=791637
3281,2017-11-30,HotLine대웅제약나보타의미국허가가능성높아목표가↑,http://news.mk.co.kr/newsRead.php?year=2017&no=793190
3282,2017-11-30,ET투자뉴스대웅제약미국유럽시판매수유지DB금융투자,http://www.etnews.com/20171130000234
3283,2017-11-30,유나이티드제약가스티인CR정특허분쟁대웅제약에승소,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=212597
3284,2017-11-30,유나이티드가스티인CR특허심판대웅에승소,http://medipana.com/news/news_viewer.asp?NewsNum=212470&MainKind=A&NewsKind=5&vCount=12&vKind=1
3285,2017-11-30,유나이티드제약가스티안CR정특허訴대웅에승리,http://www.medical-tribune.co.kr/news/articleView.html?idxno=75902
3286,2017-11-30,유나이티드가스티인CR정대웅과특허소송서승소,http://www.mt.co.kr/view/mtview.php?type=1&no=2017113014332145058&outlink=1
3287,2017-11-30,한국유나이티드제약가스티인CR정특허분쟁서대웅제약에승소,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017113015052525871
3288,2017-11-30,유나이티드제약대웅과가스티인CR정특허소송서승소,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201711300266
3289,2017-11-30,윤재승대웅제약회장글리아티린쓴맛보톡스는,http://www.newsway.co.kr/view.php?tp=1&ud=2017113015094913583
3290,2017-11-30,대웅제약나보타美허가가능성이높다,http://www.newsworks.co.kr/news/articleView.html?idxno=152198
3291,2017-11-30,한국유나이티드제약가스티인CR정특허분쟁대웅제약에승소,http://www.kukinews.com/news/article.html?no=505592
3292,2017-11-30,한국유나이티드제약가스티인CR정대웅제약이청구한특허권리범위확인심판심결각하,http://www.munhwa.com/news/view.html?no=20171130MW165936315830
3293,2017-11-30,한국유나이티드제약대웅제약과특허심판승소,http://www.dt.co.kr/contents.html?article_no=2017113002109976029009&ref=naver
3294,2017-11-30,대웅제약미국과유럽에시판가능성높아짐,http://daily.hankooki.com/lpage/economy/201711/dh20171130174541138110.htm
3295,2017-11-30,한국유나이티드제약대웅제약과특허분쟁승소,http://www.newspim.com/news/view/20171130000331
3296,2017-11-30,유나이티드제약가스티인CR정특허분쟁서대웅제약에승소”,http://biz.chosun.com/site/data/html_dir/2017/11/30/2017113003152.html
3297,2017-11-30,유나이티드제약대웅과의소화제가스티인CR특허심판승소,http://www.viva100.com/main/view.php?key=20171130020021613
3298,2017-12-01,대웅나보타美FDA허가가능성높아,http://www.dailymedi.com/detail.php?number=824983&thread=22r05
3299,2017-12-01,유나이티드가스티인CR정특허소송서대웅에勝,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1049723
3300,2017-12-01,대웅제약경동제약등7개제약사와알비스D특허소송승소,http://www.mdtoday.co.kr/mdtoday/index.html?no=303462
3301,2017-12-01,아파야챙길래대웅제약유한양행일동제약,http://www.g-enews.com/ko-kr/news/article/news_all/201712011015379666e6a49afa8d_1/article.html
3302,2017-12-01,대웅제약향남공장일하기좋은기업재인증,http://www.medicaltimes.com/News/1115511
3303,2017-12-01,대웅제약경기가족친화일하기좋은기업재인증,http://www.dailypharm.com/News/234074
3304,2017-12-01,대웅제약향남공장경기가족친화일하기좋은기업재인증,http://news.mk.co.kr/newsRead.php?year=2017&no=796810
3305,2017-12-01,대웅향남공장GGWP재인증획득,http://www.monews.co.kr/news/articleView.html?idxno=108426
3306,2017-12-01,대웅제약경기가족친화일하기좋은기업재인증,http://medipana.com/news/news_viewer.asp?NewsNum=212522&MainKind=A&NewsKind=5&vCount=12&vKind=1
3307,2017-12-01,대웅제약향남공장2017경기가족친화일하기좋은기업재인증,http://www.mdtoday.co.kr/mdtoday/index.html?no=303529
3308,2017-12-01,대웅제약향남공장경기가족친화기업재인증,http://www.kpinews.co.kr/news/articleView.html?idxno=60616
3309,2017-12-01,대웅제약향남공장2017경기가족친화일하기좋은기업재인증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=212643
3310,2017-12-01,대웅제약향남공장2017경기가족친화일하기좋은기업GGWP재인증,http://www.lawissue.co.kr/view.php?ud=201712011043058698d7f4c63cc6_12
3311,2017-12-01,대웅제약향남공장일하기좋은기업재인증,http://www.medical-tribune.co.kr/news/articleView.html?idxno=75928
3312,2017-12-01,대웅제약향남공장경기가족친화일하기좋은기업재인증,http://news.heraldcorp.com/view.php?ud=20171201000495
3313,2017-12-01,대웅제약향남공장경기가족친화일하기좋은기업재인증획득,http://www.fnnews.com/news/201712011145107366
3314,2017-12-01,속도내는대웅항궤양제신약PPI제제대체가능할까,http://www.kpanews.co.kr/article/show.asp?idx=189524&table=article&category=D
3315,2017-12-01,뉴스투데이J대웅제약향남공장2017경기가족친화일하기좋은기업재인증,http://www.news2day.co.kr/95797
3316,2017-12-01,대웅제약향남공장일하기좋은기업재인증,http://www.newstomato.com/ReadNews.aspx?no=792017
3317,2017-12-01,가스티인CR상대특허심판청구한대웅심결각하결론,http://www.mdtoday.co.kr/mdtoday/index.html?no=303047
3318,2017-12-01,대웅제약향남공장경기가족친화일하기좋은기업GGWP재인증,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017120113455064860
3319,2017-12-01,대웅제약경기가족친화일하기좋은기업재인증,http://www.newsprime.co.kr/news/article.html?no=397414
3320,2017-12-01,대웅제약향남공장경기가족친화일하기좋은기업재인증,http://www.bosa.co.kr/news/articleView.html?idxno=2073681
3321,2017-12-01,한국유나이티드제약가스티인CR정특허분쟁대웅제약에승소,http://www.mdtoday.co.kr/mdtoday/index.html?no=303573
3322,2017-12-01,대웅향남공장경기가족친화일하기좋은기업재인증,http://www.dailymedi.com/detail.php?number=825017&thread=22r05
3323,2017-12-01,대웅제약향남공장일하기좋은기업재인증획득,http://www.rapportian.com/news/articleView.html?idxno=107672
3324,2017-12-01,대웅제약향남공장2017경기가족친화일하기좋은기업GGWP재인증,http://www.newscj.com/news/articleView.html?idxno=469752
3325,2017-12-02,대웅제약향남공장2017경기가족친화일하기좋은기업재인증,http://www.viva100.com/main/view.php?key=20171201020021626
3326,2017-12-02,대웅향남공장2017경기가족친화일하기좋은기업재인증,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1049752
3327,2017-12-02,대웅제약향남공장2017경기가족친화일하기좋은기업재인증,http://www.enewstoday.co.kr/news/articleView.html?idxno=1134091
3328,2017-12-03,보령제약겔포스대웅제약스멕타편의점서판매유력,http://daily.hankooki.com/lpage/life/201712/dh20171203152514138940.htm
3329,2017-12-04,보령제약겔포스대웅제약스멕타편의점판매유력,http://www.sedaily.com/NewsView/1OOQ1V8R29
3330,2017-12-04,서방정vs서방정대웅제약모사프리드품목맞불,http://www.medicaltimes.com/News/1115546
3331,2017-12-04,대웅제약보툴리눔톡신나보타美허가가능성높아,http://www.mdtoday.co.kr/mdtoday/index.html?no=303607
3332,2017-12-04,대웅가스모틴SR허가가스티인CR과본격경쟁,http://www.dailypharm.com/News/234160
3333,2017-12-04,대웅제약신약개발RD연구에속도내다,http://www.lawissue.co.kr/view.php?ud=201712041809066141d7f4c63cc6_12
3334,2017-12-05,대웅제약가스모틴SR허가가스티인CR과의다가오는경쟁국면,http://www.mdtoday.co.kr/mdtoday/index.html?no=303858
3335,2017-12-05,대웅제약편의성높인가스모틴SR정시판승인,http://medipana.com/news/news_viewer.asp?NewsNum=212681&MainKind=A&NewsKind=5&vCount=12&vKind=1
3336,2017-12-05,대웅제약복약편의성높인가스모틴SR정식약처허가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=212766
3337,2017-12-05,대웅제약가스모틴SR정식약처품목허가,http://www.dailypharm.com/News/234210
3338,2017-12-05,대웅제약소화불량치료제가스모틴SR정식약처허가,http://www.asiae.co.kr/news/view.htm?idxno=2017120509575130574
3339,2017-12-05,대웅제약하루한번먹는소화불량치료제허가,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171205064100017&did=1195m
3340,2017-12-05,대웅제약복약편의성높인가스모틴SR정식약처허가,http://www.sportsseoul.com/news/read/577608
3341,2017-12-05,대웅제약복약편의성제고가스모틴SR정식약처허가,http://www.sisajournal-e.com/biz/article/176864
3342,2017-12-05,대웅제약가스모틴SR정식약처허가,http://www.monews.co.kr/news/articleView.html?idxno=108548
3343,2017-12-05,대웅제약가스모틴SR정식약처품목허가획득,http://www.mt.co.kr/view/mtview.php?type=1&no=2017120510224676076&outlink=1
3344,2017-12-05,대웅제약가스모틴SR정품목허가,http://www.asiatime.co.kr/news/articleView.html?idxno=160431
3345,2017-12-05,대웅제약가스모틴SR정식약처허가,http://www.newsprime.co.kr/news/article.html?no=397719
3346,2017-12-05,대웅제약글로벌RD기지통한연구개발활발,http://www.mt.co.kr/view/mtview.php?type=1&no=2017120510565224161&outlink=1
3347,2017-12-05,아파야챙길래대웅제약한미약품동화약품外,http://www.g-enews.com/ko-kr/news/article/news_all/201712051140467199e6a49afa8d_1/article.html
3348,2017-12-05,대웅제약하루한번복용하는소화불량치료제가스모틴SR허가받아,http://news.mk.co.kr/newsRead.php?year=2017&no=805425
3349,2017-12-05,대웅제약의활발한연구개발핵심은글로벌R＆D기지,http://news.heraldcorp.com/view.php?ud=20171205000609
3350,2017-12-05,대웅제약하루1알로효과지속소화불량치료제허가,http://news1.kr/articles/?3171292
3351,2017-12-05,대웅제약가스모틴SR정허가,http://www.medical-tribune.co.kr/news/articleView.html?idxno=75990
3352,2017-12-05,대웅제약가스모틴SR정식약처허가,http://www.bosa.co.kr/news/articleView.html?idxno=2073893
3353,2017-12-05,모사프리드시장新라이벌유나이트디제약에반격나선대웅제약,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1049890
3354,2017-12-05,대웅제약하루한번먹는소화불량치료제허가,http://www.sedaily.com/NewsView/1OOQKDYGNF
3355,2017-12-05,대웅제약소화불량치료제가스모틴SR정식약처품목허가획득,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201712050168
3356,2017-12-05,대웅제약복약편의성높인소화불량치료제가스모틴SR정식약처허가,http://www.techholic.co.kr/news/articleView.html?idxno=172204
3357,2017-12-05,대웅제약복약편의성높인가스모틴SR정식약처허가,http://news.hankyung.com/article/201712051120f
3358,2017-12-05,대웅제약복약편의성높인가스모틴SR정식약처허가,http://www.enewstoday.co.kr/news/articleView.html?idxno=1134696
3359,2017-12-05,대웅제약가스모틴SR식약처허가,http://www.kormedi.com/news/news/drug_dist/1225381_2906.html
3360,2017-12-05,파워브랜드대웅제약우루사,http://www.seoulfn.com/news/articleView.html?idxno=294239
3361,2017-12-05,대웅제약가스모틴SR정식약처허가,http://www.ciobiz.co.kr/news/article.html?id=20171205120037
3362,2017-12-05,대웅제약하루한알복용가스모틴SR식약처허가,http://www.newsis.com/view/?id=NISX20171205_0000167800&cID=13001&pID=13000
3363,2017-12-05,대웅제약소화불량치료제식약처허가,http://www.seoulfn.com/news/articleView.html?idxno=294250
3364,2017-12-05,대웅제약복약편의성높인가스모틴SR정식약처허가,http://www.dailian.co.kr/news/view/678586/?sc=naver
3365,2017-12-05,대웅제약글로벌RD기지통해연구개발활발,http://www.dt.co.kr/contents.html?article_no=2017120502109976029007&ref=naver
3366,2017-12-05,대웅제약가스모틴SR정식약처품목허가획득,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017120517468027261&outlink=1
3367,2017-12-05,대웅제약복약편의성높인가스모틴SR정허가,http://www.viva100.com/main/view.php?key=20171205010001654
3368,2017-12-05,대웅제약복약편의성높인가스모틴SR정식약처허가,http://www.newscj.com/news/articleView.html?idxno=470975
3369,2017-12-05,대웅제약복약편의성높인가스모틴SR정식약처허가,http://www.lawissue.co.kr/view.php?ud=20171205220916895d7f4c63cc6_12
3370,2017-12-05,대웅제약소화불량치료제서방정가스모틴SR정식약처허가,http://www.viva100.com/main/view.php?key=20171205020021653
3371,2017-12-06,대웅제약복약편의성높인가스모틴SR정식약처허가,http://www.kpanews.co.kr/article/show.asp?idx=189656&table=article&category=D
3372,2017-12-06,매출14를신약개발에투자한대웅제약,http://www.ajunews.com/view/20171204180235713
3373,2017-12-06,대웅제약가스모틴SR정허가소화불량치료제시장본격경쟁,http://news.heraldcorp.com/view.php?ud=20171206000158
3374,2017-12-06,대웅제약특화된R＆D기지박차2020년글로벌50위”,http://news.heraldcorp.com/view.php?ud=20171206000411
3375,2017-12-06,ET투자뉴스의약품업종급락세_대웅제약약세흐름두드러져,http://www.etnews.com/20171206000264
3376,2017-12-06,대웅제약글로벌신약개발속도낸다,http://www.asiae.co.kr/news/view.htm?idxno=2017120614101471420
3377,2017-12-06,셀트리온대웅제약간장약경쟁,http://www.newstomato.com/ReadNews.aspx?no=792996
3378,2017-12-07,대웅제약복약편의성높인가스모틴SR정식약처허가,http://health.chosun.com/site/data/html_dir/2017/12/07/2017120701170.html
3379,2017-12-07,대웅제약항혈전제안플원내년중자체생산한다,http://news1.kr/articles/?3172916
3380,2017-12-08,대웅윤재승일가강남황금땅2300억호화부동산,http://www.skyedaily.com/news/news_view.html?ID=68172
3381,2017-12-10,대웅제약매년매출액10이상신약개발투자,http://news.kmib.co.kr/article/view.asp?arcid=0923862700&code=14130000&cp=nv
3382,2017-12-11,대웅제약새홍보팀장에김성중씨,http://www.the-pr.co.kr/news/articleView.html?idxno=28027
3383,2017-12-11,대웅제약보톡스최대시장미국뚫나FDA실사통과가능성높아,http://biz.chosun.com/site/data/html_dir/2017/12/11/2017121102043.html
3384,2017-12-12,대웅제약전직사우모임웅비회잘나가네,http://www.bosa.co.kr/news/articleView.html?idxno=2074252
3385,2017-12-12,대웅제약해외법인최다진출불구만년적자신세,http://www.ceoscoredaily.com/news/article.html?no=35126
3386,2017-12-12,대웅제약전직사우모임웅비회가주목받는이유,http://medipana.com/news/news_viewer.asp?NewsNum=213002&MainKind=A&NewsKind=5&vCount=12&vKind=1
3387,2017-12-13,대웅제약우루사회식잦은연말간건강부터챙기세요,http://news.mk.co.kr/newsRead.php?year=2017&no=823382
3388,2017-12-13,대웅제약우루사도美간다이르면2019년허가,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1050252
3389,2017-12-13,ET투자뉴스대웅제약_주요매물구간인113000원선이지지대로작용,http://www.etnews.com/20171213000138
3390,2017-12-13,대웅바이오종근당글리아티린대조약선정부당행정심판제기,http://www.g-enews.com/ko-kr/news/article/news_all/201712131656403868e6a49afa8d_1/article.html
3391,2017-12-13,대웅바이오종근당글리아티린대조약선정에행정심판제기,http://www.sedaily.com/NewsView/1OOU9OW9GT
3392,2017-12-13,대웅바이오대조약선정공고취소행정심판제기,http://news.mt.co.kr/mtview.php?no=2017121317015972774
3393,2017-12-13,대웅제약종근당대조약말도안돼”행정심판제기,http://www.newsway.co.kr/view.php?tp=1&ud=2017121317023152583
3394,2017-12-13,대웅바이오다국적제약사가대조약선정좌지우지비판,http://www.kpanews.co.kr/article/show.asp?idx=189867&table=article&category=D
3395,2017-12-13,대웅바이오콜린알포세레이트대조약지정심판청구,http://www.dailypharm.com/News/234532
3396,2017-12-13,대웅바이오대조약선정공고취소행정심판제기,http://www.sportsseoul.com/news/read/580622
3397,2017-12-13,대웅바이오대조약선정공고취소행정심판제기,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017121317245443450
3398,2017-12-13,대웅바이오다국적제약사가대조약선정좌우한다”,http://www.dt.co.kr/contents.html?article_no=2017121302109976029004&ref=naver
3399,2017-12-13,대웅바이오종근당글리아티린대조약선정에행정심판제기,http://www.asiae.co.kr/news/view.htm?idxno=2017121317242704124
3400,2017-12-13,대웅바이오종근당글리아티린대조약부당행정심판제기,http://news.hankyung.com/article/201712139579f
3401,2017-12-13,글리아티린대조약은내것대웅바이오행정심판제기,http://www.monews.co.kr/news/articleView.html?idxno=108850
3402,2017-12-13,대웅바이오종근당글리아티린대조약선정에행정심판,http://www.newsis.com/view/?id=NISX20171213_0000175806&cID=13001&pID=13000
3403,2017-12-13,대웅바이오식약처대조약선정기준바꿔야”,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017121317478053698&outlink=1
3404,2017-12-13,대웅바이오종근당글리아티린대조약선정또반발법정가자,http://www.ebn.co.kr/news/view/921633
3405,2017-12-13,대웅바이오대조약선정공고취소행정심판제기,http://medipana.com/news/news_viewer.asp?NewsNum=213136&MainKind=A&NewsKind=5&vCount=12&vKind=1
3406,2017-12-13,대웅바이오종근당글리아티린대조약선정부당행정심판제기,http://www.techholic.co.kr/news/articleView.html?idxno=172412
3407,2017-12-13,대웅바이오다국적제약사가대조약선정좌지우지,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=213128
3408,2017-12-13,대웅바이오종근당글리아티린대조약선정부당행정심판제기,http://biz.chosun.com/site/data/html_dir/2017/12/13/2017121302987.html
3409,2017-12-13,대웅바이오다국적제약사가대조약선정을좌지우지”비판,http://www.lawissue.co.kr/view.php?ud=201712131901004497d7f4c63cc6_12
3410,2017-12-13,대웅바이오또정부에반기종근당대조약취소행정심판,http://www.seoulfn.com/news/articleView.html?idxno=294942
3411,2017-12-13,대웅대조약지정취소행정심판제기,http://www.medical-tribune.co.kr/news/articleView.html?idxno=76159
3412,2017-12-14,해외현지화전략청신호‥대웅실적빛발하기시작,http://medipana.com/news/news_viewer.asp?NewsNum=213132&MainKind=A&NewsKind=5&vCount=12&vKind=1
3413,2017-12-14,대웅바이오대조약선정공고취소행정심판제기,http://www.bosa.co.kr/news/articleView.html?idxno=2074507
3414,2017-12-14,대웅바이오대조약선정공고취소행정심판제기,http://www.mdtoday.co.kr/mdtoday/index.html?no=305013
3415,2017-12-14,대웅바이오콜린알포세레이트제제행정심판제기,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1050288
3416,2017-12-14,fnRASSI대웅제약52주신고가424↑,http://www.fnnews.com/news/201712140923090622
3417,2017-12-14,대웅식약처상대로치매치료제대조약논쟁2라운드나서,http://news.mk.co.kr/newsRead.php?year=2017&no=827222
3418,2017-12-14,대웅글리아티린대조약지위재탈환도전,http://www.dailymedi.com/detail.php?number=825425&thread=22r05
3419,2017-12-14,수급골든타임실시간수급시그널종목신세계대웅제약,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017121411214166403
3420,2017-12-14,뇌기능개선제우리가기준약대웅바이오행정심판제기,http://www.newstomato.com/ReadNews.aspx?no=794867
3421,2017-12-14,대웅우루사美진출시도내년하반기허가신청,http://www.mdtoday.co.kr/mdtoday/index.html?no=305132
3422,2017-12-14,끝까지간다대웅제약또대조약행정소송기존주장되풀이,http://biz.newdaily.co.kr/news/article.html?no=10148617
3423,2017-12-14,대웅바이오식약처상대로대조약선정취소행정심판제기,http://www.businesspost.co.kr/BP?command=article_view&num=66976
3424,2017-12-14,대웅종근당글리아티린인정못해또불붙은대조약지위분쟁,http://www.wolyo.co.kr/news/articleView.html?idxno=50353
3425,2017-12-15,클릭e종목대웅제약높아지는나보타기대감목표가↑,http://www.asiae.co.kr/news/view.htm?idxno=2017121507274044180
3426,2017-12-15,대웅제약미국시장진출기대감목표가↑”SK증권,http://www.dailian.co.kr/news/view/680710/?sc=naver
3427,2017-12-15,대웅제약나보타기대감높아져SK,http://biz.chosun.com/site/data/html_dir/2017/12/15/2017121500528.html
3428,2017-12-15,대웅제약나보타미국시장진출기대목표가↑SK,http://www.edaily.co.kr/news/newspath.asp?newsid=01361206616158848
3429,2017-12-15,대웅제약더욱높아지는기대감목표가상향SK증권,http://www.newstomato.com/ReadNews.aspx?no=795013
3430,2017-12-15,대웅제약나보타美진출기대감상승목표가18만원SK증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1574494
3431,2017-12-15,SK증권대웅제약내년에도사업정상화목표가↑”,http://www.newsway.co.kr/view.php?tp=1&ud=2017121508291682605
3432,2017-12-15,SK증권대웅제약나보타美진출기대목표가↑,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171215032000008&did=1195m
3433,2017-12-15,ET투자뉴스대웅제약더욱높아지는나보매수유지SK증권,http://www.etnews.com/20171215000008
3434,2017-12-15,대웅제약높아지는나보타기대감SK증권,http://www.fnnews.com/news/201712150853162607
3435,2017-12-15,대웅제약나보타美진출기대목표가↑SK증권,http://www.seoulfn.com/news/articleView.html?idxno=295058
3436,2017-12-15,대웅제약목표주가상향보톡스나보타의미국진출가시화,http://www.businesspost.co.kr/BP?command=article_view&num=67013
3437,2017-12-15,특징주대웅제약나보타기대감상승분석에신고가,http://www.newstomato.com/ReadNews.aspx?no=795036
3438,2017-12-15,대웅제약전현직임직원화합의장웅비회마련,http://medipana.com/news/news_viewer.asp?NewsNum=213217&MainKind=A&NewsKind=5&vCount=12&vKind=1
3439,2017-12-15,fnRASSI대웅제약06962052주신고가528↑,http://www.fnnews.com/news/201712151021588514
3440,2017-12-15,대웅제약제6회웅비회송년의밤,http://www.ebn.co.kr/news/view/921893
3441,2017-12-15,대웅제약웅비회송년의밤소통하며유대감쌓아,http://www.dailypharm.com/News/234602
3442,2017-12-15,대웅제약선후배들퇴직자모임웅비회송년행사서만나소통,http://news.mk.co.kr/newsRead.php?year=2017&no=830307
3443,2017-12-15,대웅제약제6회웅비회송년의밤개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=213212
3444,2017-12-15,대웅제약나날이높아지는나보타기대감,http://daily.hankooki.com/lpage/economy/201712/dh20171215110313138110.htm
3445,2017-12-15,특징주대웅제약나보타미국시장진출기대로5↑,http://www.asiae.co.kr/news/view.htm?idxno=2017121511124870725
3446,2017-12-15,대웅제약전현직임직원화합제6회웅비회송년의밤개최,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017121511178043543&outlink=1
3447,2017-12-15,대웅제약나보타보톡스최대시장인미국진출기대감높아져,http://www.news2day.co.kr/96427
3448,2017-12-15,대웅제약퇴직사우모임웅비회송년의밤가져,http://www.rapportian.com/news/articleView.html?idxno=107939
3449,2017-12-15,대웅제약퇴직사우모임웅비회송년의밤,http://www.bosa.co.kr/news/articleView.html?idxno=2074627
3450,2017-12-15,대웅제약더욱높아지는나보타기대감,http://www.newsworks.co.kr/news/articleView.html?idxno=155336
3451,2017-12-15,뉴스투데이L대웅제약제6회웅비회송년의밤통해전현직임직원의화합의장마련,http://www.news2day.co.kr/96434
3452,2017-12-15,대웅제약제6회웅비회송년의밤개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=305225
3453,2017-12-15,대웅제약웅비회송년의밤개최,http://www.newstomato.com/ReadNews.aspx?no=795080
3454,2017-12-15,대웅제약퇴직사우모임웅비회송년의밤개최,http://www.k-health.com/news/articleView.html?idxno=33308
3455,2017-12-15,SK대웅제약2018년에도사업정상화흐름지속전망,http://www.nbntv.co.kr/news/view.php?idx=72662
3456,2017-12-15,대웅제약제6회대웅웅비회송년의밤진행,http://www.newsprime.co.kr/news/article.html?no=399182
3457,2017-12-15,대웅제약제6회대웅웅비회송년의밤개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1137435
3458,2017-12-15,대웅제약전∙현직임직원의화합의장제6회웅비회송년의밤성료,http://www.lawissue.co.kr/view.php?ud=201712151413418712d7f4c63cc6_12
3459,2017-12-15,이벤트대웅제약웅비회송년의밤,http://www.seoulfn.com/news/articleView.html?idxno=295103
3460,2017-12-15,유대웅제약장중신고가돌파148000→152000▲4000,http://www.sedaily.com/NewsView/1OOV6VGVTE
3461,2017-12-15,대웅바이오대조약선정공고취소행정심판,http://www.kormedi.com/news/news/drug_dist/1225496_2906.html
3462,2017-12-15,대웅제약제6회웅비회송년의밤개최,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201712150241
3463,2017-12-15,대웅제약전현직임직원의화합의장제6회웅비회송년의밤개최,http://www.newscj.com/news/articleView.html?idxno=474499
3464,2017-12-16,대웅제약웅비회송년의밤개최,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1050384
3465,2017-12-16,대웅제약제6회웅비회송년의밤,http://www.kpanews.co.kr/article/show.asp?idx=189946&table=article&category=D
3466,2017-12-17,동아제약일반약시장서두각대웅제약성장세도눈길,http://www.kpinews.co.kr/news/articleView.html?idxno=61791
3467,2017-12-17,나보타로사상최고가넘은대웅제약더달린다,http://www.edaily.co.kr/news/newspath.asp?newsid=01256246616159504
3468,2017-12-17,제약산업이모저모대웅제약전현직임직원의화합의장열어外,http://www.kukinews.com/news/article.html?no=509945
3469,2017-12-17,대웅제약전현직임직원의화합의장제6회웅비회송년의밤개최,http://ilyo.co.kr/?ac=article_view&entry_id=284540
3470,2017-12-18,대웅제약나보타신공장가동률증가로수출성장목표가↑,http://www.edaily.co.kr/news/newspath.asp?newsid=01420246616159832
3471,2017-12-18,대웅제약나보타실적가시화목표가↑”한화투자증권,http://www.dailian.co.kr/news/view/681154/?sc=naver
3472,2017-12-18,빅데이터MSI시장심리톱5대웅제약금호타이어현대중공업현대상선현대모비스,http://www.newsis.com/view/?id=NISX20171218_0000179067&cID=10401&pID=10400
3473,2017-12-18,대웅제약삼페넷국내독점판매,http://www.dt.co.kr/contents.html?article_no=2017121802109976029002&ref=naver
3474,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급계약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=213250
3475,2017-12-18,대웅제약삼성바이오삼페넷국내독점공급계약,http://medipana.com/news/news_viewer.asp?NewsNum=213286&MainKind=A&NewsKind=5&vCount=12&vKind=1
3476,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2017121809078079239&outlink=1
3477,2017-12-18,ET투자뉴스대웅제약숫자로나타나는나매수유지한화투자증권,http://www.etnews.com/20171218000033
3478,2017-12-18,대웅삼성바이오에피스삼페넷국내판권가져와,http://www.dailypharm.com/News/234666
3479,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점판매계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=305399
3480,2017-12-18,대웅제약삼성바이오항암제삼페넷국내판권확보,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20171218042400017&did=1195m
3481,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점판매계약,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201712180071
3482,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급,http://biz.chosun.com/site/data/html_dir/2017/12/18/2017121800662.html
3483,2017-12-18,대웅제약삼성바이오허셉틴바이오시밀러삼페넷국내판권확보,http://news.mk.co.kr/newsRead.php?year=2017&no=834785
3484,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급계약,http://www.newsis.com/view/?id=NISX20171218_0000179112&cID=13001&pID=13000
3485,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급계약,http://www.viva100.com/main/view.php?key=20171218010006003
3486,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급계약,http://www.kpanews.co.kr/article/show.asp?idx=189959&table=article&category=D
3487,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급계약,http://www.medigatenews.com/news/1098982402
3488,2017-12-18,대웅제약삼성항암바이오시밀러삼페넷국내독점공급,http://news1.kr/articles/?3182751
3489,2017-12-18,아파야챙길래종근당대웅제약녹십자外,http://www.g-enews.com/ko-kr/news/article/news_all/201712180954143992e6a49afa8d_1/article.html
3490,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급계약,http://www.kukinews.com/news/article.html?no=510057
3491,2017-12-18,빅데이터MSI오전10시시장심리톱5대웅제약금호타이어현대중공업현대모비스현대상선,http://www.newsis.com/view/?id=NISX20171218_0000179232&cID=10401&pID=10400
3492,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점판매,http://www.newspim.com/news/view/20171218000051
3493,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급,http://www.medical-tribune.co.kr/news/articleView.html?idxno=76212
3494,2017-12-18,fnRASSI대웅제약06962052주신고가198↑,http://www.fnnews.com/news/201712181025469540
3495,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급계약,http://www.asiae.co.kr/news/view.htm?idxno=2017121809574889319
3496,2017-12-18,대웅제약삼성바이오에피스바이오시밀러삼페넷국내독점공급계약,http://www.etnews.com/20171218000086
3497,2017-12-18,대웅제약삼성바이오항암제삼페넷국내판권확보,http://www.asiatoday.co.kr/view.php?key=20171218010008747
3498,2017-12-18,대웅제약항암제삼페넷국내독점계약,http://www.asiatime.co.kr/news/articleView.html?idxno=161373
3499,2017-12-18,대웅제약삼성바이오에피스삼페넷국내판권확보,http://www.newstomato.com/ReadNews.aspx?no=795332
3500,2017-12-18,대웅삼성유방암복제약판다,http://www.edaily.co.kr/news/newspath.asp?newsid=02279606616159832
3501,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급계약,http://www.medicaltimes.com/News/1115823
3502,2017-12-18,대웅제약삼성바이오에피스항암제삼페넷국내독점판권따내,http://www.businesspost.co.kr/BP?command=article_view&num=67154
3503,2017-12-18,삼성바이오유한대웅과손잡아,http://news.mt.co.kr/mtview.php?no=2017121811164334319
3504,2017-12-18,대웅제약항암치료제삼페넷국내독점판매계약체결,http://www.newsprime.co.kr/news/article.html?no=399356
3505,2017-12-18,대웅제약허셉틴시밀러삼성표삼페넷독점계약,http://www.doctorsnews.co.kr/news/articleView.html?idxno=120464
3506,2017-12-18,대웅제약항암치료제시장본격진출삼성바이오에피스와삼페넷국내독점공급계약,http://www.lawissue.co.kr/view.php?ud=201712181147485351d7f4c63cc6_12
3507,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급계약,http://www.kormedi.com/news/news/drug_dist/1225516_2906.html
3508,2017-12-18,대웅제약나보타기대효과수출실적성장전망,http://www.mdtoday.co.kr/mdtoday/index.html?no=305436
3509,2017-12-18,삼성바이오시밀러삼페넷국내선대웅제약이판매,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1050434
3510,2017-12-18,대웅제약삼성바이오에피스항암바이오시밀러삼페넷국내공급계약,http://www.kukinews.com/news/article.html?no=510155
3511,2017-12-18,뉴스투데이E대웅제약삼성바이오에피스와손잡고삼페넷독점공급,http://www.news2day.co.kr/96511
3512,2017-12-18,대웅제약항암제시장공략고삐죈다,http://www.econovill.com/news/articleView.html?idxno=328617
3513,2017-12-18,대웅제약숫자로나타나는나보타효과,http://daily.hankooki.com/lpage/economy/201712/dh20171218134032138110.htm
3514,2017-12-18,대웅제약나보타실적가시화,http://www.newsworks.co.kr/news/articleView.html?idxno=155834
3515,2017-12-18,대웅제약삼성바이오삼페넷독점판매,http://www.sedaily.com/NewsView/1OOWKMF5VR
3516,2017-12-18,대웅제약항암제분야본격진출,http://www.bosa.co.kr/news/articleView.html?idxno=2074735
3517,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급계약,http://www.kpinews.co.kr/news/articleView.html?idxno=61856
3518,2017-12-18,대웅제약항암치료제시장본격진출삼성바이오에피스삼페넷국내독점공급,http://www.techholic.co.kr/news/articleView.html?idxno=172513
3519,2017-12-18,대웅제약삼성바이오에피스삼페넷국내공급계약,http://www.enewstoday.co.kr/news/articleView.html?idxno=1138011
3520,2017-12-18,대웅제약삼성바이오항암제삼페넷국내독점판매,http://www.seoulfn.com/news/articleView.html?idxno=295257
3521,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급계약,http://www.newsway.co.kr/view.php?tp=1&ud=2017121815005621403
3522,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급계약,http://www.metroseoul.co.kr/news/newsview?newscd=2017121800047
3523,2017-12-18,대웅삼페넷국내독점공급맡는다,http://www.monews.co.kr/news/articleView.html?idxno=108988
3524,2017-12-18,대웅제약삼성바이오에피스항암제바이오시밀러삼페넷국내독점판매계약체결,http://www.fnnews.com/news/201712181640143130
3525,2017-12-18,대웅제약삼성바이오항암제삼페넷국내판권확보,https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=101&oid=050&aid=0000046247
3526,2017-12-18,대웅제약바이오시밀러로항암제사업넓힌다,http://www.ajunews.com/view/20171218170445638
3527,2017-12-18,대웅제약삼페넷독점공급계약항암제시장본격진출,http://www.rapportian.com/news/articleView.html?idxno=107974
3528,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점판매계약,http://news.hankyung.com/article/2017121839141
3529,2017-12-18,대웅제약삼성바이오에피스삼페넷국내독점공급계약,http://www.newscj.com/news/articleView.html?idxno=475289
3530,2017-12-19,RD투자액1위셀트리온한미녹십자대웅종근당順,http://www.dailymedi.com/detail.php?number=825538&thread=22r05
3531,2017-12-19,천억시장서만난셀트리온대웅제약허셉틴3파전,http://medipana.com/news/news_viewer.asp?NewsNum=213340&MainKind=A&NewsKind=5&vCount=12&vKind=1
3532,2017-12-19,대웅자회사가치↑매수할시점골든브릿지,http://news.hankyung.com/article/2017121954236
3533,2017-12-19,대웅대웅제약기업가치상승매수적기골든브릿지,http://news.mt.co.kr/mtview.php?no=2017121907513294679
3534,2017-12-19,대웅자회사기업가치상승골든브릿지투자증권,http://www.fnnews.com/news/201712190830237415
3535,2017-12-19,빅데이터MSI시장심리톱5대웅제약LG삼성전기신세계롯데케미칼,http://www.newsis.com/view/?id=NISX20171219_0000180247&cID=10401&pID=10400
3536,2017-12-19,ET투자뉴스대웅자회사기업가치상매수유지골든브릿지투자증권,http://www.etnews.com/20171219000075
3537,2017-12-19,대웅제약알비스D특허소송종결제네릭개발사들제품판매영향없어,http://www.newspim.com/news/view/20171218000120
3538,2017-12-19,빅데이터MSI10시시장심리톱5대웅제약LG삼성전기신세계롯데케미칼,http://www.newsis.com/view/?id=NISX20171219_0000180387&cID=10401&pID=10400
3539,2017-12-19,대웅제약나보타전세계유일한보톡스대항마”,http://www.koreaittimes.com/story/77951/%E2%80%9C%EB%8C%80%EC%9B%85%EC%A0%9C%EC%95%BD-%EB%82%98%EB%B3%B4%ED%83%80-%EC%A0%84%EC%84%B8%EA%B3%84-%EC%9C%A0%EC%9D%BC%ED%95%9C-%EB%B3%B4%ED%86%A1%EC%8A%A4-%EB%8C%80%ED%95%AD%EB%A7%88%E2%80%9D
3540,2017-12-19,대웅제약삼페넷판권독점계약항암치료제시장공략나서,http://www.wolyo.co.kr/news/articleView.html?idxno=50534
3541,2017-12-19,대웅제약삼성바이오에피스삼페넷독점판매,http://www.incheonilbo.com/?mod=news&act=articleView&idxno=791970
3542,2017-12-20,대웅제약셀트리온1000억규모허셉틴시장도전,http://www.mdtoday.co.kr/mdtoday/index.html?no=305664
3543,2017-12-20,fnRASSI대웅제약06962052주신고가1424↑,http://www.fnnews.com/news/201712200907467688
3544,2017-12-20,fnRASSI대웅00309052주신고가971↑,http://www.fnnews.com/news/201712200907533371
3545,2017-12-20,대웅대웅제약나보타기대감에이틀째급등,http://www.newsprime.co.kr/news/article.html?no=399696
3546,2017-12-20,특징주한올바이오파마上대웅제약급등5400억기술수출효과,http://www.asiae.co.kr/news/view.htm?idxno=2017122009253033742
3547,2017-12-20,특징주대웅제약계열사한올바이오파마해외기술수출로강세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1576023
3548,2017-12-21,박터지는바이오시밀러내년도대웅LG화학녹십자진출,http://www.mdtoday.co.kr/mdtoday/index.html?no=305822
3549,2017-12-21,케이프투자증권대웅제약한올바이오파마기술수출로지분법이익증가”,http://www.newsway.co.kr/view.php?tp=1&ud=2017122108173936648
3550,2017-12-21,대웅제약이지듀프리미엄홈케어프로그램DWEGF더마니들프로그램3000출시,http://sports.chosun.com/news/ntype.htm?id=201712210100165310011595&servicedate=20171221
3551,2017-12-21,대웅제약5000억규모자가면역질환신약기술수출,http://www.sisaweek.com/news/articleView.html?idxno=100462
3552,2017-12-22,대웅제약나보타제2공장생산제품첫출하선진국규격연료공정적용,http://www.g-enews.com/ko-kr/news/article/news_all/201712221338367281e6a49afa8d_1/article.html
3553,2017-12-22,대웅제약나보타제2공장첫제품정상출하성상포장변경,http://news.mk.co.kr/newsRead.php?year=2017&no=846830
3554,2017-12-22,대웅제약나보타신공장패키지∙성상변경제품첫출하,http://medipana.com/news/news_viewer.asp?NewsNum=213593&MainKind=A&NewsKind=5&vCount=12&vKind=1
3555,2017-12-22,대웅제약나보타신공장서패키지8729성상변경제품첫출하,http://news.mt.co.kr/mtview.php?no=2017122213553455051
3556,2017-12-22,대웅제약나보타제2공장생산제품첫출하,http://www.fnnews.com/news/201712221400323035
3557,2017-12-22,대웅제약나보타신공장패키지성상변경제품첫출하,http://www.viva100.com/main/view.php?key=20171222010008112
3558,2017-12-22,대웅제약나보타신공장서성상∙패키지변경제품첫출하,http://biz.chosun.com/site/data/html_dir/2017/12/22/2017122201567.html
3559,2017-12-22,대웅제약나보타제2공장첫제품정상출하,http://www.sedaily.com/NewsView/1OOYDLKNK2
3560,2017-12-22,대웅제약나보타제2공장서패키지성상변경제품첫출하,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201712220203
3561,2017-12-22,대웅제약나보타제2공장생산제품첫출하,http://www.newsprime.co.kr/news/article.html?no=400125
3562,2017-12-22,대웅제약나보타신공장패키지∙성상변경제품첫출하,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=213508
3563,2017-12-22,대웅제약나보타신공장패키지∙성상변경제품첫출하”,http://www.kpanews.co.kr/article/show.asp?idx=190142&table=article&category=D
3564,2017-12-22,대웅제약나보타패키지성상변경제품첫출하,http://www.dt.co.kr/contents.html?article_no=2017122202109976029007&ref=naver
3565,2017-12-22,대웅제약나보타2공장제품첫출하제품성상포장변경,http://www.econovill.com/news/articleView.html?idxno=328956
3566,2017-12-22,대웅제약新나보타화성제2공장서첫출하,http://www.newspim.com/news/view/20171222000235
3567,2017-12-22,1시의증시데이트2018년무술년새해황금株는룽투코리아게임빌엠젠플러스대웅,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017122215310112625
3568,2017-12-22,대웅제약나보타신공장패키지성상변경제품첫출하,http://www.newsis.com/view/?id=NISX20171222_0000184626&cID=13001&pID=13000
3569,2017-12-22,대웅제약나보타신공장패키지성상변경제품첫출하,http://www.newscj.com/news/articleView.html?idxno=476651
3570,2017-12-22,대웅제약나보타제2공장첫출하생산고삐바짝,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201712221637002&code=900303
3571,2017-12-22,대웅제약나보타패키지성상변경제품첫출하,http://www.mdtoday.co.kr/mdtoday/index.html?no=306088
3572,2017-12-22,대웅제약나보타제2공장첫출하패키지∙성상변경제품선보여,http://www.techholic.co.kr/news/articleView.html?idxno=172685
3573,2017-12-22,뉴스투데이E대웅제약나보타제2공장첫출하패키지∙성상포장변경,http://www.news2day.co.kr/96785
3574,2017-12-22,대웅제약나보타제2공장서생산된제품첫출하,http://www.rapportian.com/news/articleView.html?idxno=108089
3575,2017-12-22,대웅제약나보타제2공장첫제품정상출하성상포장변경,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017122217015464903
3576,2017-12-22,기자수첩대웅제약반항보다본업에집중할때,http://www.seoulfn.com/news/articleView.html?idxno=295665
3577,2017-12-22,대웅제약나보타제2공장첫제품출하,http://www.seoulfn.com/news/articleView.html?idxno=295668
3578,2017-12-22,대웅제약나보타제2공장생산제품첫출하,http://www.ebn.co.kr/news/view/922980
3579,2017-12-22,대웅제약나보타신공장패키지∙성상변경제품첫출하”,http://www.lawissue.co.kr/view.php?ud=201712222226409209d7f4c63cc6_12
3580,2017-12-23,대웅한올바이오MA3년시너지효과도가시화,http://www.dailypharm.com/News/234935
3581,2017-12-23,대웅제약엑스자이드시장도전생동성시험승인,http://medipana.com/news/news_viewer.asp?NewsNum=213614&MainKind=A&NewsKind=5&vCount=12&vKind=1
3582,2017-12-23,대웅제약나보타신공장패키지성상변경제품첫출하,http://www.insight.co.kr/news/131861
3583,2017-12-24,제약산업소식대웅제약나보타신공장패키지성상변경제품첫출하外”,http://www.kukinews.com/news/article.html?no=511851
3584,2017-12-24,대웅제약나보타제2공장서제품첫출하,http://www.enewstoday.co.kr/news/articleView.html?idxno=1139628
3585,2017-12-24,대웅제약나보타2공장서첫제품출하,http://www.edaily.co.kr/news/newspath.asp?newsid=01731846616161800
3586,2017-12-25,대웅제2공장나보타첫출하성상포장변경,http://www.dailymedi.com/detail.php?number=825725&thread=22r05
3587,2017-12-25,대웅항체신약5000억원대美기술수출쾌거,http://www.dailymedi.com/detail.php?number=825730&thread=22r05
3588,2017-12-26,대웅제약나보타신공장패키지성상변경제품첫출하,http://www.bosa.co.kr/news/articleView.html?idxno=2075168
3589,2017-12-26,대웅제약해외현지투자확대,http://www.newstomato.com/ReadNews.aspx?no=796842
3590,2017-12-26,대웅철중독증시장도전데페라시록스생동성돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=306333
3591,2017-12-26,한올제넥신기술수출계약MA반사이익누리는대웅제약한독,http://biz.newdaily.co.kr/news/article.html?no=10149390
3592,2017-12-27,더벨이종욱대웅제약부회장CEO자리서물러나나,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201712260100040510002453
3593,2017-12-27,한올바이오파마대웅제약품에안긴지2년만에기술수출선물,http://www.mdtoday.co.kr/mdtoday/index.html?no=306348
3594,2017-12-27,유대웅제약전일대비888상승일일회전율은086기록,http://www.sedaily.com/NewsView/1OP0NLZJUE
3595,2017-12-27,대웅제약나보타신공장본격가동,http://www.kormedi.com/news/news/drug_dist/1225625_2906.html
3596,2017-12-27,대웅제약선진국규격원료적용나보타제2공장서제품첫출하,http://www.munhwa.com/news/view.html?no=2017122701032203000001
3597,2017-12-27,공략9to102018년종목선발시점관심주대웅제약,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2017122717125341101
3598,2017-12-28,제약톡톡대웅삼성바이오에피스삼페넷판매로슈셀트리온과3파전예상,http://news.heraldcorp.com/view.php?ud=20171228000060
3599,2017-12-28,특징주대웅제약삼성바이오에피스삼페넷판매에상승,http://news.mt.co.kr/mtview.php?no=2017122809074924850
3600,2017-12-28,대웅제약삼성바이오에피스삼파넷유통파트너소식에상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=306552
3601,2017-12-28,대웅제약이지듀신제품홈쇼핑론칭방송서완판,http://medipana.com/news/news_viewer.asp?NewsNum=213785&MainKind=A&NewsKind=5&vCount=12&vKind=1
3602,2017-12-28,대웅제약이지듀출시하루만에완판기록,http://www.bosa.co.kr/news/articleView.html?idxno=2075374
3603,2017-12-28,대웅제약이지듀프리미엄홈케어라인신제품첫론칭방송에서완판,http://www.sedaily.com/NewsView/1OP143IQFT
3604,2017-12-28,대웅제약이지듀코스메티컬신제품론칭과동시완판기록,http://www.nbnnews.co.kr/news/view.php?idx=121597
3605,2017-12-28,대웅제약이지듀신제품DWEGF더마니들프로그램3000완판기념이벤트진행,http://www.cctvnews.co.kr/news/articleView.html?idxno=76484
3606,2017-12-28,아파야챙길래대웅제약동국제약유유제약,http://www.g-enews.com/ko-kr/news/article/news_all/201712281114209086e6a49afa8d_1/article.html
3607,2017-12-28,대웅제약이지듀신제품론칭당일완판,http://www.mdtoday.co.kr/mdtoday/index.html?no=306582
3608,2017-12-29,더벨대웅제약창립첫연매출1조돌파눈앞,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201712280100044990002731
3609,2017-12-29,제약10대뉴스⑧소송또소송대웅제약은전쟁중,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1050816
3610,2017-12-29,제약사바이오텍투자성적표대웅제약한올로올해1700억잭팟,http://news.hankyung.com/article/201712298390f
